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Abstract 
 
The detoxification mechanisms of living organisms are crucial for their normal growth 
and survival. Aquatic organisms are in face of a particularly difficult task since their 
habitats have long been the last receptacle for several different types of pollutant 
compounds, mainly resultant from anthropogenic sources. One of the best studied 
mechanisms of detoxification is the biotransformation of the xenobiotic compounds into 
more easily excreted forms, in a two phase (I and II) process of enzymatic reactions. In 
recent years, the cellular efflux of pollutants and/or their metabolites by some proteins 
of the ATP-Binding Cassette Superfamily (ABC) has also been considered as an 
important defence mechanism. ABC proteins were first recognized for their role in 
multidrug resistance (MDR) in chemotherapeutic treatments, which is a major 
impediment for the successful treatment of many forms of malignant tumors in humans. 
These proteins, found to be highly conserved throughout vertebrate species, were later 
related to cellular detoxification and accounted as responsible for protecting aquatic 
organisms from xenobiotic insults in the so-called multixenobiotic resistance 
mechanism (MXR). Moreover, recent studies in different mammalian models have 
provided some evidence that, ABC efflux transporters and biotransformation enzymes, 
act in coordination, resulting in an effective global mechanism of cellular detoxification. 
Hence, the full knowledge of the functionality of these detoxification processes is 
needed, both for environmental as for human health. 
Nevertheless, despite the importance of these mechanisms, and although ABC efflux 
transporters have been identified in several fish species, information regarding their 
mode of action is still scarce, namely on the integration of these transporters in the 
detoxification pathway, and on the cooperation with the biotransformation enzymes. 
This study was delineated to fill these gaps, by assessing the responses of the three 
phases of cellular detoxification after in vivo exposures of a fresh water species (Nile 
tilapia, Oreochromis niloticus) to a highly toxic polycyclic aromatic hydrocarbon (PAH), 
Benzo(a)pyrene (BaP).  
The biotransformation of BaP by phase I and phase II enzymes was first investigated in 
Nile tilapia in order to determine the effectiveness of their biotransformation system. 
Based on the obtained results, we concluded that the pathway of detoxification was 
dependent on the route of exposure to the contaminant. Different barrier tissues were 
primarily involved in BaP metabolism whether the exposure occurred through the water 
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(liver, gills and intestine) or through the ingestion of contaminated food (intestine). 
These findings are of sovereign value for environmental risk assessment studies since 
they imply that, besides liver, the study of extra-hepatic tissues, as gills and intestine, 
may provide valuable information on the major sources of the contamination in the 
field. The phase I enzyme cytochrome P4501A (CYP1A) was demonstrated to display 
a paramount role on the metabolism of BaP in the different barrier tissues (liver, gills 
and intestine), at gene, protein and activity levels. Moreover, phase II enzymes 
(Glutathione-S-Transferases, GSTs and UDP-glucuronyl transferases, UGTs) were 
shown to be capable of neutralizing the toxic phase I metabolites, including 3-OH-BaP, 
since since the majority of BaP metabolites found in bile and plasma of Nile tilapia were 
phase II conjugates. Therefore, our findings have shown that Nile tilapia has a well-
developed biotransformation system, capable of providing an effective detoxification 
pathway to BaP, despite the main route of exposure. 
In order to assess the cooperation between ABC transporter genes and drug 
metabolizing enzymes, ecotoxicologically relevant ABC efflux transporter genes 
(ABCB1b, ABCB11, ABCC1, ABCC2 and ABCG2) were isolated, and their modulation, 
along with phase I and II biotransformation enzymes, to BaP was evaluated after 
dietary and waterborne exposure routes in Nile tilapia. Although ABCB1b was found 
not to be altered by BaP exposure (indicating that BaP should not be a substrate for 
Pgp), both at gene at protein level, ABCC2 and ABCG2a could be related to the efflux 
of phase II metabolites, and they probably display major roles in gills and proximal 
intestine of fish. Thus, our results clearly reflected the cooperation between efflux 
transporters and biotransformation enzymes in BaP detoxification in Nile tilapia. 
Evidence of the crucial role of these transporters and biotransformation enzymes in the 
protection of organisms were further provided, as they were found to be expressed 
since the onset of Nile tilapia embryos development.  ABCB1b, ABCC1, CYP1A and 
GSTα genes were maternally transmitted to Nile tilapia, which suggests that they are 
essential for the embryos survival. ABCB11, ABCC2 and ABCG2 gene transcription 
was initiated later in the development, but preceding the highly sensitive period of 
hatching, indicating that the higher defence levels that may be necessary at this stage 
can be assured by these particular proteins.  These findings are, therefore, important to 
support the highly valuable role of ABC transporters and biotransformation enzymes in 
the protection against xenobiotics in fish and reflect that these groups of proteins 
cooperate to provide aquatic organisms with an effective mechanism of cellular 
detoxification. 
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Resumo 
Os mecanismos de destoxificação de todos os seres vivos são cruciais para o seu 
normal desenvolvimento e sobrevivência. Os organismos aquáticos estão perante uma 
tarefa particularmente difícil uma vez que, ao longo dos anos, o seu habitat tem sido o 
recipiente final para um vasto conjunto de poluentes, principalmente resultantes de 
fontes antropogénicas. Um dos mecanismos de destoxificação mais estudado é a 
biotransformação de compostos xenobióticos, em metabolitos mais facilmente 
excretáveis, através de reacções enzimáticas em duas fases (fase I e fase II). 
Recentemente, o efluxo cellular de poluentes e/ou dos seus metabolitos, por acção de 
proteínas pertencentes à superfamília ATP-Binding Cassette (ABC), tem sido também 
considerado um importante mecanismo de defesa. As proteínas ABC foram 
inicialmente reconhecidas pelo seu papel na resistência a multi-drogas (MDR) durante 
tratatamentos quimioterapêuticos, factor que tem sido responsável pela diminuição da 
taxa de sucesso no que respeita ao tratamento de várias formas de tumores malignos 
em humanos. Estas proteínas, que são muito conservadas ao longo das várias 
espécies de vertebrados, foram, mais tarde, relacionadas com a destoxificação celular, 
e indicadas como responsáveis pela proteção de organismos aquáticos contra danos 
causados por xenobióticos, num mecanismo de resistência multi-xenobiótica (MXR). 
Adicionalmente, estudos recentes em diferentes modelos animais de mamíferos têm 
fornecido evidências de que os transportadores ABC e as enzimas de 
biotransformação actuam em cooperação, formando um mecanismo efectivo de 
destoxificação celular. Desta forma, o conhecimento da funcionalidade destes 
mecanismos de destoxificação torna-se necessário, tanto para a saúde ambiental 
como para a saúde humana. 
No entanto, apesar da importância destes mecanismos, e embora os transportadores 
de efluxo ABC tenham vindo a ser identificados em diferentes espécies de peixes, há 
ainda pouca informação sobre o seu mecanismo de acção, nomeadamente na 
integração destes transportadores nas vias de destoxificação, e na cooperação com as 
enzimas de biotransformaçao. Este estudo foi delineado para preencher essas 
lacunas, através da avaliação das respostas das três fases de destoxificação celular 
após exposições in vivo, de uma espécie de água doce (Tilápia do Nilo, Oreochromis 
niloticus), a um hidrocarboneto aromático policíclico (PAH) com propriedades 
altamente tóxicas, o Benzo(a)pireno (BaP) 
A biotransformação do BaP pelas enzimas de fase I e fase II foi investigada na tilápia 
do Nilo por forma a determinar a eficácia mecanismo de biotransformação desta 
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espécie. Com base nos resultados obtidos, concluímos que a via de destoxificação 
está dependente da via de exposição ao contaminante. Diferentes tecidos barreira 
estiveram primeiramente envolvidos no metabolismo do BaP consoante a exposição 
ocorreu através da água (fígado, brânquia e intestino), ou através da ingestão de 
alimento contaminado (intestino). Estes resultados são importantes em estudos de 
avaliação de risco ambiental uma vez que implicam que, para além do fígado, o estudo 
de tecidos extra-hepáticos, tais como a brânquia e o intestino, pode fornecer 
informação de valor sobre as fontes maioritárias de contaminação ambiental. A enzima 
de fase I, Citocromo P4501A (CYP1A), demonstrou desempenhar um importante papel 
no metabolismo do BaP nos diferentes tecidos barreira (fígado, brânquia e intestino), 
ao nível do gene, da proteína e da actividade catalítica. Adicionalmente, as enzimas de 
fase II (Glutationa-STransferases, GSTs e UDP-Glucoronil transferases, UGTs) 
mostraram ser capazes de neutralizar os metabolitos tóxicos de fase I, incluindo o 3-
OH-BaP, visto que a maioria dos metabolitos de BaP encontrados na bílis e no plasma 
eram conjugados da fase II. Assim, foi possível demonstrar que a tilápia do Nilo possui 
um sistema de biotransformação bem desenvolvido, capaz de fornecer uma via de 
destoxificação efectiva para o BaP, independentemente da via de exposição. 
De forma a avaliar a cooperação entre os transportadores ABC e as enzimas de 
biotransformação, os genes para transportadores ABC com relevância ecotoxicológica 
(ABCB1b, ABCB11, ABCC1, ABCC2 and ABCG2a) foram isolados e a sua modulação, 
juntamente com a das enzimas de biotransformação de fases I e II, foi avaliada após 
exposição ao BaP pela água e pela dieta na tilápia do Nilo. Apesar de a expressão 
génica do ABCB1b não se ter alterado após exposição ao BaP, tanto a nível do gene 
como da proteína (indicando que, provavelmente, o BaP não é um substrato para a 
Pgp), o aumento da expressão génica de ABCC2 e ABCG2a pode ser relacionado 
com o efluxo de metabolitos de fase II, indicando que, provavelmente, estes 
transportadores desempenham importantes papéis na brânquia e intestino dos peixes. 
Estes resultados reflectem claramente a cooperação entre os transportadores de 
efluxo e as enzimas de biotransformação na destoxificação do BaP na tilápia do Nilo. 
Indicações adicionais sobre o papel crucial destes transportadores e das enzimas de 
biotransformação na protecção dos organismos foram fornecidas, já que os genes que 
codificam para estas proteínas são expressos desde o início do desenvolvimento 
embrionário da tilápia do Nilo. Os genes de ABCB1b, ABCC1 e CYP1A e GSTα são 
transmitidos maternalmente, sugerindo que serão essenciais para a sobrevivência dos 
embriões. A transcrição génica de ABCB11, ABCC2 e ABCG2 teve início mais 
tardiamente, mas precedendo um período muito sensível do desenvolvimento, a 
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eclosão, o que indica que, nesta fase, serão necessários níveis mais elevados de 
protecção, que serão assegurados por estas proteínas em particular. Assim, estes 
resultados são importantes para suportar o importante papel dos transportadores ABC 
e das enzimas de biotransformação na protecção dos peixes contra xenobióticos e 
reflectem que estes grupos de proteínas actuam em cooperação para prover os 
organismos com um mecanismo efectivo de destoxificação celular. 
 
 
x 
 
 xi 
 
Index 
1. General Introduction ............................................................. 3 
1.1. The superfamily of ABC efflux transporters ..................................................... 4 
1.2. Multidrug resistance (MDR) associated ABC transporters .............................. 7 
1.2.1. Subfamily ABCB ...................................................................................... 7 
1.2.2. Subfamily ABCC (MRPs – Multiresistance associated proteins) ............ 10 
1.2.3. Subfamily ABCG – ABCG2, BCRP, MXR or ABCP................................ 12 
1.3. From MDR to MXR - ABC efflux transporters in aquatic organisms .............. 13 
1.4. Biotransformation enzymes .......................................................................... 19 
1.4.1. Phase I enzymes ................................................................................... 19 
1.4.2. Phase II enzymes .................................................................................. 22 
1.5. From phase 0 to phase III – a complete pathway for cellular 
detoxification ........................................................................................................... 24 
1.6. PAHs (Polyciclic aromatic hydrocarbons) ..................................................... 27 
1.7. Model species – Oreochromis niloticus (Nile tilapia) ..................................... 29 
1.8. Objectives ..................................................................................................... 31 
1.9. References ................................................................................................... 32 
2. Comparision of the waterborne and dietary routes of 
exposure on the effects of Benzo(a)pyrene on 
biotransformation pathways in Nile tilapia (Oreochromis 
niloticus) ...................................................................................... 53 
2.1. Abstract ........................................................................................................ 53 
2.2. Introduction ................................................................................................... 54 
2.3. Materials and methods ................................................................................. 55 
2.3.1. Chemicals .............................................................................................. 55 
2.3.2. Animals .................................................................................................. 56 
2.3.3. Stock solutions of BaP and preparation of contaminated food ............... 56 
2.3.4. Xenobiotic exposures ............................................................................ 57 
xii 
 
2.3.5. Sampling ............................................................................................... 57 
2.3.7. Biochemical analysis ............................................................................. 58 
2.3.8. BaP metabolites in fish bile .................................................................... 59 
2.3.9. Statistical analysis ................................................................................. 60 
2.3.10. Ethics statement ................................................................................ 60 
2.4. Results ......................................................................................................... 60 
2.4.1. Water exposure ..................................................................................... 62 
2.4.2. Diet exposure ........................................................................................ 65 
2.5. Discussion .................................................................................................... 70 
2.6. Acknowledgements ....................................................................................... 73 
2.7. References ................................................................................................... 73 
3. Evaluation of 3-hydroxy-benzo[a]pyrene levels in Nile 
tilapia (Oreochromis niloticus) after waterborne exposure 
to Benzo[a]pyrene ....................................................................... 85 
3.1. Abstract ........................................................................................................ 85 
3.2. Introduction ................................................................................................... 86 
3.3. Material and methods ................................................................................... 87 
3.3.1. Chemicals and materials ....................................................................... 87 
3.3.2. Animals and exposure experiment ......................................................... 87 
3.3.3. Sampling ............................................................................................... 88 
3.3.4. Biochemical analysis ............................................................................. 88 
3.3.5. Determination of BaP ............................................................................. 89 
3.3.6. Determination of free and conjugates of 3-OH-BaP ............................... 89 
3.3.7. Methods validation ................................................................................. 91 
3.3.8. Chromatographic conditions .................................................................. 93 
3.3.9. Statistical analysis ................................................................................. 93 
3.3.10. Ethics statement ................................................................................ 93 
3.4. Results ......................................................................................................... 94 
3.4.1. BaP concentration in water .................................................................... 94 
 xiii 
 
3.4.2. Bile and plasma analysis ....................................................................... 95 
3.4.3. UGT activities and correlations between biotransformation enzymes 
and 3-OH-BaP levels ........................................................................................... 97 
3.5. Discussion .................................................................................................... 99 
3.6. Conclusion .................................................................................................. 101 
3.7. Acknowledgements ..................................................................................... 101 
3.8. References ................................................................................................. 101 
4. Gene expression analysis of ABC efflux transporters, 
CYP1A and GSTα in Nile tilapia after exposure to 
Benzo(a)pyrene.......................................................................... 109 
4.1. Abstract ...................................................................................................... 109 
4.2. Introduction ................................................................................................. 110 
4.3. Materials and methods ............................................................................... 112 
4.3.1. Animals ................................................................................................ 112 
4.3.2. Stock solutions of BaP and preparation of contaminated food ............. 112 
4.3.3. Xenobiotic exposures .......................................................................... 113 
4.3.4. BaP determination in water and food samples ..................................... 113 
4.3.5. Sampling ............................................................................................. 114 
4.3.6. RNA isolation, RT-PCR, cloning and sequence analysis ..................... 114 
4.3.7. Quantitative real-time PCR (qRT-PCR) ................................................ 117 
4.3.8. Statistical analysis ............................................................................... 118 
4.3.9. Ethics statement .................................................................................. 119 
4.4. Results ....................................................................................................... 119 
4.4.1. Identification of ABC transporters related genes .................................. 119 
4.4.2. Quantification of ABCB1b, ABCB11, ABCC1, ABCC2, ABCG2, 
CYP1A and GSTα mRNA expression in liver, gill and proximal intestine of 
Nile tilapia, after BaP exposures ........................................................................ 126 
4.5. Discussion .................................................................................................. 132 
4.5.1. Identification and tissue distribution of ABC transporters, CYP1A 
and GSTα .......................................................................................................... 132 
xiv 
 
4.5.2. ABC transporters CYP1A and GSTα transcriptional responses upon 
BaP exposure .................................................................................................... 134 
4.6. Conclusion .................................................................................................. 137 
4.7. Acknowledgements ..................................................................................... 137 
4.8. References ................................................................................................. 138 
5. Tissue distribution and response patterns of Pgp and 
CYP1A proteins in Nile tilapia (Oreochromis niloticus) after 
waterborne exposure to Benzo(a)pyrene (BaP) ...................... 149 
5.1. Abstract ...................................................................................................... 149 
5.2. Introduction ................................................................................................. 150 
5.3. Materials and methods ............................................................................... 152 
5.3.1. Animals ................................................................................................ 152 
5.3.2. Water exposure to BaP ........................................................................ 152 
5.3.3. Sampling ............................................................................................. 153 
5.3.4. Membrane vesicle and microsomes preparation .................................. 153 
5.3.5. Antibodies ............................................................................................ 153 
5.3.6. SDS-Page and Western blotting .......................................................... 154 
5.3.7. Immunofluorescence microscopy ......................................................... 155 
5.3.8. Statistical analysis ............................................................................... 156 
5.3.9. Ethics statement .................................................................................. 156 
5.4. Results ....................................................................................................... 156 
5.4.1. Western blot detection of P-glycoprotein .............................................. 156 
5.4.2. Cellular localization of P-glycoprotein .................................................. 157 
5.4.3. Western blot detection of CYP1A ......................................................... 162 
5.4.4. Cellular localization of CYP1A ............................................................. 165 
5.5. Discussion .................................................................................................. 171 
5.6. Conclusions ................................................................................................ 175 
5.7. Acknowledgements ..................................................................................... 175 
5.8. References ................................................................................................. 175 
 xv 
 
6. ABC transporters, CYP1A and GSTα gene 
transcription patterns in developing stages of the Nile 
tilapia (Oreochromis niloticus) ................................................. 185 
6.1. Abstract ...................................................................................................... 185 
6.2. Introduction ................................................................................................. 186 
6.3. Materials and methods ............................................................................... 188 
6.3.1. Biological material ............................................................................... 188 
6.3.2. Embryos collection and rearing conditions ........................................... 188 
6.3.3. RNA isolation and cDNA synthesis ...................................................... 189 
6.3.4. Quantitative real-time PCR (qRT-PCR) ................................................ 189 
6.3.5. Statistical analysis ............................................................................... 190 
6.3.6. Ethics statement .................................................................................. 190 
6.4. Results ....................................................................................................... 192 
6.5. Discussion .................................................................................................. 198 
6.6. Acknowledgments....................................................................................... 201 
6.7. References ................................................................................................. 202 
7. Final remarks ..................................................................... 211 
7.1. General discussion ..................................................................................... 211 
7.2. Conclusions ................................................................................................ 219 
7.3. Future perspectives .................................................................................... 220 
7.4. References ................................................................................................. 222 
Appendix .................................................................................... 227 
 
 xvi 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xvii 
 
Acronyms list 
 
3MC  3-methylcholantrene 
4MU  4-methylumbelliferone 
7-ER  7-ethoxyresorufin 
aa  aminoacid 
ABC  Adenosine tris-phosphate Binding Cassette 
ABCP  Placenta specific ABC protein 
afu  arbitrary fluorescence units 
AhR  Aryl-hydrocarbon Receptor 
ANOVA Analysis of variance 
Arnt  Aryl-hydrocarbon Receptor translocator 
ATP  Adenosine Tris-Phosphate 
ATSDR Agency for Toxic Substances and Disease Registry 
BaP   Benzo(a)pyrene 
BCRP  Breast Cancer Resistance Associated Protein 
BSA  Bovine Serum Albumine 
BSEP  Bile Salt Export Pump 
BWSF  Biodegradated water-soluble fraction 
CAR  Constitutive Androstane Receptor 
cDNA  Complementar Deoxyribonucleic Acid 
CDNB  1-chloro-2,4-dinitrobenzene 
CF  Condition Factor 
CIIMAR Centro Interdiciplinar de Investigação Marinha e Ambiental 
CYP  Cytochrome P-450 
CYP1A Cytochrome P450 1A 
DABCO 1,4-diazabicyclo[2.2.2]octane 
DAPI  4´6-diamino-2-phenylindole 
DGV  Direccção Geral de Veterinária 
 xviii 
 
DIC  Differential Interference Contrast 
DNA  Deoxyribonucleic acid 
DNTPs Deoxyribonucleotide 
dpf  days post-fertilization 
EDTA  Ethylenediamine tetraacetic acid 
EF1  Elongation factor 1 
EPA  United States Environmental Protection Agency 
ER  Endoplasmatic reticulum 
EROD  Ethoxyresorufin-O-deethylase 
EST  Expressed Sequenced Tags 
FACs  Fluorescent Aromatic Compounds 
FAO  Food and Agriculture Organization 
FCT  Fundação para a Ciência e Tecnologia 
FD  Fluorescence detector 
FF  Fixed wavelength fluorescence 
FXR  Farnesoid X Receptor 
GA  Glucuronic acid 
GADPH Glyceraldehyde 3-phosphate dehydrogenase 
GSH  Glutathione 
GSTs  Glutathione- S-Transferases 
GSTα  Glutathione-S-Transferase α 
hpf  hours post-fertilization 
HPLC  High-performance liquid chromatography 
HRP  Horseradish Peroxidase 
HSI  Hepatic Somatic Index 
HSP90 Heat Shock Protein 90 
IHC  Immunohistochemistry 
IPTG  Isopropyl β-D-1-thiogalactopyranoside 
LOD  Limit of detection 
 xix 
 
LOQ  Limiti of quantification 
LXR  Liver X Receptor 
mAb   Monoclonal Antibody 
MDR  Multidrug Resistance 
MFO  Mixed-Function Oxidase 
miRNAs Micro ribonucleic acids 
MO  Monooxygenase enzymes 
mRNA  Messenger Ribonucleic Acid 
MRPs  Multiresistance Associated Proteins 
MSDs  Membrane Spawning Domains 
MW  Molecular Weight 
MXR  Multixenobiotic Resistance 
MZT  Maternal to zygote transition 
NADPH Nicotinamide Adenine Dinucleotide Phosphate-Oxidase 
NBDs  Nucleotide Binding Domains 
NCBI  National Centre for Biotechnology Information 
PAHs  Polycyclic Aromatic Hidrocarbons 
PBS  Phosphate Buffer Saline 
PC  Pyruvate Carboxylase 
PCBs  Polychlorinated Biphenyls 
PCR  Polymerase Chain Reaction 
PFA  Paraformaldehyde 
PFIC  Progressive Familiar Intrahepatic Cholestasis 
Pgp  Permeability glycoprotein 
PMSF  Phenylmethanesulfonylfluoride 
POPs  Persistent Organic Pollutants 
PPAR  Proliferator activated Receptor 
PPCPs Pharmaceuticals and Personal Care Products 
PTFE  Polytetrafluoroethylene 
 xx 
 
PXR  Pregnane X Receptor 
qRT-PCR Quantitative reverse transcription polymerase chain reaction 
RNA  Ribonucleic acid 
rRNA  Ribossomal ribonucleic acid 
RXR   Retinoid X Receptor 
SDS  Sodium Dodecyl Sulphate 
SDS-Page Sodium Dodecyl Sulphate – Polyacrilamide Gel 
Spgp  Sister of permeability glycoprotein 
TAE  Tris-acetate-ethylenediamine tetraacetic acid 
TBS  Tris Buffer Saline 
TM  Transmembrane  
TMH  Transmembrane Helice 
UASEs Ultrasound AssistedSolvent Extractions 
UGTs  Uridine diphosphate glucuronyl transferases 
UTAD  Universidade de Trás-os-Montes e Alto Douro 
UV  Ultraviolet 
WB  Western Blot 
XRE  Xenobiotic Responsive Elements 
X-Gal  5-bromo-4-chloro-indolyl-β-D-galactopyranoside 
 
 
 
 
 
 
 
 
 xxi 
 
IIustrations índex 
 
Figure 1.1 – Schematic representation of a typical ABC protein and characteristic 
amino acid sequences found in Nucleotide Binding Domains (NBDs) ........................... 6 
Figure 1.2 – Predicted structures of MDR associated members of ABC 
transporters .................................................................................................................. 9 
Figure 1.3 - Schematic representation showing probable localization of ABC 
transporters in liver and intestine of fish, as determined in mammals. ......................... 17 
Figure 1.4 - Schematic representation of the mechanisms involved in 
biotransformation of xenobiotic compounds in cells. ................................................... 21 
Figure 1.5 - Schematic representation  of drugs/chemicals/xenobiotics induced 
stress response, leading to the activation of specific receptor-mediated gene 
expression of phase I enzymes, phase II enzymes, other stress enzymes and 
phase 0 and phase III transporters, which result in the enhancement of xenobiotic 
detoxification. .............................................................................................................. 25 
Figure 1.6 - Schematic representation of the possible cooperation of ABC efflux 
transporters (phase 0 and phase III) and biotransformation enzymes (phase I and 
phase II) in cellular detoxification (adapted from Bard et al., 
2000).......................................................................................................................... 
Figure 1.7 - Biotransformation pathways of BaP. Source: IARC, 1983 ....................... 29 
Figure 1.8 - Nile tilapia, Oreochromis niloticus, the model specie used in the 
present study. ............................................................................................................. 30 
Figure 2.1 - EROD activities in liver (a), gill (b) and intestine (c) of Nile Tilapia after 
waterborne exposure to BaP (Solvent, 10, 25, 50 and 100 µg/L). ............................... 61 
Figure 2.2 - GST activities in liver (a), gill (b) and intestine (c) of Nile Tilapia after 
waterborne exposure to BaP (Solvent, 10, 25, 50 and 100 µg/L). ............................... 63 
Figure 2.3 – BaP type metabolites in bile after waterborne exposure to BaP (a), 
first dietary exposure to BaP (b) and second dietary exposure to BaP (c). .................. 64 
Figure 2.4 – EROD activities in liver (a), gill (b) and intestine (c) of Nile tilapia after 
the first dietary exposure to BaP (Solvent, 1 and 10 µg of BaP/g of food). .................. 66 
Figure 2.5 – GST activities in liver (a), gill (b) and intestine (c) of Nile tilapia after 
the first dietary exposure to BaP (Solvent, 1 and 10 µg of BaP/g of food). .................. 67 
Figure 2.6 – EROD activities in liver (a), gill (b) and intestine (c) of Nile tilapia after 
the second dietary exposure to BaP (Solvent, 100 and 200 µg of BaP/g of food)........ 68 
Figure 2.7 – GST activities in liver (a), gill (b) and intestine (c) of Nile tilapia after 
the second dietary exposure to BaP (Solvent, 100 and 200 µg of BaP/g of food)........ 69 
26 
 xxii 
 
Figure 3.1 - BaP (in percentage) in water at 0, 8 and 24 h after the addition of 10 
and 100 µg of BaP L-1 of water.................................................................................... 94 
Figure 3.2 -  Free (a), total (b) and glucuronide (c) 3-OH-BaP levels in bile after 
waterborne exposure to BaP (10 and 100 µg L-1) for 7 and 14 d. ................................ 96 
Figure 3.3 - Total 3-OH-BaP levels in plasma after waterborne exposure to BaP 
(10 and 100 µg L-1) for 7 and 14 d. .............................................................................. 97 
Figure 4.1 - Multiple alignments of the deduced amino acid sequences for 
ABCB1b (a), ABCB11 (b), ABCC1 (c), ABCC2 (d) and ABCG2 (e) in N. tilapia with 
other fish species and human. .................................................................................. 122 
Figure 4.2 – Predicted topologies of Nile tilapia partial ABCB1b (a), ABCB11 (b), 
ABCC1 (c), ABCC2 (d) and ABCG2 (e) proteins with membrane spanning domains 
(MSDs) and nucleotide binding domains (NBDs) according to the Polyphobius 
algorithm. .................................................................................................................. 123 
Figure 4.3 - Phylogenetic trees based on the multiple alignments (Clustal W) of 
closely related proteins from ABCB, ABCC and ABCG subfamilies found in other 
species. .................................................................................................................... 125 
Figure 4.4 – Relative mRNA expression of ABC transporters, CYP1A and GST α 
in Nile tilapia liver (a), gill (b) and proximal intestine (c). ............................................ 127 
Figure 4.5 – Relative mRNA expression of ABCB1b (a), ABCC1 (b), ABCC2 (c), 
ABCG2 (d), CYP1A (e) and GSTα (f) in liver, gill and proximal intestine of animals 
exposed to waterborne BaP. ..................................................................................... 129 
Figure 4.6 - Relative mRNA expression of ABCB1b (a), ABCC1 (b), ABCC2 (c), 
ABCG2 (d), CYP1A (e) and GSTα (f) in liver, gill and proximal intestine of animals 
exposed to dietary BaP. ............................................................................................ 131 
Figure 5.1 - Western blot of membrane vesicles from liver, gill and proximal 
intestine of Nile tilapia. .............................................................................................. 157 
Figure 5.2 - Representative immunofluorescence results of liver, gill and proximal 
intestine in Nile tilapia probed with mammalian Pgp antibodies, C219 and C494. ..... 161 
Figure 5.3 - Representative immunoblots of Nile tilapia CYP1A protein in liver, gills 
and proximal intestine after waterborne exposures to BaP (10µg/L, 25µg/L and 
50µg/L) for 7 and 14 days. ........................................................................................ 161 
Figure 5.4 - Western blot results of CYP1A protein fold induction over control after 
Nile tilapia waterborne exposure to BaP in liver (a), gill (b) and proximal intestine 
(c). ............................................................................................................................ 163 
Figure 5.5 - Representative CYP1A immunostaining in liver samples of Nile tilapia 
exposed to BaP. ....................................................................................................... 167 
 xxiii 
 
Figure 5.6 - Representative CYP1A immunostaining in gill samples of Nile tilapia 
exposed to BaP. ....................................................................................................... 169 
Figure 5.7 - Representative CYP1A immunostaining in proximal intestine of Nile 
tilapia exposed to BaP. ............................................................................................. 171 
Figure 6.1 – Relative mRNA expression of ABCB1b (a), ABCC1 (b), CYP1A (c) 
and GSTα (d) during the first five stages (1-5) of embryonic development in O. 
niloticus comprising the zygote and cleavage periods. .............................................. 193 
Figure 6.2 -  Relative mRNA expression of ABCB1b (a), ABCC1 (b), CYP1A (c) 
and GSTα (d) during the blastula and gastrula periods of embryonic development 
in O. niloticus. ........................................................................................................... 195 
Figure 6.3 - Relative mRNA expression of ABCB1b (a), ABCC1 (b), CYP1A (c) 
and GSTα (d) during the last embryonic (segmentation to hatching) and larval 
periods (early and late larvae) in O. niloticus development. ...................................... 196 
Figure 6.4 – Relative mRNA expression of ABCB11 (a), ABCC2 (b) and ABCG2a 
(c) during the embryonic and larval periods (zygote to late larvae) in O. niloticus 
development. ............................................................................................................ 197 
Figure 6.5  – Schematic representation of the main results achieved in this study, 
showing the temporal pattern of mRNA expression for the genes in study 
(ABCB1b, ABCB11, ABCC1, ABCC2, ABCG2a, CYP1A and GSTα) in Nile tilapia 
developmental stages. Adapted from Kimmel et al. (1995) and Fujimura and 
Okada (2007). ........................................................................................................... 201 
 
 
 
 
 
 
 
 
 
 xxiv 
 
Tables index 
Table 1.1– List of known ABC genes, functions and number of members found in 
human and zebrafish genomes ..................................................................................... 5 
Table 1.2 – ABC transporters involved the efflux of toxic compounds, fish species 
where they were identified and tissue distribution pattern in mammals and fish. ......... 15 
Table 3.1 -  Recoveries ± RSD, instrument linear dynamic ranges, determination 
coefficients (r2) and limits of detection (LOD) and quantification (LOQ) in μg L-1 
(n=5) ........................................................................................................................... 92 
Table 3.2 - EROD, GST and UGT activities in liver, intestine and gill of Nile tilapia 
after waterborne exposure to BaP (10 and 100 µg L-1) ................................................ 98 
Table 4.1 – Primer sequences, sequence lengths, annealing temperatures, 
GenBank accession numbers and homology percentages with other animal 
species of ABC transporters identified in Nile tilapia. ................................................ 116 
Table 4.2 – Primer sequences, amplicon lengths and efficiency of reaction, used in 
ABC transporters, CYP1A, GSTα  and 18S rRNA gene expression quantification 
by qRT-PCR in Nile tilapia ........................................................................................ 118 
Table 5.1 - Cellular localization of Pgp in liver, gill and proximal intestine of Nile 
tilápia exposed to different concentrations of waterborne BaP. ................................. 159 
Table 5.2– Cellular localization of CYP1A in liver, gill and proximal intestine of Nile 
tilápia exposed to different concentrations of waterborne BaP. ................................. 164 
Table 6.1 – Primer sequences, amplicon lengths and efficiency of reaction, used in 
ABC transporters, CYP1A, GSTα and 18S rRNA gene expression quantification by 
qRT-PCR in Nile tilapia ............................................................................................. 191 
 
 
 
  
 
 
 
 
 
Chapter 1 
General Introduction 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
General introduction 
 
3 
 
1. General Introduction 
 
The aquatic ecosystems have unpaired importance for the maintenance and 
support of the overall environmental health, due to the enormous economic and 
aesthetic value of aquatic biodiversity. Humans have long depended on aquatic 
resources for food, medicines, materials, as well for recreational and commercial 
purposes, such as fishing and tourism. As a result declining levels of aquatic 
biodiversity, in both freshwater and marine environments, are recognized. Several 
factors, as species overexploitation, pollution from urban, industrial and agricultural 
areas, as well as habitat loss and alteration have been contributing to the situation of 
aquatic environment “health” decline. Although aquatic pollution has a long history, 
significant international laws to counter it were only enacted in the twentieth century. 
The aquatic environments were for many years, and still are, the ultimate destination 
for different type of pollutants from anthropogenic origins. Toxic heavy metals and 
nanomaterials resultant from industrial processes, persistent organic pollutants (POPs) 
from agricultural and industrial sources and polycyclic aromatic hydrocarbons (PAHs) 
mainly resultant from oil spills are among the sources of major concern regarding water 
pollution, due to their known toxic effects on the aquatic biota. More recently, a highly 
diverse group of bioactive chemicals, denominated pharmaceuticals and personal care 
products (PPCPs), have been receiving attention, since these compounds are 
continually introduced into the aquatic environment as complex mixtures via a number 
of routes, but primarily by both untreated and treated sewage (Daughton and Ternes, 
1999). In order to survive in polluted environments, living organisms have well 
developed strategies of protection to the adverse effects of pollutants. Whenever 
possible, organisms avoid or escape from the polluted areas; additionally, chronically 
exposed organisms use detoxification mechanisms in order to reduce the toxic effects 
of pollutants. These mechanisms include the activity of specific proteins to preclude the 
permanence of toxic compounds or their metabolites in the cells - some members of 
the ATP-Binding Cassette (ABC) superfamily - and enzymatic systems to transform the 
chemicals into a more easily excreted form - phase I and phase II biotransformation 
enzymes. Thus, the knowledge of the functionality of these detoxification pathways is 
of critical importance, to maintain the balance of nature and support the availability of 
the aquatic resources for future generations.  
The main focuses of this PhD thesis are the detoxification mechanisms adopted 
by fish species, namely the ecotoxicologically relevant ABC efflux transporters and 
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biotransformation enzymes of phase I and phase II. Recent studies have raised the 
possibility of a coordinated action between these three groups of proteins, resulting in a 
powerful and effective mechanism of cellular detoxification, and the cooperation of 
these systems will be the main focus of this dissertation. To achieve this goal, we have 
developed in vivo assays of exposure of the freshwater fish Nile tilapia (Oreochromis 
niloticus) to Benzo(a)pyrene (BaP), a toxic polycyclic aromatic hydrocarbon (PAH) that 
is a ubiquitous contaminant of the aquatic environments, and whose carcinogenic and 
mutagenic effects to the aquatic biota are well recognized. The presence and 
functionality of ABC transporters and biotransformation enzymes was subsequently 
evaluated in Nile tilapia barrier tissues (liver, gills and intestine) at gene, protein and 
activity levels, in order to assess the cooperation between these groups of proteins in 
the detoxification of this pollutant. 
 
1.1. The superfamily of ABC efflux transporters 
 
The ABC genes represent the largest family of transmembrane proteins encoded 
in the human genome. These proteins bind to ATP and use that energy to drive the 
transport of a wide variety of molecules across cellular membranes (table 1.1) (Higgins, 
1992; Dean et al., 2001). So far, 56 members of the ABC family have been described, 
including 48 human ABC genes and 9 additional genes found in other animal species. 
From the 56 genes, 68% are present in all vertebrate genomes, suggesting that theirs 
proteins´ structures and functions have been largely conserved throughout the 
evolution of vertebrate species (Dean and Annilo, 2005). Based on the sequence and 
the organization of the ATP-binding domains, also known as nucleotide binding 
domains (NBDs), ABC proteins were grouped into eight subfamilies in eukaryotes (A–
H), with seven of these (A–G) present in the human genome (Dean and Annilo, 2005), 
as shown in table 1.1. The NBDs are located in the cytoplasm and transfer the 
necessary energy to transport the substrate across the cellular membrane. These 
domains contain characteristic motifs with specific amino acid sequences (Walker A, 
Walker B and C-motif) described in all ABC proteins (Walker et al., 1982; Hyde et al., 
1990) (figure 1.1b).  
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Table 1.1– List of known ABC genes, functions and number of members found in human and zebrafish genomes 
Subfamily Members Functions Human Zebrafish* 
ABCA  ABCA1 to ABCA13 Cholesterol efflux, phosphatidil choline efflux, N-retinylidiene-PE efflux 12 members 7 members 
ABCB ABCB1 to ABCB11 Peptide transport; iron transport; Fe/S cluster transport; bile salt transport; xenobiotics transport 11 members 9 members 
ABCC ABCC1 to ABCC13 Organic anion efflux, nucleoside transport, chloride ion channel, sulfonylurea receptor, potassium channel regulation, 
xenobiotics transport 
13 members 11 members 
ABCD ABCD1 to ABCD4 Very long chain fatty acids transport regulation 4 members 4 members 
ABCE ABCE1 Elongation factor complex 1 member 1 member 
ABCF ABCF1 to ABCF3 Unknown function 3 members 3 members 
ABCG ABCG1 to ABCG5 Cholesterol transport, sterol transport, toxin transport 5 members 5 members 
ABCH  ABCH1 Unknown function no members 1 member 
* This genome is incompletely assembled and annotated and the gene numbers may be higher. Adapted from Dean and Annilo 2005 
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Typically, a functional protein contains two NBDs and two membrane spawning 
domains (MSDs), the latter being composed by 6-10 membrane spawning α-helices that 
confer the substrate specificity (figure 1.1a) (Locher 2009). Eukaryotic ABC proteins are 
organized either as full transporters (containing two NBDs and two MSDs), or as half 
transporters (containing one NBD and one MSD), that have to form homo- or heterodimers 
in order to constitute a functional protein (Dean et al., 2001). Some variation exists in 
protein structure in the different subfamilies, as it will be described further ahead, but a high 
degree of structural and sequence homology is shared among all ABC transporter proteins 
(Higgins, 2007). The linker region is a central sequence that connects the two homologous 
halves of the protein, and plays an important role due to its flexible secondary structure that 
coordinates the functioning of both halves, which is required for the proper interaction of the 
two ATP binding sites. Evidence exist that, for the efficient ATP hydrolysis, the two NBDs 
have to interact and form a sandwich dimer, so that C-motif of one NBD comes in contact 
with Walker-A of the other NBD, forming a nucleotide-binding pocket (Lee et al., 2008).  
 
 
Figure 1.1 – Schematic representation of a typical ABC protein and characteristic amino acid 
sequences found in Nucleotide Binding Domains (NBDs) 
a) lipidic bilayer is shown in grey, membrane spawning domains (MSDs) in light brown and 
nucleotide binding domains (NBDs) in blue ( W-A - Walker A and W-B - Walker B), dashed line 
represents the linker region; b) aminoacid (aa) sequences characteristic from the conserved domains 
Walker A (x represents any aa), C-motif and Walker-B (ф represents hydrophobic residues). Adapted 
from Dean et al. 2001. 
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1.2. Multidrug resistance (MDR) associated ABC transporters 
 
Resistance to multiple anticancer agents is a major impediment for the successful 
treatment of many forms of malignant tumours. Juliano and Ling (1976) described a 
multidrug resistance (MDR) phenomenon, found in tumor cell lines of mammals, as the 
result of low intracellular accumulation of anti-cancer drugs, and related it with the 
overexpression of a transmembranar protein, responsible for an ATP-dependent efflux of 
those drugs into the extracellular medium. This protein denominated as Permeability 
glycoprotein (Pgp) and encoded by the ABCB1 gene was, for that reason, the first ABC 
transporter to gain importance and later related to cellular detoxification. From this point, 
several other members of the ABC transporter efflux family have been identified as capable 
of transporting endo- or xenobiotic compounds, including members of the ABCC and ABCG 
subfamilies (Cole et al., 1992; Doyle et al., 1998). Due to their ecotoxicological role, these 
three subfamilies of transporters will be addressed in higher detail in the following sections.  
 
1.2.1. Subfamily ABCB 
 
1.2.1.1. ABCB1 – P-glycoprotein (Pgp) 
 
The best characterized ABC transporter is Pgp (subfamily B, member 1: ABCB1; 
MDR1). In humans, Pgp is encoded by two different isoforms of the gene, MDR1 and 
MDR3, and the class 1 has been implicated in drug resistance whereas the function of class 
III isoform is still unknown (Georges et al., 1990). ABCB1 (MDR1) was the first eukaryotic 
ABC member identified in result of its implication in MDR of cancer cells to chemotherapy 
(Gottesman and Ling, 2006). Further evidence of its MDR abilities included decreased drug 
accumulation in cells transfected with ABCB1 gene (Ueda et al., 1987), and increased drug 
accumulation in gene knockouts organisms, compared to the wild-type organism (Schinkel 
et al., 1994). In humans, ABCB1 is a 170 - 180 kDa protein containing ~1280 amino acids, 
with a predicted four-domain structure, typical of most eukaryotic ABC transporters, with two 
NBDs each preceded by a MSD composed of six transmembrane (TM) helices (Loo and 
Clarke, 1999) (figure 1.2a).  MDR provided by Pgp is a consequence of its remarkable non-
specificity with respect to the substrates. Several researchers have focused their attention 
on the understanding of the promiscuity of this transporter regarding its substrates, and 
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have indicated common characteristics among them, such as moderate hydrophobicity, 
small size and positively charged or neutral domains, and include natural products, 
chemotherapeutic drugs or steroids (reviewed in Schinkel and Jonker, 2003). Pgp can also 
interact with modulators that are able to reverse MDR by blocking or saturating Pgp binding 
locations, called chemosensitizers (described in section 1.3). 
Besides being expressed in cancerous tissues ABCB1 is also expressed in normal 
tissues, such as kidney, intestine, lung, brain, placenta, adrenal cortex, testis, uterus, 
lymphocytes and hematopoietic cells of mammals, in most cases adopting an apical 
localization in the cells (reviewed in Szakács et al., 2008). Due to this cellular  localization 
determined in mammals, it is believed that ABCB1 functions in three main areas: 1) limiting 
the drug entry into the body after oral drug or toxin administration, due to its expression in 
the apical membrane of enterocytes; 2) once the xenobiotic has reached the blood 
circulation, ABCB1 promotes drug elimination into bile and urine, as a result of its 
expression in the canalicular membrane of hepatocytes and luminal membrane of proximal 
tubule cells in the kidneys, respectively; and, 3) once a xenobiotic has reached the systemic 
blood-circulation, Pgp limits drug penetration into sensitive tissues, like the blood-brain-
barrier (BBB) (Fromm, 2004) where its localized in both luminal and abluminal membranes 
of capillary endothelial cells, pericytes and astrocytes (Bendayan et al., 2006). These 
different localizations of ABCB1 in barrier tissues strongly support the role of this transporter 
as a key player in the cellular defence mechanisms, emphasizing its ecotoxicological 
relevance.  
Besides mammals, highly conserved MDR genes have been described in animals 
from diverse taxa including nematode worms (Broeks et al., 1995), fruit fly (Vaché et al., 
2006), plants (Wang et al., 1996) and bacteria (van Veen et al., 1998).   
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Figure 1.2 – Predicted structures of MDR associated members of ABC transporters 
a) predicted structure of ABCB1 and ABCB11; b) predicted structure of “long-chain” ABCC proteins, 
ABCC1, 2 and 3; c) predicted structure of ABCG2. 
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1.2.1.2. ABCB11 – Spgp or BSEP 
 
Sister of P-glycoprotein (Spgp, ABCB11, BSEP) was ﬁrst cloned from porcine liver 
(Childs et al., 1995), and named for its close sequence homology with Pgp. It follows the 
same predicted structure as ABCB1 (figure 1.2a). Recently, this transporter has become 
more widely known as the bile salt export pump (BSEP), since studies in rats showed 
predominant expression in liver, canalicular localization, and high affinity to transport 
primary and secondary bile salts (Gerloff et al., 1998). ABCB11 is thus positioned to 
mediate active, ATP dependent, bile acid secretion across the canalicular membrane of 
hepatocytes, limiting intracellular bile acid concentrations and maintaining the enterohepatic 
circulation of bile acids. Conclusive evidence that BSEP is indeed the bile salt export pump 
in liver came from a study in which mutations in the human ABCB11 gene resulted in type 2 
progressive familial intrahepatic cholestasis (PFIC2), a disease characterized by an 
interruption in hepatic bile salt secretion (Strautnieks et al., 1998). Despite its predominance 
in liver, ABCB11 was also found in other porcine tissues, such as large and small intestinal 
mucosa and in brain (Török et al., 1999). This suggests that ABCB11 may perform 
additional, extrahepatic functions, possibly limiting other tissues exposure to bile salts. As 
well as its endogenous role as a hepatic bile salt export pump, studies in mammals cell 
lines transfected with murine ABCB11 showed that ABCB11 was capable of transporting 
some Pgp substrates (vinblastine and calcein-acetoxymethyl ester), although it was unable 
to efflux others  (rhodamine 123, vincristine, daunorubicin, paclitaxel, and digoxin) (Lecureur 
et al., 2000). Thus the role of ABCB11 in drug disposition, if any, is considerably more 
limited than that of its close relative, Pgp.     
 
1.2.2. Subfamily ABCC (MRPs – Multiresistance associated proteins) 
 
After the discovery of ABCB1, the study on cancer cells displaying MDR phenotype 
not associated with ABCB1 expression, led to the discovery of ABCC1, the founding 
member of the ABCC subfamily (Cole et al., 1992). So far, this subfamily includes a total of 
13 members, most of which are active ATP-dependent membrane transporters for organic 
anions of therapeutic compounds (Honorat et al., 2009). Among its members, at least five 
(ABCC1, ABCC2, ABCC3, ABCC4 and ABC5) are potentially involved in mediating drug 
resistance (Cole et al., 1992; Kool et al., 1997; Evers et al., 1998). At present, there are no 
high-resolution structural data available on any eukaryotic ABCC transporter, but 
considering predicted membrane topologies, phylogenetic position and domain 
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arrangements, members of the ABCC subfamily can fall in one of two different subclasses, 
“short” and “long” (Kast and Gros, 1997; Bakos and Homolya, 2007; Honorat et al., 2009). 
The so called “long” ABCC transporters (ABCC1, 2, 3 and 6) present an additional N- 
terminal MSD (MSD0), of approximately 250 amino acids, a unique feature of these specific 
transporters (figure 1.2b) in comparison to the “short” transporters. ABCCs are ~190kDa 
proteins, and share only 14-25% amino acid identity with ABCB proteins (Cole et al., 1992; 
Keppler and Konig, 1997). From the ABCC subfamily, ABCC1 and ABCC2 are the best 
characterized transporters with existing evidence from animal models to have a role in 
tissue defence, while other members like ABCC3, 4 and 5, are far less studied and 
characterized. The toxicological relevance of ABCC1 and ABCC2 will be evaluated in this 
dissertation. ABCC2 gene was identified based on its similarity to ABCC1 and absence of 
its expression of homozygously ABCC2-deficient rats and humans (Mayer et al., 1995; 
Keppler and KÖNig, 2000). The absence of the ABCC2 gene in hepatocytes canalicular 
membrane causes the Dubin–Johnson syndrome (Konig et al., 1999), and affected 
individuals suffer from a conjugated hyperbilirubinemia, since ABCC2 normally mediates the 
hepatobiliary excretion of bilirubin (König et al., 1999). As for ABCB1, ABCC1 and ABCC2 
are also expressed in non-malignant tissues. In mammals, ABCC1 shows a ubiquitous 
expression throughout the different tissues, with relatively high levels found in kidney, lung, 
testis, skeletal muscle, peripheral blood mononuclear cells, while relatively low levels were 
found in liver (Cole et al., 1992; Flens et al., 1996; Stride et al., 1996). Similarly, ABCC2 has 
also been found in tissues important for the pharmacokinetics of substrate drugs, namely 
liver, kidney, placenta, lungs, intestine and BBB (for a review see Schinkel and Jonker, 
2003). Although without a complete overlap, many similarities exist between the spectrum 
of compounds transported by ABCC1 and ABCC2, which are mainly composed by 
amphipathic anionic drugs and endogenous compounds, encompassing GSH-, glucoronide- 
and sulphate- conjugates (reviewed in Schinkel and Jonker, 2003). In most tissues, ABCC1 
efflux transporter is localized in the basolateral surface of the cells, which, in certain tissues, 
results in the efflux of its substrates into the blood (Evers et al., 1996). In contrast to 
ABCC1, and similarly to ABCB1 and ABCB11, ABCC2 is localized in the apical membrane 
of the cells in which it is expressed (Evers et al., 1998).  
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1.2.3. Subfamily ABCG – ABCG2, BCRP, MXR or ABCP 
  
The second member of the ABCG subfamily, ABCG2, is a ~72kDa efflux transporter, 
whose overexpression in permanent cell-lines has been associated with high levels of 
resistance to a variety of anticancer drugs, such as mitoxantrone, doxorubicin, and 
daunorubicin, without evidence of expression of the well-characterized genes for ABCB1 or 
ABCCs therefore contributing to a MDR phenotype. Moreover reduced accumulation of 
such drugs could be reversed by incubation of the cells in ATP-depleting conditions, 
indicating the presence of an ATP-dependent transporter (Ross et al., 1999; Bates et al., 
2001; Allen and Schinkel, 2002). This protein is also known as breast resistance associated 
protein (BCRP) (Doyle et al., 1998), mitoxantrone-resistance protein (MXR) (Miyake et al., 
1999) or placenta-specific ABC protein (ABCP) (Allikmets et al., 1998) since it was cloned 
independently by 3 different groups. Members of the ABCG subfamily have a unique 
domain organization; unlike the remaining subfamilies, these are half-transporters, 
composed by one single NBD followed by one MSD (figure 1.2c). In addition, they also 
present a unique protein configuration, in which the NBD precedes the MSD, whereas 
ABCBs and ABCCs have an opposite domain arrangement, that is, the MSD is followed by 
the NBD (figure 1.2c). There are increasing evidence to suggest that these proteins may 
operate either as homodimers or heterodimers (Graf et al., 2003; Xu et al., 2004). ABCG2 is 
believed to function probably as a homodimer (Doyle et al., 1998; Miyake et al., 1999; Kage 
et al., 2002) or homotetramer (Xu et al., 2004).  
Functional characterization studies have demonstrated that ABCG2 can transport a 
wide range of substrates, from chemotherapeutic agents to organic anion conjugates 
(reviewed in Mao, 2005). Moreover, it seems that ABCG2 has higher affinity to transport 
sulphated conjugates of steroids and xenobiotics over GSH and glucoronide metabolites 
(Chen et al., 2003). High levels of ABCG2 have been found in placenta, brain, prostate, 
intestine, liver and ovary, mostly in an apical localization (Rocchi et al., 2000; Scheffer et al., 
2000; Maliepaard et al., 2001).This tissue localization is consistent with the ability of ABCG2 
to function as a protective efflux pump, limiting absorption of drugs and increasing 
elimination of its substrates. 
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1.3. From MDR to MXR - ABC efflux transporters in aquatic organisms  
 
Aquatic organisms are able to survive and thrive in heavily polluted environments, 
showing surprisingly low accumulation of pollutants in body tissues (Kurelec and Pivčević, 
1989). Kurelec and coworkers were the first to demonstrate that aquatic organisms adopt 
strategies of xenobiotic transport, in order to improve adaptation to pollutants in their 
habitats. To this phenomenon of resistance, Kurelec coined the term of multixenobiotic 
resistance (MXR) (Kurelec, 1992), and identified its biochemical basis as similar to the one 
adjacent to the MDR phenotype. The presence of a drug transporter resembling Pgp 
(ABCB1) sensitive to verapamil and trypsin (known inhibitors of human Pgp) was described 
in two bivalves species (Anodonta cygnea and Mytilus galloprovinciallis) (Kurelec and 
Pivčević, 1989, 1991). This study was the starting point for the identification and 
characterization of the MXR phenotype in several other species of aquatic organisms, such 
as sponges (Kurelec et al., 1992), molluscs (McFadzen et al., 2000; Minier et al., 2002; 
Smital et al., 2003; Luckenbach and Epel, 2008; Faria et al., 2011), crabs (Kohler et al., 
1998) and sea urchins (Toomey and Epel, 1993; Hamdoun et al., 2002). In fish, the 
presence of ABC efflux transporters have been described for an increasing number of 
species, such as winter flounder (Chan et al., 1992), rock cod (Zucchi et al., 2010), rainbow 
trout (Zaja et al., 2008; Fischer et al., 2010; Loncar et al., 2010), zebrafish (Long et al., 
2011a; Long et al., 2011b), mullet (Diaz de Cerio et al., 2012) and killifish (Paetzold et al., 
2009) (table 1.2). 
Identification of ABC transporters and characterization of the MXR mechanism has 
been achieved by the use of several detection methods, including quantitative or semi-
quantitative reverse transcription polymerase chain reaction (qRT-PCR or RT-PCR) and in 
situ hybridization to evaluate mRNA expression of genes, immunochemical techniques for 
protein detection applying mammals monoclonal antibodies to ABCB1 (western blotting or 
immunohistochemistry), northern-blotting and activity assays (through the measurement of 
efflux or accumulation of fluorescent model substrates).  
Most studies aiming to determine tissue distribution pattern of ABC transporters in 
aquatic organisms have been directed to Pgp by the use of the mammalian anti-Pgp 
monoclonal antibody (mAb) C219. This mAb recognizes an epitope common to all known 
Pgps (in human MDR1 and MDR3) and also to Spgp (ABCB11) (Georges et al., 1990; 
Childs et al., 1995; van den Elsen et al., 1999). After probing with the mammalian mAb 
C219, an immunologically related to the mammalian MDR protein was identified in embryos 
and gills of a few aquatic invertebrates (Toomey and Epel, 1993; Cornwall et al., 1995). In 
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fish, a positive reaction was seen in the hepatic bile canaliculi (Kleinow et al., 2000; Doi et 
al., 2001; Bard et al., 2002a; Bard et al., 2002b; Klobučar et al., 2010), apical membrane of 
enterocytes (Kleinow et al., 2000; Doi et al., 2001; Bard et al., 2002a), kidney (Kleinow et 
al., 2000) and in endothelial capillaries of brain (Miller et al., 2002). A negative reaction of 
the mAb C219 was patent in gills, kidney, gonad, brain, spleen, heart of killifish and 
blenny (Bard et al., 2002a; Bard et al., 2002b). In summary, the suggested Pgp localization 
in fish reveals a pattern similar to that described in mammals, with Pgp present in epithelial 
tissues involved in secretion, absorption or serving a barrier function. However, due to the 
known cross-reactivity of the mAb C219 with ABCB11 (Childs et al., 1995), results from 
these studies should be addressed with care, since until the development of fish-specific 
Pgp probes, ABCB1 definitive tissue localization cannot be demonstrated in fish (Sturm and 
Segner 2005). 
For other ABC efflux transporters no fish-functional antibodies are available, thus 
information on their distribution pattern is quite limited and restricted to the mRNA 
expression among the various fish tissues.  As in mammals, ABCB11 was found to be 
almost exclusively expressed in trout liver, with low expression in proximal intestine, and 
very low expression in other tissues as gills, brain, gonads and kidney (Loncar et al., 2010), 
supporting its role in the efflux of bile salts from hepatocytes into the bile. In trout tissues, 
low ABCC1 expression was found, and kidney was the only tissue showing notable ABCC1 
expression while significant expression levels of ABCC2 in major detoxification tissues were 
reported (Loncar et al., 2010). High ABCC2 expression was also previously reported in 
kidney, intestine and liver of little skate (Cai et al. 2003) and in apical membrane of proximal 
kidney tubule of killifish (Miller et al., 2007). Regarding ABCG2, Loncar and coworkers 
(2010) have examined the tissue distribution pattern of this protein in trout tissues, and 
found high expression levels in gonads and moderate expression in distal part of intestine, 
kidney and brain. Relatively high expression of ABCG2 was reported in trout liver and 
primary hepatocytes (Zaja et al., 2008) (table 1.2).  
Based on these results and on mammal studies, investigators believe that, in aquatic 
organisms, ABC eflux transporters should follow a similar distribution pattern and cellular 
localization, with expression in tissues involved in secretion, absorption or serving a barrier 
function, like liver and intestine (figure 1.3). Thus, ABCB1, ABCB11, ABCC2 and ABCG2 
should be localized in the apical membrane of polarized cells, pumping substrates into the 
intestinal lumen or bile canaliculi, while ABCC1 localization in basolateral membrane results 
in the export of its substrates into the blood. Additionally, ABCB1 should efflux mostly 
unmodified compounds, while ABCCs and ABCG2 should efflux organic anions conjugated 
by phase II enzymes (figure 1.3) (reviewed in Epel et al., 2008).  
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Table 1.2 – ABC transporters involved the efflux of toxic compounds, fish species where they were identified and tissue distribution pattern in 
mammals and fish. 
 Mammals Fish 
Protein Tissue distribution 
Localization in 
polarized cell 
Specie Common name 
GenBank accession 
number  
Tissue distribution 
ABCB1 
BBB, liver, intestine, 
kidney, placenta, stem 
cells 
apical 
Barbus barbus  
Carassius auratus 
Chondrostoma nasus 
Cyprinus carpus 
Danio rerio 
Dicenthrarchus labrax 
Fundulus heteroclitus 
Leuciscus cephalus 
Mullus barbatus 
Oncorhynchus mykiss 
Plactichthys flesus 
Pleuronectes americanus 
Poeciliopsis lucida 
Scophtalmus maximus 
 
Trematomus bernacchii 
 
Barbel 
Goldfish 
Nase 
Carp 
Zebrafish 
European seabass 
Killifish 
Chub 
Red mullet 
Rainbow trout 
European flounder 
Winter flounder 
Topminnow 
Turbot 
Rock cod 
DQ059069.1 
DQ059072.1 
AY948951.1 
AY999964.1 
XP_001922717 
GQ273979.1 
AF099732.1 
AY999966 
AY850375.1 
AY863423.3 
AF175686.1 
AY053461.1 
DQ842514.2 
AJ291813 
FJ938210.1 
liver, intestine, kidney, brain, 
gonads
1,2,3,4,6,7
 
ABCB11 liver apical 
Danio rerio
 
Dicenthrarchus labrax 
Fundulus heteroclitus 
Oncorhynchus mykiss  
Platichthys flesus  
Zebrafish 
European seabass 
Killifish 
Rainbow trout 
European flounder 
XP_001923538 
GQ273980.1 
AF135793.1 
DQ865266.2 
AJ344042.1 
liver, intestine
1 
ABCC1 
lung, testis, kidney, 
peripheral blood 
mononuclear cells, 
skeletal and cardiac 
muscle, placenta 
basolateral (apical in 
brain endothelial 
cells) 
Barbus barbus 
Danio rerio 
Dicenthrarchus labrax 
Oncorhynchus mykiss 
Oryzias melastigma 
Plactichthys flesus 
Barbel 
Zebrafish 
European seabass 
Rainbow trout 
Medaka 
European flounder 
FJ890350.1 
XM_002661202 
GQ273982.1 
GQ166973.1 
JN629038.1 
AJ344044.1 
testis, ovary, kidney, muscle, gills, heart, 
liver, intestine, brain, eye
1,8
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Poeciliopsis lucida 
Trematomus bernacchii
 
Topminnow 
Rock cod 
HM102361.1 
FJ938212.1 
ABCC2 
BBB, liver, intestine, 
kidney, placenta, lung 
apical 
Carassius auratus 
Chondrostoma nasus 
Cyprinus carpio 
Danio rerio 
Dicenthrarchus labrax
 
Leuciscus cephalus 
Mullus barbus 
Oncorhynchus mykiss 
Plactichthys flesus 
Poeciliopsis lucida 
 
Trematomus bernacchii  
Raja erinácea  
Goldfish 
Nase 
Carp 
Zebrafish 
European seabass 
Chub 
Barbel 
Rainbow trout 
European flounder 
Topminnow 
Rock cod 
Little skate 
FJ890349.1 
AY948950 
AY679169 
NM_200589.1 
GQ273983.1 
FJ890348.1 
AY275434.1 
NM_001124655.1 
AJ344045.1 
HM102360.1 
FJ938211.1 
AF486830 
liver, kidney, intestine, brain, 
muscle
1,9,10,11 
ABCG2 
BBB, placenta, liver, 
intestine, breast, stem 
cells 
apical 
Chelon labrosus 
Dicenthrarchus labrax 
Oncorhynchus mykiss 
Poeciliopsis lucida  
Salmo salar 
 
Mullet 
European seabass 
Rainbow trout 
Topminnow 
Atlantic salmon 
HM467811.1 
GQ273981.1 
EU163724.1 
HM102358.1 
NM_011736655.1 
liver, kidney, gonads, intestine, gills
1 
1(Loncar et al., 2010), 2 (Kleinow et al., 2000), 3(Doi et al., 2001), 4(Bard et al., 2002a), 5(Bard et al., 2002b), 6(Klobučar et al., 2010), 7(Miller et al., 2002), 8(Long et al., 2011a), 9(Long et al., 
2011b), 10(Miller et al., 2007), 11 (Cai et al., 2003)  
 
Table 1.2 (continued) 
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Figure 1.3 - Schematic representation showing probable localization of ABC transporters 
in liver and intestine of fish, as determined in mammals. 
 (a) liver hepatocytes, b) enterocytes. Parent xenobiotic compounds, phase I metabolites and 
phase II metabolites are shown as red, yellow and green circles, respectively. Adapted from 
Schinkel and Jonker 2003, Brand et al., 2006. 
 
The bulk of the studies conducted in aquatic organisms, on the interaction of 
environmental contaminants with ABC efflux transporters have been mostly performed 
on Pgp. Some compounds, as Pgp model reversal agents (verapamil and/or 
cyclosporine A) and xenobiotics (like the insecticide malathion) were shown to inhibit 
Pgp activity in fishes, resulting in an increase of the bioaccumulation of toxic 
compounds like 2-aminoanthracene, hydrocarbon-rich Diesel-2 oil, and/or model Pgp 
substrates like rhodamine B (Kurelec et al., 1992; Kurelec, 1995; Smital and 
Sauerborn, 2002).  Other studies have demonstrated the ability of some xenobiotics to 
induce Pgp expression in fish, such as cadmium (Zucchi et al., 2010), the 
organophosphate insecticide chloropyrifos and the carcinogen N-nitrosodiethylamine 
(Albertus and Laine, 2001). Similarly, resistance-killifish populations from highly 
polluted sites also demonstrated enhanced Pgp expression (Cooper et al., 1999; Bard 
et al., 2002a) suggesting a protective role of Pgp. Nevertheless, in another study 
performed in killifish from a heavily polluted site with polycyclic aromatic hydrocarbons 
(PAHs), polychlorinated biphenyls (PCBs) and heavy metals, Paetzold and coworkers 
(2009) found no up-regulation of hepatic ABCB1 transcripts. Moreover, after in vivo 
exposures of fishes to different xenobiotics, such as prochloraz, nonylphenol 
diethoxylate, ß-naphthoflavone, BaP and 3,4,3´,4´-tetrachlorobiphenyl  no changes 
were seen in the levels of hepatic and/or intestinal Pgp (Doi et al., 2001; Sturm et al., 
2001). 
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Few studies have addressed the response of other ABC efflux transporters upon 
animals’ exposure to pollutants. Paetzold and co-workers (2009) described an up-
regulation of hepatic transcripts for ABCC2 and ABCG2 in a multiresistant population of 
killifish living in a pond heavily polluted with PAHs, PCBs and heavy metals, while no 
up-regulation was seen in ABCB1 and ABCB11 mRNA. Expression of ABCC2 in 
excretory organs of zebrafish including kidney, liver and intestine was induced by 
exposure to heavy metals (Long et al., 2011b). Moreover, an up-regulation of ABCC2 
was observed in red mullet liver from an oil contaminated site (Della Torre et al., 2010). 
In another study, Long and co-workers have described an up-regulation of ABCC1 
gene in ZF4 cells and embryos of zebrafish exposed to heavy metals (Long et al., 
2011a; Long et al., 2011b). Similarly, ABCB1 and ABCC2 transcripts were also up-
regulated in liver of Cd-exposed Trematomus bernachii (Zucchi et al., 2010).  
These findings demonstrate that, although some compounds have been shown 
to interact with ABC efflux transporters data remains fragmented and largely restricted 
to laboratory observations. It remains uncertain which classes of environmental 
toxicants can induce and/or repress the activity of these proteins, and to what extent 
this MXR mechanism protects aquatic animals from the toxic action of xenobiotics. 
Most ABC efflux transporters are remarkably non-specific with respect to its substrates. 
This feature can be an important advantage, as it provides protection against many 
novel anthropogenic products, but it can also render the system vulnerable to the 
presence of multiple substrates that will compete for binding sites, saturating these 
locations, or directly inhibit the transporter activity (chemosensitization). Thus, there is 
a fundamental need to identify the common features of ABC efflux transporters 
substrates, but also of its inhibitors. Chemosensitization, can compromise the 
effectiveness of the defence system, since toxic substances that would normally be 
excluded, will, in those situations, remain in the cell and exert their toxic effects 
(Higgins, 2007). While in clinical research the goal is to inhibit the activity of these 
efflux proteins, in a toxicological approach their optimal functioning is of critical 
importance.  
Research on these proteins has been delayed due to the inexistence of specific 
probes/antibodies for these transporters in aquatic organisms. Hence, there is the need 
to overcome this limitations, and direct further investigations to the MXR mechanism in 
order to fully understand the physiological and toxicological functions of ABC 
transporters in aquatic organisms, including fish. 
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1.4. Biotransformation enzymes 
 
Biotransformation of xenobiotics is a well known and described strategy adopted 
by living organisms to cope with the presence of xenobiotics present in their habitats. 
This detoxification mechanism consists on a two-phase process of enzymatic reactions 
that alter the chemistry of non-polar lipophilic chemicals to polar water soluble 
metabolites, leading to the detoxification and elimination of the parent compound 
(Black and Coon, 1987; Buhler and Williams, 1989). Biotransformation alters the 
toxicity of pollutant compounds, resulting in either a decrease of the toxicity of the 
compound followed by its excretion, or in the formation of more reactive metabolites, 
which leads to increased toxicity (for a review see van der Oost et al., 2003). Originally 
found in mammalian liver, biotransformation enzymes were later described in several 
other animals, plants, bacteria and fungi (Nelson et al., 1996). In mammals, the activity 
and or expression of biotransformation enzymes is found in almost all tissues, but due 
to its function, position and blood supply, liver is considered to be the major organ 
involved in the biotransformation of xenobiotics in all species (Guengerich, 1993). 
Nevertheless, other organs that function as the body´s first-pass barrier are often 
endowed with biotransformation capacity, such as skin, intestine and lung in mammals 
(Raunio et al., 1995) and, in aquatic organisms, gills and intestine (McElroy and 
Kleinow, 1992; James, 1997; Jönsson et al., 2004; Jönsson et al., 2006; Nahrgang et 
al., 2010a; Nahrgang et al., 2010b). Unlike ABC efflux transporters, the 
characterization of biotransformation enzymes is well known for aquatic organisms, 
including fish. Thus, throughout the following sections, we will mostly focus on the 
studies performed with fish species and their major findings regarding drug 
metabolizing enzymes. 
 
1.4.1. Phase I enzymes 
 
The enzymes of phase I metabolism (oxidation, reduction, hydration, hydrolysis) 
introduce a functional group (-OH, -COOH, -NO2, etc.) into the xenobiotic, therefore 
providing a non-synthetic alteration of the parent compound (Commandeur et al., 
1995). For the majority of xenobiotics, phase I reactions are catalysed by microsomal 
monooxygenase (MO) enzymes, also known as the mixed-function oxidase (MFO) 
system (i.e. cytochrome P450, cytochrome b5 and NADPH cytochrome reductase). The 
cytochrome P450s (CYPs) constitute a superfamily of heme-containing proteins that 
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catalyse biological oxidation and reduction reactions, and are predominantly located in 
the endoplasmic reticulum (Stegeman et al., 1992). Currently 18 CYP gene families 
have been identified in fish (CYP1-8, CYP11, CYP17, CYP19-21, CYP24, CYP26-27, 
CYP39, CYP46 and CYP51) (Nelson, 2003). Members of the CYP family responsible 
for xenobiotics metabolism belong to the subfamilies CYP1, CYP2, CYP3 and CYP4, 
and CYP1A is the most studied isoform in fish, and has been frequently used as a 
biomarker to assess contamination in the aquatic environment (reviewed in Uno et al., 
2012). In our study, CYP1A activity and expression was used as indicative of phase I 
metabolism, thus it will be described in further detail in the following section. 
 
1.4.1.1. CYP1A 
 
cDNAs encoding for CYP1A enzymes have been isolated from several fish species 
such as rainbow trout (Råbergh et al., 2000), mummichog (Morrison et al., 1998), 
European seabass (Stien et al., 1998), Atlantic salmon (Arukwe, 2002), medaka, 
mangrove rivulus (Kim et al., 2004), yellow catfish (Kim et al., 2008) and  crucian carp 
(Fu et al., 2011). As in mammal studies, results from fish studies have shown that the 
mRNA expression of CYP1A is regulated by the aryl hydrocarbon receptor (AhR), and 
that this cytosolic transcription factor has, in turn, a high affinity to planar compounds, 
such as dioxins and PAHs (van der Oost et al., 2003). 
The mechanism of AhR-mediated induction of CYP1A is initiated by the binding of 
the ligand (e.g. a xenobiotic) to the citosolic AhR, which exists as a multiprotein 
complex with heat shock protein 90 (HSP90). Ligand binding causes a conformational 
change that facilitates nuclear translocation and association with the AhR nuclear 
translocator (Arnt). In the nucleus the AhR/Arnt heterodimer, associates with xenobiotic 
responsive elements (XRE) to initiate the transcription and translation of AhR-
responsive genes, including CYP1A (Schlenk et al., 2008) (figure 1.4). The evaluation 
of phase I metabolism can be done with the use of different approaches, like the 
measurement of the mRNA levels, immunochemical methods to measure CYP1A-
reactive protein or by measurement of CYP1A isoenzyme catalytic activity. The 
measurement of ethoxyresorufin-O-deethylase (EROD) activity in fish is a well-
established and highly sensitive biomarker of exposure to PAHs and other structurally 
similar compounds (Bucheli and Fent 1995; Stegeman and Hahn 1994), providing 
evidence of receptor-mediated induction of CYP1A by xenobiotic chemicals. EROD 
activity describes the rate of the CYP1A mediated deethylation of the substrate 7-
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ethoxyresorufin (7-ER) to form the product resorufin, being an indication of the amount 
of CYP1A enzyme present (Whyte et al., 2000).  
 
Figure 1.4 - Schematic representation of the mechanisms involved in biotransformation 
of xenobiotic compounds in cells. 
AhR, aryl hydrocarbon receptor; HSP90, heat shock protein 90kDa; Arnt, aryl receptor nuclear 
translocator; XRE, xenobiotic responsive elements; CYP1A, cytochrome P450 1A; GSTs, 
glutathione-S-transferases; UGTs, UDP-glucoronyl transferases. Adapted from van der Oost et 
al., 2003. 
 
Using one or more these evaluation methods, CYP1A presence was reported in 
liver, and also in various extra-hepatic tissues of aquatic organisms, such as gills, 
intestine, olfactory epithelium and heart (Smolowitz et al., 1992; Van Veld et al., 1997; 
Jönsson et al., 2006). Moreover, it has been demonstrated in different fish species that 
CYP1A expression and/or activity is strongly induced by different xenobiotic 
compounds, such as PAHs, PCBs and dioxins (James, 1997; Richardson et al., 2001; 
Ferreira et al., 2006; Calò et al., 2009). All these evidence make phase I metabolism as 
a vital process, among the mechanisms adopted to deal with the threat of pollutant 
exposure, and to diminish deleterious effects. In addition, the knowledge on CYP1A 
regulation makes it a validated biomarker applied in environmental risk assessment. 
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1.4.2. Phase II enzymes 
 
Phase II of the biotransformation process involves the conjugation of the xenobiotic 
parent compound or its phase I metabolites with an endogenous ligand. Conjugations 
are addition reactions in which large and often polar chemical groups or compounds, 
such as sugars or amino acids, are covalently added to the xenobiotic chemical (Lech 
and Vodicnik, 1985). The majority of phase II enzymes catalyse these synthetic 
conjugations, thus facilitating the excretion of chemicals by the addition of more polar 
groups (e.g. glutathione (GSH), glucuronic acid (GA), sulphate) (Schlenk et al., 2008). 
Accordingly to their cofactor, examples of phase II enzymes are gluthathione-S-
transferases (GSTs), UDP-glucuronyl transferases (UGTs) and sulfotransferases 
(SULT). 
Studies in fish have shown that the activity of some phase II enzymes, like GSTs 
and UGTs, are under the regulatory pathways of the AhR, and  that UGTs  genes can 
also  be induced via the nuclear pregnane X receptor (PXR) (George, 1994; Schlenk et 
al., 2008) (figure 1.4). In our study, GSTs and UGTs expression and/or activity was 
used as indicative of phase II metabolism, thus these enzymes will be described in 
higher detail in the following sections.  
 
1.4.2.1. GSTs (Glutathione-S-Transferases) 
 
GSTs are a multigene superfamily of dimeric, multifunctional enzymes, widely 
distributed throughout all eukaryotic species (Hayes and Pulford, 1995b). The majority 
of GSTs catalyze the conjugation of GSH with compounds that contain an electrophilic 
centre, through the formation of a thioether bound between the sulphur atom of GSH 
and the substrate (Chasseaud, 1979; Mannervik, 1985). Two major superfamilies of 
mammalian GSTs with transferase activity have been described, cytosolic and 
membrane-bound (Hayes and Strange, 2000). Based on their sequence homology, 
cytosolic mammalian enzymes have been assigned into one of eight families or 
classes, Alpha (α), Mu (μ), Pi (π), Sigma (σ), Theta (θ), Zeta (ζ), Omega (ω) and 
Kappa (κ) (Mannervik, 1985; Meyer et al., 1991; Pemble et al., 1996; Board et al., 
1997; Board et al., 2000). The second group of membrane-bound transferases was 
more recently discovered and is composed by at least six families (Jacobsson et al., 
2000). The soluble, or cytosolic, GSTs appear to be primarily involved in the 
metabolism of foreign chemicals, such as carcinogens, environmental pollutants, and 
cancer chemotherapeutic drugs, as well as detoxification of potentially harmful 
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endogenously derived reactive compounds (Hayes and Pulford, 1995a). Additionally, 
many endogenous GST substrates are formed as a consequence of macromolecules 
modification by reactive oxygen species, and these transferases are also considered to 
have an antioxidant function (Hayes and McLellan, 1999).  In addition to the 
measurement of the mRNA levels for the different GST isoforms, in a great number of 
studies GST is evaluated by the determination of the total catalytic activity using the 
artificial substrate 1-chloro-2,4-dinitrobenzene (CDNB), which is conjugated by the 
majority of GST isoforms (van der Oost et al., 2003). GST activity and/or expression 
has been frequently used as a biomarker of exposure to xenobiotic compounds in 
studies conducted with aquatic organisms to evaluate environmental contamination 
levels (Martínez-Lara et al., 1996; Perez-Lopez et al., 2002; Ferreira et al., 2008; Della 
Torre et al., 2010; Kim et al., 2010). Nevertheless, the feasibility of this enzyme as a 
biomarker of exposure is a matter of discussion, since in a high number of studies no 
significant alterations have been described in the activity of these enzymes after 
contaminant exposure (van der Oost et al., 2003).  
Nevertheless, these enzymes display crucial functions in the detoxification process 
facilitating the excretion of xenobiotics by increasing their polarity, which can then be 
easily translocated by ABC transporters due to a high affinity of these proteins to phase 
II metabolites, mainly ABCCs and ABCG2. 
 
 
1.4.2.2. UGTs (UDP-glucuronyl transferases) 
 
UGTs, represent another major group of phase II conjugating enzymes in vertebrate 
species. In addition to their role in the biotransformation of natural toxins and 
anthropogenic contaminants, UGTs are also active in the metabolism of endogenous 
compounds, such as steroids and thyroid hormones, and waste products such as 
bilirubin (Dutton, 1990). Due to their importance in the breakdown of therapeutic drugs, 
extensive research of these phase II enzymes has been performed in the medical and 
pharmaceutical fields (Parkinson, 2001). These phase II enzymes are located in the 
endoplasmatic reticulum (ER), and catalyse the conjugation of GA to a wide variety of 
acceptor substrates to form ß-glucuronides, increasing the water solubility of the 
substrates, thus facilitating transport and excretion. In mammals, 17 UGT genes have 
been characterized, subdivided in two different families (1 and 2). Expressed sequence 
tags (ESTs) have been cloned from several fish species, and analysis of the currently 
published zebrafish EST sequences, and the latest assembly of the genome, reveals 
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that at least 14 distinct UGTs are expressed (Schlenk et al., 2008). UGT isoforms are 
found in a variety of fish species, and, as in mammalian systems, a diverse group of 
compounds have been identified as UGTs substrates (e.g. chlorinated phenols, 
aromatic hydrocarbons metabolites, pesticides) (George, 1994). The liver is 
quantitatively the most important site for glucuronidation of xenobiotics in fish, 
nevertheless significant activities have also been detected in extrahepatic tissues, 
including kidney, gills and intestine (George, 1994). 
UGT activity is often used as a biomarker of exposure to xenobiotic compounds in 
studies conducted with aquatic organisms to evaluate environmental contamination 
levels, and generally an increase of hepatic UGT activity is reported, either in 
laboratory or field studies (van der Oost et al., 2003). However, low sensitivity of this 
enzyme has also been reported in field studies conducted in fish (Schreiber et al., 
2006; Della Torre et al., 2010).  
 
 
1.5. From phase 0 to phase III – a complete pathway for cellular 
detoxification 
 
Biological membranes are barriers for the uptake, distribution and elimination of 
xenobiotics in the organism (Simkiss, 1995). Bioaccumulation of organic compounds 
occurs mainly passively, driven by the compound´s hydrophobicity. Once absorbed, the 
xenobiotic may undergo a detoxification pathway, in order to be excreted from the 
organism before it exerts toxic effects. The most studied pathway for cellular 
detoxification is the biotransformation of xenobiotics by phase I and phase II enzymes. 
In recent years it has been proposed that two additional steps of drug disposition, 
called phase 0 and phase III, are equally important as biotransformation (Szakács et 
al., 2008). These phases involve the modulation of cellular efflux, by ABC transporters, 
of either unmodified or metabolized compounds. Thus, xenobiotic efflux transporters 
and biotransformation enzymes may be part of a coordinated defence mechanism that 
protects cells from xenobiotic insults (Xu  et al., 2005). Evidence to this coordination 
came from mammalian models, where several receptors, including the AhR and orphan 
nuclear receptors, such as liver X receptor (LXR), pregnane X receptor (PXR), 
farnesoid X receptor (FXR), peroxissome proliferator activated receptor (PPAR), 
constitutive androstane receptor (CAR), retinoid X receptor (RXR), were shown to be 
key mediators of drug-induced changes in phase I and phase II metabolizing enzymes, 
as well as phase III transporters involved in efflux mechanisms (reviewed in Xu  et al., 
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2005) (figure 1.5). However, whether phase I and II enzymes inducers coordinately 
regulate ABC efflux transporters genes requires further studies that can shed some 
light on the roles of receptors, transcription factors and signalling cascades of this 
metabolism/transport of endogenous and exogenous compounds (Xu  et al., 2005). 
Moreover, in mammals, 1) induction of Pgp has been reported after exposure to known 
inducers of phase I (CYP1A) and phase II enzymes, like BaP and 3-
methylcholanthrene (3MC) (Chao Yeh et al., 1992; Fardel et al., 1996),and 2) ABCC1, 
ABCC2 and ABCG2 are known to efflux mainly phase II metabolites, xenobiotics 
conjugated with GSH, GA and/or sulphate (for a review see Leslie et al., 2005). These 
results have also strengthened the cooperative role of ABC efflux transporters and 
biotransformation enzymes in xenobiotic breakdown and elimination. 
 
 
Figure 1.5 - Schematic representation  of drugs/chemicals/xenobiotics induced stress 
response, leading to the activation of specific receptor-mediated gene expression of 
phase I enzymes, phase II enzymes, other stress enzymes and phase 0 and phase III 
transporters, which result in the enhancement of xenobiotic detoxification. 
Ahr, aryl hydrocarbon receptor; Arnt, aryl receptor nuclear translocator; XRE, xenobiotic 
responsive element; CAR, constitutive androstane receptor; PBREM, phenobarbitol responsive 
enhanced module; RXR, retinoid X receptor; PXR, pregnane X receptor; PXRRE, pregane X 
receptor responsive elements; PPAR, peroxissome proliferator activated receptor; PPRE, PPAR 
responsive element; LXR, liver X receptor; LXRE, liver X receptor responsive element; FXR, 
farnesoid X receptor; FXRE, farnesoid X receptor responsive element. Adapted from Xu et al. 
(2005). 
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Thus, considering these characteristics of common regulation mechanisms and 
complementarity of substrates, it is believed that ABCB1 acts as a ﬁrst line of defence 
preventing unmodiﬁed compounds from accumulating in the cell (phase 0 of cellular 
detoxiﬁcation), while ABCCs and ABCG2 transport phase I and II metabolites, 
therefore acting in phase III of cellular detoxiﬁcation (Bard, 2000; Sturm and Segner, 
2005) (figure 1.6). Nevertheless, in aquatic organisms, only a few studies have been 
conducted in an attempt to elucidate this cooperative mechanism (Cooper et al., 1999; 
Sturm et al., 2001; Bard et al., 2002b; Paetzold et al., 2009). The majority of these 
studies have been confined to the study of Pgp and CYP1A, and results suggest that 
these two proteins should not be coordinately regulated in fish, but enhance the fact 
that they may act in complementarity in cellular detoxification. However, the database 
on the relation between Pgp and biotransformation enzymes in fish is small and 
dispersed, and the role of other ABC efflux transporters, besides Pgp, is even more 
poorly documented. Thus, the full characterization of this mechanism of cellular 
detoxification, where ABC efflux transporters and biotransformation enzymes display 
title-roles is yet far from being completely understood. Therefore, further studies are 
still needed to enlighten the underlying basis of these mechanisms of cellular 
detoxification, since this additional knowledge has implications for environmental, but 
also for human health. 
 
 
Figure 1.6 – Schematic representation of the possible cooperation of ABC efflux 
transporters (phase 0 and phase III) and biotransformation enzymes (phase I and phase 
II) in cellular detoxification (adapted from Bard et al., 2000) 
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The medical relevance of ABC transporters is evidenced by their MDR abilities 
and, under this point of view there is a fundamental need to know how to properly block 
the action of these transporters to assure the targeting efficacy of chemotherapeutic 
drugs. In addition, the study of ABC efflux transporters is also very important from an 
environmental point of view, since they are believed to an integral part of the cellular 
detoxification system. For environmentalists, the goal is to understand how these efflux 
transporters keep toxicants out of the cells, and to ensure that they operate optimally in 
order to protect the cells from environmental contaminants. 
 
1.6. PAHs (Polyciclic aromatic hydrocarbons) 
 
Polycyclic aromatic hydrocarbons (PAHs) are prevalent environmental contaminants 
commonly found in aquatic sediments and waters associated with urbanized estuarine 
and coastal areas (Meador et al., 1995). Although these contaminants can arise from 
natural sources, such as oil seeps, volcanoes and forest ﬁres, anthropogenic sources 
as vehicle exhaust, power generation and oil pollution are the main causes for 
environmental PAH contamination  (Latimer and Zheng, 2003). Structurally, PAHs are 
a large group or organic compounds with two or more fused aromatic rings, and those 
with fewer aromatic rings are more water-soluble than heavier PAHs, and therefore 
more bioavailable. PAHs are readily absorbed by fish and other aquatic animals upon 
exposure to contaminated food, water and sediments (Neff, 1985). Relative 
concentrations of PAHs in aquatic ecosystems are, generally higher in sediments, 
medium in aquatic biota and lower in water column. In the aquatic environment, the 
degradation of PAHs can occur by photo-oxidation and biological transformations 
(Valerio et al., 1984). In fish, biotransformation of PAHs occurs mostly in the liver, but 
also in the extra-hepatic tissues, like the gills and the intestine (Van veld et al., 1997). 
These compounds are easily metabolized by phase I enzymes of the MO into more 
hydrophilic products like phenols, dihydrodiols, quinines and epoxides (Lech and 
Vodicnik, 1985). Some of the PAHs can be excreted directly as unconjugated polar 
metabolites in bile, but most of them will only be excreted after conjugation by phase II 
enzymes (van der Oost et al., 2003). The major PAHs-metabolization pathway involves 
CYP MO, epoxide hydroxilase and several conjugating enzymes. Several hundreds of 
different PAHs exists, and one of the best known is Benzo(a)pyrene (BaP). BaP is a 
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benzopyrene formed by a benzene ring fused to a pyrene, and is a result of incomplete 
combustion processes. This compound was classified as a group 2A carcinogen 
(probably carcinogenic to humans) by the International Agency for Research on 
Cancer, Word Health Organization (IARC, WHO) and, due to new information 
regarding its effects, was recently upgraded to a group 1 carcinogen (carcinogenic to 
humans). Additionally, BaP is one of the 16 PAH selected by the US Environmental 
Protection Agency (EPA) as priority pollutants, due to its carcinogenic and mutagenic 
properties (Agency for Toxic Substances and Disease Registry - ATSDR 1995). In 
addition, BaP is also one of the most commonly found PAHs in aquatic environments, 
and its toxicity to aquatic biota has been intensively studied and demonstrated (James 
et al., 1991; Reynaud and Deschaux, 2006; Amanuma et al., 2008), becoming a model 
compound for the study of PAHs biotransformation (Buhler and Williams, 1989; 
Stegeman and Hahn, 1994). BaP is a procarcinogen, meaning that its carcinogenicity 
is dependent of the enzymatic metabolism that can originate toxic electrophilic 
metabolites, with the ability to covalently bind to macromolecules, such as DNA and 
proteins (James et al., 1991; Cachot et al., 2004). BaP metabolism by phase I and II 
can follow different pathways, as described in figure 1.7. Some intermediates, such as 
phenols, quinones, and dihydrodiols are non toxic, as they can be detoxified by 
conjugation with phase II enzymes (IARC, 1983). However, besides conjugation, the 
dihydrodiols can undergo further oxidative metabolism, originating more toxic 
metabolites, as for example 7,8-dihydrodiol-9,10-epoxide, a compound considered to 
be the ultimate carcinogenic metabolite of BaP (Jerina and Dansette, 1984; Schlenk et 
al., 2008).  
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Figure 1.7 - Biotransformation pathways of BaP. Source: IARC, 1983 
 
 
BaP was chosen as the model contaminant in this study, since its properties and 
effects on aquatic biota have been widely studied, and is representative of one of the 
most toxic group of pollutants commonly found in aquatic environments. Moreover, 
BaP is readily metabolized by phase I and II biotransformation enzymes, and it was 
proposed that the parent compound and/or its metabolites could have high affinity for 
ABC efflux transporters (Chao Yeh et al.,1992; Bard, 2000), thus gathering important 
characteristics for its selection as the model pollutant to assess the cooperation 
between efflux proteins and biotransformation enzymes in this study. 
 
1.7. Model species – Oreochromis niloticus (Nile tilapia) 
 
Fish offer many advantages for investigating the organism-environment interface 
due to their intimate physiological contact with the surrounding environment, and 
because they are sensitive sentinels of environmental challenge, particularly pollution. 
Additionally, their extraordinary diversity allows responses to the environment to be 
mapped onto an extensive phylogeny that extends over 500 million years of history, 
Chapter 1 
30 
 
providing insights into a range of evolutionary processes, from ancient to modern 
(Cossins and Crawford, 2005).  In this study we have used the specie Oreochromis 
niloticus, Nile tilapia, as the model species (figure 1.8). Nile tilapia is an african 
endemic cichlid species, belonging to the order of perciformes. This tropical freshwater 
species lives in shallow waters, in temperature ranges from 31 to 36 °C, but it can 
tolerate lower (<12 ºC) or higher temperatures (>42ºC), and also higher salinities (up to 
20ppt). It is an omnivorous grazer that feeds on phytoplankton, periphyton, aquatic 
plants, small invertebrates, benthic fauna, detritus and bacterial films associated with 
detritus. Presently, Nile tilapia is one of the most widely farmed freshwater fish in the 
world (Food and Agriculture Organization, FAO, 2006), having a high economical 
potential. Due to its easy handling, culture and maintenance in the laboratory, and 
because tilapia promptly responds to environmental alterations, this species is also a 
well-established model for research in a wide range of areas like toxicology (Almeida et 
al., 2001; Abdel-Tawwab et al., 2007; Coimbra et al., 2007), physiology (Wright and 
Land, 1998), endocrinology (Coimbra et al., 2005; Barreto and Volpato, 2007), genomic 
biology and molecular genetics (McConnell et al., 2000; Lee et al., 2005; Santini and 
Bernardi, 2005).  Moreover, Nile tilapia is easy to maintain and reproduce in laboratory 
conditions since it has a high fecundity rate (hundreds of eggs in a clutch), year-round 
breeding capability (2–3-week spawning cycle), and a short generation period (half a 
year). Due to the high amount of studies conducted with Nile tilapia as a model, the 
biology and physiology of this specie is well characterized (Morrison et al., 2001; 
Morrison et al., 2003; Fujimura and Okada, 2007), and, recently, detailed genomic 
information of Nile tilapia has also became available (www.ensemble.org), opening 
new comparative approaches on gene function across vertebrate species.  
 
Figure 1.8 - Nile tilapia, Oreochromis niloticus, the model specie used in the present 
study. 
a) embryos, b) larvae, c) juvenile, d) adult. 
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1.8. Objectives 
 
Studies directed to the expression and/or co-expression of ABC efflux transporters 
and biotransformation enzymes are important to better understand the mechanisms of 
cellular detoxification, and this knowledge has implications to environmental and also to 
human health. Moreover, the role of ABC efflux transporters in the efflux of metabolized 
or unmodified compounds, and the cooperation with biotransformation enzymes is 
poorly documented in the different animal models, especially in aquatic organisms. In 
order to fill these gaps, the main goals of this PhD dissertation were the following: 
1. to characterize the role of ecotoxicologically relevant ABC efflux 
transporters (ABCB1, ABCB11, ABCC1, ABCC2 and ABCG2) in the 
detoxification of PAHs in different barrier tissues of Nile tilapia; 
2. to assess the cooperation between ABC efflux transporters and 
biotransformation enzymes of phase I and phase II in the detoxification 
pathway of PAHs in fish. 
In order to achieve these goals, the following specific tasks were defined: 
1) The in vivo assessment of BaP biotransformation mechanisms in Nile tilapia, after 
different routes of exposure to the contaminant (waterborne and dietary) through the 
evaluation of phase I and phase II catalytic activities and BaP metabolites formed. 
2) The characterization of the expression, and response patterns, of ABC efflux 
transporters (ABCB1, ABCB11, ABCC1, ABCC2 and ABCG2) and biotransformation 
enzymes (CYP1A, GSTs and UGTs) in different barrier tissues of Nile tilapia (liver, gills 
and intestine) upon dietary and waterborne exposures to BaP. Characterization will be 
performed at gene level and, when possible, at protein (ABCB1 and CYP1A) and 
activity levels (CYP1A, GSTs, UGTs).  
3) The characterization of the transcriptional patterns of ABC efflux transporters and 
biotransformation enzymes of phase I and phase II during the developmental stages of 
Nile tilapia. 
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The goals of this thesis were explored throughout the following chapters: 
 Chapter 1 – General Introduction 
 Chapter 2 -  Comparision of the waterborne and dietary routes of exposure on 
the effects of Benzo(a)pyrene on biotransformation pathways in Nile tilapia 
(Oreochromis niloticus) 
 Chapter 3 - Evaluation of 3-hydroxy-benzo[a]pyrene levels in Nile tilapia 
(Oreochromis niloticus) after waterborne exposure to Benzo(a)pyrene  
 Chapter 4 - Gene expression analysis of ABC efflux transporters, CYP1A and 
GSTα in Nile tilapia after exposure to Benzo(a)pyrene  
 Chapter 5 - Tissue distribution and response patterns of Pgp and CYP1A 
proteins in Nile tilapia (Oreochromis niloticus) after waterborne exposure to 
Benzo(a)pyrene (BaP) 
 Chapter 6 - ABC transporters, CYP1A and GSTα gene transcription patterns in 
developing stages of the Nile tilapia (Oreochromis niloticus) 
 Chapter 7 – Final remarks 
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2. Comparision of the waterborne and dietary routes of exposure on 
the effects of Benzo(a)pyrene on biotransformation pathways in Nile 
tilapia (Oreochromis niloticus) 
2.1. Abstract 
 
BaP is one of the most studied PAH, due to its ubiquitous presence in aquatic 
environments and toxicity to aquatic organisms. The main goal of this study was to assess 
BaP effects in Nile Tilapia after waterborne and dietary exposures, through the evaluation 
of EROD and GST activities in liver, gills and intestine, and BaP metabolites in bile; and 
also to evaluate the usefulness of these commonly used biomarkers after two different 
routes of exposure. Waterborne exposure to BaP led to a significant induction of EROD in 
all tissues analyzed (644, 1640 and 2880% in relation to solvent in liver, gill and intestine 
respectively) while in dietary exposures EROD was induced only in intestine (3143%) after 
exposure to high BaP concentrations. GST activities with CDNB were slightly induced in 
liver (40%) and in gill (66%) after water exposure to BaP, and in intestine after dietary 
exposure to low BaP concentrations (182%). BaP metabolites in bile increased after both 
exposure routes, and were highly correlated with EROD activity after water exposure. In 
summary, this work has shown that the effects of BaP on biotransformation pathways 
depend on the route of exposure. Moreover, barrier tissues like gills and intestine also 
have an important role in the first-pass metabolism of BaP, reducing the amount of parent 
compound that reaches the liver to be metabolized. For that reason, EROD activity as a 
biomarker of exposure should also be applied in extrahepatic organs, like gills and 
intestine, in monitoring studies. Biliary BaP type metabolites are good reflectors of 
contamination levels under both exposure routes, while GST activity with CDNB as 
substrate, as a phase II enzyme, does not seem a reliable biomarker of exposure to BaP 
regardless the route of exposure. 
Keywords: Benzo(a)pyrene, biomarkers, tilapia, EROD, GST, bile metabolites 
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2.2. Introduction 
 
Polycyclic aromatic hydrocarbons (PAHs) are prevalent environmental contaminants 
commonly found in aquatic sediments and waters associated with urbanized estuarine and 
coastal areas (Meador et al. 1995). Although these contaminants can arise from natural 
sources, such as oil seeps, volcanoes and forest fires, anthropogenic sources as vehicle 
exhaust, power generation and oil pollution are the main causes for environmental PAH 
contamination  (Latimer and Zheng 2003). In aquatic organisms, the uptake of pollutants 
can occur through the contact of contaminated food, water and sediments (Bruggeman et 
al. 1984; Hendricks et al. 1985), and the degree of toxicity can be influenced by the route, 
by the dose and by the duration of exposure (Grimmer et al. 1988; Driver et al. 1991; 
Bloomquist 1992). One of the most common and toxic PAH in the aquatic environments is 
Benzo(a)pyrene (BaP) and its carcinogenic and mutagenic properties are widely studied 
(Buhler and Williams 1989; Tsukatani et al. 2003). The great majority of the studies 
focusing on BaP effects in the detoxification mechanisms in aquatic organisms have used 
intraperitoneal injections (Van Der Weiden et al. 1994; Pacheco and Santos 1998; Nacci et 
al. 2002; Wang et al. 2006; Wang et al. 2008; Nahrgang et al. 2009) as the route of 
exposure. Some studies have investigated the effects on the detoxification mechanisms of 
BaP after dietary (Hendricks et al. 1985; Wolkers et al. 1996; Reynolds et al. 2003), and 
waterborne exposure routes (Levine and Oris 1999; Wu et al. 2007; Ortiz-Delgado et al. 
2008; Wang et al. 2008) which are two of the most important routes of pollutants uptake in 
aquatic organisms. However, to our knowledge, there is still a lack of studies that directly 
compare the biochemical effects of different concentrations of the same contaminant after 
both exposures routes in the same species.  
In fish, as in other vertebrates, exposure to PAHs results in the induction of 
enzymatic systems involved in the metabolism of the xenobiotic compound, for the 
detoxification of the organism (Black and Coon 1987; Buhler and Williams 1989) due to a 
high-affinity of these pollutants to bind the aryl-hydrocarbon receptor (AhR). Studies in 
mammals have shown that the activation of the AhR-dependent signal transduction 
pathway controls the expression of several genes, including cytochrome P4501A (CYP1A) 
and some glutathione-S-transferase (GST) genes (Hankinson 1995, Schmidt and Bradfield 
1996, George 1994). Like in mammals, in fish these genes are believed to be primarily 
involved in hepatic biotransformation of pollutants, like PAHs (reviewed in Van der Oost et 
al. 2003). The measurement of phase I and phase II biotransformation enzymes hepatic 
activities, have been widely applied as biomarkers of biochemical effects, and as a 
complement to chemical analysis (Ferreira et al. 2006, Ferreira et al. 2008, Richardson et 
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al. 2001, Nahrgang et al. 2009; Reis-Henriques et al. 2009, Jönsson et al. 2009). However, 
despite the fact that the liver is considered to be main site of CYP1A expression, its 
expression and induction has been observed in other tissues as well, including those in 
direct contact to the environment, such as gills (Jönsson et al., 2004, 2006, Nahrang et al., 
2010a, 2010b) and intestine (James et al., 1997, McElroy and Kleinow, 1992). 
Nevertheless, the relative importance of branchial and intestinal uptake route to the overall 
exposure remains poorly understood. After PAH metabolism in the liver, their metabolites 
are secreted into the bile, stored in the gall bladder and excreted to the intestinal tract (Au 
et al. 1999). Therefore, due to their high metabolism rate in fish (Meador et al. 1995), 
PAHs tend not to bioaccumulate in tissues, and the direct quantification of these 
compounds in fish tissues may not yield an accurate estimation of contaminant exposure 
and uptake. As a result, the measurement of PAHs metabolites in fish bile is considered a 
reliable method for assessing the degree of exposure of the organisms to these types of 
pollutants (Krahn et al. 1986). In this study, Nile tilapia (Oreochromis niloticus) was used 
as model species. Besides being an economically important cultured species, namely in 
Asia and Africa, Nile tilapia is also a well established model in many toxicological studies 
(Almeida et al. 2001; Straus 2003; Coimbra et al. 2005, 2007; Figueiredo-Fernandes et al. 
2006).  
The main objectives of the present work were to evaluate differences in the 
detoxification mechanisms in juvenile Nile tilapia, after waterborne and dietary exposure 
routes to BaP. Biochemical effects of BaP were assessed, by means of 7-ethoxyresorufin 
O-deethylase (EROD) and glutathione-S-transferase (GST) activities as a measure of 
phases I and II of the biotransformation mechanism, in liver, gills and intestine. 
Additionally, fixed wavelength fluorescence (FF) was used to quantify BaP type 
metabolites as fluorescent aromatic compounds (FACs) in bile.  
 
2.3. Materials and methods 
 
2.3.1. Chemicals  
Benzo(a)pyrene (99% purity), resorufin sodium salt, 7-ethoxyresorufin, ß-NADPH 
(95% purity), BSA (99% purity), 1-chloro-2,4-dinitrobenzene  (CDNB, 97% purity), α-
Dithiothreitol (99% purity), GSH (99% purity) were purchased from Sigma Aldrich, 
Germany. All the other chemicals were of analytical grade, and were purchased from local 
companies.  
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2.3.2. Animals  
 
All animals used in this study were born and raised in the laboratory (CIIMAR, Porto, 
Portugal). The corresponding breeders stock was obtained from the Aquaculture Station of 
UTAD (Universidade de Trás-os-Montes, Portugal). Fish used in all assays were juveniles, 
and therefore not sexually mature, as confirmed by macroscopic analysis of the gonads 
when animals were sacrificed. Until the start of the exposure assays, fish were kept in 60 L 
aquaria supplied with biological filtration. Prior to the experiments, animals were randomly 
distributed in the experimental aquaria (30 L), and submitted to an acclimatation period of 
one week. All tanks were supplied with continuous aeration to maintain dissolved oxygen 
near saturation. Dechlorinated tap water was used at a temperature of 20 ± 2 ºC, with a 
12h:12h (light:dark) photoperiod, and fish were fed commercial food pellets (Aquasoja, 
Portugal) until satiation, once a day.  
 
2.3.3. Stock solutions of BaP and preparation of contaminated food 
 
For the waterborne exposures, stock solutions of BaP were prepared in acetone 
(0.5, 1.25, 2.5 and 5 g/L) and were administered directly in the experimental aquaria. The 
percentage of solvent added in the experimental aquariums was 0.002%. For the dietary 
exposures stock solutions of BaP with concentrations of 0.1 and 40 g/L were prepared, 
respectively for the first and second assays. The contaminated diets were prepared by 
immersion of food pellets in BaP stock solutions diluted in acetone, in a proportion of 0.32 
ml/g of food. For control groups, nothing was added to the food pellets, and for solvent 
control groups only acetone was added to the food pellets. Acetone was evaporated under 
air current for 24 hours, until the pellets were completely dry, and diets were stored at -20 
ºC until further use.  
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2.3.4. Xenobiotic exposures 
 
For the water exposure, juvenile Nile tilapia (N=116, average weight of 14.2±0.6 g, 
average length of 9.30±0.14 cm) were exposed to nominal water concentrations of 10, 25, 
50 or 100 µg of BaP/L for 14 days. Also, a control group and a solvent control group (only 
solvent was added) were maintained. All treatments were performed in duplicate, with two 
exposure tanks per concentration. Waterborne exposures were conducted in semi-static 
conditions in 30 L aquaria. Daily, 80% of the water was renewed, followed by the addition 
of fresh BaP solution or solvent to each one of the treatment groups. Animals were fed to 
satiation every two days, with the exception of the day before sampling. Sampling was 
performed prior to the first BaP addition, and 7 and 14 days after the contaminant addition. 
For dietary exposures two experiments were conducted, and fish were maintained in 
30 L aquaria in continuous water flow conditions, which assured 100% of water renewal 
per day. In the first assay, juvenile tilapia (N=72, average weight of 11.21±1.00 g, average 
length of 8.47±0.27 cm) were exposed to 1 and 10 µg of BaP/g of food for 14 days. In the 
second dietary assay, fish (N=129; average weight: 11.15±0.42 g, average length of 
8.49±0.09 cm) were exposed to 100 and 200 µg of BaP/g of food for 21 days. Fish were 
sampled before the addition of BaP contaminated diets, and at days 7, 14 and 21 (only in 
the second experiment).  In both assays a control (uncontaminated food) and a solvent 
control group (acetone alone) were maintained, and duplicates were made for each 
treatment, with two exposure tanks per concentration. Fish were fed daily at a rate of 3% 
of body weight. After feeding, animals were observed, to assure that the total of the food 
was consumed in 2 or 3 minutes. After every sampling point, animals were weighted in 
order to recalculate the amount of food necessary for each tank, to maintain the 
percentage of feeding at 3% body weight.  
 
2.3.5. Sampling 
 
Fish were anesthetized on ice cold water and sacrificed by decapitation, and body 
weight and length were recorded for subsequent calculation of condition factor (CF = body 
weight (g) X 100/ body length3 (cm)). Liver, gills and intestine were excised from the 
animal, and bile was collected from the gall bladder with a 1ml syringe. Liver weight was 
recorded for the calculation of hepatic somatic index (HSI = liver weight (g)/body weight (g) 
X100). Liver, gills, intestine, and bile were immediately frozen in liquid nitrogen, and stored 
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at -80ºC until further use. CF and HSI prior to the beginning of the water assay were 
1.66±0.04 and 1.33±0.11, respectively. Before the dietary exposures, CF and HSI were 
1.62±0.07 and 1.21±0.07 for the first assay, and 1.68±0.03 and 1.95±0.05 for the second 
assay, respectively. No significant differences were seen in these parameters during the 
course of the experiments, indicating that the overall condition of the animals was 
maintained during the experimental periods (Ricker 1975, Grant and Brown 1999). 
 
2.3.6. BaP determination in water and food samples 
 
To determine the real concentration of BaP in the water of the experimental aquaria, 
BaP was extracted from water samples according to the method described by Cheikyula et 
al. (2008), and assessed by the method of Rey-Salgueiro et al. (2008). After the addition of 
the contaminant, the real concentrations of BaP in water samples were 10.49, 22.51, 41.46 
and 84.77 µg/L, respectively for the nominal concentrations of 10, 25, 50 and 100 µg/L. 
After 24 hours, and before the addition of fresh contaminant to the aquaria, the amount of 
BaP still present in each one of the treatment groups was 0.34, 0.69, 12.19 and 25.70 
µg/L. In water collected from control and solvent control groups no BaP was detected at 
both times. 
Food pellets supplied to the fish in dietary exposures were also analyzed in terms of 
BaP concentration, according to the method described by Rey-Salgueiro et al. (2009). The 
real BaP concentrations in the food pellets were 0.06, 0.07, 0.42, 3.99, 36.24 and 92.70 
µg/g, respectively for control, solvent, 1, 10, 100 and 200 µg/g. 
 
2.3.7. Biochemical analysis 
 
EROD activity was measured according to Ferreira et al. (2008) in the microssomal 
fraction of liver, gills and the first one-third of the intestine. Briefly, tissues were 
homogenized in ice cold buffer (50 mM Tris-HCl, 0.15 M KCl, pH 7.4), and microsomes 
were obtained by centrifugation of the 9000 g supernatant at 36000 g for 90 minutes at 4 
ºC.  The pellet was then ressuspended in buffer (50 mM Tris-HCl, 1 mM Na2EDTA, 1 mM 
dithiothreitol, 20% v/v glycerol pH 7.4) and spun down at 36000 g for 120 minutes (Bucheli 
and Fent 1995). Microsomes were suspended in EDTA-free resuspension buffer and 
stored at -80 ºC until use. Microsomal suspension (20 µl), with average protein 
concentration of 3.01±0.20 mg/ml, was incubated with ethoxyresorufin (2 µM in 50 mM 
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Tris-HCl, 1 mM dithiothreitol, 0.15 M KCl, pH 8.0) for 1 minute, and the enzymatic reaction 
was initiated by the addition of NADPH 4.5 µM. EROD activity was measured for 5 minutes 
at λex530 nm and λem585 nm, by fluorometry, and determined by comparison to a 
resorufin standard curve (concentrations range from 3 to 100 nM). Hepatic EROD activity 
was expressed in pmol/min/mg protein. During the procedure of microsomes isolation, an 
aliquot of the cytosolic fraction (obtained after the 9000 g centrifugation) was separated for 
the analysis of GST activity. GST was determined according to the method of Habig et al. 
(1974), adapted to microplates as described in Ferreira et al. (2008), using glutathione 
(GSH) 10 mM in phosphate buffer 0.1 M, pH 6.5, CDNB 60 mM in ethanol prepared just 
before the assay. The reaction mixture was composed by 1.5 mM GSH and 1.5 mM CDNB 
in phosphate buffer. In the microplate, 0.2 ml of the reaction mixture was added to 0.1 ml 
of sample, corresponding to 0.3 mg of protein, with a final concentration of 1 mM GSH and 
1 mM CDNB in the assay. The GST activity was measured immediately every 20 seconds, 
at 340 nm, during the first 5 minutes, and calculated in the period of linear change of the 
absorbance. GST activity was expressed in nmol/min/mg protein. In each treatment group, 
EROD and GST activities were analysed in 4-10 individuals, depending on the tissue. 
Protein content in all assays was determined by Lowry method (Lowry et al. 1951), in the 
correspondent fraction.  
 
2.3.8. BaP metabolites in fish bile 
 
BaP metabolites in the bile were determined through fixed wavelength fluorescence 
(FF). Bile samples from control and solvent control of water exposed animals, and from 
food exposed groups were diluted 1:1000 in ethanol 48%. Bile from water exposed 
animals was further diluted to 1:10000 (10 and 25 µg/L) and 1:100000 (50 and 100 µg/L). 
FF was performed at the excitation/emission wavelength pair 380/430 nm, since BaP 
metabolites are more efficiently detected at these wavelengths (Krahn et al. 1993, Lin et al. 
1996). Measurements were performed on a BIOTEK SFM25 fluorimeter. The FF values 
were expressed as arbitrary fluorescence units (a.f.u.) after subtracting the signal levels of 
the solvent. The bile pigment biliverdin was measured at 380 nm in all samples to estimate 
bile density, and BaP metabolites fluorescence was normalised to biliverdin, to check if 
differences in fluorescence intensity could result from differences in bile densities. BaP 
metabolites were analysed in bile of 4-10 individuals of each treatment group. 
 
Chapter 2 
60 
 
2.3.9. Statistical analysis 
 
Exposure time and treatment effects were evaluated by means of a one-way ANOVA 
for each one of the mentioned factors, followed by a multiple comparision test (Tukey´s 
test) at a 5% significance level. Some data had to be log transformed in order to fit ANOVA 
assumptions. Correlations and all the tests were performed using the software Statistica 7 
(Statsoft, Inc., 2004). No differences were observed between replicates of the same 
treatment, nor in control treatments between days, nor between control and solvent control 
during the exposure time. Therefore, in all biomarkers analysed, results were presented as 
percentage in relation to solvent control only. Results were shown as mean±standard 
error. 
 
2.3.10. Ethics statement 
 
The animals used in the research that is described in this paper were treated in 
accordance with the Portuguese Animals and Welfare Law (Decreto-Lei nº 197/96) 
approved by the Portuguese Parliament in 1996. 
 
2.4. Results 
 
Mean control values of EROD activity in all assays were 38.09±3.85, 2.09±0.23 and 
1.10±0.10 pmol/min/mg of protein, respectively for liver, gill and intestine. GST had mean 
activities in control groups of 120.79±4.46, 63.96±3.51 and 49.16±3.73 nmol/min/mg of 
protein, in liver, gill and intestine, respectively. BaP metabolites in bile were 4584±410 
a.f.u. in control animals. 
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Figure 2.1 - EROD activities in liver (a), gill (b) and intestine (c) of Nile Tilapia after 
waterborne exposure to BaP (Solvent, 10, 25, 50 and 100 µg/L).  
Values are expressed in percent of activity (pmol/min/mg of protein) in relation to solvent set to 
100%, and are shown as mean ± standard error. Asterisks (*) denote significant differences 
(p<0.05) in comparison to solvent. Capital letters denote significant differences (p<0.05) between 
days within the same treatment. n = 4-10. 
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2.4.1. Water exposure 
 
Biomarkers evaluated after waterborne exposure to BaP are shown in figures 2.1 
(EROD activity), 2.2 (GST activity) and 2.3a (BaP metabolites in bile).   
Results show that water exposure caused BaP dose-related increases of EROD 
activity in liver (figure 2.1a), gills (figure 2.1b) and intestine (figure 2.1c). Moreover, EROD 
activity was, in most of the treatments, significantly different from solvent control (p<0.05) 
in all three tissues. Exceptions were exposure to 10 and 25 µg/L at day 14 in liver, and in 
intestine exposure to 10 µg/L (at days 7 and 14) and 25 µg/L (at day 7). Regarding the 
effects of time of exposure, a significant increase between days 7 and 14 was seen in gills 
and intestine after exposure to 25 µg/L of BaP. When comparing the extent of EROD 
activity increase over the solvent control, maximum increases were seen in intestine (from 
105 to 2876% increase, figure 2.1c), followed by gills (from 544 to 1639% increase, figure 
2.1b) and liver (from 70 to 644% increase, figure 2.1a).  
Regarding phase II enzyme, GST, its activity, increased significantly (p<0.05) in liver 
(after 14 days of exposure – figure 2.2a) and gills (after 7 days of exposure – figure 2.2b) 
upon exposure to 100 µg/L of BaP (39 and 66% increases respectively). At day 7 no 
differences were seen in GST intestine activity, but after 14 of exposure its activity 
decreased significantly (p<0.05) after exposure to 50 and 100 µg/L, achieving a maximum 
decrease over solvent control of 64% after exposure to 100 µg/L of BaP (figure 2.2c).   
BaP metabolites in bile of exposed animals (10, 25, 50 and 100 µg/L) were always 
significantly higher than the levels recorded in solvent, and increased with the 
concentration of the contaminant and with the time of exposure, with the exception of 100 
µg/L at day 14 (figure 2.3a). Results showed that after 7 days of exposure to 10 µg/L, BaP 
type metabolites were 83 times higher when comparing to the solvent (8256% increase), 
and the maximum levels were seen after 14 days of exposure to 50 µg/L, with a 356 fold 
increase (35590%). Moreover, BaP metabolites showed significant positive correlations 
(p<0.05) with EROD activity in liver (r=0.92), gills (r=0.89) and intestine (r=0.65).  
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Figure 2.2 - GST activities in liver (a), gill (b) and intestine (c) of Nile Tilapia after waterborne 
exposure to BaP (Solvent, 10, 25, 50 and 100 µg/L).  
Values are expressed in percent of activity (nmol/min/mg of protein) in relation to solvent set to 
100%, and are shown as mean ± standard error. Asterisks (*) denote significant differences 
(p<0.05) in comparison to solvent. Capital letters denote significant differences (p<0.05) between 
days within the same treatment. n = 4-10. 
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Figure 2.3 – BaP type metabolites in bile after waterborne exposure to BaP (a), first dietary 
exposure to BaP (b) and second dietary exposure to BaP (c).  
Values are expressed percent of arbitrary units of fluorescence (a.f.u.) in relation to solvent set to 
100%, and are shown as mean ± standard error. Asterisks (*) denote significant differences 
(p<0.05) in comparison to solvent. Capital letters denote significant differences (p<0.05) between 
days within the same treatment. n = 4-10. 
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2.4.2. Diet exposure  
 
Results of EROD and GST activities in Nile tilapia after dietary exposure to 1 and 10 
µg of BaP/ g of food are shown in figures 2.4 and 2.5, respectively. 
EROD activity in exposed animals was not different from solvent control during the 
exposure periods in any of the tissues analyzed (figure 2.4). A significant decrease in 
EROD activity was seen from day 7 to day 14 at 1 µg/g of BaP in liver (figure 2.4a) and in 
gills (figure 2.4b). Phase II enzyme activity, GST, did not change in liver (figure 2.5a) nor in 
gill (figure 2.5b), and was only induced in the intestine, and after 7 days of exposure to 10 
µg/g; however this induction was not sustained until day 14 (figure 2.5c). Regarding BaP 
metabolites in bile (figure 2.3b), BaP exposed groups showed higher levels when 
comparing to the solvent group, with significant differences at 10 µg/g of BaP at days 7 
(149% increase) and 14 (158% increase) (p<0.05).  
EROD and GST activities in liver, gills and intestine measured in the second diet 
experiment are displayed in figures 2.6 and 2.7, respectively.  
In liver (figure 2.6a), results point to a pattern of EROD activity reduction after dietary 
exposure to 100 and 200 µg of BaP/g of food. This reduction was statistically supported at 
day 7 after exposure to 200 µg of BaP/g (45% decrease), and at days 14 and 21 to both 
BaP concentrations (p<0.05), with a maximum decrease of 68% after 14 days of exposure 
to 200 µg/g. Moreover, lower levels of EROD activity were detected in 200 µg of BaP/g of 
food than 100 µg/g at days 7 and 14, and at day 21 similar levels of EROD were recorded 
in both concentrations. Gill EROD activity did not change during the exposure to dietary 
BaP (figure 2.6b). However, a significant increase of intestinal EROD activity was seen in 
exposed animals during the course of the experiment, with a maximum increase occurring 
after 21 days of exposure to 100 µg/g (3142% increase over solvent control). Furthermore, 
there was a significant increase in intestinal EROD activity from day 7 to day 21 at this 
BaP concentration (figure 2.6c).  
High dietary exposures caused no significant changes in GST activity in any of the 
tissues analyzed, as it can be seen in figure 2.7. BaP type metabolites (figure 2.3c) were 
always significantly higher in exposed animals (100 and 200 µg/g), with increases in 
relation to solvent ranging from 471% (200 µg/g, day 7) to 980% (200 µg/g, day 14). 
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Figure 2.4 – EROD activities in liver (a), gill (b) and intestine (c) of Nile tilapia after the first 
dietary exposure to BaP (Solvent, 1 and 10 µg of BaP/g of food).  
Values are expressed in percent of activity (pmol/min/mg of protein) in relation to solvent set to 
100%, and are shown as mean ± standard error. Asterisks (*) denote significant differences 
(p<0.05) in comparison to solvent. Capital letters denote significant differences (p<0.05) between 
days within the same treatment. n=4-8. 
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Figure 2.5 – GST activities in liver (a), gill (b) and intestine (c) of Nile tilapia after the first 
dietary exposure to BaP (Solvent, 1 and 10 µg of BaP/g of food).  
Values are expressed in percent of activity (nmol/min/mg of protein) in relation to solvent set to 
100%, and are shown as mean ± standard error. Asterisks (*) denote significant differences 
(p<0.05) in comparison to solvent. Capital letters denote significant differences (p<0.05) between 
days within the same treatment. n=4-8. 
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Figure 2.6 – EROD activities in liver (a), gill (b) and intestine (c) of Nile tilapia after the 
second dietary exposure to BaP (Solvent, 100 and 200 µg of BaP/g of food).  
Values are expressed in percent of activity (pmol/min/mg of protein) in relation to solvent set to 
100%, and are shown as mean ± standard error. Asterisks (*) denote significant differences 
(p<0.05) in comparison to solvent. Capital letters denote significant differences (p<0.05) between 
days within the same treatment. n=4-10 
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Figure 2.7 – GST activities in liver (a), gill (b) and intestine (c) of Nile tilapia after the second 
dietary exposure to BaP (Solvent, 100 and 200 µg of BaP/g of food).  
Values are expressed in percent of activity (nmol/min/mg of protein) in relation to solvent set to 
100%, and are shown as mean ± standard error. Asterisks (*) letters denote significant differences 
(p<0.05) in comparison to solvent. Capital letters denote significant differences (p<0.05) between 
days within the same treatment. n = 4-9. 
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2.5. Discussion  
 
In recent years, there has been an increasing concern over the possible degradation 
of aquatic environments due to chemical pollution caused by PAHs, among other 
pollutants.  The main reasons for that concern lie in the fact that these are widely spread 
contaminants with a high toxic potential for living organisms (Icarus Allen and Moore 
2004). As a result, increased efforts have been made in order to understand the causal 
relationships between contaminant exposure and measurable biological and biochemical 
effects in aquatic organisms, with the integrated use of biomarkers of exposure. In the 
present study we aimed to achieve a deeper understanding of the effects of BaP in Nile 
tilapia, after two routes of exposure, waterborne and dietary exposures, and also to assess 
the usefulness of widely used biomarkers in monitoring studies.  
After water exposure to BaP, EROD activity in liver (figure 2.1a), gills (figure 2.1b) 
and intestine (figure 2.1c) increased during the exposure period. These results show that 
waterborne exposure led to BaP metabolism in liver and also in extrahepatic tissues, as 
gills and intestine. Liver is considered to be the main metabolizing organ in fish, having 
larger amounts of CYP1A enzymes than other tissues (as gills and intestine) (Hinton et al. 
2008), and induction of hepatic EROD activity upon exposure to PAHs has been described 
in other studies (Whyte et al. 2000; Van der Oost et al. 2003; Ortiz-Delgado et al. 2008; 
Kopecka-Pilarczyk and Correia 2009). This is in agreement with our study since hepatic 
EROD was strongly induced after exposure to waterborne BaP, and the levels of EROD 
activity were considerably higher in liver than in gill or intestine. The strong gill EROD 
induction observed after waterborne exposure to BaP also indicates that a rapid absorption 
of this compound occurs in this tissue, and supports the idea that gills work in the first-pass 
metabolism of BaP. Similar results, with gill EROD induction following BaP exposure, were 
obtained in other fish species as polar cod (Nahrgang et al.2010a) and rainbow trout 
(Jönsson et al. 2006). EROD induction observed in the intestine of BaP exposed animals 
was due to ingested contaminated water that was metabolized by intestine CYP1A 
enzymes, before reaching the liver. Although Nile tilapia is  a freshwater specie, and 
therefore a specie who doesn´t drink water in large quantities, there is always some 
ingestion of water during feeding and breathing behaviors. Furthermore, our results are in 
agreement with immunohistochemical studies that compared the cellular expression of 
CYP1A in different tissues, and that showed that exposure to waterborne BaP resulted in 
high staining in gill pillar cells and hepatocytes and mildly staining in gut mucosal 
epithelium (Van Veld et al. 1997). 
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Some authors have shown that gill EROD activity turned out to be more sensitive than the 
liver in terms of CYP1A induction to waterborne BaP (Jönsson et al., 2006). The same 
happened in our study, with gill and intestine showing to be more sensitive than liver to the 
presence of BaP, which strengthens the idea that it becomes useful to measure EROD 
activity in extrahepatic tissues, that are involved in the first-pass metabolism of this 
compound (Levine and Oris, 1999). 
After dietary exposures to BaP, the most significant result was the induction of 
EROD activity in the intestine, after exposure to the highest BaP concentrations (figure 
2.6c). This type of response, with induction of intestinal but not hepatic EROD activity, 
have also been shown in other studies in liver (Reynolds et al. 2003, Van Veld et al. 1987) 
and intestine (Van Veld et al., 1987, James et al., 1997, McElroy et al., 1992) of fish 
exposed to dietary PAHs. Also, immunohistochemical studies showed that exposure to 
dietary BaP resulted in moderate CYP1A staining in liver but high intensity staining in gut 
mucosal epithelium (Van Veld et al. 1997; Ortiz-Delgado et al. 2005). We believe that, in 
our study, the absence of hepatic EROD induction following dietary exposures maybe 
directly related to partial BaP biotransformation in the intestine (by CYP1A enzymes), 
limiting the amount of parent compound that reaches the liver for hepatic metabolism, as 
confirmed by the induced intestinal EROD activity of these animals. However, in the 
second dietary assay, a reduction of hepatic EROD activity was seen after exposure to 
high BaP concentrations (figure2.6a), being statiscally significant at both concentrations at 
day 21. This situation could have been a result of protein degradation caused by the high 
concentrations of BaP used (reviewed in Whyte et al. 2001), or due to suppression of 
CYP1A at a post-transcriptional level mediated through a down regulation of the CYP1A 
protein (Schlezinger and Stegeman 2001). On the other hand, it is well known that BaP 
biotransformation can originate more toxic metabolites (Bauer et al., 1995; Kim et al., 
1998, Morthy et al. 2003), and it is possible that part of this metabolites (formed mostly 
after intestinal CYP1A metabolism) could have entered systemic circulation (Kleinow et al., 
1998), causing toxic effects at hepatic level that may have reflected in the lower EROD 
activities of this tissue. However, although the decrease of hepatic EROD activity was 
statistically significant, it was relatively weak, leading us to also consider the hypothesis of 
not being physiologically relevant.  
BaP type metabolites measured in bile, increased after water exposure to BaP 
(figure 2.3a), and were highly correlated with liver (r=0.92; p<0.05), gill (r=0.89; p<0.05) 
and intestine (r=0.65; p<0.05) EROD activities. The liver correlation corroborates the fact 
that exposure of fish to waterborne BaP, leads to a pathway of high hepatic metabolism by 
CYP1A enzymes. Moreover, correlations between EROD and bile metabolites in 
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extrahepatic tissues also suggest that the majority of BaP metabolites formed in gill and 
intestine are reabsorbed into the blood stream and then released in the gall bladder. 
Regarding BaP type metabolites in the dietary experiments, an increase was also seen in 
BaP exposed animals (figures 2.3b and 2.3c), that was correlated with intestinal EROD 
activity (r=0.62, p>0.05), but not with hepatic EROD activity. Taken together these results 
indicate that, probably, dietary BaP metabolites formed in the intestine were reabsorbed 
into the blood for enterohepatic circulation and then excreted in the bile, as shown by 
Kleinow et al. 1998. Although we cannot compare the real amount of BaP that is 
metabolized under each one of the routes of exposure, it seems also important to highlight 
the fact that, levels of BaP metabolites were much more elevated after water exposure 
(achieving a fold increase of 356 times over solvent) than after dietary exposures 
(achieving a fold increase of 10 times over the solvent), despite the very high levels of BaP 
used after both exposures routes. These results suggest that, in field studies, the levels of 
biliary metabolites may give an indication of the main route of exposure to the 
contaminant. 
Results obtained for phase II enzyme GST were not very clear, since in the case of 
changes in activity after BaP exposure, only slight variations were seen. The data available 
in the literature regarding GST use as a biomarker of exposure to pollutants is not very 
consistent, since some authors reported increases in this enzyme activity, while others did 
not observe any changes or even reported considerable reductions in its activity after 
exposure to PAH contaminants (reviewed in Van der Oost et al. 2003). Induction of GST 
activity was reported after waterborne exposure to BaP of P. microps (Vieira et al. 2008) 
and S. marmoratus (Wu et al. 2007). When it comes to dietary exposures to contaminants, 
some authors reported inductions of intestinal GST activities, but no induction of hepatic 
GST (Van Veld et al. 1991; James et al. 1997), suggesting a complementary role with 
phase I EROD in biotransformation of contaminants. Our findings corroborate the idea that 
phase II enzyme GST with CDNB as substrate has low sensibility to the presence of BaP, 
and should not be applied per se, as a biomarker of exposure to this pollutant. However, 
on the basis of substrate specificity, immunological cross reactivity and protein sequence 
data, mammalian citosolic GSTs have been grouped into seven classes: Alpha, Mu, Pi, 
Theta, Sigma, Omega and Zeta (Hayes et al., 2005) and previous publications have 
considered that the GST isoforms have distinct affinities towards the substrate CDNB 
(Hoarau et al. 2002; Martinez-Lara et al., 1996). Moreover, some studies have shown that, 
in fish, different responses are seen in GST isoforms after exposure to xenobiotics (Kim et 
al., 2010; Pérez-Lopez et al., 2002; Martinez-Lara et al., 1996), with some showing 
inducing patterns, while others do not. Therefore it is possible that, if some isoforms were 
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upregulated and others downregulated due to BaP exposure, the net result could be no 
change on total GST activity, which can possibly mean that the lack of changes in GST 
activity after BaP exposure does not necessarily indicate that this compound had no effect 
on GST activity.  
In conclusion, this study has shown that the disposition and effects of BaP in 
biotransformation pathways in Nile tilapia depend on the route of exposure to the 
contaminant. Waterborne exposure to BaP resulted in an induction of phase I enzyme 
EROD in liver, gill and intestine, while in dietary exposure route induction of EROD was 
only seen in intestine, and after exposure to the highest concentrations of the pollutant. 
Therefore, EROD activity is a reliable biomarker of exposure to BaP in Nile tilapia and, 
besides liver, barrier tissues, like gills and intestine, should also be considered in 
biomonitoring studies. BaP metabolites are good reflectors of exposure to BaP, despite the 
route of exposure, and the levels of metabolites can also be indicative of the route of 
exposure, since water exposure leads to much higher levels of the metabolites than dietary 
exposure. The activity of phase II enzyme GST with CDNB does not seem as a reliable 
biomarker of exposure to BaP regardless the route of exposure. 
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3. Evaluation of 3-hydroxy-benzo[a]pyrene levels in Nile tilapia 
(Oreochromis niloticus) after waterborne exposure to Benzo[a]pyrene 
 
3.1. Abstract 
 
3-hydroxy-benzo[a]pyrene (3-OH-BaP), a toxic compound with the ability to 
covalently bind to macromolecules (proteins and DNA), is one of the major phenolic 
metabolites of benzo(a)pyrene (BaP). The purpose of this study was to evaluate the 
presence of 3-OH-BaP in bile and plasma of Nile tilapia by HPLC with fluorescence 
detection, after waterborne exposure to BaP (10 and 100 µg L-1). Metabolites were 
detected in bile and plasma, and conjugates of 3-OH-BaP (glucuronide and/or sulphate 
conjugates) were the majority forms in both biological fluids, being the glucuronide 3-OH-
BaP the main metabolite in bile. Our data suggest that extrahepatic tissues as intestine or 
gill are important in BaP metabolism and should be considered sources of metabolites 
released into the blood. Although, low levels of 3-OH-BaP in toxic form (free form) were 
detected in plasma, we must not exclude the possibility of circulating levels leading to toxic 
effects. 
 
 
 
Keywords: PAHs, metabolites, plasma, fish, bile, HPLC-fluorescence 
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3.2. Introduction 
 
Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous contaminants present in the 
marine environment as a result of natural sources, such as incomplete combustion of 
organic material, but mainly arising from human activities, as uncontrolled spills, river 
transport, surface runoff and atmospheric deposition (Latimer and Zheng 2003). 
Benzo(a)pyrene (BaP), one of the 16 PAHs selected by the US Environmental Protection 
Agency (EPA) as priority pollutants, is probably the most thoroughly studied and the most 
representative of this class of contaminants due to its carcinogenic and mutagenic 
properties (ATSDR 1995; IPCS 1998). 
Fish can absorb BaP through the body surface, the gills and by ingestion of 
contaminated sediment or food, being distributed to tissues by the blood flow (Di Giulio 
and Hinton 2008; Fragoso et al. 2006; Varanasi et al. 1989). Upon exposure, fish have a 
well-developed system that will rapidly metabolize BaP in two phases (Varanasi et al. 
1989), in a complex mixture of quinones, phenols, dihydrodiols, triols and tretols (Kennedy 
and Tierney 2008; Willett et al. 2000; Zhu et al. 2008). In phase I, BaP is metabolized into 
hydroxylated derivatives (OH-BaP) by the multienzymatic system cytochrome P450 
(CYP450), being predominant the CYP 1A1 isozyme, although 1A2, 2A1 and 1B1 can also 
be active at a minor extent (Kim et al. 1998). In phase II, the OH-BaP metabolites are 
conjugated with polar endogenous constituents such as glucuronic acid, sulphate or 
glutathione by UDP-glucuronyl transferase, sulfotransferase and glutathione-S-transferase, 
respectively, to produce water-soluble conjugates that are easily excreted by fish (Ferreira 
et al. 2010; Tuvikene 1995). BaP metabolites produced in liver are secreted into the bile, 
concentrated and stored in the gallbladder before excretion into the intestine (Ferreira et 
al. 2006; Wang et al. 2008; Zhu et al. 2008). Although the liver is a major site of 
biotransformation of BaP, it can also occur in extrahepatic tissues as intestine, gills and 
kidney (Costa et al. 2011; James et al. 1996; Kleinow et al. 1998; Lemaire et al. 1990). 
Reactive metabolites produced in these tissues can be transferred to the blood for 
elimination but can also be re-distributed to other organs, interfering with their functions 
and, as a consequence, causing toxicity. 
BaP itself is a relatively inert molecule, but their electrophilic metabolites are toxic, 
mutagenic, with the ability to covalently bind to macromolecules, such as proteins and 
DNA (Cachot et al. 2004; Fertuck et al. 2001; James 1991). One of the major phenolic 
metabolites of BaP formed in many species, including fish, is the 3-hydroxy-
Benzo(a)pyrene (3-OH-BaP) which is produced in liver (Wang et al. 2008; Zhu et al. 2008) 
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and intestine (James et al. 2001). Due to toxic features of 3-OH-BaP, it should be more 
studied in the toxicological context, including it distribution to fish tissues. And, although, 
the blood plays an important role in the distribution of chemicals to organs, there is a lack 
of studies that measure BaP and metabolites in this tissue. Recently, BaP metabolism in 
extrahepatic tissues has been confirmed in Nile tilapia (Costa et al. 2011) which makes 
reasonable for the presence of metabolites in blood. Nile tilapia has been used in several 
toxicological studies and is considered a good model species to assess pollutants 
biological effects (Coimbra et al. 2007; Pereira Trídico et al. 2010). The main aim of the 
present work was to evaluate the presence of BaP and the metabolite, 3-OH-BaP, free and 
conjugated, in plasma and bile of Nile tilapia (Oreochromis niloticus) after waterborne 
exposure to BaP. Possible correlations with biotransformation enzymes in liver, intestine 
and gill, will be also assessed.  
 
3.3. Material and methods 
 
3.3.1. Chemicals and materials 
 
Benzo(a)pyrene (99% purity), 3-hydroxy-Benzo(a)pyrene, tert-butyl hydroquinone 
(97% purity), 4-Methylumbelliferone, ß-glucuronidase from bovine liver and Uridine 5′-
diphosphoglucuronic acid triammonium salt were purchased from Sigma Aldrich (Spain). 
ß-glucuronidase/aryl sulfatase from Helix pomatia was supplied by Merck (Germany) and 
Sep-Pak Plus C18 cartridges were obtained from Waters (USA). All the other chemicals 
were of analytical grade and were purchased from local companies.  
 
3.3.2. Animals and exposure experiment 
 
Nile tilapias used in this study were born and raised at CIIMAR, Porto, Portugal. Prior 
to the experiments, animals (N=112, average weight 70.3 ± 23.0 g) were randomly 
distributed (n=10) in the experimental aquaria (52 L) and submitted to an acclimation 
period of one week before the addition of the contaminant. All tanks were supplied with 
biological filtration, and continuous aeration to maintain dissolved oxygen near saturation. 
Dechlorinated tap water was used at a temperature of 21 ± 1 ºC with a 12 h:12 h 
(light:dark) photoperiod. 
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After the acclimatization period, fish were exposed to nominal water concentrations of 10 
and 100 µg of BaP L-1 for 14 d. BaP stock solutions (1.04 and 5.20 g L-1, respectively) 
were prepared in acetone and were administrated directly into the aquaria. The solvent 
concentration never exceeded 0.002%. A solvent control group (acetone alone) was also 
used. Experiment was conducted under semi-static conditions and daily 80% of the water 
was renewed, followed by the addition of fresh BaP solution or solvent to each one of the 
treatment groups. Animals were fasted for 48 h before each sampling, performed at 7 and 
14 d. 
 
3.3.3. Sampling 
 
Water samples were collected, in triplicate, at the beginning (0 d) and at the end of 
the experiment (14 d) from two aquaria, at 0, 8 and 24 h after addition of the contaminant, 
for both BaP nominal concentrations. 
Fish were anesthetized on ice cold water and blood was collected from the caudal 
vein using heparinized syringes. After blood collection, animals were sacrificed by 
decapitation. The blood was centrifuged at 4000 g for 7 min at 4 ºC and the plasma 
obtained was stored at -80 ºC until analysis. The liver, intestine and gills were excised from 
de animal, and bile was collected from the gall bladder with a 1 mL syringe, and were then 
immediately frozen in liquid nitrogen, and stored at -80 ºC until further use. 
 
3.3.4. Biochemical analysis 
 
Microsomal fractions of liver, intestine and gills were prepared as described in 
Fernandes et al. (2007). Briefly, tissues were homogenized in ice cold 100 mM 
KH2PO4/K2HPO4 (pH 7.4), containing 150 mM KCl, 1 mM dithiothreitol, 0.1 mM PMSF and 
1 mM Na2EDTA. Homogenates were centrifuged at 12000 g for 20 min and the resulting 
supernatant was further centrifuged at 100000 g for 60 min, to obtain the microsomal 
fractions. Microsomal pellets were resuspended in a ratio of 0.5 mL buffer g-1 of tissue in 
homogenization buffer containing 20% glycerol. 
UDP-glucuronyl transferase (UGT) activity was assayed according to Collier et al. 
(2000). Fifteen µL of 20 mM uridine 5´-diphosphate glucuronic acid was added to a 
reaction mixture containing 15 µL of microsomal fraction and 120 µL of 125 µM 4-
methylumbelliferone (4MU) in 0.1 M Tris-HCl containing 5 mM MgCl2 and 0.05% BSA (pH 
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7.4) and incubated for 10 min at 37 ºC. Fluorescence was measured at λEX = 355 nm / 
λEM = 586 nm. Activities were expressed as pmol min-1 mg prot-1 using a standard curve 
generated with 4MU (0.031-2.50 µM). Protein content in all assays was determined by 
Lowry method (Lowry et al. 1951), in the correspondent fraction. 
 
3.3.5. Determination of BaP 
 
The pre-analytical treatment for determination of BaP in water was performed 
according to the procedure for the extraction of PAHs in water previously described by 
Cheikyula et al. (2008), based on liquid-liquid extraction with n-hexane followed by HPLC 
analysis under the conditions described below. 
For the analysis of BaP in bile and plasma, an analytical procedure similar to BaP 
extraction procedure in blood developed by Singh et al. (2008) was carried out. Bile (0.05 
mL) and plasma samples (0.5 mL) were subjected to three consecutive ultrasound-
assisted solvent extractions (UASEs) with 1 and 3 mL n-hexane, respectively, for 15 min 
each and the upper organic layer was collected and dehydrated with anhydrous sodium 
sulphate. The n-hexane extracts were evaporated to dryness under a gentle steam of 
nitrogen and the residue obtained was re-dissolved in methanol (0.1 and 0.2 mL for bile 
and plasma, respectively) and filtered through PTFE membranes (0.45 µm) for analysis 
(see section 3.3.8). Pooled samples were used (2-8 fish per pool, dependent on the 
volume of blood collected from each fish) for determination of BaP in plasma, while for bile, 
individual samples were analysed. 
 
3.3.6. Determination of free and conjugates of 3-OH-BaP 
 
The measurement of 3-OH-BaP in bile was performed according to the method of 
Ruddock et al. (2002), which included a prior enzymatic hydrolysis of the glucuronide and 
sulfate conjugated metabolites with a mixture of β-glucuronidase and aryl sulfatase (30 
and 60 U mL-1 activity, respectively) or β-glucuronidase alone (1624 U mL-1). Briefly, 10 µL 
of bile and 10 µL of enzyme solution were added to 230 µL of ultrapure water and the 
mixture was incubated at 37 ºC. After 45 min, the reaction was stopped by the addition of 
250 µL of chilled methanol. After centrifugation (16000 g for 10 min) supernatants contain 
total 3-OH-BaP (T-3-OH-BaP) (conjugated and free 3-OH-BaP) after β-glucuronidase/aryl 
sulfatase hydrolysis or a mixture of glucuronide 3-OH-BaP conjugate (G-3-OH-BaP) and 
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free 3-OH-BaP after incubation with β-glucuronidase. For the determination of the free 3-
OH-BaP, the analytical procedure was carried out without enzymatic hydrolysis and an 
extraction step was added. Bile (50 µL) was subjected to UASE with 100 µL methanol for 
10 min and, finally, the extracts were also centrifuged and filtered for HPLC analysis 
(section 3.3.8). 
In plasma samples, the pre-analytical treatment was based on procedures for the 
determination of T-3-OH-BaP in biological samples such as urine or milk (Rey-Salgueiro et 
al. 2009; Wang et al. 2005), with the extraction and enzymatic hydrolysis steps 
optimizated. To optimize the extraction step, plasma of non-exposed animals were spiked 
with 3-OH-BaP (10 µg L-1) and extracted with different solvents (acetone, methanol, 
methanol:ethyl acetate (50:50)). Despite that the higher efficiency of extraction was 
obtained using methanol:ethyl acetate (97%), acetone (95%) was selected as the 
extraction solvent because of its higher vapor pressure, which facilitates the extraction 
step by being less time consuming. So, plasma samples (1 or 0.50 mL, for 10 and 100 µg 
L-1 exposure levels, respectively) were subjected to three consecutive UASEs with 2 x 1 x 
1 mL acetone for 5 min each and the obtained extract was centrifuged (3000 g) for 3 min 
to facilitate separation of the liquid fraction, which was evaporated till dryness. To extract 
phase II metabolites from plasma samples, an enzymatic hydrolysis was conducted with a 
mixture of ß-glucuronidase/aryl sulfatase to obtain T-3-OH-BaP. Then, the obtained 
residues were filled up to a final volume of 50 mL buffer (0.10 M ammonium acetate buffer, 
0.80 g L-1 tert-butyl hydroquinone and acid acetic until pH 5.5). The dissolved oxygen in 
the solution was then displaced with a nitrogen stream. The optimization of the enzymatic 
hydrolysis step was carried out directly in pooled plasma samples of exposed individuals to 
100 μg L-1 BaP for 14 d. Volume of enzyme (10, 20 and 40 μL) and incubation time (0-16 
h) were optimized for deconjugation and 20 μL was found to be adequate enzyme amount 
to de-conjugate 3-OH-BaP (data not shown). Deconjugation time, was optimized by adding 
20 μL of enzyme solution and incubating at 37 °C. Conjugated metabolites were rapidly 
hydrolyzed in the first 2 h of incubation and slowly until 16h (data not shown), so an 
overnight deconjugation (16 h) was selected to be sufficient for hydrolysis of 3-OH-BaP in 
plasma samples. The hydrolysis conditions selected were in agreement with Fan et al. 
(2006) and Lutz et al. (2006), to enable hydrolysis of conjugated 3-OH-BaP in urine and 
milk samples, respectively. Afterwards, 5 mL methanol was added and the mixture was 
loaded onto a C18 sep-pack cartridge (previously activated with 5 mL methanol followed 
by 10 mL ultrapure water). Before the elution step with 10 mL methanol:ethyl acetate 
(50/50), the minicolumns were dried for 15 min under nitrogen stream at 15 bars. The 
eluate obtained was evaporated to dryness, re-dissolved in 0.20 mL methanol and filtered 
for HPLC analysis (section 3.3.8). For the determination of the free 3-OH-BaP, the 
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analytical procedure was carried out without enzymatic hydrolysis. Pooled samples were 
used (2-8 fish per pool) for determination of free 3-OH-BaP and T-3-OH-BaP in plasma. 
The number of animals per pool was dependent on the volume of blood collected from 
each fish. Due to the small amount of blood available, no G-3-OH-BaP was assessed in 
plasma. 
 
3.3.7. Methods validation 
 
To validate the analytical methods which were modified or optimized, plasma of non-
exposed animals were spiked with BaP or 3-OH-BaP and were processed (n=5). The set 
of samples analyzed was processed with a blank to test for the background BaP and 3-
OH-BaP levels in the material. Similar recovery rates of 3-OH-BaP, 59 and 60% with RSD 
lower than 6.80%, were obtained at two spiked concentration levels of 1 and 10 µg L-1, 
respectively, for the analytical method to measure 3-OH-BaP in plasma (table 3.1). Other 
methods based on solid phase extraction showed similar, 60-66% (Fan et al. 2006), and 
lower recoveries, <50% (Wang et al. 2005), in urine samples. Fan et al. (2006) suggested 
that this percentage of 3-OH-BaP is not due to the method, but to the instability of the 
compound in the acetate buffer, though it is stable in methanol. Therefore, the selected 
method was robust enough to quantify 3-OH-BaP in plasma samples. Detection and 
quantification limits (LOD and LOQ) were evaluated on the basis of the noise obtained with 
the analysis of unfortified blank samples (n=5) (Table 1). LOD and LOQ were defined as 
the concentration of the analyte that produced a signal-to-noise ratio of 3 and 10, 
respectively (ACS 1980) and were then tested experimentally by spiking blank samples at 
such levels. External standard calibration was used to quantify the samples by HPLC-FD 
technique using standard solutions of BaP and 3-OH-BaP (table 3.1). 
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Table 3.1 -  Recoveries ± RSD, instrument linear dynamic ranges, determination coefficients (r
2
) and limits of detection (LOD) and quantification 
(LOQ) in μg L
-1
 (n=5) 
 
Compounds Matrix LOD LOQ 
Instrument linearity 
Added (µg L
-1
) Recovery
b
±RSD (%) 
Standards 
a
 concentrations range r
2
 
BaP bile 0.83 2.50 2.5-50 0.999 5.0 96.8  ± 4.6 
 plasma 0.33 1.00 2.5-50 0.999 5.0 89.9 ± 6.0 
3-OH-BaP bile 0.17 0.50 0.5-50 0.999 1.0 98.1  ± 5.5 
 
plasma 0.07 0.20 0.5-50 0.999 
1.0 59.3  ± 6.0 
 10 60.4  ± 6.8 
a
 (n=12; 7 levels in µg L
-1
 methanol in duplicate). 
b
 (n=5 determinations) 
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3.3.8. Chromatographic conditions 
 
The liquid chromatographic system used was a Hitachi LaChrom Elite HPLC, which 
was constituted of an L-2130 quaternary pump and an in line degasser, a L-2485 FL 
detector (FD), and a L-2200 autosampler. Separations were performed with a 250 x 4.6 
mm (length × i.d.), 5 μm particle, Purospher® STAR RP-18e analytical column obtained 
from Merck (Germany) and a 4 × 4 Chmm i.d., 5 μm particle, guard column with the same 
packing material. 
Mobile phases used, methanol (A) and water (B), were at a flow rate of 1 mL min-1. 
The injection volume was set to 50 µL. For BaP elution, the temperature of the column was 
maintained at 33 °C, and the following gradient was used: 95% A change to 100% A in 5 
min, hold for 10 min, change to 95% A in 1 min and, finally, hold for 10 min giving an 
analysis time of 26 min. For 3-OH-BaP elution, the temperature of the HPLC column was 
kept constant at 40 ºC and the gradient was: 70% A for 5 min, change to 95% A in 1 min, 
hold for 10 min, change to 70% A in 1 min and, finally, hold for 10 min. Total run time was 
27 min per sample. The excitation and emission wavelengths for BaP and 3-OH-BaP 
detection, were 296/406 and 308/432, respectively (Rey-Salgueiro et al. 2008). 
 
3.3.9. Statistical analysis 
 
Exposure time and treatment effects were evaluated by means of a one-way ANOVA 
for each one of the mentioned factors, followed by a multiple comparision test (Tukey's 
test) at a 5% significance level. Some data had to be log or sqrt transformed in order to fit 
ANOVA assumptions. Correlation (=r) between all the parameters measured was tested by 
Pearson correlation analysis. All the statistical tests were performed using the software 
Statistica 7 (Statsoft, Inc., 2004). 
 
3.3.10. Ethics statement 
 
The animals used in the research described in this paper were treated in accordance 
with the Portuguese Animals and Welfare Law (Decreto-Lei nº 197/96) approved by the 
Portuguese Parliament in 1996. 
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3.4. Results 
 
3.4.1. BaP concentration in water 
 
In order to know the real concentration of BaP in the water of experimental aquaria, 
BaP levels were measured at different times after the addition at 0 d and 14 d of the 
experiment. No differences were observed between day 0 and 14 in any of the collection 
periods, so the results presented were combined (figure 3.1). There was a decline of BaP 
concentration over time at both concentrations and no BaP was detected in the solvent 
control group. Eight hours after the addition of BaP stock solution there was a marked 
decrease in BaP, mainly at the lower concentration (88%) while for 100 µg L-1 it was 41%. 
The decrease in BaP concentration was even more significant, for both concentrations, 24 
hours after the addition disappearing almost completely at lower concentration. 
 
 
Figure 3.1 - BaP (in percentage) in water at 0, 8 and 24 h after the addition of 10 and 100 µg of 
BaP L
-1
 of water.  
Values are presented as mean ± standard error. 
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3.4.2. Bile and plasma analysis 
 
BaP was not found in bile and plasma of non-exposed and exposed animals. The 
metabolite, 3-OH-BaP, was detected in free and conjugated forms in bile of exposed 
animals as can be seen in figure 3.2. The metabolite was not found in bile of solvent 
control animals, neither as free nor as conjugated form. Free 3-OH-BaP represented 0.04 
± 0.01% and 0.03 ± 0.01% of the T-3-OH-BaP for 10 and 100 µg L-1 treatments (figure 
3.2a), respectively; thus conjugated metabolites were the major forms of 3-OH-BaP in bile, 
being the G-3-OH-BaP the main conjugated form present (figure 3.2c). An increase in the 
BaP dose in water resulted in a significant increase in free 3-OH-BaP, T-3-OH-BaP and G-
3-OH-BaP levels in bile at both concentrations (figure 3.2). Regarding the effect of 
exposure time, a significant increase in free 3-OH-BaP after 14 d of exposure to higher 
BaP concentration was detected in comparison to 7 d. However, no significant differences 
were observed between days within the same treatment for T-3-OH-BaP and G-3-OH-
BaP.  
In plasma, only one pooled sample contained measurable levels of free 3-OH-BaP 
(0.40 ng mL-1) from the longer exposure period to the higher BaP exposure levels. T-3-OH-
BaP concentration in animals exposed to 10 μg L-1 was near the detection limit and the 
highest levels were quantified in fish exposed to 100 μg L-1 (figure 3.3). In contrast to bile, 
there was a significant increase of T-3-OH-BaP 14 d after exposure to higher BaP 
concentration in comparison to 7 d of exposure.  
The levels of free 3-OH-BaP (r=0.73; p<0.05), T-3-OH-BaP (r=0.89; p<0.05) and G-
3-OH-BaP (r=0.88; p<0.05) in bile were correlated with T-3-OH-BaP levels measured in 
plasma. 
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Figure 3.2 -  Free (a), total (b) and glucuronide (c) 3-OH-BaP levels in bile after waterborne 
exposure to BaP (10 and 100 µg L
-1
) for 7 and 14 d.  
Values are shown as mean ± standard error. Different lowercase letters denote significant 
differences (p<0.05) between groups within the same day of exposure. Different capital letters 
denote significant differences (p<0.05) between days within the same treatment. 
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3.4.3. UGT activities and correlations between biotransformation enzymes and 3-
OH-BaP levels 
 
UGT had mean activities in control groups of 833.35 ± 37.90, 528.36 ± 72.78 and 
794.52 ± 92.62 pmol min-1 mg-1 protein, in liver, intestine and gill, respectively. UGT activity 
in exposed animals was not different from solvent control in any of tissues analyzed, 
however a significant increase in UGT activity was seen from 7 to 14 d at 10 µg L-1 in 
intestine and gill. UGT activity at 100 µg L-1 exposure was significant lower than at 10 µg  
L-1 at 14 d in intestine and gill (table 3.2).  
Nile tilapia EROD and GST activities in liver, intestine and gills after waterborne 
exposure to BaP (10 and 100 µg L-1; a previous work developed in our laboratory) (Costa 
et al. 2011) and UGT activities measured in this study are presented in table 3.2. Positive 
statistically significant correlations (p<0.05) were observed between T-3-OH-BaP 
concentrations in plasma and EROD activities in liver (r=0.51), intestine (r=0.73) and gills 
(r=0.76). The same was also observed between free 3-OH-BaP level in bile and EROD 
activities in intestine (r=0.71; p<0.05) and gill (r=0.59; p<0.05), in contrast, the free 
metabolite was not correlated with this enzyme activity in liver. Positive statistically 
significant correlations were obtained between T-3-OH-BaP concentration, in plasma and 
in bile, and GST activity in liver (r=0.82 and r=0.68, respectively; p<0.05) but, were not 
correlated with activity in intestine and gill. 
 
Figure 3.3 - Total 3-OH-BaP levels in plasma after waterborne exposure to BaP (10 and 100 
µg L
-1
) for 7 and 14 d.  
Values are shown as mean ± standard error. Different lowercase letters denote significant 
differences (p<0.05) between groups within the same day of exposure. Different capital letters 
denote significant differences (p<0.05) between days within the same treatment. 
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Table 3.2 - EROD, GST and UGT activities in liver, intestine and gill of Nile tilapia after waterborne exposure to BaP (10 and 100 µg L
-1
) 
Values are expressed in percent of activity (pmol min
-1
 mg
-1
 protein for EROD and UGT; nmol min
-1
 mg
-1
 protein for GST) in relation to solvent control (set to 
100%), and are shown as mean ± standard error 
Tissue BaP dose (µg L
-1
) 
EROD 
*
 GST 
*
 UGT 
7 d 14 d 7 d 14 d 7 d 14 d 
Liver 
10 310.49 ± 57.17 
#
 222.59 ± 37.75 93.82 ± 5.17 90.64 ± 6.44 99.35 ± 12.98 83.23 ± 10.19 
100 744.44 ± 144.38 
#
 504.91 ± 96.80 
#
 113.14 ± 12.98 139.20 ± 5.71 
#
 106.73 ± 13.61 74.70 ± 13.98 
Intestine 
10 510.15 ± 248.45 624.32 ± 183.13 77.90 ± 29.01 62.48 ± 5.29 73.37 ± 14.75 
A
 124.15 ± 18.48 
B, a
 
100 1586.73 ± 790.71 
#
 2372.01 ± 307.26 
#
 68.97 ± 14.43 35.81 ± 2.83 
#
 81.96 ± 17.25 73.37 ± 5.14 
b
 
Gill 
10 643.74 ± 29.77 
#
 799.58 ± 91.49 
#
 97.99 ± 9.57 119.56 ± 24.14 92.64 ± 8.13 
A
 132.92 ± 12.98 
B, a
 
100 1320.66 ± 378.50 
#
 1738.96 ± 196.69 
#
 166.13 ± 14.96 
#
 118.21 ± 13.52 82.71 ± 10.77 79.76 ± 11.15
 b
 
* 
(Costa et al., 2011) 
# 
Significant differences (p<0.05) in comparison to solvent control 
A, B
 Significant differences (p<0.05) between days within the same treatment 
a, b
 Significant differences (p<0.05) between groups within the same day of exposure 
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3.5. Discussion 
 
The contamination of aquatic ecosystems by organic contaminants as PAHs is a 
matter of great concern in environmental toxicology. BaP is one of the most common and 
toxic PAHs, and its toxicity is mainly linked to the capacity of fish species to biotransform it 
into reactive metabolites. The present study aimed at evaluating BaP metabolism into 3-
OH-BaP, a toxic metabolite, and the metabolite bioavailability in bile and plasma of Nile 
tilapia after waterborne exposure. 
The real concentration of BaP detected in the water from the experimental aquaria 
was significantly lower than the nominal concentration (figure 3.1). The decrease of BaP 
concentration observed in water was in line with studies where the stability of BaP was 
evaluated in similar conditions as the ones in our study but without fish (Swietlik et al. 
2002); the higher decrease of BaP observed in our experimental set up could be explained 
by the presence of fish. Moreover, due to the same number of animals in aquaria (at both 
concentrations), a higher decline of BaP was also observed at the lower concentration.  
Fish have a high capacity to metabolize PAHs, thus no BaP was detected in bile and 
plasma of Nile tilapia and only the detection of BaP metabolites (free and conjugated). 
Hence, our results show the uptake and the ability of Nile tilapia to metabolize BaP and 
neutralize the toxic metabolite, showing to possess a well developed biotransformation 
system, eliminating the most toxic forms of BaP (free 3-OH-BaP) into non toxic forms 
(conjugated form). In bile, the predominance of conjugates over free metabolites, mainly 
G-3-OH-BaP, was consistent with results observed in Fundulus heteroclitus after 
waterborne exposure at the same concentrations of BaP (Zhu et al. 2008). In different 
exposure conditions, by single intraperitoneal injection (10 mg Kg-1), Ictalurid catfish bile 
showed to have also a higher percentage of billiary G-3-OH-BaP (Willett et al. 2000). 
Contrary to the observed dose dependent response, time dependence responses were 
observed only with free 3-OH-BaP in bile. Comparable results, upon waterborne exposure 
to BaP, have been reported in Sparus macocephalus (Wang et al. 2008) and in sole 
(Solea solea), after dietary exposure to an equimolar mixture of BaP, pyrene and 
fluoranthene (Wessel et al. 2010). In contrast, when measuring total BaP metabolites as 
fluorescent aromatic compounds (FACs) in bile by fixed wavelength fluorescence, instead 
of the HPLC analysis, as in the previous studies (including this one), significant time 
dependent responses after BaP waterborne exposure were reported (Boleas et al. 1998; 
Costa et al. 2011). The assessment of FACs in bile gives the total metabolites and not 
specific ones, so analytical techniques, like HPLC, that allow measurement of individual 
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compounds, give more precise information about PAHs metabolism, especially when it 
concern to free metabolites and conjugation. 
In plasma, free 3-OH-BaP was detected in some plasma samples, but quantification 
was only possible in one pooled sample of animals exposed to higher BaP concentration 
for 14 d (0.40 ng mL-1). The low concentrations of free 3-OH-BaP detected in plasma could 
be due to it propensity to bound with components of the blood and form unextractable 
products (James et al. 2001), or due to the rapid phase II conjugation in liver and 
extrahepatic tissues (James et al. 1996). T-3-OH-BaP metabolite was detected and the 
levels were considerably lower than the ones detected in bile (0.30 ± 0.04 ng mL-1 vs. 2.50 
± 0.10 μg mL-1 in 10 μg L-1 at 14 d).  
In the present work, despite the high G-3-OH-BaP levels detected in bile no 
induction of UGT was observed in liver, intestine or gill. Even though an increase in UGT 
activity over time was verified at lower BaP exposure level in intestine and gill. The lack of 
UGT induction by BaP in Nile tilapia in the present study is in agreement with the low 
sensitivity of this enzyme that has been reported in fish collected in field (Della Torre e al. 
2010; Schereiber et al. 2006). Moreover after exposure via intraperitoneal injection (10 and 
50 mg Kg-1), similar results were showed in longear sunfish (Lepomis megalottis) 
(Brammell et al. 2010). In a previous study, EROD and GST induction activities were 
shown in liver, intestine and gill of Nile tilapia after BaP exposure under similar 
experimental conditions (Costa et al. 2011). A joint analysis of the results obtained in this 
study and those previously published, showed positive correlations between enzymatic 
activities and free and T-3-OH-BaP levels in bile and plasma. The gill and intestine EROD 
induction (Costa et al. 2011) and the positive correlations between enzymatic activities and 
T-3-OH-BaP concentration in plasma and free 3-OH-BaP in bile, strengthen the idea that 
these extrahepatic tissues are involved in the metabolism of BaP and that the metabolites 
formed are released into the blood stream. Moreover, phase II enzymes activity (GST and 
UGT) in intestine and gill and the predominance of conjugates metabolites in plasma, 
corroborate that these extrahepatic tissues play also an important role in the elimination of 
the toxic form of 3-OH-BaP. Taken together these results indicate that liver and 
extrahepatic tissues as intestine and gill can be important sources of metabolites into the 
blood but in addition, they work together to reduce the circulating levels of free 3-OH-BaP. 
The major concern about exposure to BaP is the toxic effects produced by the 
presence of the toxic form of 3-OH-BaP. Some studies have evaluated the in vitro 3-OH-
BaP effects and showed that low concentrations of 3-OH-BaP (from 8 to 67 ng mL-1) can 
have estrogenic activity (van Lipzig et al. 2005) and form covalent bindings with 
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macromolecules (Moorthy et al. 2003; Sugihara and James 2003), leading to toxic effects 
at the organism level. Even though we have not evaluated toxic effects and the levels of 
free 3-OH-BaP measured in plasma (0.40 ng mL-1) were lower than concentrations 
capable of producing toxic effects, since it was quantified in one pooled sample, the levels 
obtained in our study could be diluted. Hence, individual fish can have higher 
concentrations than the ones determined and as a consequence being exposed to toxic 
effects of this reactive form of 3-OH-BaP. 
 
3.6. Conclusion 
 
This study has shown that the capacity of Nile tilapia to metabolize BaP resulted in 
high concentrations of metabolites in bile and plasma. The predominance of conjugated 
over free forms of 3-OH-BaP in bile and plasma indicated the importance of phase II in 
metabolism and elimination of BaP in Nile tilapia. Our data suggest extrahepatic 
metabolism of BaP and as responsible for the presence of 3-OH-BaP metabolite in 
plasma. Although low levels of free 3-OH-BaP, reactive form, were detected in plasma, we 
must not exclude possible toxic effects in Nile tilapia. 
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4. Gene expression analysis of ABC efflux transporters, CYP1A 
and GSTα in Nile tilapia after exposure to Benzo(a)pyrene 
 
4.1. Abstract 
 
The aim of this study was to evaluate the response of ABC transporters, CYP1A 
and class alpha (α) GST genes, upon water and dietary exposures to benzo(a)pyrene 
(BaP) in Oreochromis niloticus. Partial mRNA sequences of ABC transporters 
(ABCB1b, ABCB11, ABCC1, ABCC2 and ABCG2) were identified, and their tissue 
distribution patterns evaluated in liver, gill and intestine, showing similarities with other 
fish and mammals. After 14 days of water exposure to BaP, ABC transporters mRNA 
expression was up-regulated, namely ABCC2 in gill (up to 16-fold) and ABCG2 in liver 
(up to 2-fold) and proximal intestine (up to 7-fold). CYP1A mRNA expression was up-
regulated in water exposed animals, with maximum fold inductions of 5, 35 and 155, 
respectively in liver, gill and proximal intestine. After dietary exposure, intestinal CYP1A 
mRNA showed a 13-fold increase in exposed animals. No significant changes were 
seen in ABCB1b, ABCC1 and GSTα mRNA expression after both routes of exposure to 
BaP. In conclusion, this study has shown that transcriptional expression of some ABC 
transporters and CYP1A respond to the presence of BaP, indicating a possible 
involvement and cooperation in the detoxification process in Nile tilapia. 
 
 
 
 
Keywords: ABC transporters, Cytochrome P450, Glutathione S-transferase alpha 
Detoxification, Fish, Oreochromis niloticus 
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4.2. Introduction 
 
The ATP binding cassette (ABC) superfamily is a highly conserved family of 
transmembrane proteins (Dean and Annilo, 2005), and some of its members confer 
Multixenobiotic Resistance (MXR) in aquatic organisms by acting as efflux pumps of a 
wide variety of putative toxicants, and/or its metabolites (Kurelec, 1992). MXR is similar 
to a previously described phenotype of Multi-Drug Resistance (MDR), first observed in 
mammalian tumor cells (Gottesman et al., 1996), and related to the over expression of 
an ABC transporter (ABCB1) responsible for the efflux of a high number of anti-cancer 
agents (Chan et al., 2004). In addition to ABCB1 (P-glycoprotein, Pgp), studies using 
various animal models, have indicated ABCCs 1-5 (Multiresistance Associated 
Proteins, MRPs) and ABCG2 (Breast Cancer Resistance Associated Protein, BCRP) 
as the most relevant in the toxicological context (reviewed in Leslie et al., 2005). 
Another transporter from the ABCB family, ABCB11 (Bile Salt Export Pump, BSEP), 
has also been studied in aquatic organisms (Zaja et al., 2008a; Zaja et al., 2008b; 
Loncar et al., 2010) mostly due to its high degree of similarity with ABCB1, since 
mammalian studies indicate that ABCB11 exports bile salts from hepatocytes into bile 
canaliculus, and is not involved in the efflux of xenobiotics (Gerloff et al., 1998). In 
aquatic toxicology, research on these transporters has been mainly focused on ABCB1 
(Kurelec, 1992; Bard et al., 2002a; Bard et al., 2002b) while the remaining ABC 
transporters are less studied. Although they have been identified in different fish 
species (Zaja et al., 2008a; Zaja et al., 2008c; Paetzold et al., 2009; Fischer et al., 
2010; Loncar et al., 2010) both at gene and protein levels, only a few studies have 
investigated the modulation of these transporters by environmental pollutants in fish 
(Bard et al., 2002a; Bard et al., 2002b; Paetzold et al., 2009; Zucchi et al., 2010; Long 
et al., 2011a; Long et al., 2011b). 
These proteins translocate a wide variety of substances and, although there is 
some overlap in substrate specificity, there are differences in transport mechanisms 
and chemical composition of substrates. ABCB1 transports moderately hydrophobic, 
amphiphilic, neutral or positively charged substances, including exogenous and 
endogenous compounds, while ABCCs and ABCG2 primarily transport organic anions 
conjugated to glutathione, glucoronide, sulphate or other polar groups (Leslie et al., 
2005). Considering these characteristics, it has been previously suggested that ABC 
transporters may be similarly regulated in a coordinated fashion with phase I and II 
enzymes, providing an important mean of protection to the cell from xenobiotic insults 
(Bard, 2000; Leslie et al., 2005; Xu et al., 2005). It is believed that ABCB1 acts as first 
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line of defense preventing unmodified compounds from accumulating in the cell (phase 
0 of cellular detoxification), while ABCCs and ABCG2 transport phase I and II 
metabolites, therefore acting in phase III of cellular detoxification (Bard, 2000; Sturm et 
al., 2005).  Induction of phase I cytochrome P4501A (CYP1A) and phase II glutathione 
S-transferases (GSTs) towards many environmental pollutants has been widely 
studied,  including to Polycyclic Aromatic Hydrocarbons (PAHs) which are known 
agonists of the Aryl hydrocarbon Receptor (AhR) that controls the expression of these 
genes (for a review see van der Oost et al., 2003). Recent studies have evaluated the 
hepatic expression of some ABC transporters and phase I and/or phase II enzymes in 
the presence of pollutants (Paetzold et al., 2009; Della Torre et al., 2010; Zucchi et al., 
2010), but the exact way of action of these putatively important parts of the cellular 
detoxification has not been experimentally demonstrated yet. Based on substrate 
specificity, immunological cross reactivity and protein sequence data, mammalian 
citosolic GSTs have been grouped into seven classes: Alpha (α), Mu, Pi, Theta, Sigma, 
Omega and Zeta (Hayes et al., 2005). GSTα is one of the most expressed classes in 
fish (Fu and Xie 2006; Li et al., 2010) and has been associated with a multidrug-
resistance phenotype observed in rats (Hayes et al., 1995). Benzo(a)pyrene (BaP) is a 
common PAH, widely spread in the aquatic environments, whose carcinogenic and 
mutagenic properties have been extensively studied (Buhler and Williams, 1989; 
Tsukatani et al., 2003), and was used as a model contaminant in this study. BaP is a 
known inducer of phase I and II enzymes, like CYP1A and GSTs, and the transport of 
the parent compound and/or its metabolites by ABC transporters proteins has been 
hypothesized (Chao Yeh et al., 1992; Buensen et al., 2002; Bard 2000; Lampen et al., 
2004; Myllynen et al., 2007) and remains a matter of debate. Taking in account that in 
aquatic animals the uptake of pollutants can occur through water, or through contact 
with food or sediments, we have exposed the model specie Nile tilapia (Oreochromis 
niloticus) to BaP, by waterborne and dietary exposure routes. Besides of being an 
economically important cultured species, namely in Asia and Africa, Nile tilapia is also 
a well established model in many toxicological studies (Almeida et al. 2001; Straus 
2003; Coimbra et al. 2005; Figueiredo-Fernandes et al. 2006; Coimbra et al. 2007; 
Costa et al. 2011; Rey-Salgueiro et al., 2011). 
The main objectives of this work were 1) the identification and sequence 
characterization of toxicologically relevant ABC transporters (ABCB1, ABCB11, 
ABCC1, ABCC2 and ABCG2) in O. niloticus, and 2) the quantification of mRNA 
expression of ABC transporters, CYP1A and GSTα after waterborne and dietary 
exposures to BaP, in tissues involved with the uptake and metabolism of pollutants, as 
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liver, gills and intestine, in order to evaluate, at a transcriptional level, the possible 
correlations between ABC transporters, CYP1A and GST. Novel information is 
provided regarding ABC transporters identification in O. niloticus, and on gene 
expression changes upon BaP exposure in different tissues. 
 
4.3. Materials and methods 
 
4.3.1. Animals  
 
Animals used in this study were born and raised in the laboratory (CIIMAR, Porto, 
Portugal). The corresponding breeders stock was obtained from the Aquaculture 
Station of UTAD (Universidade de Trás-os-Montes, Portugal). Animals were juvenile, 
and therefore not sexually mature, as confirmed by macroscopic analysis of the gonads 
when animals were sampled. Until the start of the exposure assays, fish were kept in 
60 L aquaria supplied with biological filtration. Prior to the experiments, animals were 
randomly distributed in the experimental aquaria (30 L), and submitted to an 
acclimatation period of one week. All tanks were supplied with continuous aeration to 
maintain dissolved oxygen near saturation. Dechlorinated tap water was used at a 
temperature of 20±2 ºC, with a 12h:12h (light:dark) photoperiod. Fish were fed 
commercial food pellets (Aquasoja, Portugal), until satiation, once a day. 
 
4.3.2. Stock solutions of BaP and preparation of contaminated food 
 
For the waterborne exposures, stock solutions of BaP were prepared in acetone 
(0.5, 1.25 and 2.5 g/L) and were administered directly to the experimental aquaria. The 
percentage of solvent added to the experimental aquaria was 0.002%. For the dietary 
exposures a stock solution of BaP with a concentration of 40 g/L was prepared. The 
contaminated diets were prepared by immersion of food pellets in BaP stock solutions 
diluted in acetone, in a proportion of 0.32 ml/g of food. For control groups, nothing was 
added to the food pellets, and for solvent control groups only acetone was added to the 
food pellets. Acetone was evaporated under forced air current for 24 hours, until the 
pellets were completely dry, and diets were stored at -20 ºC until further use.  
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4.3.3. Xenobiotic exposures 
 
After the acclimatation period, fish were exposed to BaP either via water or via 
food. For the water exposure, juvenile Nile tilapia (N=20, average weight of 16.36±0.82 
g, average length of 9.99±0.19 cm) were exposed to nominal water concentrations of 
10, 25 and 50 µg of BaP/L for 14 days. Also, a control group and a solvent control 
group (acetone alone) were maintained. The tested concentrations have been found in 
pore waters of estuaries polluted with petrochemical products (Maskaoui et al. 2002). 
Waterborne exposures were conducted in semi-static conditions in 30 L aquaria. Daily, 
80% of the water was renewed, followed by the addition of fresh BaP solution or 
solvent to each one of the treatment groups. Animals were fed to satiation every two 
days, with the exception of the day before sampling. Sampling was performed 14 days 
after the contaminant addition. 
For dietary exposures, fish were maintained in 30 L aquaria in continuous water 
flow conditions, which assured 100% of water renewal per day. Juvenile tilapia (N=16, 
average weight of 10.88±0.52 g, average length of 8.53±0.16 cm) were exposed to 100 
and 200 µg of BaP/g of food for 14 days. A control (uncontaminated food) and a 
solvent control (acetone alone) were maintained. Fish were fed daily at a rate of 3% of 
body weight. After feeding, animals were observed, to assure that the total of the food 
was consumed in 2 to 3 minutes. Fish were sampled after14 days of exposure. The 
chosen levels of dietary exposure fall within a range of PAH concentrations that may be 
found in prey or in sediment that is ingested during feeding at heavily contaminated 
locations (Naes et al. 1995, Viguri et al. 2002). 
 
4.3.4. BaP determination in water and food samples 
 
To determine the real concentration of BaP in the water of the experimental 
aquaria, BaP was extracted from water samples according to the method described by 
Cheikyula et al. (2008), based on liquid-liquid extraction with n-hexane followed by 
HPLC analysis, under the conditions described in Rey-Salgueiro et al. (2008). After the 
addition of the contaminant, the real concentrations of BaP in water samples were 
10.49, 22.51 and 41.46 µg/L, respectively for the nominal concentrations of 10, 25 and 
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50 µg/L. After 24 hours, and before the addition of fresh contaminant to the aquaria, 
the amount of BaP still present in each one of the treatment groups was 0.34, 0.69, 
12.19 and 25.70 µg/L. In water collected from control and solvent control groups no 
BaP was detected at both times. Food pellets supplied to the fish in dietary exposures 
were also analyzed in terms of BaP concentration, according to the method described 
by Rey-Salgueiro et al. (2009), based on ultrasound-assisted solvent extraction, 
followed by HPLC analysis. The real BaP concentrations in the food pellets were 0.06, 
0.07, 36.24 and 92.70 µg/g, respectively for control, solvent, 100 and 200 µg/g. When 
referring to the concentrations of BaP used in water and dietary treatments nominal 
concentrations are mentioned throughout the manuscript. 
 
4.3.5. Sampling 
 
Fish were anesthetized on ice cold water and sacrificed by decapitation. Liver, 
gills and proximal intestine (first one third of the intestine) were excised from the 
animal, placed in RNA later at 4 ºC overnight, and stored at -80 ºC until further use. 
 
4.3.6. RNA isolation, RT-PCR, cloning and sequence analysis 
 
Primer pairs for ABCB1b, ABCB11, ABCC1, ABCC2 and ABCG2 genes were 
designed based on highly conserved regions among mammalian and fish species 
(table 4.1). The oligonucleotides were purchased from Stabvida (Portugal). Total RNA 
from liver, gills and proximal intestine was isolated from, approximately 20 mg of tissue, 
using the Illustra RNAspin Mini (GE Healthcare), according to manufacturer´s protocol. 
Total RNA was quantified through the measure of the optical density at λ260 nm, and 
its quality was assessed by separation in 1% agarose gel electrophoresis (in Tris-
acetate-EDTA – TAE – buffer) stained with ethidium bromide, and by measurement of 
the ratio of the optical density at λ260/280 nm (1.8-2.0). One microgram of total RNA 
was reverse transcribed to produce the first strain of cDNA (iScript cDNA Synthesis Kit, 
BioRad), according to the manufacturer´s instructions. PCR was performed in a 
Biometra Thermocycler with 100 ng of cDNA (composed by a mixture of cDNA from 
liver, gill and proximal intestine in equal amounts), 0.2 mM of DNTPs, 0.4 µM of each 
primer and 2.5 mM of MgCl2 in a total volume of 50 µl, using Taq DNA Polymerase (5-
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Prime, Inc, EUA), with the following conditions: 2 minutes denaturation at 94 ºC, 40 
cycles of denaturation for 30 seconds, 30 seconds of annealing (different annealing 
temperatures – table 4.1) and 1 minute of 72 ºC of polymerization, and 10 minutes of 
final extension at 72 ºC. The aliquots of the PCR reactions were separated by gel-
electrophoresis on a 2% agarose gel in TAE buffer stained with ethidium bromide, and 
the PCR products were visualized under UV light. The bands of expected size were 
excised, and eluted from the gel according to manufacturer´s protocol, using the 
commercial kit Illustra GFX Tm PCR DNA and Gel Band Purification Kit, GE 
Healthcare. The isolated fragments were then inserted in pGEM plasmid vector 
(pGEM® - T Easy Vector Systems – Promega) and incorporated in E. coli using Nova 
Blue Competent Cells (Novagen). After the selection of the correct colonies developed 
for 10 hours in solid medium (35 g/L LB Broth, ampycilin 0.1 mg/ml, IPTG 0.1 mM and 
X-Gal 100 mM) at 37 ºC, the plasmids were isolated from 5 ml of overnight culture (at 
37 ºC) using Wizard Plus SV Minipreps DNA Purification System (Promega). The 
inserts were sequenced by Stabvida (Portugal), and the identities of all sequences 
were checked using the Basic Local Alignment Search Tool (Blast) at National Center 
for Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov). Predicted 
topologies for the aminoacid partial identified sequences were performed with the 
Polyphobius algorithm (http://phobius.sbc.su.se/poly.html). Alignments of the obtained 
sequences with other mammal and fish species were conducted with ClustalW Multiple 
Alignment (Thompson et al., 1994). Phylogenetic analysis was performed with Mega 
4.0.2 (Tamura et al., 2007) using neighbor-joining method and a percentage of 
concordance based on 1000 bootstrap iterations. 
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Table 4.1 – Primer sequences, sequence lengths, annealing temperatures, GenBank accession numbers and homology percentages with other 
animal species of ABC transporters identified in Nile tilapia. 
 
Target 
gene 
Sense Antisense 
Sequence 
length (bp) 
Annealing 
temperature 
Acession 
Number 
Homology with other species 
ABCB1b cctgtgtcgttcctcaaggt cctctcttgtgaggcagac 922 56ºC GQ911571 
Poeciliopsis lúcida – 80% ; Oncorhynchus 
mykiss – 75%; Trematomus bernachii – 75%; 
Homo sapiens – 63% 
ABCB11 catttcagcctggtgttcag gtcagagttctggatggtgg 820 60ºC GQ911570 
Platichthys flesus – 93%; Fundulus heteroclitus 
– 93%; Oncorhynchus mykiss – 91%; Danio 
rerio – 91%; Homo sapiens – 84% 
ABCC1 atgttcatgggctccatgttca ggatccaggttcatcctcaga 1062 56ºC GQ911567 
Danio rerio – 84%; Oncorhynchus mykiss – 
66%; Homo sapiens - 75% 
ABCC2 ctcagtgtatctgcagtacct ctaaacaggcagttggtaagac 1134 56ºC GQ911569 
Oncorhynchus mykiss – 88%; Danio rerio – 
86%; Monodelphis domestica – 71%; Homo 
sapiens – 72% 
ABCG2 atcggactcaatggcatcatga gatgaagagttcagctgctga 1100 56ºC GQ911568 Oncorhynchus mykiss – 90%; Danio rerio 88%; 
Salmo salar – 85%; Homo sapiens – 73% 
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4.3.7. Quantitative real-time PCR (qRT-PCR) 
 
Gene expression quantification of ABCB1b, ABCB11, ABCC1, ABCC2, ABCG2, 
CYP1A, GSTα was performed in liver, gill and proximal intestine, by means of quantitative 
real time PCR (qRT-PCR). Elongation factor 1 (EF1) and 18S ribosomal RNA (18S rRNA) 
were both evaluated as possible housekeeping genes, and 18S rRNA was chosen since 
its expression proved not to be affected by the treatments, and to be stable between the 
analyzed tissues (data not shown). For qRT-PCR, 1 µg of total RNA was subjected to 
digestion of genomic DNA using Deoxyribonuclease I, Amplification Grade (Invitrogen) and 
first strand cDNA was synthesized using the iScript cDNA Synthesis Kit from BioRad. 
Specific primers for ABCB1b, ABCB11, ABCC1, ABCC2 and ABCG2 were designed 
based on the previously partially sequenced genes in Nile tilapia, using Beacon 
DesignerTM software. Primers for CYP1A, GSTα, 18S rRNA and EF1 were designed 
based on partial mRNA sequences of O. niloticus, available on Genbank (accession 
numbers GI13365614 for CYP1A, EU234530 for GSTα, DQ397879 for 18S rRNA and 
AB075952 for EF1), using the Primer-Blast software (http://www.ncbi.nlm.nih.gov). To 
confirm the identities of the amplicons for qRT-PCR, RT-PCR reactions were conducted 
and, after excision from the gel, products were cloned and sequenced (as described in 
section 4.3.6). Optimal primers concentrations were determined (600/600 nM) after 
evaluation of the highest fluorescence signal at lower Ct number. Primer sequences and 
amplicon lengths of target gene sequences are given in table 4.2. Real-time PCR 
amplification was done in a IQ5 Bio Rad, with the use of IQ Sybr Green Supermix (Bio 
Rad), with 10 µl SYBR Green mix, 2 µl of each primer (6 µM) and 1 µl of cDNA in a total 
volume of 20 µl. Reactions were conducted under the following conditions: 95 ºC for 3 
minutes, followed by 40 cycles at 95 ºC for 10 seconds, 54 ºC for 30 seconds and 72 ºC 
for 30 seconds. At the end of each run a melting curve analysis was done (from 55 ºC to 
95 ºC) to determine the formation of specific products. Samples were run in duplicate. No 
template controls were run to exclude contamination and the formation of primer dimers. 
To determine the efficiency of the PCR reactions (table 4.2), standard curves were made 
for all the genes, with 6 serial dilutions of the template (concentrations range from 0.05 to 
50 ng/µl), and the slopes and regression curves were calculated. Quantification of the 
expression of the genes in study, ABCB1b, ABCB11, ABCC1, ABCC2, ABCG2, CYP1A 
and GSTα, after exposures to BaP, was done by normalization against the housekeeping 
gene (18S rRNA). The ΔCt values were calibrated against the control ΔCt, and the relative 
expression of the target genes was calculated by the 2-ΔΔCt method, considering 
efficiencies close to 100% (Livak and Schmittgen, 2001). For the purpose of inter-gene 
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comparison throughout one tissue, relative quantification was used as a method of choice. 
Target genes were normalized to the housekeeping gene (18S rRNA), according to the 
equation, MNE = (Eref) 
Ct(ref,mean) / (Etarget) 
Ct(target,mean), described in detail by Simon (2003), 
where MNE stands for mean normalized expression; Eref is the efficiency of housekeeping 
gene; Etarget is target gene efficiency; Ctref,mean is the mean CT value of the housekeeping 
gene; and Cttarget,mean stands for the mean Ct value of the target gene. Tissues from control 
animals were used, and results were presented as target gene expression relative to 
housekeeping gene expression multiplied by 10000.  
 
Table 4.2 – Primer sequences, amplicon lengths and efficiency of reaction, used in ABC 
transporters, CYP1A, GSTα  and 18S rRNA gene expression quantification by qRT-PCR in 
Nile tilapia 
Target gene Sense Antisense Amplicon length 
Efficiency of the 
PCR reaction 
ABCB1b cgttcctcaaggtgatggct ggctgcattgcaccattgat 91 pb 98.5% 
ABCB11 ctggtcagacactggccttt caggaaagacacgttgacgc 143 pb 110.0% 
ABCC1 atccgtgagagtgaccag caaatgacacaatgaagtttcc 117 pb 99.7% 
ABCC2 cctggttggcttgtctatatcc ctcgctgtattcactcactctc 123 pb 107.6% 
ABCG2a tcatgaagccgggtctcaac agacctgcagggtcctttct 96 pb 103.9% 
CYP1A cgtcgtcgtctctgttgcc catcgtcgtggtggtcatagc 70 pb 96.6% 
GSTα aaatggatggcatgaagctc tcgttctttgggatcctttg 92 pb 109.8% 
18S rRNA cggaaggatcattactggctacac agaccctcggcggcaaag 78 pb 100.1% 
 
4.3.8. Statistical analysis 
 
Treatment effects were evaluated by means of a one-way ANOVA, followed by a 
multiple comparision test (Tukeys test) at a 5% significance level. Some data had to be log 
or square root transformed in order to fit ANOVA assumptions. All tests were performed 
using the software Statistica 7 (Statsoft, Inc., 2001).  
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4.3.9. Ethics statement 
 
The animals used in the research that is described in this paper were treated in 
accordance with the Portuguese Animals and Welfare Law (Decreto-Lei nº 197/96) 
approved by the Portuguese Parliament in 1996. Institutional animal approval by 
CIIMAR/UP and DGV was granted for this study. 
 
4.4. Results 
 
4.4.1. Identification of ABC transporters related genes 
Based on the degrees of homology with the same genes in mammals and other fish 
species, we were able to identify partial gene sequences for ABCB1b, ABCB11, ABCC1, 
ABCC2 and ABCG2 in Nile tilapia. 
A 922bp sequence similar to ABCB1b, a 816bp sequence similar to ABCB11, a 
804bp sequence similar to ABCC1, a 805bp sequence similar to ABCC2 and a 659bp 
sequence similar to ABCG2 were identified. Sequences were submitted to GenBank and 
given the accession numbers provided in table 4.1. Analysis performed using blastx 
alignments, showed high degrees of homology of the identified transcripts with other fish 
and mammal species, including human (table 4.1). Multiple alignments of the deduced 
amino acid (aa) sequences in Nile tilapia with other fish species and human are shown in 
figure 4.1. In the partial aa sequences of ABCB11 and ABCG2 the following highly 
conserved regions were identified: Walker-A, Walker-B and C-Motif (figure 4.1b and 4.1e). 
Topology analysis revealed that partial aa sequence of ABCB11 and ABCG2 covered 
almost completely a nucleotide binding domain (NBD 2 for ABCB11 –figure 4.2b, and NBD 
1 for ABCG2 – figure 4.2e). The Walker A region was also identified in the partial aa 
sequences of ABCC1 (figure 4.1c) and ABCC2 (figure 4.1d), and according to the topology 
predictions, the identified sequences partially covered membrane spanning domain 2 
(MSD2) and NBD2, for both ABCC1 (figure 4.2c) and ABCC2 (figure 4.2d). No highly 
conserved regions were identified in the ABCB1b partial aa sequence (figure 4.1a), and 
topology analysis revealed that ABCB1b sequence covered almost completely the MSD2 
(figure 4.2a). Results of the phylogenetic analysis revealed that sequences identified in 
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Nile tilapia are evolutionarily closer to the same genes in other fish species, than to 
mammals (figure 4.3). 
 
a) ABCB1b multiple alignment 
 
O. niloticus  ------VSFLKVMALNTSELPYILLGTLCAIINGAMQPAFAVVFSKIINVFIEPD-QDVVRQGSVFFSLM 63    
P. lucida     EEDVPMVSFFRVLRLNASEWPYIVVGLICATINGAIQPLFAVLFSKIITVFAEPD-KNVVRERSNFFSLM 764   
T. bernachii  DENIPPVSFFKIMRLNIPEWPYILVGTICAIINGVMQPLFAIIFSNIITVFAHPD-PAVIRTRASYFSLM 651   
O. mykiss     -------SFVGSEKGDKDKT------------------------EVEEEVFAEQD-QELVRQRSSFYSIM 708   
H. sapiens    DESIPPVSFWRIMKLNLTEWPYFVVGVFCAIINGGLQPAFAIIFSKIIGVFTRIDDPETKRQNSNLFSLL 758   
 
 
O. niloticus  FAAIGAVSFVTMFLQGFCFGKSGEVLTLKLRLGAFKSMMRQDLGWFDQPKNSVGALTTRLATDAAQVQGA 133   
P. lucida     FVAIGVVCFFTMFLQGFCFGKSGEILTLKLRLGAFKSMMRQDLGWFDSPKNSVGALTTRLATDAAQVQGA 834   
T. bernachii  FVLIGAVSFVAMFFQGFCFGKSGEILTLKLRLGAFKAMMRQDLGWFDNPKNSVGALTTRLATDAAQVQGA 721   
O. mykiss     FALIGVVSFITMFLQGFCFGKAGEILTMKLRLMAFKAMMRQELGWYDSHKNSVGALTTRLATDAAQVQGA 778   
H. sapiens    FLALGIISFITFFLQGFTFGKAGEILTKRLRYMVFRSMLRQDVSWFDDPKNTTGALTTRLANDAAQVKGA 828   
 
 
O. niloticus  AGVRMATLAQNFANMGTGLILGFVYGWELTLLLLSLVPIIAVAGAIEMKMLAGHAAEDKKELEKAGKIAT 203   
P. lucida     SGVRLATFAQNIANLGTGVILAFVYGWELTLLVLAVVPVIALAGAVQMKMLTGHAAEDKKELEKAGKIAT 904   
T. bernachii  TGVRMATLAQNLANMGTSIIISFVYGWELTLLVLSVVPFMAVAGAVEMKALTGHATEDKKELEKSGKIAT 791   
O. mykiss     TGVRLATLAQNVANLGTSLIISFVYGWQLTLLILCVVPVMAVAGGIQMKMLSGHAVKDKKELEQAGKTAT 848   
H. sapiens    IGSRLAVITQNIANLGTGIIISFIYGWQLTLLLLAIVPIIAIAGVVEMKMLSGQALKDKKELEGAGKIAT 898   
 
 
O. niloticus  EAIENIRTVVCLTRELQSHPLYQENLDVPYKNSKKMAHIYGLTFSFSQAMIYFAHAACFRFGAWLIIAGR 273   
P. lucida     EAIENIRTVASLTREPKFESLYQENLVVPYKNSQKKAHVYGFTFSFSQAMIYFAYAACFRFGAWLIIEGR 974   
T. bernachii  EAIDNIRTVVSLNREPKFESLYQENLEIPFRNSQRNAHVHGLTFSFSQAMIYFAYAGCFRFGAWLVEENR 861   
O. mykiss     EAIENIRTVASLTREQKFESLYQENLIVPYKNSQKKAHVYGITFSFSQAMIYFAYVGCFRFGAWLIEEGI 918   
H. sapiens    EAIENFRTVVSLTQEQKFEHMYAQSLQVPYRNSLRKAHIFGITFSFTQAMMYFSYAGCFRFGAYLVAHKL 968   
 
 
O. niloticus  MDVEDVFLVISAILCGAMAVGQVNSFAPNYAK-------------------------------------- 305   
P. lucida     MDVEGVFLVISAVLFGAMAVGEANSFAPNYAKAKMSASHLLMLLNKEPAIDNLSEQGDTPDIFHGNVSFE 1044  
T. bernachii  MDIQGVFLVVSAILYGAMALGEANSFAPNYAKAKISAAHLMALMGREPAIDNLSQAGESPDTFDGNVQFD 931   
O. mykiss     MTFENVFLVISAVLYGAMAVGEANSFTPNYAKAKISASHLMFLINREPAIDNCSQGGETPDHFDGNVRFQ 988   
H. sapiens    MSFEDVLLVFSAVVFGAMAVGQVSSFAPDYAKAKISAAHIIMIIEKTPLIDSYSTEGLMPNTLEGNVTFG 1038  
 
 
b) ABCB11 multiple alignment 
 
O. niloticus     ----------HFSLVFRVISAIVTSGTALGRASSYTPDYAKAKISAAR-FFQLLDRVPQISVYNDKGEKW 59    
P. flesus        GGYLVRQEGLHFSLVFRVISAIVTSGTALGKASSYTPDYAKAKISAAR-FFKLLDRVPQISVYSDKGDKW 1106  
F. heteroclitus  GGYLVEQEGLHFSLVFRVISAIVTSGTALGRASSYTPDYAKAKTSAARFFFQLLDRVPPISVYSNRGEKW 515   
O. mykiss        GGYLVRQEGLHFSLVFRVISAIVTSGTALGRASSYTPDYAKAKISAAR-FFQLLDRVPKIRVYSNEGDKW 1086  
D. rerio         GGYLVYHEGLHFSFVFRVISAIVTSGTALGRASSYTPDYAKAKISAAR-FFQLLDRIPKISVYSKDGQKW 1047  
H. sapiens       GGYLISNEGLHFSYVFRVISAVVLSATALGRAFSYTPSYAKAKISAAR-FFQLLDRQPPISVYNTAGEKW 1080  
 
 
O. niloticus     DNFQGNIEFIECKFTYPSRPDIQVLNGLNVSVKPGQTLAFVGSSGCGKSTSVQLLERFYDPDHGKVLIDG 129   
P. flesus        DNFQGNLEFIDCKFTYPTRPDIQVLNGLNVSVRPGQTLAFVGSSGCGKSTSVQLLERFYDPDHGRVLIDG 1176  
F. heteroclitus  DNFQGNLEFVHCKFTYPTRPDIQVLNGLNVSVRPGQTLAFVGSSGCGKSTSAQLLERFYDPDHGKVLIDG 585   
O. mykiss        PDFRGNLEFIDCKFTYPTRPDIQVLNGLNVSVKPGQTLAFVGSSGCGKSTSVQLLERFYDPDQGKVIIDG 1156  
D. rerio         DNFKGDIEFIDCKFTYPSRPDIQVLNGLNVSVKPGQTLAFVGSSGCGKSTSVQLLERFYDPNSGRVLIDG 1117  
H. sapiens       DNFQGKIDFVDCKFTYPSRPDSQVLNGLSVSISPGQTLAFVGSSGCGKSTSIQLLERFYDPDQGKVMIDG 1150  
 
 
O. niloticus     HDTTRVNVSFLRSKIGIVSQEPILFDCSIAENIKYGDNLREISMNEVISAAKKAQLHDFVMALPEKYDTN 199   
P. flesus        HDSTGVNVPFLRSKIGIVSQEPILFDCSIADNIKYGDNSREISLNDVMSAAKKAQLHNFVMALPEKYDTN 1246  
F. heteroclitus  HESTRVSVPFLRSKIGIVSQEPVLFDCSIAENIKYGDNLREISMNEVISAAKKAQLHDFVMSLPEKYDAN 655   
O. mykiss        HDSTQVNVSYLRSKIGIVSQEPILFDCSIGDNIKYGDNLREVSMNDIISASKKAQLHNFVMTLPEKYDTN 1226  
D. rerio         RESSQINVAYLRSKIGIVSQEPILFDCSIAENIRYGDNQRELSMNDVISAAKKAQLHDFVMSLPEKYDTN 1187  
H. sapiens       HDSKKVNVQFLRSNIGIVSQEPVLFACSIMDNIKYGDNTKEIPMERVIAAAKQAQLHDFVMSLPEKYETN 1220  
 
 
O. niloticus     VGSQGSQLSRGQKQRIAIARAIIRDPKILLLDEATSALDTESEKTVQEALDKARQGRTCIVIAHRLSTIQ 269   
P. flesus        VGAQGSQLSRGQKQRIAIARAIIRDPKILLLDEATSALDTESEKIVQEALDKAREGRTCIVIAHRLSTIQ 1316  
F. heteroclitus  VGSQGSQLSRGQKQRIAIARAIIRDPKILLLDEATSALDTESEKTVQEALDKRREGRTCIVIAHRLSTIQ 725   
O. mykiss        VGSQGSQLSRGQKQRIAIARAIIRDPKILLLDEATSALDTESEKTVQEALDKAREGRTCIVIAHRLSTIQ 1296  
D. rerio         VGSQGSQLSRGQKQRIAIARAIIRDPKILLLDEATSALDTESEKTVQEALDKAREGRTCIVIAHRLSTIQ 1257  
H. sapiens       VGSQGSQLSRGEKQRIAIARAIVRDPKILLLDEATSALDTESEKTVQVALDKAREGRTCIVIAHRLSTIQ 1290  
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O. niloticus     NSD------------------------------------- 272   
P. flesus        NSDIIAVMSRGYVIEKGTHNQLMLLKGAYYKLVTTGAPIS 1356  
F. heteroclitus  NSDIIAVMSRGFVIEKGSHDQLMALKGAYYKLVTTGAPIS 765   
O. mykiss        NSDIIAVMSRGFVIEQGPHDQLMALKGAYYKLVTTGAPIS 1336  
D. rerio         NSDIIAVMSRGYVIEKGTHDYLMGLKGAYYKLVTTGAPIS 1297  
H. sapiens       NADIIAVMAQGVVIEKGTHEELMAQKGAYYKLVTTGSPIS 1330  
 
 
c) ABCC1 multiple alignment 
 
O.niloticus  --GLIYFFVQRFYVSSSRQLKRLESVSRSPIYTHFNETPLGTSVIRAFGEQERFIRESDQRVDHNQKAYY 68    
D.rerio      PLGLLYFFVQRFYVASSRQMKRLESVSRSPVYTHFNETLLGTSVIRAFGEQQRFIKESDGRVDHNQKAYF 1187  
O.mykiss     PLTLLYAFIQSFYVATSCQLRRLEAVSRSPIYTHFNETFQGASVIRAFSEQERFTLQANGRIDHNQTAYF 1124  
H.sapiens    PLGLIYFFVQRFYVASSRQLKRLESVSRSPVYSHFNETLLGVSVIRAFEEQERFIHQSDLKVDENQKAYY 1075  
 
 
O.niloticus  PSIVANRWLAVRLEFVGNFIVSFAALFAVIARESLSPGIMGLAISYALQLTASLTWLVRMSSDVETNIVA 138   
D.rerio      PSIVANRWLAVRLEFVGNCIVTFAALFAVMARNNLSPGIMGLSISYALQVTASLNWLVRMSSELETNIVA 1257  
O.mykiss     PRFVATRWLAVNLEFLGNLLVLAAATLAVMGRDTLSPGIVGLAVSHSLQVTGILSWIVRSWTDVENNIVS 1194  
H.sapiens    PSIVANRWLAVRLECVGNCIVLFAALFAVISRHSLSAGLVGLSVSYSLQVTTYLNWLVRMSSEMETNIVA 1145  
 
 
O.niloticus  VERVKEYSDTEKEAEWKQESSSLPPGWPTKGCTDIRGFSLRYRHDLDPAIHNINININGGEKVGIVGRTG 208   
D.rerio      VERVKEYGDTEKEAEWKLENSNLPPGWPTAGHIEIHKFGLRYREDLELAICDISVNIAGGEKVGIVGRTG 1327  
O.mykiss     VERVKEYADTPKEAPWTIEGSMLPLAWPTHGTIEMEEYGLQYRKGLDWALKGISLSIQEKEKVGIVGRTG 1264  
H.sapiens    VERLKEYSETEKEAPWQIQETAPPSSWPQVGRVEFRNYCLRYREDLDFVLRHINVTINGGEKVGIVGRTG 1215  
 
 
O.niloticus  AGKSSLTLGLFRIIEAAEGHIFIDGVDIAQLGLHDLRSRITIIPQDPVLFSGSLRMNLD----------- 267   
D.rerio      AGKSSLTLGLFRIIEAAEGEIRIDGVNIADLGLHELRSRITIIPQDPVLFSGSLRMNLDPFDGYTDEEVW 1397  
O.mykiss     AGKSSLALGIFRILEAAKGEIYIDGINIAQIGLHELRSRITIIPQDPVLFSGSLRMNLDPFDGYSDEEVW 1334  
H.sapiens    AGKSSLTLGLFRINESAEGEIIIDGINIAKIGLHDLRFKITIIPQDPVLFSGSLRMNLDPFSQYSDEEVW 1285  
 
 
d) ABCC2 multiple alignment 
 
O.niloticus  NRFAKDIFTIDEAIPNSFRSWLLCFLGVLGTLFVICLATPFFAIVIIPLAVIYFFVQRFYVATSRQLRRL 70    
O.mykiss     NRFAKDIFTVDEAIPQSFRSWIMCFLGVLGTLFVICLATPIFTAIIIPLAVVYYFVQRFYVASSRQLRRL 1175  
D.rerio      NRFAKDIFTVDEMIPMSFRSWILCLLGVLGTLFVICLATPIFTAVVVPMAVVYYFVQRFYVATSRQLRRL 1154  
M.domestica  NRFANDISTVDDTIPMSFRSWTMCFLSIISTAVMICVATPVFIVVIIPLAIIYIFVQRFYMATSRQLRRL 1161  
H.sapiens    NRFAGDISTVDDTLPQSLRSWITCFLGIISTLVMICMATPVFTIIVIPLGIIYVSVQMFYVSTSRQLRRL 1151  
 
 
O.niloticus  DSVSRSPIYSHFGETVSGLSVIRAYKHQDRFLKHNEVTIDENLKSVYPWIVSNRWLAIRLEFVGNLVVFF 140   
O.mykiss     DSVSRSPIYSHFGETVSGLSVIRAYGHQDRFLKHNEKIIDENPKSVYLWIISNRWLAIRLEFLGNLVVFF 1245  
D.rerio      DSVSRSPIYSHFGETVSGLSVIRAYGHQDRFLKHNEHTIDQNLKSVYPWIVSNRWLAMRLESLGNLVVFF 1224  
M.domestica  DSVTKSPIYSHFSETVSGLSIIRAFEHQQRFLKHSEGIIDTNQKCVFSWIISNRWLAVRLELVGNLVVFF 1231  
H.sapiens    DSVTRSPIYSHFSETVSGLPVIRAFEHQQRFLKHNEVRIDTNQKCVFSWITSNRWLAIRLELVGNLTVFF 1221  
 
 
O.niloticus  SALFAVTSRDSIDSGLVGLSISYALNVTQTLNWLVRMTSELETNIVAVERVSEYTELENEADWVTDTRPP 210   
O.mykiss     LALLAVIARDSLDSGLVGLSISYALNVTQTLNWLVRMTSELETNIVAVERVSEYTEMENEADWVSGIRPS 1315  
D.rerio      AALFAVISRDSLNSGLVGLSISYALNVTQTLNWLVRMTSELETNIVAVERVREYAEIQNEAPWVTSVRPP 1294  
M.domestica  SALLIVIYRDNLKGDMVGLVLSNALNITQTLNWLVRMTSELETNIVSVERINEYIKVKNEAPWLLEKRPP 1301  
H.sapiens    SALMMVIYRDTLSGDTVGFVLSNALNITQTLNWLVRMTSEIETNIVAVERITEYTKVENEAPWVTDKRPP 1291  
 
 
O.niloticus  QQWPEAGRVQFENYKVRYRPELDLVLHGITCDIDSTEKIGIVGRTGAGKSSLTNCLF------------- 267   
O.mykiss     EKWPEAGRLRFENFKVRYRPELDLVLHGITCDIDSTEKIGIVGRTGAGKSSLTNCLFRIIEAAEGRILID 1385  
D.rerio      DDWPSAGNIRFEDYKVRYRPELELVLHGVTCDIQSTEKIGIVGRTGAGKSSLTNCLFRIVEAADGRILID 1364  
M.domestica  DNWPSKGEIRFTDYKVRYRPELDLILHGITCNIEGTEKIGVVGRTGAGKSSLTNCLFRILEAAEGQITID 1371  
H.sapiens    PDWPSKGKIQFNNYQVRYRPELDLVLRGITCDIGSMEKIGVVGRTGAGKSSLTNCLFRILEAAGGQIIID 1361  
 
e) ABCG2 multiple alignment 
 
O.niloticus  ----IGLNGIMKPGLNAIMGATGSGKSSFLDVLAARKDPAGLTGEVLIDGAPQPPNFKCLSGYVVQDDVV 66   
O.mykiss     KDILIDLNGLMKPGLNAIMGATGSGKSSFLDVLAARKDPAGLAGEVLMDGAPQPPNFKCLSGYVVQDDVV 131  
D.rerio      KNILIGLNGIMKPGLNAILGATGSGKSSFLDVLAARKDPAGLSGEVLIDGAPQPPNFKCLSGYVVQDDVV 125  
S.salar      REILVDLNGIMRPGLNAILGPTGSGKSSFLDVLAARKDPSGLSGEVLIDGAPQPPNFKCLSGYVVQDDVV 139  
H.sapiens    KEILSNINGIMKPGLNAILGPTGGGKSSLLDVLAARKDPSGLSGDVLINGAPRPANFKCNSGYVVQDDVV 130  
 
 
O.niloticus  MGTLTVRENFTFSAALRLPSSISQKEKKAKVDRLIKELGLGRVADSRVGTQLIRGISGGERKRTNIGMEL 136  
O.mykiss     LGTLTVRENFRFSAALRLPSSVSQKEKEDKVNRLITELGLTKVADSRVGTQLIRGISGGERKRTNIGMEL 201  
D.rerio      MGTLTVRENLRFSAALRLPKSIKQREKDEKVERLIQELGLSKVADSRVGTQLIRGVSGGERKRTNIGMEL 195  
S.salar      MGTLTVRENLRFSAALRLPRSVPQKEKEARVNDLITELGLTKVADAKVGTQMIRGISGGERKRTNIGMEL 209  
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H.sapiens    MGTLTVRENLQFSAALRLATTMTNHEKNERINRVIQELGLDKVADSKVGTQFIRGVSGGERKRTSIGMEL 200  
 
 
O.niloticus  IIDPPVLFLDEPTTGLDASTANSVLLLLKRMANSGRTIILSIHQPRYTIYRLFDSLTMLVNGHQVYHGPA 206  
O.mykiss     IIDPPVLFLDEPTTGLDASTANSVLLLLKRMSSHGRTIILSIHQPRYSIFRLFDSLTLLVSGKQVYHGPA 271  
D.rerio      IIDPPVLFLDEPTTGLDASTANSVLMLLKKMGNNGRTIILSIHQPRYSIYRLFDSLTLLVGGKLVYHGPA 265  
S.salar      IIDPSVLFLDEPTTGLDASTANSVLLLLKRMANQGRTIIMSIHQPRYSIYRLFDSLTLLVSGKQVYHGPA 279  
H.sapiens    ITDPSILFLDEPTTGLDSSTANAVLLLLKRMSKQGRTIIFSIHQPRYSIFKLFDSLTLLASGRLMFHGPA 270  
 
 
O.niloticus  RSALEYFSDIGYT--------------------------------------------------------- 219  
O.mykiss     QSALDYFSNIGYTCEPHNNPADFFLDVINGDSTSIAFDRIKEADDSDPDRVTSSKQNIEDHLVQEYRGSQ 341  
D.rerio      QDALSYFSQIGYTCEPHNNPADFFLDVINGDSSAVTLNKLY--EEVDQDQLSSSLKGIEDRLVEEYQRSS 333  
S.salar      QNALDYFADIGYACEAHNNPADFFLDVINGDSTATAMNKIQ-GEDIDFEELSGSRQTIEERLVEEYRNCS 348  
H.sapiens    QEALGYFESAGYHCEAYNNPADFFLDIINGDSTAVALNREEDFKATEIIEPSKQDKPLIEKLAEIYVNSS 340  
 
 
 
Figure 4.1 - Multiple alignments of the deduced amino acid sequences for ABCB1b (a), 
ABCB11 (b), ABCC1 (c), ABCC2 (d) and ABCG2 (e) in N. tilapia with other fish species and 
human.  
Arrows indicate transmembrane helices (TMH), and/or ABC signature regions (C-Motif), Walker-A 
(W-A) and Walker-B (W-B), in each partial amino acid sequence. Identical and similar amino acids 
are indicated in dark and light grey, respectively. ABCB1: Poeciliopsis lucida ADQ20481.1; 
Trematomus bernachii ACX30417.1; Oncorhynchus mykiss AAW56424; Homo sapiens 
NP000918.2. ABCB11: Platichthys flesus CAC86593.1, Fundulus heteroclitus AAD29692.1, 
Oncorhynchus mykiss NP001118128.1, Danio rerio XP001923538, Homo sapiens NP003733.2. 
ABCC1: Danio rerio XP001341895.3, Oncorhynchus mykiss NP001161802.1, Homo sapiens 
NP004987.2. ABCC2: Oncorhynchus mykiss NP001118127.1, Danio rerio XP002664118, 
Monodelphis domestica XP001372990.1, Homo sapiens CAB45309.1. ABCG2: Oncorhynchus 
mykiss NP001118155.1, Danio rerio NP001036240.1, Salmo salar NP001167126.1, Homo sapiens 
AAH92408.1. Alignments were done with Clustal W program. 
C-motif 
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Figure 4.2 – Predicted topologies of Nile tilapia partial ABCB1b (a), ABCB11 (b), ABCC1 (c), 
ABCC2 (d) and ABCG2 (e) proteins with membrane spanning domains (MSDs) and 
nucleotide binding domains (NBDs) according to the Polyphobius algorithm.  
In NBDs, highly conserved regions of the ABC transporters superfamily are indicated: W-A (Walker A), C-motif 
(Signature motif) and W-B (Walker B). Regions of partial ABC transporters aa sequences identified in this 
study are enclosed in red frame. 
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Figure 4.3 - Phylogenetic trees based on the multiple alignments (Clustal W) of closely 
related proteins from ABCB, ABCC and ABCG subfamilies found in other species.  
Evolutionary history was inferred using neighbor-joining method and the percentage of concordance 
based on 1000 bootstrap iterations is shown at the nodes. a) ABCB subfamily: ABCB1 fc – Felix 
catus NP001164535.1, hs – Homo sapiens NP000918.2, mm – Mus musculus NP035205.1, gg – 
Gallus gallus NP990225.1, dr – Danio rerio a ENSDARG00000021787, xl – Xenopus laevis 
NP001081394.1, tb – Trematomus bernachii ACX30417.1, om – Oncorhynchus mykiss AAW56424, 
dr – Danio rerio b ENSDARG00000010936, pl – Poeciliopsis lucida ADQ20481.1; ABCB11 mm – 
Mus musculus NP066302.2, rn – Ratus norvegicus NP113948.1, dr – Danio rerio XP001923538, pf 
– Platichthys flesus CAC86593.1, om – Oncorhynchus mykiss NP001118128.1; b) ABCC subfamily: 
ABCC1 ec – Equinus caballus NP001075232, hs – Homo sapiens NP004987.2, clv – Canis lupus 
vulgaris NP001002971.1, mm – Mus musculus NP032602, rn – Ratus norvegicus NP071617, gg – 
Gallus gallus NP001012540.1, dr – Danio rerio XP001341895.3, om – Onchorhynchus mykiss 
NP001161802.1, dm – Drosophila melanogaster NP723772.2-a, NP609591.2-b, NP995699.1-c; 
ABCC2 hs – Homo sapiens CAB45309.1, le – Leucoraja erinacea AAL92112.1, dr – Danio rerio 
XP002664118; c) ABCG subfamily: ABCG2 hs – Homo sapiens AAH92408.1, mm – Macaca 
mulatta NP001028091.1, clv – Canis lupus vulgaris NP 001041486, musmus – Mus musculus 
NP036050.1, xl – Xenopus laevis NP001091141, ss – Salmo salar NP001167126.1, dr – Danio 
rerio NP001036240.1, om – Oncorhynchus mykiss NP 001118155.1. Tree was designed using 
Mega 4.0.2 software. 
________________________________________________________________________________________ 
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4.4.2. Quantification of ABCB1b, ABCB11, ABCC1, ABCC2, ABCG2, CYP1A and 
GSTα mRNA expression in liver, gill and proximal intestine of Nile tilapia, after BaP 
exposures 
 
4.4.2.1. ABC transporters, CYP1A and GSTα mRNA expression in the different 
tissues  
 
Relative quantification was used for comparison of different genes mRNA expression 
within each target tissue, and results are given in figure 4.4 (a-c). The highest levels of 
ABCB1b mRNA relative expression were found in proximal intestine (155-fold), while in 
liver expression was about 9 times lower; oppositely, ABCB11 mRNA expression was 
about 8 times higher in liver (26.2-fold) than in proximal intestine (3.4-fold). Neither ABCB1 
nor ABCB11 mRNA expression were detected in gill. ABCC1 mRNA expression increased 
from liver (8.6-fold), to proximal intestine (14.1-fold) and to gill (36.9-fold). Liver and gill 
showed similar levels of ABCC2 mRNA expression (15.1 and 8.9-fold, respectively) while 
in proximal intestine expression was about 10 times higher (104.1-fold). ABCG2 was about 
3 times more expressed in proximal intestine (23.5-fold) than in liver and gill (7.9-fold). 
CYP1A mRNA was much more expressed in liver and gill (3183.1 and 3462.4-fold, 
respectively), than in proximal intestine, where its expression was about 17 times lower 
(199.2-fold). The highest mRNA expression of GSTα was seen in gill (1842.0-fold). In 
proximal intestine and liver its expression was 20 and 100 times lower (86.0 and 19.0-fold, 
respectively). Considering each tissue individually, in liver, CYP1A mRNA expression was 
different (p<0.05) from all ABC transporters and GSTα, and ABCB1b and ABCB11 were 
the most expressed transporters (figure 4.4a). In gill, CYP1A and GSTα showed a 
markedly higher expression than ABC transporters, and ABCC1 was the highest 
expressed transporter (figure 4.4b). In proximal intestine, results showed similar 
expressions of ABCB1b, ABCC2 and CYP1A, while ABCB11, ABCC1, ABCG2 and GSTα 
mRNA expression was lower (figure 4.4c). 
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Figure 4.4 – Relative mRNA expression of ABC transporters, CYP1A and GST α in Nile tilapia 
liver (a), gill (b) and proximal intestine (c).  
Neither ABCB1b  nor ABCB11 mRNA expression was detected in gill. 18S rRNA mRNA expression 
was set to 10000 in all tissues. Different letters denote significant differences (p<0.05) between 
genetic expression of target genes (ABCB1b, ABCB11, ABCC1, ABCC2, ABCG2, CYP1A and 
GSTα) within the same tissues. Results are presented as mean±SE (n=4). 
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4.4.3. Water exposure to BaP 
 
ABC transporters, CYP1A and GSTα mRNA expression levels after water exposure 
to different BaP concentrations are displayed in figure 4.5 (a-f).   
Relative mRNA expressions of ABCC2 (in gill) and ABCG2 (in liver and proximal 
intestine) were up regulated after BaP exposure, with significant differences to control 
animals. Gill mRNA ABCC2 fold induction over control was dose-dependent, ranging from 
6 (in 10 µg/L) to 16 (in 50 µg/L) (figure 4.5c). Similar results were seen in intestinal ABCG2 
mRNA expression, where a maximum 7-fold increase was detected in animals exposed to 
50 µg/L of BaP. In liver, ABCG2 mRNA expression had a maximum fold increase of 2 after 
exposure to 25 µg/L (figure 4.5d). ABCB1b followed a pattern of increasing mRNA 
expression in both liver and proximal intestine as the concentration of BaP rose (figure 
4.5a), even though without statistical support. CYP1A mRNA was significantly up-
regulated after waterborne BaP exposure in all three tissues (figure 4.5e). In liver, animals 
exposed to 50 µg/L of BaP showed a relative 5-fold induction in CYP1A mRNA expression. 
In gill and proximal intestine, induction of CYP1A mRNA was seen at all BaP 
concentrations, with relative increases of 14 and 19-fold (at 10 µg/L), 11 and 81-fold (at 25 
µg/L) and 35 and 155-fold (at 50 µg/L), respectively for gill and proximal intestine. No 
significant differences were seen in GSTα mRNA expression in all three tissues, although 
an increasing pattern with BaP concentration was patent in gill (figure 4.5f). 
Expression of CYP1A was highly correlated with ABCC2 mRNA in gill (r=0.99, 
p=0.002) and with ABCG2 mRNA expression in intestine (r=0.99, p=0.05). Both in gill and 
proximal intestine, high CYP1A correlations matched the ABC transporters that showed 
dose-dependent mRNA up-regulations after BaP waterborne exposure. GSTα and ABCC2 
mRNA expressions were highly correlated (r=0.97, p=0.004) in gill tissue. Biliary BaP 
metabolites (measured as Fluorescent Aromatic Compounds – FACs), 7-ethoxyresorufin 
O-deethylase (EROD) and glutathione S-transferase activity in liver, gill and intestine from 
the same animals were previously determined in our laboratory (results published in Costa 
et al., 2011). Biliary BaP metabolites were significantly correlated with liver CYP1A mRNA 
(r=0.91, p=0.004), gill ABCC2 mRNA (r=0.93, p=0.022), CYP1A mRNA (r=0.95, p=0.013) 
and GSTα mRNA (r= 0.90, p=0.036). EROD activity and CYP1A mRNA correlations were 
r=0.95 in liver (p=0.014), r=0.76 in gill (p=0.131) and r=0.86 in proximal intestine 
(p=0.062). 
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Figure 4.5 – Relative mRNA expression of ABCB1b (a), ABCC1 (b), ABCC2 (c), ABCG2 (d), 
CYP1A (e) and GSTα (f) in liver, gill and proximal intestine of animals exposed to waterborne 
BaP. 
ABCB1b mRNA expression was not detected in gill. Insert in (e) refers to detailed CYP1A mRNA 
expression in control and solvent. Expression was quantified by qRT-PCR, and fold changes to 
control were determined using the 2
-ΔΔCT
 method. Results are given as mean±SE (n=4). Different 
letters denote significant differences (p<0.05) between treatments within the same tissue.  
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4.4.4. Dietary exposure to BaP 
 
Gene expression levels of ABCB1b, ABCC1, ABCC2, ABCG2, CYP1A and GSTα of 
animals from dietary exposure to 100 and 200µg of BaP/g of food are displayed in figure 
4.6 (a-f). 
In this exposure route, high variability between animals of the same treatment was 
seen in mRNA expression levels of the ABC transporters. Unexpectedly, expression of 
ABCC1 (figure 4.6b) and ABCG2 (figure 4.6d) in proximal intestine of solvent exposed 
animals was higher than the levels seen in the remaining treatments. Gill of animals 
exposed to 100 µg of BaP/g of food had the highest levels of ABCC2 mRNA expression 
(figure 4.6c). Moreover, although without significant differences to control groups, ABCB1b 
gene expression in liver increased in animals exposed to 100 and 200 µg of BaP/g of food 
(figure 4.6a). No significant changes were seen in GSTα mRNA expression after Bap 
exposure (figure 4.6f). 
In this assay, the most significant result was the induction of intestinal CYP1A mRNA 
in dietary exposed animals (figure 4.6e), seen after exposure to 100 and 200 µg of BaP/g 
of food (maximum of 13-fold increase in the latter BaP concentration).  Biliary BaP 
metabolites (measured as FACs), EROD and GST activities in liver, gill and intestine from 
the same animals were previously determined in our laboratory (results published in Costa 
et al., 2011). Intestinal CYP1A mRNA expression was highly correlated with EROD activity 
(r=0.95, p=0.048) and biliary BaP metabolites (r=0.97, p=0.025).  
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Figure 4.6 - Relative mRNA expression of ABCB1b (a), ABCC1 (b), ABCC2 (c), ABCG2 (d), 
CYP1A (e) and GSTα (f) in liver, gill and proximal intestine of animals exposed to dietary 
BaP. 
ABCB1b mRNA expression was not detected in gill. Expression was quantified by qRT-PCR, and 
fold changes to control were determined using the 2
-ΔΔCT
 method. Results are given as mean±SE 
(n=4). Different letters denote significant differences (p<0.05) between treatments within the same 
tissue. 
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4.5. Discussion  
 
In this study, expressional changes of ABC transporters (ABCB1b, ABCB11, 
ABCC1, ABCC2 and ABCG2), CYP1A and GSTα were determined upon waterborne and 
dietary BaP exposures in O. niloticus. After the identification of the target partial 
sequences in this specie, relative mRNA expression was measured in tissues involved 
with the captation and excretion of pollutants and/or its metabolites (liver, gill and proximal 
intestine).  
 
4.5.1. Identification and tissue distribution of ABC transporters, CYP1A and GSTα  
 
Molecular data on Nile tilapia obtained in this study, demonstrated that, with 
exception of ABCB1b, all the remain deduced aa sequences of the target ABC 
transporters (ABCB11, ABCC1, ABCC2 and ABCG2), have at least one of the classical 
features of this protein family, C-Motif (LSGGQ), Walker A (GxxGxGKS/T, where x equals 
any aa) and/or Walker B (xxxxD, where x equals hydrophobic residues), cytoplasmatic 
highly conserved amino acid sequences that can be found in all vertebrate ABC proteins 
(Hyde et al., 1990). Topology analysis (figure 4.2) revealed that partial aa sequences for 
the ABC transporters identified in this study are analogous to what has been described for 
other species (Lage 2003; Leslie et al., 2005). Moreover, the high degree of homologies 
with other fish and mammals seen after multiple alignments (figure 4.1), and clustering of 
the sequences with other fish species in phylogenetic analysis (figure 4.3) consequently 
demonstrate the presence of the genes for the ABC transporters in Nile tilapia. In the case 
of ABCB1, two copies of ABCB1 gene can be found in zebrafish genome, called ABCB1a 
and ABCB1b (Annilo et al., 2006). Recently, a novel ABCB1 isoform was identified in trout 
and named ABCB1b (Fisher et al., 2011). Results show that Nile tilapia sequence has 
higher degree of identity with zebrafish ABCB1b (ABCB4), and trout ABCB1a, than to 
zebrafish ABCB1a (figure 4.3). Thus, based on the similarities with the isoforms originally 
named in zebrafish, Nile tilapia ABCB1 identified in this study should be of type b.  
Regarding ABCG2 gene, four isoforms (from a to d) are described in the zebrafish genome 
(Annilo et al., 2006). Our results have shown that ABCG2 identified in Nile tilapia has 
higher degree of homology with zebrafish ABCG2a (figure 4.3). 
In this study, relative mRNA expression of the different ABC transporters, CYP1A 
and GSTα in liver, gill and proximal intestine of O. niloticus was assessed. Only a few 
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studies have described the distribution pattern of ABC transporters in aquatic organisms, 
namely in different tissues of trout (Zaja et al., 2008a; Zaja et al., 2008c; Loncar et al., 
2010), zebrafish (Long et al., 2011a), little skate (Cai et al., 2003), shipshead meadow 
(Hemmer et al., 1998) and Poecilia reticulata (Hemmer et al., 1995). The distribution 
pattern of ABCB1b, ABCB11, ABCC1, ABCC2 and ABCG2 found in Nile tilapia follows the 
ones described in those studies, and is also in agreement with tissue distribution pattern 
determined in mammals (Flens et al., 1996; Keppler and Konig, 1997; Gerloff et al., 1998; 
Mottino et al., 2000; Malliepaard et al., 2001; Brady et al., 2002), with highest expression 
levels of ABC transporters found in important physiological/pharmacological barriers 
(Szakács et al., 2008).  
ABCB1b and ABCB11 mRNA expression was not detected in gill, and these results 
are in agreement to what is described in the literature for other fish species (Zaja et al., 
2008a; Loncar et al., 2010). Zaja et al. (2008a) suggested that the high blood content in 
the gills could potentially mask the gene expression in specific cells types, such as gill 
epithelial cells, and indicated primary gill epithelial cells as a more adequate model for 
studying ABC transporters in gills. In subsequent works, ABCB1 and ABCB11 were 
detected at low levels in a gill cell line in trout (Fisher et al., 2011). ABCB11 mRNA tissue 
distribution pattern observed in this study, with almost exclusive expression in liver (very 
low expression was seen in intestine and no expression in gill), is in agreement with its 
described function of transporter of bile salts from hepatocytes into the bile (Gerloff et al., 
1998). Similarly to what has been described for mammals and other fish species, this 
study has shown that, also in Nile tilapia ABC transporters have distinct mRNA expression 
patterns in different tissues. In mammals, these different patterns of expression have been 
shown to be function related (Szakács et al., 2008). Therefore, this might also be true for 
Nile tilapia, although more research on this matter remains necessary, namely at a post 
transcriptional level and on cellular localization of ABC transporters in fish. However, this 
kind of approach is still difficult to achieve since, with exception of ABCB1, no functional 
antibodies are available for ABC transporters in fish species. 
Higher levels of CYP1A mRNA expression were seen in liver and gill when 
comparing to the proximal intestine, with gill showing slightly higher levels of CYP1A 
mRNA expression than liver (figure 4.4). This data is in agreement with previous results 
reported in Salmo salar, where gill tissue had highest basal levels of CYP1A mRNA, than 
liver, kidney and brain (Rees et al., 2003). Considering that mRNA CYP1A expression 
found in tilapia tissues is well correlated with the levels of CYP1A activity measured in the 
same animals in a previous study (Costa et al., 2011), the higher basal levels of steady 
state CYP1A mRNA found in gill tissue may reflect the biotransformation function of gills, 
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when the exposure to contaminants is mainly through water (Levine and Oris, 1999; Rees 
et al. 2003). Additionally, major CYP1A expression and/or activity typically found in liver, is 
consistent with the role of this organ in xenobiotic metabolism and excretion (Levine and 
Oris, 1999; Sarasquete and Segner, 2000), whose overall contribution to detoxification is 
well accepted. GSTα mRNA expression was considerably higher in gill, than in liver and 
intestine (figure 4.4). GST sequences have been isolated and characterized in several fish 
species, such as plaice (Leaver et al, 1993; Martinez-Lara et al., 2002), largemouth bass 
(Doi et al., 2004), red-seabream (Konishi et al., 2005), mangrove killifish (Lee et al., 2005),  
river pufferfish (Kim et al., 2010), common carp (Fu and Xie 2006) and bighead carp (Li et 
al., 2010). The majority of these works reported high hepatic expression of several GST 
isoforms, indicating that different GST isoforms are associated with hepatic detoxification 
of xenobiotics (Kim et al, 2010). Moreover, high intestinal levels of GSTs have also been 
reported in fish (Kim et al., 2010, Li et al., 2010) and mammals (Landi, 2000), indicating a 
role of this tissue in xenobiotic breakdown. Studies that compared GSTα expression in fish 
tissues indicated that this specific isoform has higher expression in liver and intestine than 
gill in bighead carp (Li et al., 2010) and river pufferfish (Kim et al., 2010), oppositely to 
what was found in Nile tilapia. Higher GSTα mRNA levels in gill reinforce the idea that gills 
also display an important role in xenobiotic metabolism (Jönsson et al., 2006; Nahrgang et 
al., 2010; Costa et al., 2011).  
 
4.5.2. ABC transporters CYP1A and GSTα transcriptional responses upon BaP 
exposure 
 
After exposure to BaP, mRNA levels of some of the studied ABC transporters, and of 
CYP1A were up-regulated in Nile tilapia. The most significant results were seen after water 
exposure, with increased mRNA expression of ABCC2 (in gill), ABCG2 (in liver and 
proximal intestine) and CYP1A (in liver, gill and proximal intestine). Although without 
significant differences, hepatic and intestinal ABCB1b and gill GSTα mRNA showed a 
tendency to increase in animals exposed to waterborne BaP. In dietary assays only 
intestinal CYP1A mRNA was significantly up-regulated in BaP exposed animals.  
A small number of studies have addressed the modulation of ABC transporters in 
liver of fish species, and an increase of the hepatic transcripts of ABCC2 and ABCG2 in 
killifish exposed to PAHs (Paetzold et al., 2009) and of hepatic mRNA ABCC2 in zebrafish 
and Antartic fish exposed to heavy metals (Zucchi et al., 2010; Long et al., 2011b) has 
been reported. Our results follow the pattern of expression seen in those studies, since 
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ABCC2 and ABCG2 were the transporters with more pronounced changes to BaP 
exposure.   
CYP1A mRNA up-regulation in liver, gill and proximal intestine of water exposed 
animals, is consistent to what is described in the literature (Van Veld et al., 1997; Ortiz-
Delgado et al., 2005; Ortiz-Delgado et al., 2008). Correlations between CYP1A mRNA and 
CYP1A catalytic activity (EROD) measured in a previous study performed in our laboratory 
using the same animals (Costa et al., 2011), were high for all tissues, although only 
significant in the liver (r=0.95, p=0.014), providing evidence that an increase in mRNA 
expression of CYP1A reflects an increase in protein functionality. In Costa et al., 2011, we 
have demonstrated that waterborne BaP exposure results in high rates of metabolism (by 
CYP1A enzymes) in liver, gill and intestine, and that total BaP metabolites measured in 
bile are correlated with CYP1A activity (measured as EROD activity), in the different 
tissues. Probably, BaP metabolites formed in extra-hepatic tissues are reabsorbed into the 
blood stream and released in the gall bladder (Kleinow et al., 1998; Costa et al., 2011). 
Moreover, BaP metabolites profile in plasma and bile of Nile tilapia exposed to BaP in 
water showed that these are mostly phase II conjugates (Rey-Salgueiro et al., 2011). In 
our study, high correlations were also found between total BaP metabolites (Costa et al., 
2011) and 1) ABCC2 mRNA expression in gill (r= 0.93, p=0.022), and 2) ABCG2 mRNA 
expression in intestine (r=0.85, p=0.066).  Although we cannot draw any conclusions about 
the activity of these transporters, since no protein or functionality studies were done, 
mRNA up-regulation and the correlations observed with biliary BaP metabolites can 
suggest that, after water exposure, efflux of phase II BaP metabolites most probably 
occurs via  ABCC2 in gill, and ABCG2 in intestine. Previous studies have reported that 
ABCC2 efflux of xenobiotics occurs through a co-transport mechanism with reduced 
glutathione (GSH) (reviewed in Leslie et al., 2005), and the significant correlation seen 
between GSTα and ABCC2 mRNA in gill further supports this hypothesis. Regarding the 
intestine, it has been hypothesized that ABC transporter proteins may be involved in the 
luminal directed transport of BaP metabolites in a human colon adenocarcinoma cell line 
and ABCB1, ABCC1 and ABCC2 transporters were ruled out as possible candidates 
involved in this efflux (Buensen et al., 2002; Lampen et al., 2004). However, Ebert et al. 
(2005) has identified ABCG2 as one of the efflux transporters of BaP conjugates formed in 
Caco-2 cells back into the intestinal lumen, supporting our results of ABCG2 mRNA 
expression in Nile tilapia intestine.  Moreover, Mao et al. (2005) reported that ABCG2 
seems to preferentially transport sulfated conjugates of steroids and xenobiotics over GSH 
and glucoronide metabolites, which is in agreement with the lack of correlation seen 
between mRNA expression of this transporter and GSTα mRNA.  
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Despite the lack of statistical significance, we also observed an increase in ABCB1b 
transcriptional levels in liver and proximal intestine of water exposed animals. Up-
regulation of ABCB1 in response to xenobiotics is not usually large (1-2 -fold) (Smital et al., 
2003), and the individual variability can be masking that response in this study. Although 
BaP itself has been indicated as a non substrate for ABCB1 in mammals (Schuetz et al., 
1998, Buesen et al., 2002), others indicate the opposite (Chao Yeh et al., 1992; Fardel et 
al., 1996) and the subject remains in discussion. Nevertheless, in a recent work by Zaja et 
al. (2011) no BaP interaction was seen with ABCB1 activity in a hepatoma cell line of 
Poeciliopsis lucida. In general, mRNA up-regulation of ABC transporters reported in this 
study could be a response to the presence of BaP and/or its metabolites. However, more 
work is necessary at post-transcriptional and protein levels, in order to confirm these 
hypothesis. Induction of ABC transporters has also been associated with a non-specific 
general stress response in Mytilus californianus, rather than to the presence of specific 
substrates of those transporters (Eufemia and Epel 2000). In our study, morphological and 
behavioral indices (data not shown) were not altered in the animals exposed to BaP, which 
gives us an indication that these animals were not under stressful conditions, and that they 
were responding to the presence of the contaminant or its metabolites.  
As previously stated, no significant changes were seen in ABC transporters after 
dietary exposures to BaP. Intestinal, but not hepatic, up-regulation of CYP1A 
transcriptional levels can indicate that animals were under BaP induced stress, and that 
the majority of BaP metabolism will occur at intestinal level, limiting the amount of parent 
compound that reaches the liver to be metabolized. This type of response has been 
reported at post-transcriptional levels in liver (Van Veld et al. 1987; Reynolds et al. 2003; 
Costa et al. 2011) and intestine (McElroy et al., 1992; James et al., 1997; Costa et al., 
2011) of fish exposed to dietary PAHs. Moreover, high correlations were seen between 
intestinal CYP1A mRNA and intestinal EROD activity and biliary BaP metabolites (Costa et 
al., 2011) reinforcing the idea that mRNA expression of CYP1A reflects protein 
functionality, similarly to what was observed in water exposure.  
Among the ABC transporters identified in this study, ABCC1 mRNA expression was 
not significantly altered by the presence of BaP and/or its metabolites, and was not 
correlated with the remaining parameters evaluated. Despite our results, much of the in 
vitro evidence indicates that ABCC1 has a role in the removal of toxins as glutathione, 
glucoronide or sulphate conjugated metabolites from cells (reviewed in Leslie te al., 2001). 
Additionally, ABCC1 gene induction was seen in zebrafish exposed to heavy metals (Long 
et al., 2011a) indicating that this transporter can be involved in heavy metal detoxification 
in this specie.  
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In dietary exposure to BaP, high variability was observed within each treatment, probably 
due to the fact that it is not possible to control the exact amount of food that each animal 
eats. This variability can be masking a possible response of ABC transporters mRNA 
expression, which is usually not very large, as opposed to CYP1A mRNA response (10-
100 fold induction) (Epel et al., 2008; Smital et al., 2003). The induction of intestinal 
ABCC2 and ABCG2 mRNA expression in solvent exposed animals is an unexplainable 
result, as we cannot input the observed up-regulation to the presence of the solvent, since 
BaP exposed groups did not show the same response pattern, and were simultaneously 
exposed to same quantity of solvent. Moreover, this response to the solvent was only seen 
in these genes and, in waterborne exposure, no such effect was seen for any of the 
assessed genes.  
 
4.6. Conclusion 
 
In conclusion, partial mRNA sequences of ABCB1b, ABCB11, ABCC1, ABCC2 and 
ABCG2 were identified in O. niloticus, and the gene expression tissue distribution pattern 
of these transporters in Nile tilapia follows the ones already described in mammals and in 
other aquatic species. Furthermore, novel information about ABC transporters 
transcriptional levels after controlled exposure to BaP, a ubiquitous contaminant in aquatic 
environments, in liver, gill and proximal intestine is provided. Up-regulation of ABCC2 and 
ABCG2 transcriptional levels could be related to a possible role of these transporters in the 
efflux of BaP metabolites in these tissues. New information about ABC transporters 
provided in this work can be applied in future toxicological or physiological studies, helping 
to achieve a wider knowledge of the contribution of these proteins in the overall process of 
xenobiotic detoxification in aquatic species. 
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5. Tissue distribution and response patterns of Pgp and CYP1A 
proteins in Nile tilapia (Oreochromis niloticus) after waterborne 
exposure to Benzo(a)pyrene (BaP) 
 
 
5.1. Abstract 
 
The possible correlation between P-glycoprotein (Pgp) and Cytochrome P450 
(CYP1A) in the pathway of detoxification of xenobiotic compounds in aquatic organisms is 
still not well characterized and was under investigation in this study. After waterborne 
exposure of Nile tilapia (Oreochromis niloticus) to different Benzo(a)pyrene (BaP) 
concentrations, the protein levels and the tissue distribution patterns of Pgp and CYP1A 
were evaluated by immunochemical approaches. Pgp protein levels and distribution 
pattern were evaluated with two different mammalian Pgp antibodies (C219 and C494), 
with different results for each antibody. Similarly to what has been described for other fish 
species, C219 reacted with a ~170kDa protein in liver samples, and was localized to the 
bile canaliculi. No positive reaction was seen in gills, and in gut epithelial cells only 1.35% 
of the samples showed a mild positive reaction. After probing with C494, a positive 
reaction was seen in liver, gills and intestine, covering a wider set of cell types, with a 
similar cellular localization described for mammals and other fishes using the same 
antibody. Levels of Pgp expression were not altered after in vivo exposure to BaP. CYP1A 
was detected with the mAb C10-7 in liver, gills and intestine of Nile tilapia, showing a 
tissue distribution pattern similar to what has been described for other species and 
following a BaP dose-dependent fold induction. Taken together, these results suggest that 
BaP is not itself a substrate for Pgp, while CYP1A is involved in its metabolism in barrier 
tissues such as liver, gills and intestine. 
 
Keywords: Pgp, ABCB1, MXR, Nile tilapia, Immunohistochemistry, Western blot 
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5.2. Introduction 
 
The toxicity of many xenobiotics is influenced by the target organism’s ability to deal 
with the compounds through detoxification mechanisms, inherently expressed in certain 
cell types. The multidrug resistance (MDR) membrane P-glycoprotein (Pgp), first 
discovered in mammalian tumour cells (Juliano and Ling, 1976), is an energy dependent 
pump that translocates a wide variety of structurally and functionally diverse substrates 
across cellular membranes (Leslie et al., 2005). This efflux transporter belongs to the 
highly conserved ATP-Binding Cassette (ABC) superfamily of transmembrane proteins that 
comprises members with highly diverse physiological functions (Dean and Annilo, 2005). 
Since some substrates are endo- and xenobiotics, it is believed that Pgp displays an 
ecotoxicological role in cellular detoxification (Leslie et al., 2005). Research on ABC efflux 
transporters in aquatic organisms is still limited, although an increasing number of studies 
conducted to elucidate the presence and function of these proteins in fish species have 
been made (Bard et al., 2002a; Bard et al., 2002b; Costa et al., 2012; Fischer et al., 2011; 
Zaja et al., 2008). Another important mechanism of cellular detoxification is the 
biotransformation of xenobiotics into more easily excreted compounds by enzymatic 
systems, such as the cytochrome P450 enzymes (CYP). These enzymes, in phase I of 
biotransformation, convert the chemicals into more hydrophilic forms, through oxidation, 
reduction or hydrolysis reactions, favouring their excretion (Okey et al., 1986). Cytochrome 
P4501A (CYP1A) are among the major oxidative enzymes induced in fish and other 
vertebrates by several types of pollutants, including polycyclic aromatic hydrocarbons 
(PAHs). CYP1A gene expression, protein levels and activity usually respond in a dose-
dependent manner to environmental contamination levels (Buhler and Williams, 1989; 
Costa et al., 2011; Costa et al., 2012; van der Oost et al., 2003; Van Veld et al., 1997). In 
light of their functions, some studies have investigated the possibility that Pgp (ABCB1) 
and CYP1A proteins could act in a coordinated fashion providing an important mean of 
protection of the cells against xenobiotic insults, due to the existence of common 
substrates (Bard et al., 2002b; Fardel et al., 1996; Xu  et al., 2005). Benzo(a)pyrene (BaP) 
is a common PAH, widely distributed in aquatic environments, whose carcinogenic and 
mutagenic properties have been intensively studied (Buhler and Williams, 1989; Tsukatani 
et al., 2003). Additionally, this xenobiotic is also a known CYP1A inducer in several 
experimental models (Costa et al., 2011; Costa et al., 2012; Jönsson et al., 2006; Ortiz-
Delgado et al., 2005; van der Oost et al., 2003; Van Veld et al., 1997), and has been 
proposed as a possible substrate for Pgp in mammalian in vitro studies (Chao Yeh et al., 
1992; Fardel et al., 1996). However, this subject remains a matter of debate, as other 
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studies report opposing results, both in mammals as in fish (Buesen et al., 2002; Colombo 
et al., 2003; Schuetz et al., 1998; Zaja et al., 2011). A previous study conducted in our 
laboratory showed that Pgp mRNA (ABCB1b) was not significantly up-regulated in Nile 
tilapia exposed to waterborne and dietary BaP, although an increasing trend of hepatic and 
intestinal ABCB1b mRNA expression was observed after 14 days of water exposure to this 
compound (Costa et al., 2012). Tissue distribution patterns of CYP1A and Pgp have been 
characterized in different experimental models, and the results showed high expression of 
these proteins in tissues that function as important physiological/pharmacological barriers 
for the uptake, distribution and elimination of xenobiotics (Hyyti et al., 2001; Sarasquete 
and Segner, 2000; Szakács et al., 2008). In fishes, as in other vertebrates, liver and 
intestine are important organs for xenobiotic detoxification, and expression of CYP1A and 
Pgp has been described for different species (Bard et al., 2002a; Cooper et al., 1999; 
Costa et al., 2011; Costa et al., 2012; Van Veld et al., 1997). Fish gills also constitute an 
important physiological barrier in fishes, since they are endowed with biotransformation 
enzymes, important for the first-pass metabolism of waterborne pollutants, including 
CYP1A (Costa et al., 2011; Jönsson et al., 2006; Nahrgang et al., 2010). However, the 
study of the presence and functionality of Pgp in gills of aquatic organisms has giving 
origin to contradictory results, since some studies in mussels and fish report its presence 
(Hemmer et al., 1995; Keppler and Ringwood, 2001b; Smital et al., 2003), while Pgp 
mRNA was not found to be expressed in gills of Nile tilapia (Costa et al., 2012) nor in trout 
(Loncar et al., 2010; Zaja et al., 2008).  Nile tilapia, Oreochromis niloticus, is one of the 
most important and commonly used species of cichlid fish, not only for fresh water 
aquaculture (FAO 2004), but also for research in a wide range of scientific areas (Almeida 
et al., 2001; Costa et al., 2011; Costa et al., 2012; Lee et al., 2005; Rey-Salgueiro et al., 
2011) and was used as the model organism in this study. This study was conducted to 
further elucidate the tissue distribution patterns and the possible correlations of Pgp and 
CYP1A in Nile tilapia, after waterborne exposure to BaP. To fulfill our objectives we have 
used an immunohistochemical approach and the quantification of the protein level, by 
western blot technique, in tissues involved with the uptake and detoxification of xenobiotics 
(liver, gills and proximal intestine), after waterborne exposure to BaP.  
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5.3. Materials and methods 
 
5.3.1. Animals 
 
Oreochromis niloticus used in this study were born and raised in the laboratory 
(CIIMAR, Porto, Portugal). Animals used were juveniles, and therefore not sexually 
mature, as confirmed by macroscopic analysis of the gonads at sampling. Until the start of 
the exposure experiment, fish were kept in 60 L aquaria supplied with biological filtration. 
Prior to the experiment, animals were randomly distributed in the experimental aquaria (30 
L), and submitted to an acclimatation period of one week. All tanks were supplied with 
continuous aeration to maintain dissolved oxygen near saturation. Dechlorinated tap water 
was used at a temperature of 20±2 ºC, with a 12h:12h (light:dark) photoperiod. Fish were 
fed commercial food pellets (Aquasoja, Portugal), until satiation, once a day. 
 
5.3.2. Water exposure to BaP 
 
Stock solutions of BaP were prepared in acetone (0.5, 1.25 and 2.5 g/L) and were 
administered directly to the experimental aquaria. The percentage of solvent added to the 
experimental aquaria was 0.002%. For the water exposure, juvenile Nile tilapia (N=20, 
average mass of 16.36±0.82 g, average length of 9.99±0.19 cm) were exposed to nominal 
water concentrations of 10, 25 and 50 µg of BaP/L for 14 days. Also a solvent control 
group (acetone alone) was maintained. The tested concentrations have been found in pore 
waters of estuaries polluted with petrochemical products (Maskaoui et al. 2002). 
Waterborne exposures were conducted in semi-static conditions in 30 L aquaria. Daily, 
80% of the water was renewed, followed by the addition of fresh BaP solution or solvent to 
each one of the treatment groups. Animals were fed to satiation every other day, and were 
not fed the day before sampling.  
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5.3.3. Sampling 
 
Sampling was performed at days 7 and 14 after the beginning of the exposure to 
BaP. Fish were anesthetized on ice cold water and sacrificed by decapitation. Liver, gills 
and proximal intestine (first one third of the intestine) were excised, and portions of each 
tissue were stored at -80ºC (for western blot analysis) or fixed in 4% paraformaldehyde 
(PFA) in phosphate buffer saline (PBS) for 24 hours at 4ºC (for immunofluorescence 
analysis). Immunofluorescence samples were washed in 50% ethanol (3 X 20 minutes) 
followed by 70 % ethanol (3 X 20 minutes) prior to storage in 70% ethanol until further use. 
 
5.3.4. Membrane vesicle and microsomes preparation 
 
Plasma membrane vesicles and microsomes were prepared according to the method 
described by Zaja et al. (2008) with minor modifications. Briefly 50-70 mg of tissue were 
sonicated (40A for 20 seconds) in 1ml of vesicle buffer (10mM Tris, 250mM sucrose, 
0.2mM CaCl2, 1mM Na2EDTA, 0.1mM PMSF, pH 7.5), centrifuged (1000 x g, 10min, 4ºC) 
and the supernatant layered on 35% sucrose. Samples were centrifuged at 16000 x g, 
30min at 4ºC using SW32 Ti rotor (Beckamn Coulter) and the layer formed at the top of 
35% sucrose was collected, diluted in sample buffer (10mM tris, 250mM sucrose, pH 7.5) 
and centrifuged at 100000 x g (90Ti rotor, Beckman Coulter) for 1 hour at 4ºC. Pellets 
were ressuspended in 100 µl of sample buffer. 
 
5.3.5. Antibodies 
 
The ABCB1 mouse monoclonal antibody C219 (Gene Tex Inc.) recognizes internal, 
highly conserved amino-acid sequences, VQEALD and VQAALD, corresponding to the C-
terminal and N-terminal regions, respectively found in both human MDR1 and MDR3 
isoforms (predicted molecular weight of ~170kDa) (Georges et al., 1990; van den Elsen et 
al., 1999).  It also recognizes the ~170 kDa sister of P-glycoprotein (Spgp, ABCB11) 
(Childs et al., 1995). The ABCB1 mouse monoclonal antibody C494 (Gene Tex Inc.) is 
specific for the human MDR1 isoform, and does not cross reacts with MDR3 (Georges et 
al., 1990). It has been shown to cross-react with Pyruvate Carboxylase, an abundant 
mitochondrial enzyme (130 kDa), on both immunoblots and immunohistochemical tissue 
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sections of mammals (Rao et al., 1994). Mouse monoclonal antibody C10-7 (Abcam plc, 
Cambridge, UK) reacts with hepatic CYP1A protein (~55kDa) from  rainbow trout 
(Oncorhynchus mykiss). It has also shown a positive reaction with CYP1A in different 
tissues of Spaurus aurata (Ortiz-Delgado et al., 2005). 
 
5.3.6. SDS-Page and Western blotting 
 
Protein content in all samples was determined according to the method described by 
Lowry et al. (1951). Samples were diluted in Laemmli buffer 2X (1:1). Non-reduced (no 
dithiothreitol added in Laemmli buffer) and non-denaturated samples (no boiling prior to 
the gel loading, no sodium dodecyl sulphate, SDS, in migration buffer) were used for 
probing with C219, while reduced and denaturated samples were used for probing with 
CYP1A. Five micrograms (for CYP1A - C10-7) or thirty micrograms (for ABCB1 - C219) of 
protein were separated by electrophoresis in 6% SDS - polyacrilamide gel (SDS-Page), 
using a Hoefer SE 250 system (GE Healthcare). Protein bands were transferred to 
nitrocellulose membranes (Hybond ECL, GE Healthcare), using a wet transfer unit (Hoefer 
TE 22, GE Helthcare). Membranes were rinsed in TTBS (for C10-7, 0.05% tween 20 in 
tris-buffered-saline, pH 7.4) or TPBS (for C219, 0.05% tween 20 in phosphate-buffered-
saline), and blocked for 1 hour at room temperature in 5% skim milk diluted in the 
corresponding washing buffer. After rinsing in washing buffer, membranes were probed 
either with C10-7 (Abcam plc) or C219 (GenTex, Inc) diluted 1/500 in blocking buffer (5% 
skim milk in TTBS or TPBS), overnight at 4ºC. Membranes were rinsed for 5, 10 and 15 
minutes in washing buffer, and incubated with a Horseradish Peroxidase (HRP) 
conjugated secondary antibody (HRP-Goat anti-mouse IgG, Invitrogen) diluted 1/20000 in 
washing buffer, for 1 hour at room temperature. After final washes of 5, 10 and 15 minutes 
in the correspondent washing buffer, signal was detected by enhanced 
chemiluminescence (Immobilon western chemiluminescent HRP substrate, Millipore). The 
mammalian mAb C494, directed to Pgp, was tested but no specific reactivity was detected 
in Nile tilapia tissues applying this antibody by the western blot technique. Images were 
visualized using a LAS 4000 mini imaging system (Fujifilm) and quantification was 
performed using Multi gauge software, Fuji Photo Film Co., ltd. 
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5.3.7. Immunofluorescence microscopy 
 
Tissues stored in 70% ethanol were dehydrated in an ethanol series, cleared in 
clear-rite 3 (Richard Allen Scientific) and infiltrated and embedded in paraffin (Type 6, 
Richard Allen Scientific). Paraffin sections (3µm) were collected onto 3-
aminopropyltriethoxysilane (Sigma Aldrich) coated slides, air dried and de-waxed in clear-
rite 3. Sections were processed for immunofluorescence according to Wilson et al. (2007) 
with some minor modifications. After antigen retrieval (30 minutes at 98ºC in 0.05% 
citacronic anhydride) the sections were circled with a hydrophobic pen (PAP pen, Sigma-
Aldrich) and blocked with 5% normal goat serum in 1%BSA, 0.05% sodium azide in TPBS, 
pH 7.4, for 20 minutes at room temperature. Sections were then incubated in a humidity 
chamber with primary antibodies to CYP1A (C10-7, 1/500) and Pgp (C219, 1/50; C494, 
1/50) diluted in 1%BSA/TPBS/0.05% sodium azide, pH 7.4, overnight at 4ºC. Following 
washes in TPBS (5, 10 and 15 minutes) in a coplin jar, slides were incubated in a humidity 
chamber with goat anti-mouse Alexa Fluor 568 conjugated secondary antibody (Invitrogen) 
diluted 1/400 in TPBS, for 1 hour at 37ºC. After a 5 minute wash in TPBS, the nuclei were 
stained with DAPI (4´6-diamino-2-phenylindole) for 10 minutes and slides were rinsed in 
TPBS for 15 minutes. Coverslips were mounted using a glycerol-based fluorescence 
mounting media (10% mowiol, 40% glycerol, 0.1% 1,4-diazabicyclo[2.2.2]octane 
(DABCO), 0.1M Tris, pH 8.5). In each slide a control section was included with dilution 
buffer (1%BSA/TPBS/0.05% sodium azide, pH 7.4) instead of the primary antibody. 
Sections were immediately observed in a Leica DM6000 B wide field epi-fluorescence 
microscope, and images captured using a cooled digital camera (Leica DFC340FX) along 
with the corresponding differential interference contrast (DIC) image. Plates were 
assembled using Adobe Photoshop CS3 software, and images enhanced while 
maintaining the integrity of the data. A subjective evaluation of staining intensity in sections 
probed with the different tested antibodies (C219, C494 and C10-7) was performed 
according to the method described by Van Veld et al. (1997). Staining was assigned a 
numeric value of 0 (negative), 0.5 (negative/mild), 1 (mild), 1.5 (mild/moderate), 2 
(moderate), 2.5 (moderate/high) or 3 (high) according to its intensity. Negative values 
indicate that no staining was visible. Values obtained for each treatment in each cellular 
type were average, and data presented as mean±SE. 
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5.3.8. Statistical analysis 
 
Treatment and time effects were evaluated by means of a two-way ANOVA, followed 
by a multiple comparison test (Tukeys test) at a 5% significance level. Some data had to 
be log or square root transformed in order to fit ANOVA assumptions. All tests were 
performed using the software Statistica 7 (Statsoft, Inc., 2001).  
 
5.3.9. Ethics statement 
 
The animals used in the research that is described in this paper were treated in 
accordance with the Portuguese Animals and Welfare Law (Decreto-Lei nº 197/96) 
approved by the Portuguese Parliament in 1996 and with the European directive 
2010/63/UE approved by the European Parliament in 2010. Institutional animal approval 
by CIIMAR/UP and Direcção Geral Veterinária was granted for this study. 
 
5.4. Results 
 
5.4.1. Western blot detection of P-glycoprotein 
 
Western blot results showed the presence of a protein in Nile tilapia liver that was 
cross-reactive with the mammalian mAb C219. A single band of, approximately, 170 kDa 
was detected in liver membrane vesicles both from solvent control and BaP exposed 
animals, but no immunoreactivity was seen in gill nor in proximal intestine. No significant 
differences were seen in the reaction intensity between solvent control and BaP exposed 
animals (figure 5.1).  
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Figure 5.1 - Western blot of membrane vesicles from liver, gill and proximal intestine of Nile 
tilapia.  
Samples from solvent control animals and animals exposed for 14 days to 50µg/L of waterborne 
BaP. Blots were probed with the mammalian mAb C219 for P-glycoprotein. Five µl of molecular 
weight (MW) standard were used. Thirty µg of protein were loaded in each lane. 
 
 
5.4.2. Cellular localization of P-glycoprotein 
 
The cellular localization of Pgp was investigated by immunofluorescence in liver, gill 
and proximal intestine of Nile tilapia exposed to different concentrations of waterborne BaP 
for 7 and 14 days. The mammalian mAbs C494 and C219 were used to probe the tissue 
sections, and different results were seen with each antibody (table 5.1, figure 5.2).  
 
Liver 
After labelling with C494, a positive reaction was seen in plasma membrane, 
hepatocytes cytoplasm, vascular endothelium and bile canaliculi from liver samples (table 
5.1, figure 5.2a). Frequency of staining in bile canaliculi and vascular endothelium was 
very consistent and all liver samples showed a positive labelling. Staining of the plasma 
membrane showed a high frequency between samples analysed, although there was 
some variety in the number of hepatocytes that showed this particular labelling. Some 
tissue sections showed a higher percentage of labelled hepatocytes than others, without 
any clear correlation pattern with the exposure to BaP. Cytoplasm of the hepatocytes 
presented a weaker but consistent labelling (figure5.2a). The C219 labelling was confined 
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to biliary canaliculi, with consistent frequency of staining (figure 5.2b). No other cell types 
showed a positive reaction with C219. For both antibodies, no significant differences to 
control were seen in the staining intensity in tissues of animals exposed to the different 
BaP concentrations after 7 and 14 days of exposure (table 5.1). No positive reaction was 
seen in control sections (dilution buffer only). 
Gill 
In gill sections labelled with C494, positive staining was observed in several cell 
types (pillar cells, epithelial cells, chloride cells and undifferentiated cells) as described in 
table 5.1 and figure 5.2c. Frequency of staining was consistent throughout the samples 
analysed, and staining intensity varied from mild/moderate to high in the different cell types 
(table 5.1). No significant differences were observed between control and samples from 
animals exposed to the different concentrations of BaP at 7 and 14 days of exposure.  No 
positive labelling was observed in gill sections probed with C219 (figure 5.2d). In some 
tissue sections, including control (dilution buffer only), some samples showed a mild cross-
reactivity of erythrocytes. No other cell types showed a positive reaction in control 
sections. 
Proximal intestine 
Probing with C494 resulted in a positive labelling in enterocytes and vascular 
endothelium of proximal intestine, as described in table 5.1 and figure 5.2e. Frequency of 
staining was consistent, since we observed a positive reaction in all samples analysed. In 
general, labelling intensity increased from the base of the crypts to the tips of the villi 
(figure 5.2e). No significant differences to control were seen in staining intensity in 
proximal intestine of animals exposed to the different concentrations of BaP during the 7 
and 14 days of exposure (table 5.1). In 1.35% of the samples analysed, a mild reaction 
was detected in the apical membrane of enterocytes after probing with C219 (figure 5.2f) 
while for all the remaining samples no positive reaction was observed (table 5.1). Samples 
that showed positive reaction with C219 were randomly distributed throughout the different 
treatments (solvent control, 10 and 50 µg/L of BaP), indicating that there was no 
correlation of the labelling with the exposure to BaP.  
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Table 5.1 - Cellular localization of Pgp in liver, gill and proximal intestine of Nile tilápia exposed to different concentrations of waterborne BaP.  
Samples were probed with two different Pgp mammalian antibodies, C219 and C494. Values are reported as mean immunofluorescence staining score ± SD 
 
 
 
 
Tissue Cell type 
C219 C494 
Day 7 Day 14 Day 7 Day 14 
Solvent 
Control 
10µg/L 25µg/L 50 g/L 
Solvent 
Control 
10µg/L 25µg/L 50µg/L 
Solvent 
Control 
10µg/L 25µg/L 50µg/L 
Solvent 
Control 
10µg/L 25µg/L 50µg/L 
Liver 
Hepatocytes 
cytoplasm 
0 0 0 0 0 0 0 0 1.7±0.3 1.8±0.3 2.2±0.3 1.3±0.9 1.2±0.3 1.8±0.3 1.3±0.3 1.6±0.3 
Plasma 
membrane 
0 0 0 0 0 0 0 0 2.0±0.0 2.1±0.3 2.0±0.9 1.6±1.1 1.0±1.1 1.4±1.4 1.2±1.0 1.4±0.9 
Bile canaliculi 2.0±1.0 2.7±0.3 2.2±0.3 2.5±0.5 2.2±0.8 2.3±0.6 2.3±0.3 2.8±0.4 2.5±0.0 2.5±0.0 2.5±0.0 2.0±0.7 1.3±1.1 2.6±0.5 2.0±0.9 1.3±1.2 
Vascular 
endothelium 
0 0 0 0 0 0 0 0 2.3±0.3 2.5±0.6 1.8±0.8 2.1±0.9 1.7±1.4 2.6±0.5 2.5±0.9 1.3±1.2 
Gill 
Pillar cells 0 0 0 0 0 0 0 0 2.3±0.3 2.3±0.6 2.7±0.6 2.7±0.3 2.0±0.6 2.3±0.5 2.5±0.5 2.0±0.5 
Epithelial cells 0 0 0 0 0 0 0 0 2.3±0.3 2.3±0.6 2.3±0.6 2.7±0.3 2.1±0.5 2.0±0.7 2.5±0.5 1.8±0.3 
Chloride cells 0 0 0 0 0 0 0 0 2.8±0.3 2.8±0.3 2.7±0.6 2.7±0.3 2.6±0.3 2.3±0.9 3.0±0.0 1.8±0.3 
Undiferentiated 
cells 
0 0 0 0 0 0 0 0 1.7±0.3 2.3±0.6 2.3±0.6 2.7±0.3 1.8±0.3 1.9±0.6 2.5±0.5 1.8±0.3 
Proximal 
intestine 
Apical membrane 0.2±0.3 0.3±0.4 0 0.5±0.9 0.2±0.3 0.4±0.8 0 0 2.7±0.3 2.8±0.4 2.8±0.3 2.8±0.3 2.3±0.3 2.6±0.5 2.8±0.3 2.5±0.0 
Enterocytes 0 0 0 0 0 0 0 0 2.3±0.6 2.3±0.4 1.4±0.9 1.4±0.9 1.5±0.5 1.4±1.1 1.9±0.3 2.0±0.0 
Submucosal 
regions 
0 0 0 0 0 0 0 0 2.2±0.8 2.3±0.4 2.3±0.5 2.3±0.5 1.0±0.5 0.9±0.8 1.6±0.6 2.2±0.3 
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Figure 5.2 - Representative immunofluorescence results of liver, gill and proximal intestine 
in Nile tilapia probed with mammalian Pgp antibodies, C219 and C494.  
Liver sections stained with C494 (a) and C219 (b), showing positive staining in bile canaliculi (white 
arrows), hepatocytes cytoplasm (*) and hepatocytes plasma membrane (#). Gill sections stained 
with C494 (c) and C219 (d), showing positive labelling for C494 in pillar cells (white arrows), 
epithelial cells (#) and undiferenciated cells (*). Proximal intestine sections stained with C494 (e) 
and C219 (f), showing positive labelling in plasma membrane (white arrows) and enterocytes (*). To 
provide structural information, blue nuclei were counterstained with DAPI and DIC image was 
overlaid (2), image (3) represents a higher magnification of square showed in (2). Scale bar = 
75µm. 
_______________________________________________________________________________ 
 
 
 
 
Figure 5.3 - Representative immunoblots of Nile tilapia CYP1A protein in liver, gills and 
proximal intestine after waterborne exposures to BaP (10µg/L, 25µg/L and 50µg/L) for 7 and 
14 days.  
Five µg of protein were loaded in each lane and probed with C10-7 mAb. Five µl of molecular 
weight marker (MW) were loaded in first lane. 
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5.4.3. Western blot detection of CYP1A 
 
The cross-reactivity of the monoclonal antibody C10-7 with CYP1A protein in Nile 
tilapia tissues was verified by western blot, using microsomal fractions of liver, gill and 
proximal intestine. The antibody detected one strong band of approximately 55 kDa, and a 
secondary weaker band of about 50kDa in heavily reactive samples (figure 5.3). 
 
 
In general, CYP1A reactivity increased with the concentration of BaP in the three 
tissues analysed (figures 5.3 and 5.4). In liver, CYP1A protein levels were significantly 
higher than solvent control in all BaP treatments (both at 7 and 14 days of exposure) 
(p<0.05) (figure 5.4a).  Both in gill as in proximal intestine, differences of CYP1A protein 
levels in BaP exposed animals (to all BaP concentrations, both at 7 and 14 days of 
exposure) in comparision to control were not statistically significant (figure 5.4b and 5.4c). 
Maximum fold inductions of CYP1A protein levels were observed in intestine (175.6±75.2; 
7 days of exposure to 50 µg/L of BaP), followed by gill (16.2±11.2; 14 days of exposure to 
50 µg/L of BaP) and liver (15.6±1.2; 14 days of exposure to 50 µg/L of BaP). No significant 
differences in CYP1A reactivity were observed, within each treatment, between days 7 and 
14 for none of the tissues. In unexposed animals (solvent control) levels of CYP1A protein 
were higher in liver, followed by gill and intestine with respective values of 3778.6±1478.5, 
1306.9±963.9 and 98.9±97.5 arbitrary units (mean±SE). 
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Figure 5.4 - Western blot results of CYP1A protein fold induction over control after Nile 
tilapia waterborne exposure to BaP in liver (a), gill (b) and proximal intestine (c).  
Different letters denote significant differences over the solvent control (p<0.05). Results presented 
as mean±SE. n=3-4. 
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Table 5.2– Cellular localization of CYP1A in liver, gill and proximal intestine of Nile tilápia exposed to different concentrations of waterborne BaP.  
Samples were probed with CYP1A mAb C10-7. Values are reported as mean immunofluorescence staining score ± SD.  
 
Tissue Cell type 
Day 7 Day 14 
Solvent 
control 
10µg/L 25µg/L 50µg/L 
Solvent 
control 
10µg/L 25µg/L 50µg/L 
Liver 
Hepatocytes cytoplasm 0 1.3±0.3 2.0±0.0 2.2±0.6 0 1.5±0.5 1.5±0.4 2.2±0.8 
Vascular endothelium 0 1.0±0.9 2.0±0.0 1.7±0.6 0 1.0±1.0 1.3±0.9 1.0±1.7 
Gill 
Pillar cells 0 1.9±0.3 2.3±0.4 2.7±0.3 0 2.4±0.8 3.0±0.0 2.5±0.6 
Epithelial cells 0 0.4±0.8 0.5±0.7 1.3±0.6 0 0.8±0.9 0.7±0.8 1.0±1.2 
Proximal intestine 
Enterocytes 0 1.3±0.4 1.5±0.6 1.3±1.2 0 1.5±1.0 1.4±0.9 1.8±0.9 
Vascular elements 0 2.3±0.4 2.0±0.4 2.5±0.0 0 2.3±0.3 2.3±0.3 2.8±0.5 
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5.4.4. Cellular localization of CYP1A 
 
In liver, gills and proximal intestine of solvent control fish no immunoreactivity of 
CYP1A protein was detected both at days 7 and 14 (table 5.2, figures 5.5, 5.6 and 5.7). 
Animals´ exposure to BaP resulted in positive labelling of CYP1A protein both in 
hepatocytes cytoplasm and hepatic vascular endothelium (table 5.2, figure 5.5). 
Hepatocyte staining was visible in all samples from exposed animals, while a lower 
frequency of positive labelling was observed in endothelial cells (75% of the samples). 
Intensity of staining showed an increase with the concentration of BaP, while no 
differences were seen with the increase of exposure time (from 7 to 14 days) (figure 5.5, 
table 5.2). Hepatocytes staining intensity varied from negative (solvent control) to 
moderate/high (50µg/L of BaP), and vascular endothelium staining varied from negative 
(solvent control) to mild/moderate (50 µg/L of BaP) (table 5.2). In gills, exposure to BaP 
resulted in CYP1A labelling in pillar cells, with all samples showing a positive reaction 
(table 5.2, figure 5.6). Epithelial gill cells also stained positively for CYP1A protein after 
BaP exposure, although showing a lower frequency of staining (55% of the samples). 
Overall, an increase in the staining intensity was seen with the increase of the 
concentration of BaP in gill pillar and epithelial cells (table 5.2, figure 5.6), although without 
statistical significance. Higher staining intensity was seen in pillar cells (from negative to 
high) than epithelial cells (from negative to mild/moderate) (table 5.2). In intestine, 
exposure to BaP resulted in positive CYP1A labelling of gut epithelial cells and gut 
vascular elements (table 5.2, figure 5.7) in all samples analysed. Staining intensity was 
slightly higher in vascular elements (from moderate to high) than enterocytes (from mild to 
moderate) (table 5.2). No significant differences were seen in the intensity of staining after 
exposure to the different concentrations of BaP tested, nor with the time of exposure. In 
control sections of all tissues (dilution buffer only) no positive immunoreaction was 
observed.  
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Figure 5.5 - Representative CYP1A immunostaining in liver samples of Nile tilapia exposed 
to BaP. 
 (a) 7 days of exposure, solvent control; (b) 7 days of exposure to 10µg/L of BaP; (c) 7 days of 
exposure to 25µg/L of BaP; (d) 7 days of exposure to 50µg/L of BaP; (e) 14 days of exposure, 
solvent control; (f) 14 days of exposure to 10µg/L of BaP; (g) 14 days of exposure to 25µg/L of BaP; 
(h) 14 days of exposure to 50µg/L of BaP. To provide structural information, blue nuclei were 
counterstained with DAPI and DIC image was overlaid (2), image (3) represents a higher 
magnification of square showed in (2). White arrows indicate positive labelling in vascular elements, 
(*) indicate positive labeling in hepatocytes cytoplasm. Scale bar = 75µm. 
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Figure 5.6 - Representative CYP1A immunostaining in gill samples of Nile tilapia exposed to 
BaP.  
(a) 7 days of exposure, solvent control; (b) 7 days of exposure to 10µg/L of BaP; (c) 7 days of 
exposure to 25µg/L of BaP; (d) 7 days of exposure to 50µg/L of BaP; (e) 14 days of exposure, 
solvent control; (f) 14 days of exposure to 10µg/L of BaP; (g) 14 days of exposure to 25µg/L of BaP; 
(h) 14 days of exposure to 50µg/L of BaP. To provide structural information, blue nuclei were 
counterstained with DAPI and DIC image was overlaid (2), image (3) represents a higher 
magnification of square showed in (2). White arrows indicate positive labelling of gill pillar cells. 
White circles indicate immunolabelling in gill epithelial cells. Scale bar = 75µm. 
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Figure 5.7 - Representative CYP1A immunostaining in proximal intestine of Nile tilapia 
exposed to BaP.  
(a) 7 days of exposure, solvent control; (b) 7 days of exposure to 10µg/L of BaP; (c) 7 days of 
exposure to 25µg/L of BaP; (d) 7 days of exposure to 50µg/L of BaP; (e) 14 days of exposure, 
solvent control; (f) 14 days of exposure to 10µg/L of BaP; (g) 14 days of exposure to 25µg/L of BaP; 
(h) 14 days of exposure to 50µg/L of BaP. To provide structural information, blue nuclei were 
counterstained with DAPI and DIC image was overlaid (2), image (3) represents a higher 
magnification of square showed in (2). White arrows indicate positive labelling of intestinal vascular 
elements. (*) indicate positive labelling in enterocytes. Scale bar = 75µm. 
_______________________________________________________________________________ 
 
 
5.5. Discussion 
 
This study was conducted to further elucidate the presence of Pgp and CYP1A 
proteins in different tissues of the freshwater Nile tilapia, through the evaluation of protein 
levels and tissue distribution patterns after waterborne exposure to different BaP 
concentrations. The mammalian monoclonal antibodies C219 and C494, which recognize 
mammalian MDR1 gene product, were applied in Nile tilapia tissues with immunochemical 
approaches to detected Pgp (ABCB1), and different results were seen for each of the 
antibodies used. To our knowledge, antibodies raised against fish Pgp are not yet 
commercially available. Nevertheless, the C219 antibody, raised against mammalian Pgp, 
has been frequently used in immunochemical studies to determine the tissue distribution 
pattern of Pgp expression in a number of different aquatic species, such as worms 
(Urechis caupo, Toomey and Epel, 1993), mussels (Mytilus californianus, Cornwall at al., 
1995) and fishes (Bard et al., 2002a; Bard et al., 2002b; Doi et al., 2001; Hemmer et al., 
1995; Kleinow et al., 2000; Paetzold et al., 2009). This antibody recognizes an epitope 
common to both Pgp (ABCB1) and Spgp (ABCB11) (Childs et al., 1995; Georges et al., 
1990; van den Elsen et al., 1999), hence it does not specify which ABCB protein is being 
labelled. Immunochemical results revealed that C219 reacted positively with a ~170kDa 
protein in liver samples of Nile tilapia (figure 5.1), and that the cellular localization of that 
protein was confined to hepatic bile canaliculi (table 5.1, figure 5.2b) of both solvent control 
and BaP exposed animals. Additionally, a very scarce positive reaction (1.35% of the 
samples analysed) was seen in apical surface of the enterocytes (table 5.1, figure 5.2f), 
and no staining was observed in gill after probing with C219 (figure 5.2d). Similar Pgp 
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staining patterns with the mAb C219 in liver and intestine were previously described for 
different fish species including high cockscomb blenny (Anoplarchus purspurescens; Bard 
et al., 2002b), several cyprinid fishes (Klobučar et al., 2010), catfish (Ictalurus punctatus; 
Doi et al., 2001), killifish (Fundulus heteroclitus; Bard et al., 2002a) and guppy (Poecilia 
reticulata; Hemmer et al., 1995), suggesting a positive reaction of C219 with Pgp in Nile 
tilapia. Nevertheless, we must also consider the possibility that C219 is also reacting with 
Spgp, rather than to Pgp alone in this study. In a previous work, we have found that neither 
Pgp (ABCB1b) or Spgp (ABCB11) genes were expressed in gills of Nile tilapia, moreover 
expression of Pgp in proximal intestine was higher than in liver, while Spgp showed higher 
mRNA expression in liver and lower expression in proximal intestine (Costa et al., 2012). 
Spgp is a bile-salt export pump predominantly, but not exclusively, found in the bile 
canaliculi of mammalian liver (Gerloff et al., 1998). This pattern is in accordance with our 
immunofluorescence and western blot results of C219, with an almost exclusive labelling in 
hepatic bile canaliculi, raising the possibility of a cross-reactivity of this antibody to Spgp in 
Nile tilapia.  
The mammalian antibody C494 specifically recognizes an epitope in the C-terminal 
half of MDR1, and was shown to also cross-react with the mitochondrial enzyme Pyruvate 
Carboxylase (PC) (~130 kDa), on both immunoblots and immunohistochemical tissue 
sections of mammals (Rao et al., 1994). This antibody, unlike C219, showed a strong 
positive reaction in all the analysed tissues of Nile tilapia (liver, gills and proximal 
intestine), and covered a wider set of cellular types (figure 5.1, table 5.1). The hepatic and 
intestinal plasma membrane patterns of immunostaining seen in this study should 
represent true P-glycoprotein expression, given this is a transmembranar protein. 
Nevertheless, weak homogeneous, cytoplasmic or granular patterns of reactivity may 
represent staining of the mitochondrial PC cross-reactive epitope rather than positive 
staining for P-glycoprotein, in particular in liver and intestine, which are gluconeogenic 
tissues with proven PC activity (Böttger et al., 1969; Croset et al., 2001). Simultaneous 
positive labelling for C219 and C494 was seen in biliary canaliculi of liver and apical 
surface of the enterocytes, although the latter was much more frequent and intense after 
probing with C494. The mAb C494 has rarely been applied in fish tissues to detect the 
presence of Pgp. To our knowledge only Hemmer and coworkers (1995) have used this 
antibody in teleost fish, and also reported different tissue staining patterns in comparison 
to C219. In that study positive staining for both C219 and C494 was seen in intestine, 
kidney and exocrine pancreatic tissues. Tissues that stained positive for C219 but not 
C494 were bile canaliculi, pseudobranch and gill chondrocytes. Interrenal tissue, blood 
vessels and branchial transverse septum stained positive with C494, but not with C219. 
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Gin and coworkers (Ginn, 1996) have evaluated the cellular localization of Pgp in normal 
and neoplastic canine tissues with different antibodies (including C219 and C494), and 
indicated C494 as the antibody of choice for canine tissues based on quality of staining 
produced, specificity and economic advantages. In feline tissues, the cellular distribution 
pattern of Pgp was different when probing with C219 or C494, and the C494 staining 
pattern revealed a tissue distribution and cellular localization of Pgp similar to those found 
in human and canine tissues when using the same antibody (Van Der Heyden et al., 
2009), and also similar to Nile tilapia liver and intestine staining patterns. As stated above, 
no Pgp (ABCB1b) mRNA expression was detected in Nile tilapia gill (Costa et al., 2012), 
which strongly contrasts with the results from this study, with labelling of the gill after 
probing with the mAb C494. The absence of Pgp mRNA expression in fish gills has also 
been described for other species, like trout (Loncar et al., 2010; Zaja et al., 2008). 
Nevertheless, Fischer and coworkers (2011) detected the presence of mRNA transcripts of 
two different Pgp isoforms in a permanent gill cell line of trout, and there is also 
immunochemical evidence of Pgp expression in gill of other aquatic species (Hemmer et 
al., 1995; Keppler and Ringwood, 2001a). In light of these results, and assuming the 
recently proposed possibility of the existence of more than one Pgp isoform in fish (Annilo 
et al., 2006; Fischer et al., 2011), it is possible that a different Pgp isoform is being 
detected in Nile tilapia gills in this study, when compared to our previous study (Costa et 
al., 2012). Although we have tried different testing conditions, including what is described 
in previous studies with the use of mAb C494 (Rao  et al., 2004), we were unable to 
confirm the size of the protein that was reacting positively in Nile tilapia tissues to the mAb 
C494, as the antibody was not functional in the western blot technique. There is limited 
information on the use of this antibody in western blot, as the majority of the studies have 
been applying the mAb C494 only in immunohistochemical sections (Gin, 1996; Van Der 
Heyden et al., 2009, 2011). Nevertheless, tissue distribution pattern of reactive Pgp to the 
mAb C494 in Nile tilapia tissues, revealed similar results to those described in mammals 
and other fish species (Ginn, 1996; Hemmer et al., 1995; Van Der Heyden et al., 2009), 
with labelling of epithelial tissues involved in secretion, absorption or serving a barrier 
function, which is in agreement with the assumed role of Pgp in protection against 
xenobiotic insults (Szakács et al., 2008). Pgp expression, considering probing results with 
both mAb antibodies C219 and C494, was not altered in animals exposed to BaP, in 
comparison to solvent control. The question of whether or not BaP is a Pgp substrate 
remains in discussion, with some studies presenting controversial results in various animal 
models (Buesen et al., 2002; Chao Yeh et al., 1992; Colombo et al., 2003; Fardel et al., 
1996; Schuetz et al., 1998; Zaja et al., 2011). Specifically in Nile tilapia, some doubts 
remained after analysing the mRNA expression of Pgp after exposure to BaP (Costa et al., 
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2012), and the findings from this study indicate that BaP compound is not itself a substrate 
for Pgp. 
Immunochemical results showed that the fish monoclonal antibody C10-7, directed 
against CYP1A protein, detected a ~55kDa protein in liver, gills and proximal intestine of 
Nile tilapia (figure 5.3). Additionally, the cellular distribution pattern of CYP1A (figures 5.5-
5.7, table 5.2), is in agreement with those described in other fish studies (Bard et al., 
2002b; Jönsson et al., 2006; Ortiz-Delgado et al., 2005; Van Veld et al., 1997). These 
results validate the use of this mAb to specifically detect CYP1A in Nile tilapia. Higher 
basal levels of CYP1A protein (i.e. non-exposed animals from solvent control group) were 
found in liver, followed by gill and proximal intestine. Additionally, a dose-dependent 
induction of CYP1A protein was observed in all tissues after exposure to BaP, with liver 
showing statistically significant differences in CYP1A protein of exposed animals in 
comparison to the control (figures 5.3 and 5.4). Maximum fold inductions of CYP1A were 
seen in proximal intestine (up to -176 fold), followed by liver and gill (up to -16 fold). 
Concordant results were seen with immunofluorescence analysis (table 5.2, figures 5.5 – 
5.7). Moreover, these results are highly correlated with CYP1A-associated catalytic activity 
and CYP1A mRNA expression seen after BaP waterborne exposure in Nile tilapia tissues 
(Costa et al., 2011; Costa et al., 2012), validating the importance of extra-hepatic tissues 
(like gills and intestine) in the first-pass metabolism of waterborne pollutants. CYP1A 
induction is also in agreement with what was expected, considering the high affinity of 
these type of pollutants to bind the aryl-hydrocarbon receptor (AhR). AhR controls the 
expression of CYP450 enzymes, including CYP1A (Hankinson, 1995), and this response 
pattern has been described for other fish species (Jönsson et al., 2006; Ortiz-Delgado et 
al., 2008; Van Veld et al., 1997).  
The hypothesis that Pgp and CYP1A share regulatory controls has been widely 
investigated in mammals (Buesen et al., 2002; Fardel et al., 1996; Lampen et al., 2004; 
Schuetz et al., 1998) and, to a lesser extent, in aquatic organisms (Bard et al., 2002b; 
Paetzold et al., 2009). In contrast to CYP1A, which is induced by AhR agonists, Pgp 
exhibits a more variable response, depending on the chemical and on the experimental 
model used. In Nile tilapia, CYP1A and Pgp showed different response patterns to the 
presence of BaP, suggesting that these two defence mechanisms do not share the same 
regulatory controls in this species. Nevertheless, these results point to the need to further 
elucidate the apparently complex regulatory mechanisms of Pgp, a putatively important 
protein in all organisms.  
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5.6. Conclusions 
 
In conclusion, different tissue distribution patterns of Pgp in Nile tilapia were seen 
after probing with two different mammalian mAb, C219 and C494. Results for both 
antibodies follow the cellular distribution patterns described in previous studies, with C219 
showing an almost exclusive labeling of the hepatic bile canaliculi, while the C494 staining 
pattern covered a wider set of cell types in liver, gills and proximal intestine. The mAb C10-
7 was validated in this study to specifically detect CYP1A protein in Nile tilapia, and this 
protein was found to be expressed in liver, gill and proximal intestine of Nile tilapia.  
Results suggest that, while in Nile Tilapia BaP apparently is not a substrate for Pgp, 
CYP1A is involved in its metabolism in barrier tissues, such as liver, gills and intestine. 
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6. ABC transporters, CYP1A and GSTα gene transcription patterns 
in developing stages of the Nile tilapia (Oreochromis niloticus)  
 
6.1. Abstract 
In fish, some ABC transporters are implicated in a multixenobiotic resistance (MXR) 
mechanism to deal with the presence of xenobiotics, by effluxing them, or their 
metabolites, from inside the cells. These efflux transporters have been considered an 
integral part of the cellular detoxification pathways, acting in coordination with phase I and 
II detoxification enzymes. However, the full characterization of this detoxification system is 
still incomplete, especially during the developmental stages of aquatic organisms, which 
are particularly sensitive periods to the presence of anthropogenic contamination. The goal 
of this study was to evaluate the mRNA expression dynamics of putatively important MXR 
proteins (ABCB1b, ABCB11, ABCC1, ABCC2 and ABCG2a) and phase I (CYP1A) and II 
(GSTα) biotransformation enzymes, during the embryonic and larval development of the 
specie Oreochromis niloticus (Nile tilapia). Our results showed that ABCB1b, ABCC1, 
CYP1A and GSTα transcripts are maternally transmitted. Transcripts for ABCB11, ABCC2 
and ABCG2a were only detected after the pharyngula period, which precedes a highly 
sensitive stage in embryonic development, the hatching. This study has shown, for the first 
time, very distinct expression patterns of genes encoding for proteins involved in protection 
mechanisms against pollutants during the development of Nile tilapia. Moreover, the 
temporal pattern of gene expression suggests that increased intrinsic protection levels are 
required at specific developmental stages.  
 
Keywords: MXR, Biotransformation enzymes, embryogenesis, Oreochromis niloticus, 
qRT-PCR 
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6.2. Introduction  
 
The aquatic environment is persistently loaded with complex mixtures of structurally 
different chemicals, resulting in the exposure of living organisms to these toxicants with 
consequent negative effects. Recent studies have indicated that the phenotype of 
multixenobiotic resistance (MXR), occurring in aquatic organisms, represents a general 
biological defense mechanism and may be responsible for their ability to deal with both 
endo- and xenobiotics (Bard, 2000). Some members of the ATP binding cassette (ABC) 
superfamily have been implicated in this mechanism, by acting as efflux pumps of a wide 
variety of toxicants and/or their metabolites from inside the cells in an ATP driven process 
(Epel, 1998; Kurelec, 1992). MXR is analogous to a previously described phenotype of 
multi-drug resistance (MDR), first observed in mammalian tumor cells (Gottesman et al., 
1996), and related to the overexpression of an ABC transporter (ABCB1) responsible for 
the efflux of a high number of anti-cancer agents (Chan et al., 2004). As reviewed by 
Leslie and collaborators (2005) ABC proteins that confer multidrug resistance include, but 
are not limited to, P-glycoprotein (ABCB1), multidrug-resistance associated proteins 1 and 
2 (ABCC1 and ABCC2) and the breast cancer resistance associated protein 2 (ABCG2). 
Additionally, the bile salt export pump (BSEP, ABCB11), responsible for the excretion of 
the highly toxic bile salts from hepatocytes into the bile has also been studied in aquatic 
organisms (Costa et al., 2012; Loncar et al., 2010; Zaja et al., 2008) due to its 
physiological function and also due to the high degree of similarity with ABCB1. These 
proteins have a broad range of substrates, and some specificity exists within each 
subfamily when it comes to transport mechanisms and chemical composition of substrates 
(Leslie et al., 2005).  Based on the substrate specificity of each subfamily, these efflux 
transporters have been considered as an integral part of the cellular detoxification system, 
acting in a coordinated fashion with phase I and II biotransformation enzymes (Bard, 2000; 
Szakács et al., 2008; Xu  et al., 2005). It is believed that ABCB1 acts as a first line of 
defense preventing unmodified compounds from accumulating in the cell (phase 0), while 
ABCCs and ABCG2 transport products of phase I and II metabolisms in the form of 
organic anions conjugated to glutathione, glucoronide sulphate or other polar groups, thus 
acting in phase III of cellular detoxification (Bard, 2000; Leslie et al., 2005; Paetzold et al., 
2009). Although information regarding ABC transporters in aquatic organisms is still 
limited, these proteins have been identified in various species, and studies involving their 
response patterns to environmental pollutants have increased in the last years (Bard et al., 
2002a; Bard et al., 2002b; Costa et al., 2012; Diaz de Cerio et al., 2012; Long et al., 
2011b; Paetzold et al., 2009; Zucchi et al., 2010). Cytochrome P450 1A (CYP1A) and 
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Glutathione S-transferase α (GSTα) are important phase I and II detoxification enzymes 
that catalyze reactions of xenobiotic conversion (oxidation/reduction – phase I, conjugation 
– phase II) into a more water-soluble form, which can be more easily excreted from the cell 
than the parent compound (Lech and Vodicnik, 1985). The presence and function of these 
enzymes have been extensively studied and demonstrated in several animal species 
(Bilbao et al., 2010; Doi et al., 2004; Ferreira et al., 2008; Ferreira et al., 2010; Van Veld et 
al., 1997), including Nile tilapia (Costa et al., 2011; Costa et al., 2012). Recent studies 
have evaluated the simultaneous expression of ABC transporters and biotransformation 
enzymes in fish exposed to environmental pollutants (Costa et al., 2012; Della Torre et al., 
2010; Paetzold et al., 2009; Zucchi et al., 2010), but the exact way of action of these 
important parts of cellular detoxification has not been fully demonstrated. Moreover, the 
vast majority of these studies have been conducted in juvenile or adult animals, and only a 
few have investigated the role of these proteins in the developing stages of aquatic 
organisms. The early life stages in fish development are particularly sensitive to 
anthropogenic contaminants (Buhl and Hamilton, 1991), implying that proteins involved in 
the protection of the organism, like ABC efflux transporters and biotransformation enzymes 
are of crucial importance during this period in all animals. High transcription and activity of 
efflux transporters  have been reported in invertebrate larvae of aquatic species (Faria et 
al., 2011; McFadzen et al., 2000; Roepke et al., 2006; Toomey et al., 1996), but studies in 
vertebrate aquatic species, such as fish, are still very scarce (Long et al., 2011a; Long et 
al., 2011b).  
Nile tilapia, Oreochromis niloticus, is one of the most important and useful species of 
cichlid fish, not only for fresh water aquaculture (FAO 2004), but also for research in a 
wide range of areas like toxicology (Almeida et al., 2001; Coimbra et al., 2007; Costa et al., 
2011; Costa et al., 2012; Rey-Salgueiro et al., 2011), physiology (Wright and Land, 1998), 
endocrinology (Coimbra et al., 2005; Melamed et al., 1998), genomic biology  and 
molecular genetics (Lee et al., 2005; McConnell et al., 2000; Santini and Bernardi, 2005). 
The aim of this study was to evaluate the transcription patterns of genes involved in 
the detoxification pathways of aquatic organisms (ABCB1, ABCB11, ABCC1, ABCC2, 
ABCG2, CYP1A and GSTα) during embryonic and larval stages of O. niloticus, which are 
highly sensitive periods to the presence of toxicants in the environment.  
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6.3. Materials and methods 
 
6.3.1. Biological material 
 
Embryos used in the present work were obtained from breeders raised in the 
laboratory (CIIMAR, Porto, Portugal). Breeders stock (approximately 2 years old) were 
maintained in 500 L tanks (5-7 animals per tank), supplied with biological filtration and 
continuous aeration. During the non-reproductive season, dechlorinated tap water was 
used at a temperature of 20±2 ºC, with a 12 h:12 h (light:dark) photoperiod. Fish were fed 
commercial food pellets (Aquasoja, Portugal), until satiation, once a day. 
 
6.3.2. Embryos collection and rearing conditions 
 
Embryos and larvae used in this study were collected after natural female spawning 
and subsequent male fertilization of the eggs. Embryos from three different mothers were 
used in the study to reduce the variations in the rate of development previously seen 
among embryos of the same clutch, as well as among different clutches (Fujimura and 
Okada, 2007; Morrison et al., 2001). To induce reproduction, water temperature was 
gradually raised to 28±1 ºC. After approximately one week at high temperature, both males 
and females started to show clear signs of reproductive activity, including protuberant 
genital papilla in females, and the digging of circular holes in the substrate by dominant 
males. Animals were monitored during this period, and embryos were collected from 
female´s mouth immediately after fertilization. Embryos were separated into 5 L aquaria 
(250 eggs per aquarium) at 28±1 ºC and were allowed to develop with constant water 
renewal, and strong aeration to assure the continuous movement of the eggs. At different 
time points, embryos or larvae were collected and, after observation under a stereo 
microscope, those showing normal development were placed in RNAlater at 4 ºC 
overnight, and stored at -80 ºC until total RNA extraction. 
Time points for embryo and larvae collection were chosen based on the 
developmental embryonic and larval stages of O. niloticus described by Fujimura and 
Okada (2007). Samples were collected in 18 embryonic stages (1-18), grouped in 7 
periods (zygote, cleavage, blastula, gastrula, segmentation, pharyngula and hatching), and 
7 larval stages (19-25), grouped in 2 periods (early larvae and late larvae).  
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6.3.3. RNA isolation and cDNA synthesis 
 
Total RNA from embryo and larvae was isolated from pools of the three different 
clutches of embryos composed by 4-6 six eggs and 2-4 larvae using the PureZOL RNA 
isolation reagent (Biorad), according to the manufacturer´s protocol. Quality of total RNA 
was assessed by separation in 1% agarose gel electrophoresis (in Tris-acetate-EDTA – 
TAE – buffer) stained with Gel Red (Biotium), and by the measurement of the ratio of the 
optical density at λ260/280 nm (1.8-2.0). RNA was quantified using Quant-IT RiboGreen 
RNA Reagent and Assay Kit (Invitrogen) using a Fluoroskan Ascent, Labsystems, to 
measure fluorescence at λexcitation 480nm and λemission 520nm. One microgram of total 
RNA was subjected to digestion of genomic DNA using Deoxyribonuclease I, Amplification 
Grade (Invitrogen), and first strand cDNA was synthesized using the iScript cDNA 
Synthesis Kit from BioRad, according to the manufacturer´s protocol.  
 
6.3.4. Quantitative real-time PCR (qRT-PCR) 
 
Gene expression of ABCB1b (Annilo et al., 2006; in www.ensemble.org ABCB1b is 
annotated as ABCB4), ABCB11, ABCC1, ABCC2, ABCG2a, CYP1A and GSTα was 
assessed in embryo and larvae at the different time points of development, by means of 
quantitative real time PCR (qRT-PCR). Specific primers for ABCB1b, ABCB11, ABCC1, 
ABCC2, ABCG2a, CYP1A, GSTα and 18S rRNA were used according to Costa et al. 
(2012). Identities of the amplicons for qRT-PCR were confirmed by cloning and 
sequencing of the DNA fragments as described in Costa et al. (2012). Primer sequences, 
amplicon lengths, qRT-PCR efficiencies and Genbank accession numbers of target 
sequences are given in table 6.1. Reactions for qRT-PCR were conducted in a IQ5 
BioRad, with 10 µl of SYBR Green Supermix (BioRad), 2 µl of each primer (6 µM) and 1 µl 
of cDNA, in a total volume of 20 µl. Conditions were as follows: 95 ºC for 3 min, followed 
by 40 cycles of 95 ºC for 10 s, 54 ºC for 30 s and 72 ºC for 30 s. At the end of each run a 
melting curve analysis was done (from 55 to 95 ºC) to determine the formation of the 
specific products. Samples were run in duplicate. No template controls were run to exclude 
contamination and the formation of primer dimers. To determine the efficiency of the PCR 
reactions (table 6.1), standard curves were made for all genes, with 6 serial dilutions of the 
template (concentrations range from 0.05 to 50 ng/µl), and the slopes and regression 
curves were calculated.  
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Quantification of the mRNA expression of the genes in study, ABCB1b, ABCB11, ABCC1, 
ABCC2, ABCG2a, CYP1A and GSTα, during the embryonic and larvae development of O. 
niloticus was performed by normalization against the housekeeping gene (18S rRNA), by 
the 2-ΔΔCt method (Livak and Schmittgen, 2001), since efficiency of the PCR reactions was 
close to 100% (table 6.1). The mean mRNA expression of the different stages/periods was 
calculated based on the samples showing detectable expression. 18S rRNA, 
Glyceraldehyde 3-phosphate dehydrogenase (GADPH), Elongation factor 1 (EF1), 
Ribossomal protein L17 and ß-actin were evaluated as possible reference genes, and 18S 
rRNA was chosen, since it has been shown to be the most stable gene at the analyzed 
developmental stages (data not shown). Even though 18S rRNA showed to be the most 
stable gene throughout the development, it was differently expressed from cleavage to 
blastula and from gastrula to segmentation, being stable in three clustered groups during 
the stages that were analyzed in this study. Thus, the final data will be presented in 
separated graphs following the stability of the housekeeping gene (zygote to cleavage; 
blastula to gastrula and segmentation to late larvae). For this reason, no comparison of the 
gene transcription data from cleavage to blastula or from gastrula to segmentation will be 
performed.  
 
6.3.5. Statistical analysis  
 
Differences between gene expression in the different time points of embryonic and 
larvae development were evaluated by means of a one-way ANOVA, followed by a 
multiple comparison test (Tukeys test) at a 5% significance level. Some data had to be log 
or square root transformed in order to fit ANOVA assumptions. All tests were performed 
using the software Statistica 7 (Statsoft, Inc., 2001).  
 
6.3.6. Ethics statement 
 
The animals used in the research described in this paper were treated in accordance 
with the Portuguese Animals and Welfare Law (Decreto-Lei nº 197/96) approved by the 
Portuguese Parliament in 1996. Institutional animal approval by CIIMAR/UP and Direcção 
Geral de Veterinária was granted for this study. 
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Table 6.1 – Primer sequences, amplicon lengths and efficiency of reaction, used in ABC transporters, CYP1A, GSTα and 18S rRNA gene 
expression quantification by qRT-PCR in Nile tilapia 
 
Target gene Sense Antisense Amplicon length 
Efficiency of the 
PCR reaction 
Genbank ID 
ABCB1b cgttcctcaaggtgatggct ggctgcattgcaccattgat 91 pb 98.5% GQ911571 
ABCB11 ctggtcagacactggccttt caggaaagacacgttgacgc 143 pb 110.0% GQ911570 
ABCC1 atccgtgagagtgaccag caaatgacacaatgaagtttcc 117 pb 99.7% GQ911567 
ABCC2 cctggttggcttgtctatatcc ctcgctgtattcactcactctc 123 pb 107.6% GQ911569 
ABCG2a tcatgaagccgggtctcaac agacctgcagggtcctttct 96 pb 103.9% GQ911568 
CYP1A cgtcgtcgtctctgttgcc catcgtcgtggtggtcatagc 70 pb 96.6% GI13365614 
GSTα aaatggatggcatgaagctc tcgttctttgggatcctttg 92 pb 109.8% EU234530 
18S rRNA cggaaggatcattactggctacac agaccctcggcggcaaag 78 pb 100.1% DQ397879 
 
 
 
 
 
 
 
 
 
 
Chapter 6 
192 
 
 
6.4. Results 
 
Results for the mRNA expression during zygote and cleavage periods of the genes 
evaluated in this study are displayed in figure 6.1. Only ABCB1b, ABCC1, CYP1A and 
GSTα showed to be expressed since the initial periods of embryonic development of O. 
niloticus, zygote and cleavage. According to Fujimura and Okada (2007), in O. niloticus 
embryo development, these periods can be divided into five stages (1 to 5) that comprise 
the first 4 hours post fertilization (hpf). Gene expression showed a downward trend from 
stage 1 (zygote) to stage 2 (first cleavage stage), followed by an increase after stage 3. 
This pattern was clear for ABCC1 mRNA expression (figure 6.1b), where no mRNA was 
detected in samples from stage 2, and only 25 and 50% of the samples from stages 3 and 
4, respectively, showed ABCC1 mRNA expression. Moreover, gene expression in final 
cleavage stages (4 and 5) was significantly higher than in earlier stages (1 to 3). 
Regarding CYP1A, although no significant differences were seen in mRNA expression 
during zygote and cleavage periods (figure 6.1c), mRNA expression was only detected in 
50% of stage 2 and 75% of stage 3 samples. Gene expression of ABCB1b (figure 6.1a) 
and GSTα (figure 6.1d) was detected in all samples during the first five stages of O. 
niloticus development. Additionally, ABCB1b and GSTα were the most expressed genes in 
these stages, followed by ABCC1 and CYP1A. 
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Figure 6.1 – Relative mRNA expression of ABCB1b (a), ABCC1 (b), CYP1A (c) and GSTα (d) 
during the first five stages (1-5) of embryonic development in O. niloticus comprising the 
zygote and cleavage periods. 
Expression was measured by qRT-PCR and quantified by normalization against the housekeeping 
gene (18S rRNA) by the 2
-ΔΔCt
 method. Results are given as mean±SE (n = 4). Calculated mean 
include samples with detectable mRNA expression only. Different letters denote significant 
differences (p<0.05) between stages.  
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In blastula (4-22 hpf) and gastrula (22-26 hpf) stages, only mRNA expression of 
ABCB1b, ABCC1, CYP1A and GSTα was detected, as for zygote and cleavage. According 
to the staging system described by Fujimura and Okada (2007), each of these periods can 
be subdivided in 2 stages (6 and 7 for blastula, 8 and 9 for gastrula). Since no significant 
differences were seen in mRNA expression between the stages of each period, data from 
stages 6 and 7 was grouped in blastula, and data from stages 8 and 9 was grouped in 
gastrula and results are presented in figure 6.2. No significant differences were seen 
between mRNA transcriptions of the two periods for any of the genes, although a tendency 
for an increase from blastula to gastrula was observed. Moreover, all genes detected at 
these stages showed similar levels of expression.  
Gene expression of ABCB1b, ABCC1, CYP1A and GSTα from segmentation (26 to 
30 hpf) to late larvae (11 to 13 days post fertilization – dpf) are displayed in figure 6.3. Data 
from stages belonging to the same period of development were grouped together 
(according to Fujimura and Okada, 2007). ABCB1b and CYP1A mRNA expression 
decreased after the segmentation period. ABCB1b mRNA levels at segmentation were 
significantly higher than the following stages (figure 6.3a), while CYP1A mRNA showed a 
pattern of decreasing expression until late larvae (figure 6.3c). A different scenario was 
seen for GSTα, with a significant increase in mRNA after the hatching period that was 
maintained until the end of the late larvae period (figure 6.3d). ABCC1 mRNA expression 
showed no significant changes from segmentation to late larvae (figure 6.3b). ABCB1b 
mRNA levels were higher than ABCC1, CYP1A and GSTα in the segmentation period, but 
decreased to similar levels in the following stages. 
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Figure 6.2 -  Relative mRNA expression of ABCB1b (a), ABCC1 (b), CYP1A (c) and GSTα (d) 
during the blastula and gastrula periods of embryonic development in O. niloticus.  
Expression was measured by qRT-PCR and quantified by normalization against the housekeeping 
gene (18S rRNA) by the 2
-ΔΔCt
 method. Results are given as mean±SE (n = 4-5). 
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Figure 6.3 - Relative mRNA expression of ABCB1b (a), ABCC1 (b), CYP1A (c) and GSTα (d) 
during the last embryonic (segmentation to hatching) and larval periods (early and late 
larvae) in O. niloticus development.  
Expression was measured by qRT-PCR and quantified by normalization against the housekeeping 
gene (18S rRNA) by the 2
-ΔΔCt
 method. Results are given as mean±SE (n = 8-12). Different letters 
denote significant differences (p<0.05) between stages.  
 
In figure 6.4, mRNA expression of ABCB11, ABCC2 and ABCG2a during embryonic 
and larval developmental stages in O. niloticus is displayed.  Gene expression was only 
detected in pharyngula and following developmental periods, with a pattern of increasing 
mRNA expression. This pattern was particularly clear for ABCB11 (figure 6.4a) and 
ABCC2 (figure 6.4b) where a significant increase (p<0.05) was seen after the pharyngula 
period. Similar levels of mRNA were seen in ABCB11, ABCC2 and ABCG2a from 
pharyngula to late larvae. Main results obtained in this study are summarized in figure 6.5. 
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Figure 6.4 – Relative mRNA expression of ABCB11 (a), ABCC2 (b) and ABCG2a (c) during the 
embryonic and larval periods (zygote to late larvae) in O. niloticus development.  
Expression was measured by qRT-PCR and quantified by normalization against the housekeeping 
gene (18S rRNA) by the 2
-ΔΔCt
 method. Results are given as mean±SE (n = 5-12). Different letters 
denote significant differences (p<0.05) between periods. 
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6.5. Discussion 
 
Several studies have addressed the hypothesis of a coordinated regulation of MXR 
proteins and biotransformation enzymes in aquatic organisms, resulting in the activation of 
an important mechanism of cellular protection against xenobiotic insults (Bard, 2000; 
Costa et al., 2012; Leslie et al., 2005; Xu et al., 2005). Although the presence and 
functionality of these proteins have been demonstrated in several aquatic species (Diaz de 
Cerio et al., 2012; Fischer et al., 2011; Loncar et al., 2010; Paetzold et al., 2009; Zaja et 
al., 2008), the full characterization of this mechanism is not yet complete mainly during the 
early life stages of fish development, which is a particularly sensitive period to the 
presence of contaminants (Buhl and Hamilton, 1991). In this study, we analyzed the gene 
transcription patterns of several ABC transporters (ABCB1b, ABCB11, ABCC1, ABCC2 
and ABCG2a) and phase I (CYP1A) and II (GSTα) biotransformation enzymes, during the 
embryonic and larval stages of O. niloticus. 
Only ABCB1b, ABCC1, CYP1A and GSTα mRNA were expressed since the onset of 
development of the embryo (figures 6.1 and 6.5). ABCB11, ABCC2 and ABCG2a mRNA 
expression was only detected after the pharyngula period (figures 6.4 and 6.5). In 
mammals, murine oocytes and early embryos express ABCB1 (Elbling et al., 1993) and in 
porcine oocytes both ABCB1 and ABCC1 mRNA expression was detected (Takebayashi 
et al., 2001). In the early stages of embryonic development of aquatic invertebrate species, 
proteins associated with MXR mechanism were shown to play an active role in embryos 
protection. ABCB1 expression was detected by western blot in Urechis caupo embryos 
since 2-cell stage, and a biodegraded crude oil fraction (BWSF) was non-toxic to those 
embryos/larvae, while in Lytechinus anemesus embryos, where no MXR efflux capacity 
was observed, exposure to BWSF caused developmental abnormalities (Hamdoun et al., 
2002). In zebra mussel, ABCB1 mRNA was detected in eggs, although MXR mediated 
efflux capacity only occurred in one day old larvae (Faria et al., 2011). In fish 
developmental stages ABC transporters characterization is still very limited. However, 
zebrafish transcripts of ABCC1 gene were detectable in four-cell stage embryos (1hpf), 
indicating that this gene is maternally expressed, and mRNA expression was significantly 
induced by toxic heavy metals (Long et al., 2011a).  In other fish species, CYP1A mRNA 
and/or activity was also found to be present and inducible by the exposure to contaminants 
in later developmental stages, like hatching (Engwall et al., 1994; Goksøyr et al., 1991; 
Hodgson and George, 1998; Peters et al., 1996; Sarasquete et al., 2001). Nevertheless, 
CYP1A activity was already inducible by the presence of PCBs in killifish pre-hatched 
embryos (Binder et al., 1985), and the knockdown of CYP1A mRNA enhanced the 
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frequency of developmental disorders in zebrafish 26 hpf pre-hatched embryos exposed to 
3,4-dichloroaniline, suggesting that CYP1A is translated into active protein in pre-hatching 
stages (Voelker et al., 2008). Similarly, the presence of the mRNA for phase II enzyme 
GSTα was previously described in plaice eggs (6 hpf) (Hodgson and George, 1998) and in 
early rice fish embryos (1 hpf) (Wu et al., 2011). Our results are in agreement with these 
studies, indicating that also in O. niloticus early embryos ABCB1b, ABCC1, CYP1A and 
GSTα mRNA transcripts are present, and are of maternal origin, suggesting a crucial role 
in these early stages of development, of these particular proteins. The mRNA expression 
of these maternally transmitted genes has decreased from zygote to cleavage first stage 
(figure 6.1). This pattern reflects the natural processes occurring in the embryos of 
maternal to zygote transition (MZT) (Tadros and Lipshitz, 2009). When this process is 
triggered, a subset of the maternal mRNAs is eliminated by means of maternally encoded 
products, and the transcription of the zygote genome begins, leading to the production of 
transcriptional activators that enhance the efficiency of zygote transcription, including 
proteins and microRNAs (miRNAs) that provide feedback to enhance the maternal mRNA 
degradation (Tadros and Lipshitz, 2009). Thus, we propose that degradation of maternal 
transcripts, in Nile tilapia, is occurring in stages 2 and 3, followed by the beginning of 
zygote transcription in stages 4 and 5 (figure 6.1). Blastula and gastrula periods follow the 
early mitotic cycles, and roughly coincide with the major wave of zygote genome activation 
in fish (Kane and Kimmel, 1993), generally resulting in the rise of mRNA transcripts of 
most genes. In our study, 18S rRNA transcripts increased significantly from the cleavage 
to blastula periods (data not shown), precluding the comparison of mRNA expression 
transcripts between these periods. Genes that were found to be expressed since the 
zygote period were also detected during the blastula and gastrula periods (figure 6.2), 
being an indication that transcripts are being produced by zygote genome at this point. 
Characteristic processes occurring during the segmentation period in fish include the 
development of the somites, appearance of the rudiments of the primary organs, the 
beginning of morphological cell differentiation and the first movements of the body 
(Fujimura and Okada, 2007; Kimmel et al., 1995). Afterwards, the embryo enters the 
pharyngula period with a well developed notochord, and a newly completed set of somites 
that extend to the end of a long post-anal tail (Fujimura and Okada, 2007; Kimmel et al., 
1995). These set of events might explain the decrease in mRNA expression of ABCB1b 
and CYP1A after the segmentation period (figure 6.3a and 6.3c). At the beginning of the 
organogenesis mRNA expression of these genes could be confined to some specific 
organs, that function as physiological/pharmacological barriers, as previously shown in 
tissues of adult fishes (Loncar et al., 2010; Sarasquete and Segner, 2000; Zaja et al., 
2008). In particular, in Nile tilapia it was shown that ABCB1b is not expressed in the gill, 
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being more expressed in the liver and intestine, while CYP1A mRNA expression was much 
higher in the liver and gill, than in the proximal intestine (Costa et al., 2012). In contrast, 
ABCC1 and GSTα seem to be more ubiquitously expressed in adult fish tissues (Costa et 
al., 2012; Kim et al., 2010; Li et al., 2010; Long et al., 2011a), which can reflect the mRNA 
transcription patterns seen in the late embryonic and larval stages described in this study 
(figures 6.3b and 6.3d). Additionally, besides its role as a phase II enzyme, GSTα is also 
an antioxidant enzyme, protecting the cells against reactive oxygen species (reviewed in 
van der Oost et al., 2003). A previous work has reported an increase in oxidative stress 
during the embryogenesis of Japanese rice fish (until hatching), accompanied by an 
increase in the mRNA expression of GST1α (Wu et al., 2011). Our results are in 
agreement with this work, and the increase in GSTα mRNA expression after the 
pharyngula period could be a physiological response to maintain oxidative stress balance, 
important for the normal development of the embryos. The pharyngula period was marked 
by the appearance of the first mRNA transcripts for the ABC transporters ABCB11, ABCC2 
and ABCG2a in Nile tilapia (figures 6.4 and 6.5), and in the hatching period mRNA 
expression increased significantly for these three genes accompanied with GSTα (figure 
6.3d). During the hatching period the embryo continues to grow, opening of the mouth 
occurs and the morphogenesis of many of the rudiment organs, like the gills, is completed 
and slows down considerably, with some exceptions like the gut and associated organs 
(Fujimura and Okada, 2007; Kimmel et al., 1995). Moreover, the hatching of the embryos, 
a critical period during the development of many organisms, implies the loss of their 
protective “shell”, and consequently means that they become more exposed to the 
surrounding environment. The severity of this period may require an increase in the 
intrinsic defense mechanisms, which we believe is reflected by the increase of the mRNA 
expression of the majority of the genes evaluated in this study, ABCC1, ABCB11, ABCC2, 
ABCG2a and GSTα (figures 6.3 and 6.4). Previous works have reported an increase in the 
MXR mechanism after the hatching period in several invertebrate aquatic species (Faria et 
al., 2011; McFadzen et al., 2000; Minier et al., 2002). Moreover, similarly to what we found 
in Nile tilapia, ABCC2 gene in zebrafish was only detected in 72hpf embryos (right before 
hatching) and the overexpression of zebrafish ABCC2 in embryos decreased the cellular 
accumulation of heavy metals, suggesting an active role of ABCC2 protein in this stage 
(Long et al., 2011b). 
In conclusion, the expression patterns of genes encoding for some of the most 
important proteins involved in mechanisms of protection against pollutants, like MXR 
proteins (ABCB1b, ABCB11, ABCC1, ABCC2 and ABCG2) and biotransformation 
enzymes (CYP1A and GSTα), were described in embryonic and larval developmental 
stages of a teleost fish, Nile tilapia, for the first time. Overall, this work has shown that 
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these genes present different expression patterns during the embryogenesis in Nile tilapia. 
While some of these genes are present since the early stages of development (ABCB1b, 
ABCC1, CYP1A and GSTα), others are only transcribed in later embryonic stages 
preceding sensitive periods of development (ABCC2 and ABCG2), when the demand for 
these types of proteins may rise in order to assure the necessary levels of protection 
against toxicants from the surrounding environment (figure 6.5). 
 
 
 Figure 6.5  – Schematic representation of the main results achieved in this study, showing 
the temporal pattern of mRNA expression for the genes in study (ABCB1b, ABCB11, ABCC1, 
ABCC2, ABCG2a, CYP1A and GSTα) in Nile tilapia developmental stages. Adapted from 
Kimmel et al. (1995) and Fujimura and Okada (2007). 
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7. Final remarks 
7.1. General discussion 
 
In the last decades, aquatic pollution, mainly resultant from the industrialization of 
the northern hemisphere, has been recognized as a global environmental problem, 
jeopardizing the survival rates of many species inhabiting the aquatic environments. Thus, 
the understanding of the subjacent parameters of cellular detoxification is an uppermost 
need, as it can provide environmentalists with crucial information that may allow a 
sustainable future for the environment. The biotransformation of toxic compounds into 
more easily excreted metabolites by phase I and phase II enzymes is one of the most 
relevant mechanisms adopted by living organisms, in order to cope with the presence of 
pollutants in their habitats. Recently, it has been proposed that some ABC efflux 
transporters can also be involved in the removal of parent or metabolized xenobiotics from 
the inside of the cells, in an ATP driving process, acting in a coordinated fashion with the 
biotransformation enzymes. The relevance of ABC efflux transporters was first recognized 
in humans, and they were found to be responsible for a MDR phenomenon by diminishing 
the efficacy of cancer treatments. Therefore, research that follows the clinical aspect of the 
ABC transporters mode of action is mostly focused on understanding how to block their 
activity, in order to assure the effectiveness of administered drugs in chemotherapeutic 
treatments. Being highly conserved through vertebrate species, the role of ABC 
transporters as key players in cellular detoxification was later recognized. In aquatic 
organisms, they are believed to protect the cells from pollutants in a mechanism named as 
MXR and, in contrast to the clinical aims, environmentalists’ goals are to ensure that these 
transporters are operating optimally, hence continuing to keep toxicants out of the cells. 
Therefore, the full knowledge on the functionality of this cellular defence mechanism is of 
sovereign value both for environmental as for human health. Nevertheless, although there 
are increasing evidence for the presence of ABC efflux transporters in fish species at the 
genetic, immunochemical and functional levels, the knowledge of the role of these proteins 
is still rudimentary. Moreover, when addressing cellular detoxification systems, the bulk of 
the research has been done mainly in xenobiotic biotransformation and, to our knowledge, 
no in vivo studies have been directed to better acquaint the integration and cooperation of 
these efflux transporters with biotransformation enzymes in the detoxification pathway.  In 
order to fill these gaps, this study was outlined to assess, for the first time, the response 
and the cooperation of the three phases of detoxification. To fulfil our goals, in vivo assays 
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of exposure of Nile tilapia to a highly toxic PAH, BaP, were conducted using different 
routes of exposure. Subsequently, ABC efflux transporters and biotransformation enzymes 
responses to the presence of this xenobiotic were evaluated in different barrier tissues of 
Nile tilapia. 
The biotransformation pathway of BaP was characterized by assessing the catalytic 
activities of phase I (EROD) and phase II (GSTs) biotransformation enzymes (chapter 2), 
after waterborne and dietary exposures, in different tissues of Nile tilapia. The 
biotransformation pathway was shown to be dependent on the route of exposure to the 
contaminant and different tissues were involved in BaP metabolism.  Waterborne exposure 
led to BaP metabolism in liver, and also in the extra-hepatic tissues, gills and intestine, 
evidenced by a dose-dependent up-regulation of CYP1A-associated catalytic activity in 
these tissues. A different scenario was observed after the dietary exposure to BaP, where 
the induction of intestinal, but not hepatic EROD activity, pointed out that intestinal 
metabolism was the major detoxification pathway adopted by Nile tilapia. Together with the 
high correlations found between the levels of biliary BaP metabolites and EROD activity in 
all tissues, after both exposure routes, our results showed that liver, gills and intestine 
display a substantial role in the first-pass metabolism of environmental contaminants. 
Moreover, the data indicated that, after CYP1A metabolism, metabolites formed in extra-
hepatic tissues can be reabsorbed into the blood for enteropatic circulation and then 
released in the gall bladder, as suggested for other species (Kleinow et al., 1998). EROD 
activity and biliary BaP metabolites reflected properly the contamination levels that fish 
were exposed to, which strongly support their use as biomarkers of exposure to PAHs.  
Moreover, the tissue-specific differences in EROD activity and the different levels of BaP 
metabolites, measured according to the type of exposure, can provide useful indications of 
the main exposure route to the contaminants in the field. Thus, the use of these 
biomarkers of exposure in extra-hepatic tissues should be proposed as a tool to use in 
environmental risk assessment monitoring studies, as they can provide additional 
information on the characterization of the type of exposure that animals are facing in the 
environment.   
No relevant changes were observed in the activity of phase II biotransformation 
enzymes GST, in any of the tissues. In the literature, the use of GST activity as a 
biomarker of exposure to PAHs is controversial, with some authors reporting up-
regulations, while others did not observed any changes or even reported reductions in 
GST activity (van der Oost et al., 2003). Nevertheless, the different GST isoforms respond 
differently after xenobiotic exposure in fish (Martínez-Lara et al., 1996; Perez-Lopez et al., 
2002), which can indicate that the net result, measured by total GST activity, could be null 
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and not necessarily mean that GSTs were not involved in BaP metabolism. Even so, our 
results point to a low sensitivity of these enzymes as a phase II biomarker in Nile tilapia, as 
previously shown in other studies conducted in fish (Della Torre et al., 2010; Schreiber et 
al., 2006). For these reasons, more investment should be paid to the research of the 
specific isoforms that can be involved in xenobiotic metabolism.  
One important feature of BaP is the highly reactive and toxic metabolites that can be 
formed after enzymatic biotransformation. One of BaP metabolites, the 3-OH-BaP in the 
free form, is known to be toxic with the ability to bind to DNA. By analysis of the FACs in 
bile, the presence of BaP metabolites, which includes phase I (free) and phase II 
(conjugated) metabolites, was shown (chapter 2). By HPLC analysis we were able to 
detect the presence of the free (toxic) and conjugated 3-OH-BaP metabolites in bile and 
plasma of BaP water exposed Nile tilapia (chapter 3). This study has further demonstrated 
the presence of a well-developed biotransformation system in this species, since no parent 
compound was detected, and the metabolite, 3-OH-BaP, was present, in free and 
conjugated forms, in bile and in plasma of exposed animals. Moreover, gill and intestinal 
EROD activities of waterborne exposed animals were positively correlated with free 3-OH-
BaP in bile and total 3-OH-BaP in plasma, strengthening the involvement of extra-hepatic 
tissues in phase I BaP metabolism, and the release of metabolites formed in extra-hepatic 
tissues into the blood stream. The presence of the toxic form of 3-OH-BaP in plasma is of 
special concern, since this metabolite has been reported to have estrogenic activity and 
the ability to bind to macromolecules, such as DNA and proteins (hemoglobin) (van Lipzig 
et al. 2005, Sugihara and James 2003). Nevertheless, Nile tilapia has also shown to have 
the ability to neutralize the toxic phase I metabolite (free 3-OH-BaP) into non-toxic forms 
(conjugated forms) demonstrated by the predominance of conjugated over free 
metabolites in bile of waterborne exposed fish, that indicates the important role of phase II 
enzymes (GST, UGT and SULT). However, and despite the high G-3-OH-BaP levels 
detected in bile, no significant induction of UGTs activity was observed in Nile tilapia. 
UGTs, as GSTs, exhibit a broad specificity for structurally diverse compounds and different 
UGTs isoforms have been described in fish (George, 1994), Thus, the measurement of 
UGTs catalytic activities alone might be a substantial limit to the complete understanding 
of the responses of these enzymes.  
Overall, this study has shown the important role of liver and also of extra-hepatic 
tissues, such as gills and intestine, in the phase I and II metabolism of BaP in Nile tilapia, 
further supporting their function as barriers for the uptake, metabolism and distribution of 
xenobiotic compounds. 
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In order to assess the cooperation between ABC efflux transporters and 
biotransformation enzymes, we have adopted a genetic approach. Hence, the identification 
of genes coding for of ABC proteins in Nile tilapia was performed, since these transporters 
were not yet identified in this species. The presence of the genes encoding for 
ecotoxicologically relevant ABC efflux transporters (ABCB1b, ABCB11, ABCC1, ABCC2 
and ABCG2a) was demonstrated in Nile tilapia (chapter 4). The partial sequences 
obtained revealed the presence of highly conserved domains, a characteristic found in all 
vertebrate ABC efflux transporters (Walker-A, C-motif and Walker-B), and phylogenetic 
analysis showed the clustering with ABC transporter sequences from other fish species. 
These data allowed the determination of the tissue expression pattern of ABC transporters, 
CYP1A and GSTα in Nile tilapia, which showed high levels in tissues that function as 
pharmacological barriers, such as liver, gills and intestine. Among the ABC efflux 
transporters studied, ABCC1, ABCC2 and ABCG2 were ubiquitously distributed throughout 
the three tissues, although ABCC1 and ABCC2 showed slightly higher levels of expression 
in gill and proximal intestine, respectively. ABCB1b and ABCB11 revealed a more tissue-
specific expression pattern. The highest levels of ABCB1b expression were recorded in 
proximal intestine, and no expression was detected in gill. On the contrary, ABCB11 
mRNA expression was almost exclusively confined to the liver, and very low expression 
was measured in intestine and no expression was detected in gill. The expression pattern 
of ABC efflux transporters in Nile tilapia tissues follows the ones described for other fish 
species (Cai et al., 2003; Loncar et al., 2010; Long et al., 2011a; Long et al., 2011b) and 
mammals (Brady et al., 2002; Gerloff et al., 1998; Keppler and Konig, 1997; Maliepaard et 
al., 2001; Mottino et al., 2000). High basal levels of steady state CYP1A and GSTα mRNA 
were detected in liver and in extra-hepatic tissues, further supporting the fact that these 
are important locations for xenobiotic metabolism and excretion, as observed in other 
studies (Kim et al., 2010; Li et al., 2010; Rees et al., 2003; Reynolds et al., 2003), and also 
supported by the data obtained at the activity level previously described. The mRNA 
expression pattern of these players of cellular detoxification (ABC transporters and 
biotransformation enzymes), is in agreement to the xenobiotic absorption and detoxifying 
abilities described for each organ. 
Considering the transcriptional response of ABC efflux transporters to the presence 
of BaP and/or its metabolites, although ABCB1b  mRNA has shown a tendency to an 
increase in liver and intestine of BaP water-exposed animals, up-regulation was not 
significant, which suggested that, apparently, BaP is not a substrate for Pgp. On the 
contrary, a clear response to the presence of BaP and/or its metabolites was observed 
from other ABC efflux transporters, such as ABCC2 and ABCG2. Waterborne exposure to 
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BaP led to a significant up-regulation of the mRNA transcripts of ABCC2 in gill and ABCG2 
in liver and intestine. In aquatic organisms, the interaction of environmental contaminants 
with ABC efflux transporters is still poorly documented, and has been largely confined to 
the study of Pgp (ABCB1). Despite the limited information on the response of other ABC 
efflux transporters, some evidence exists on the involvement of these particular 
transporters in detoxification mechanisms. Hepatic ABCC2 and ABCG2 mRNA up-
regulation was previously reported in fish inhabiting contaminated sites (Paetzold et al., 
2009) and, after in vivo exposure to heavy metals an increase of liver ABCC2 transcripts 
was also observed in other fish species (Long et al., 2011b; Zucchi et al., 2010). Our 
findings corroborate these results and go further by showing that ABCC2 and ABCG2 can 
probably perform similar functions in different barrier tissues. The fact that the majority of 
BaP metabolites in plasma and bile of water exposed Nile tilapia were phase II conjugates 
(chapter 3), and also the correlations found between biliary BaP metabolites (chapter 2) 
and ABCC2 and ABCG2 mRNA expressions, points to a role of these transporters in the 
efflux of phase II metabolites in gill (by ABCC2) and intestine (by ABCG2).   
Biotransformation enzymes of phase I and phase II were also evaluated, by means 
of mRNA expression, in BaP exposed fish. CYP1A was significantly up-regulated, in a 
dose dependent manner, after waterborne exposure to BaP in liver, gills and intestine, and 
in intestine after dietary exposure. CYP1A expression was correlated with CYP1A-
associated catalytic activities (chapter 2) in both routes of exposure, thus providing 
evidence that the mRNA increase was further reflected on the protein functionality. 
Moreover, CYP1A mRNA expression was significantly correlated with ABCC2 in gill and 
ABCG2 in intestine, further supporting the proposed cooperative role of ABC transporters 
and biotransformation enzymes in these tissues. After waterborne exposure, an increase 
in GSTα mRNA expression was observed in gill, although it was not statistically supported. 
Moreover, GSTα mRNA expression was significantly correlated with ABCC2 transcripts, in 
the same tissue, and with biliary BaP metabolites. These data support that ABCC2 efflux 
of metabolites, in Nile tilapia, may occur preferably through a co-transport with GSH, as 
described in mammals.  
In summary, our results showed that the role of ABCCs and ABCG2 in the efflux of 
GSH, GA and/or sulphate conjugates, pointed out in mammalian models (Leslie et al., 
2005), is apparently maintained in fish species, like Nile tilapia. Moreover, for the first time, 
indications were shown that ABCC2 may be responsible for the preferential efflux of GSH 
metabolites in gills. In mammals, ABCG2 has been associated to the efflux of sulphate 
conjugates, and we must not exclude this possibility in Nile tilapia, since sulphate BaP 
conjugates were detected in bile (chapter 3) and no correlations were found between this 
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transporter mRNA expression and GSTα mRNA. However more studies are needed to 
confirm this hypothesis. 
To evaluate Pgp (ABCB1) and CYP1A at the protein level, and their cellular 
localization in Nile tilapia tissues immunochemical methods were applied (chapter 5). Pgp 
was detected using two different mAb directed to mammalian Pgp, C219 and C494. This 
kind of approach, using two or more standardized anti-Pgp antibodies that recognize 
different epitopes, improves the reliability of immunological detection of Pgp (Beck et al., 
1996; Lacueva et al., 1998; Valk et al., 1990). These antibodies are known for the different 
staining patterns, and labelling intensity, usually associated with each Pgp antibody (Ginn, 
1996; Van Der Heyden et al., 2009). In face of our results, Pgp cellular localization in Nile 
tilapia described in this study seems to be in agreement with the majority of the studies 
conducted in fish and mammals species with both antibodies, which is a positive indication 
of a specific reaction to Pgp. Despite the tendency to an increase observed in hepatic and 
intestinal ABCB1b mRNA after waterborne exposure to BaP (chapter 4), at protein level, 
no changes were detected in Pgp expression of exposed animals. Therefore, this can be 
one more evidence that Pgp is apparently not involved in the efflux of BaP in Nile tilapia 
tissues, since no significant changes in Pgp protein or ABCB1b mRNA expression were 
observed in liver, nor in intestine of animals exposed to waterborne BaP.  In mammals, the 
interaction of BaP with Pgp is still controversial, some studies indicate that this transporter 
is involved in the efflux of the parent compound (Chao Yeh et al., 1992; Fardel et al., 1996) 
while others report the opposite (Buesen et al., 2002; Schuetz et al., 1998). In fish, Zaja et 
al. (2011) also found no BaP interaction with ABCB1 in a hepatoma cell line of Poeciliopsis 
lucida, and in catfish liver and intestine, BaP dietary exposure had no effect on Pgp levels 
(Doi et al., 2001), accordingly to what we have reported in our study.  However, since both 
antibodies may cross-react with other proteins (Childs et al., 1995; Georges et al., 1990; 
Rao et al., 1994), besides Pgp, results from these studies should be taken with care, as for 
our study. Findings provided by the mAb C219 do not exclude the possibility of cross-
reactivity with Spgp (ABCB11) in Nile tilapia tissues, rather than to Pgp alone, since both 
proteins share similar molecular weight thus being indistinguishable by western blot. 
Moreover, we were unable to confirm the size of the protein reacting to the mAb C494, 
which, consequently, is a drawback on the interpretation of the results provided by this 
antibody. Nevertheless, considering a positive reaction of C494 antibody to Pgp alone, 
results showed the possibility of the existence of a different Pgp-isoform in gill, not 
previously described in other immunochemical studies in fish. mRNA transcripts of Pgp 
(ABCB1b) were not detected in Nile tilapia gill (chapter 4), similarly to other studies in a 
different fish species (Loncar et al., 2010; Zaja et al., 2008). The existence of more than 
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one Pgp isoform in fish has been proposed (Dean and Annilo, 2005; Fischer et al., 2011), 
and could explain the positive reaction observed in gills of Nile tilapia after probing with the 
mAb C494.   
Phase I biotransformation enzyme, CYP1A, was also assessed at protein level by 
the use of the mAb C10-7. Results showed that CYP1A was localized in liver hepatocytes 
and vascular endothelium, gills pillar and epithelial cells and intestinal enterocytes and 
vascular elements of Nile tilapia, which follows the cellular distribution pattern previously 
described in other fish species (Jönsson et al., 2006; Van Veld et al., 1997). A dose-
dependent induction of CYP1A protein levels was observed in liver, gills and intestine after 
waterborne exposure to BaP, in agreement to the previous results both at gene (chapter 4) 
and at functional levels (chapter 2). With this approach, we have validated the importance 
of this phase I enzyme, and also the role of extra-hepatic tissues (gills and intestine) in the 
first-pass metabolism of waterborne pollutants. ABCB1 and CYP1A were not assessed at 
protein level in dietary exposed animals, since mRNA expression levels and CYP1A–
associated catalytic activity were not altered in the three analysed tissues simultaneously, 
in opposition to waterborne exposed animals and limited information would be obtained. In 
summary, at protein level, responses of ABCB1 and CYP1A confirmed the results of the 
mRNA expression levels and catalytic activities previously measured, and supported that, 
while BaP is not a substrate for Pgp, CYP1A is involved in its metabolism in the different 
barrier tissues of Nile tilapia. 
The presence and functionality of ABC efflux transporters proteins has been 
demonstrated in adult stages of other aquatic species (Loncar et al., 2010; Zucchi et al., 
2010), but information on the characterization during the early life stages of fish 
development, which is a particularly sensitive period to the presence of xenobiotic 
compounds, is still very scarce. Only two studies have reported the sensitivity of ABCC1 
and ABCC2 of zebrafish embryos to the presence of heavy metals (Long et al., 2011a,b), 
but no information exists on the characterization of all cellular detoxification phases during 
the ontogeny of fish. In order contribute to a more detailed knowledge, we evaluated the 
mRNA transcripts of ABC transporters and biotransformation enzymes during the 
development of Nile tilapia embryos and larvae (chapter 6). At these critical stages some 
of these genes were present since the onset of embryos development (ABCB1b, ABCC1, 
CYP1A and GSTα), thus being of maternal origin, while others were transcribed in later 
embryonic stages, preceding highly sensitive periods of development (ABCB11, ABCC2 
and ABCG2). The zygote transcription initiates during the cleavage period which resulted 
in an increase of mRNA transcription of the maternally transmitted genes during the 
following stages. At the beginning of the organogenesis (occurring after segmentation 
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period), ABCB1b and CYP1A showed a decrease in mRNA expression, probably related to 
a dilution effect associated with the fact that these genes display a more tissue-specific 
distribution pattern than the remaining ones, as shown in adult tissues of Nile tilapia 
(chapter 4), and other fish species (Loncar et al., 2010; Sarasquete and Segner, 2000; 
Zaja et al., 2008). After 3-4 dpf, during the pharyngula period, the first mRNA transcripts 
for ABCB11, ABCC2 and ABCG2 were detected in Nile tilapia. This period precedes the 
most sensitive stage in fish development, the hatching period, characterized by the mouth 
opening and the loss of the chorion, implying that embryos become much more exposed to 
the surrounding environment. The need for an increase of the intrinsic defence 
mechanisms may be reflected by the increase in the mRNA expression of the majority of 
the genes evaluated, ABCB11, ABCC1, ABCC2, ABCG2 and GSTα. Higher MXR activity 
after the hatching period has been previously reported in invertebrate aquatic species 
(Faria et al., 2011; McFadzen et al., 2000; Minier et al., 2002) and in zebrafish (Long et al., 
2011b), which comes in agreement with our results. The presence of genes encoding for 
ABC efflux transporters since the onset of embryos development indicates that these 
proteins should play a crucial role in the tolerance against environmental xenobiotics 
during these critical life stages. Therefore, although more detailed functional studies are 
needed, these data point to the fact that the presence of toxicants with the ability to block 
or saturate ABC efflux transporters and/or biotransformation enzymes in early life stages of 
aquatic organisms, may compromise their normal growth and, therefore, jeopardize their 
survival. 
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7.2. Conclusions 
 
Based on the results obtained, the main conclusions driven from this study are: 
 The detoxification pathway of pollutants is dependent on the route of exposure, 
which can have implications in environmental risk assessment studies; 
 ABC efflux transporters and biotransformation enzymes act in a cooperation 
manner for the detoxification of toxic compounds in fish; 
 ABC transporters, CYP1A and GST are important defence tools for the survival of 
living organisms, and are present since the early life stages of development in fish. 
These main conclusions were based on the following results: 
 Different tissues were involved in the pathway of BaP detoxification in Nile tilapia, 
depending on whether exposure occurred through the water or through the diet. 
Waterborne exposure led to phase I metabolism in liver, gills and intestine, while 
after dietary exposure, intestinal CYP1A metabolism was the major pathway of BaP 
detoxification. EROD activity and biliary BaP metabolites reflected properly the 
contamination levels. Liver and extra-hepatic tissues, as gills and intestine display 
an important role as barriers for the uptake, metabolism and distribution of 
xenobiotic compounds, thus information provided from studies in these tissues can 
be highly valuable in environmental risk assessment studies. 
 CYP1A was shown to display a very important role in the phase I metabolism of 
BaP in liver, gills and intestine and phase II metabolism was an effective step on 
the neutralization of the toxic phase I metabolites into non-toxic forms. 
 ABC efflux transporters, ABCB1b, ABCB11, ABCC1, ABCC2 and ABCG2a showed 
to be present in Nile tilapia tissues involved with xenobiotic absorption, metabolism 
and excretion. This pattern of expression can reflect the proposed role in the 
protection against pollutants by regulating their passage and/or metabolites through 
cellular and tissue barriers. 
 While ABCB1 should not be involved in the efflux on BaP and/or its metabolites, 
ABCC2 and ABCG2a was apparently associated to the efflux of phase II 
metabolites, probably displaying major roles in gills and proximal intestine of fish, 
thus reflecting the cooperation between efflux transporters and biotransformation 
enzymes. 
 Genetic information for some ABC efflux transporters and biotransformation 
enzymes was shown to be maternally transmitted to Nile tilapia embryos, since 
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mRNA for ABCB1b, ABCC1, CYP1A and GSTα were present since the onset of 
development, which points to a substantial role of these proteins in protection 
against pollutants at these critical life stages. Other ABC efflux transporters 
(ABCB11, ABCC2 and ABCG2) were transcribed in later embryonic periods 
preceding highly sensitive stages of development, when the demand for these 
proteins may rise in order to assure the necessary levels of protection against 
toxicants from the surrounding environment. 
 
7.3. Future perspectives 
 
This work focused on the response patterns of ABC efflux transporters and 
biotransformation enzymes to the exposure to PAHs in fish. The pattern of response of 
phase I biotransformation enzyme CYP1A was demonstrated at gene, protein and activity 
level, therefore creating a very concrete scenario of its role as drug metabolizing enzymes. 
However, the function of phase II enzymes still requires further studies, in order to properly 
evaluate which specific isoforms are involved in the detoxification processes. 
The study of ABC transporters has been, in part, limited by the inexistence of 
specific techniques, probes, antibodies that can properly confirm their presence and 
functionality. Thus, in order to get irrefutable proofs of their way of action, these difficulties 
must be overcomed by directing research to the development of more specific and 
appropriate tools for their characterization.  
After evaluating the mRNA response of some of the ABC efflux transporters, namely 
ABCC2 and ABCG2, the hypothesis of them displaying a role in the efflux of phase II 
metabolites in Nile tilapia has been proposed.  Nevertheless, to fully elucidate this 
response, future functional studies are needed to demonstrate their activity as transporters 
of BaP metabolites. Moreover, ABCC2 apparently displays a more important role in gills in 
the efflux of GSH and GA conjugates, while ABCG2 probably preferentially effluxes 
sulphate conjugates in intestine. Future studies should be directed to the evaluation of 
phase II enzymes (GSTs, UGTs and SULT), and ABC transporters in order to properly 
address the proposed affinity of ABCC2 and ABCG2 to the different types of metabolites.  
Similarly, although we have shown the temporal expression pattern of ABC efflux 
transporters and biotransformation enzymes during the developmental stages of Nile 
tilapia, the role of these proteins should be addressed in future studies. The measurement 
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of the uptake of fluorescent dyes substrates for ABC transporters by the larvae in the 
absence/presence of transporter inhibitors, and the evaluation of the associated catalytic 
activities of drug metabolizing enzymes, are useful tools to confirm the functionality of 
these proteins in these critical life stages. These procedures can be valuable tools for the 
identification of chemicals that have the ability to interfere with these detoxification 
systems, therefore compromising the efficacy of these defence mechanisms. The small 
size of embrionary forms allows the testing of several different compounds in a reduced 
size “facility”, reducing the number of adult animals used and the volume of wastes 
produced in this type of studies. 
Despite ABCB1 is the most studied ABC efflux transporter, and previous works 
reported a role in the efflux of PAHs, our findings seem to point to the fact that BaP should 
not be a substrate for Pgp. Nevertheless, results at protein level for Pgp were not 
completely enlightening. In this field, the inexistence specifically-designed probes for ABC 
efflux transporters acts as a limiting factor to clearly demonstrate their cellular localization 
and response patterns at the protein level. Therefore, there is the need to further studies 
directed to unravel their response at protein level by the use of fish-specific antibodies 
directed to ABCB1, ABCCs and ABCG2. 
The possible cooperation between ABC efflux transporters and biotransformation 
enzymes of phase I and phase II in the detoxification pathway of PAHs in fish has been 
addressed in this study, and demonstrated at transcriptional level by the response patterns 
of ecotoxicologically relevant ABC transporters. Future studies directed to the evaluation of 
the transcriptional regulation of ABC efflux transporters and biotransformation enzymes, 
may shed some light on the possible cooperation and coordination between these groups 
of proteins, with paramount roles in cellular detoxification. 
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a b s t r a c t
BaP is one of the most studied PAH, due to its ubiquitous presence in aquatic environments and toxicity
to aquatic organisms. The main goal of this study was to assess BaP effects in Nile Tilapia after water-
borne and dietary exposures, through the evaluation of EROD and GST activities in liver, gills and intes-
tine, and BaP metabolites in bile; and also to evaluate the usefulness of these commonly used biomarkers
after two different routes of exposure. Waterborne exposure to BaP led to a signiﬁcant induction of EROD
in all tissues analyzed (644%, 1640% and 2880% in relation to solvent in liver, gill and intestine respec-
tively) while in dietary exposures EROD was induced only in intestine (3143%) after exposure to high
BaP concentrations. GST activities with CDNB were slightly induced in liver (40%) and in gill (66%) after
water exposure to BaP, and in intestine after dietary exposure to low BaP concentrations (182%). BaP
metabolites in bile increased after both exposure routes, and were highly correlated with EROD activity
after water exposure. In summary, this work has shown that the effects of BaP on biotransformation path-
ways depend on the route of exposure. Moreover, barrier tissues like gills and intestine also have an
important role in the ﬁrst-pass metabolism of BaP, reducing the amount of parent compound that reaches
the liver to be metabolized. For that reason, EROD activity as a biomarker of exposure should also be
applied in extrahepatic organs, like gills and intestine, in monitoring studies. Biliary BaP type metabolites
are good reﬂectors of contamination levels under both exposure routes, while GST activity with CDNB as
substrate, as a phase II enzyme, does not seem a reliable biomarker of exposure to BaP regardless the
route of exposure.
 2011 Elsevier Ltd. All rights reserved.
1. Introduction
Polycyclic aromatic hydrocarbons (PAHs) are prevalent environ-
mental contaminants commonly found in aquatic sediments and
waters associated with urbanized estuarine and coastal areas
(Meador et al., 1995). Although these contaminants can arise from
natural sources, such as oil seeps, volcanoes and forest ﬁres,
anthropogenic sources as vehicle exhaust, power generation and
oil pollution are the main causes for environmental PAH contami-
nation (Latimer and Zheng, 2003). In aquatic organisms, the uptake
of pollutants can occur through the contact of contaminated food,
water and sediments (Bruggeman et al., 1984; Hendricks et al.,
1985), and the degree of toxicity can be inﬂuenced by the route,
by the dose and by the duration of exposure (Grimmer et al.,
1988; Driver et al., 1991; Bloomquist, 1992). One of the most com-
mon and toxic PAH in the aquatic environments is Benzo(a)pyrene
(BaP) and its carcinogenic and mutagenic properties are widely
studied (Buhler and Williams, 1989; Tsukatani et al., 2003). The
great majority of the studies focusing on BaP effects in the detox-
iﬁcation mechanisms in aquatic organisms have used intraperito-
neal injections (Van Der Weiden et al., 1994; Pacheco and Santos,
1998; Nacci et al., 2002; Wang et al., 2006; Wang et al., 2008;
Nahrgang et al., 2009) as the route of exposure. Some studies have
investigated the effects on the detoxiﬁcation mechanisms of BaP
after dietary (Hendricks et al., 1985; Wolkers et al., 1996; Reynolds
et al., 2003), and waterborne exposure routes (Levine and Oris,
1999; Wu et al., 2007; Ortiz-Delgado et al., 2008; Wang et al.,
2008) which are two of the most important routes of pollutants
uptake in aquatic organisms. However, to our knowledge, there is
still a lack of studies that directly compare the biochemical effects
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of different concentrations of the same contaminant after both
exposures routes in the same species.
In ﬁsh, as in other vertebrates, exposure to PAHs results in the
induction of enzymatic systems involved in the metabolism of
the xenobiotic compound, for the detoxiﬁcation of the organism
(Black and Coon, 1987; Buhler and Williams, 1989) due to a
high-afﬁnity of these pollutants to bind the aryl-hydrocarbon
receptor (AhR). Studies in mammals have shown that the activa-
tion of the AhR-dependent signal transduction pathway controls
the expression of several genes, including cytochrome P4501A
(CYP1A) and some glutathione-S-transferase (GST) genes (George,
1994; Hankinson, 1995; Schmidt and Bradﬁeld, 1996). Like in
mammals, in ﬁsh these genes are believed to be primarily involved
in hepatic biotransformation of pollutants, like PAHs (reviewed in
van der Oost et al., 2003). The measurement of phase I and phase II
biotransformation enzymes hepatic activities, have been widely
applied as biomarkers of biochemical effects, and as a complement
to chemical analysis (Richardson et al., 2001; Ferreira et al., 2006,
2008; Jönsson et al., 2009; Nahrgang et al., 2009; Reis-Henriques
et al., 2009). However, despite the fact that the liver is considered
to be the main site of CYP1A expression, its expression and induc-
tion has been observed in other tissues as well, including those in
direct contact to the environment, such as gills (Jönsson et al.,
2004, 2006; Nahrgang et al., 2010a,b) and intestine (McElroy and
Kleinow, 1992; James et al., 1997). Nevertheless, the relative
importance of branchial and intestinal uptake route to the overall
exposure remains poorly understood. After PAH metabolism in the
liver, their metabolites are secreted into the bile, stored in the gall
bladder and excreted to the intestinal tract (Au et al., 1999). There-
fore, due to their high metabolism rate in ﬁsh (Meador et al., 1995),
PAHs tend not to bioaccumulate in tissues, and the direct quantiﬁ-
cation of these compounds in ﬁsh tissues may not yield an accurate
estimation of contaminant exposure and uptake. As a result, the
measurement of PAHs metabolites in ﬁsh bile is considered a reli-
able method for assessing the degree of exposure of the organisms
to these type of pollutants (Krahn et al., 1986). In this study, Nile
tilapia (Oreochromis niloticus) was used as model species. Besides
being an economically important cultured species, namely in Asia
and Africa, Nile tilapia is also a well established model in many
toxicological studies (Almeida et al., 2001; Straus, 2003; Coimbra
et al., 2005, 2007; Figueiredo-Fernandes et al., 2006).
The main objectives of the present work were to evaluate differ-
ences in the detoxiﬁcation mechanisms in juvenile Nile tilapia,
after waterborne and dietary exposure routes to BaP. Biochemical
effects of BaP were assessed, by means of 7-ethoxyresoruﬁn O-
deethylase (EROD) and glutathione-S-transferase (GST) activities
as a measure of phases I and II of the biotransformation mecha-
nism, in liver, gills and intestine. Additionally, ﬁxed wavelength
ﬂuorescence (FF) was used to quantify BaP type metabolites as
ﬂuorescent aromatic compounds (FACs) in bile.
2. Materials and methods
2.1. Chemicals
Benzo(a)pyrene (99% purity), resoruﬁn sodium salt, 7-ethoxy-
resoruﬁn, ß-NADPH (95% purity), BSA (99% purity), 1-chloro-2,4-
dinitrobenzene (CDNB, 97% purity), a-Dithiothreitol (99% purity),
GSH (99% purity) were purchased from Sigma Aldrich, Germany.
All the other chemicals were of analytical grade, and were pur-
chased from local companies.
2.2. Animals
All animals used in this study were born and raised in the lab-
oratory (CIIMAR, Porto, Portugal). The corresponding breeders
stock was obtained from the Aquaculture Station of UTAD (Univer-
sidade de Trás-os-Montes, Portugal). Fish used in all assays were
juveniles, and therefore not sexually mature, as conﬁrmed by mac-
roscopic analysis of the gonads when animals were sacriﬁced. Until
the start of the exposure assays, ﬁsh were kept in 60 L aquaria sup-
plied with biological ﬁltration. Prior to the experiments, animals
were randomly distributed in the experimental aquaria (30 L),
and submitted to an acclimatation period of one week. All tanks
were supplied with continuous aeration to maintain dissolved oxy-
gen near saturation. Dechlorinated tap water was used at a tem-
perature of 20 ± 2 C, with a 12 h:12 h (light:dark) photoperiod,
and ﬁsh were fed commercial food pellets (Aquasoja, Portugal) un-
til satiation, once a day.
2.3. Stock solutions of BaP and preparation of contaminated food
For the waterborne exposures, stock solutions of BaP were pre-
pared in acetone (0.5, 1.25, 2.5 and 5 g L1) and were administered
directly in the experimental aquaria. The percentage of solvent
added in the experimental aquariums was 0.002%. For the dietary
exposures stock solutions of BaP with concentrations of 0.1 and
40 g L1 were prepared, respectively for the ﬁrst and second assays.
The contaminated diets were prepared by immersion of food pel-
lets in BaP stock solutions diluted in acetone, in a proportion of
0.32 mL g1 of food. For control groups, nothing was added to the
food pellets, and for solvent control groups only acetone was added
to the food pellets. Acetone was evaporated under air current for
24 h, until the pellets were completely dry, and diets were stored
at 20 C until further use.
2.4. Xenobiotic exposures
For the water exposure, juvenile Nile tilapia (N = 116, average
weight of 14.2 ± 0.6 g, average length of 9.30 ± 0.14 cm) were ex-
posed to nominal water concentrations of 10, 25, 50 or 100 lg of
BaP/L for 14 d. Also, a control group and a solvent control group
(only solvent was added) were maintained. All treatments were
performed in duplicate, with two exposure tanks per concentra-
tion. Waterborne exposures were conducted in semi-static condi-
tions in 30 L aquaria. Daily, 80% of the water was renewed,
followed by the addition of fresh BaP solution or solvent to each
one of the treatment groups. Animals were fed to satiation every
2 d, with the exception of the day before sampling. Sampling was
performed prior to the ﬁrst BaP addition, and 7 and 14 d after
the contaminant addition.
For dietary exposures two experiments were conducted, and
ﬁsh were maintained in 30 L aquaria in continuous water ﬂow con-
ditions, which assured 100% of water renewal per day. In the ﬁrst
assay, juvenile tilapia (N = 72, average weight of 11.21 ± 1.00 g,
average length of 8.47 ± 0.27 cm) were exposed to 1 and 10 lg of
BaP g1 of food for 14 d. In the second dietary assay, ﬁsh
(N = 129; average weight: 11.15 ± 0.42 g, average length of
8.49 ± 0.09 cm) were exposed to 100 and 200 lg of BaP g1 of food
for 21 d. Fish were sampled before the addition of BaP contami-
nated diets, and at days 7, 14 and 21 (only in the second experi-
ment). In both assays a control (uncontaminated food) and a
solvent control group (acetone alone) were maintained, and dupli-
cates were made for each treatment, with two exposure tanks per
concentration. Fish were fed daily at a rate of 3% of body weight.
After feeding, animals were observed, to assure that the total of
the food was consumed in 2 to 3 min. After every sampling point,
animals were weighted in order to recalculate the amount of food
necessary for each tank, to maintain the percentage of feeding at
3% body weight.
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2.5. Sampling
Fish were anesthetized on ice cold water and sacriﬁced by
decapitation, and body weight and length were recorded for subse-
quent calculation of condition factor (CF = body weight (g)  100/
body length3 (cm)). Liver, gills and intestine were excised from
the animal, and bile was collected from the gall bladder with a
1 mL syringe. Liver weight was recorded for the calculation of he-
patic somatic index (HSI = liver weight (g)/body weight (g) 100).
Liver, gills, intestine, and bile were immediately frozen in liquid
nitrogen, and stored at 80 C until further use. CF and HSI prior
to the beginning of the water assay were 1.66 ± 0.04 and
1.33 ± 0.11, respectively. Before the dietary exposures, CF and HSI
were 1.62 ± 0.07 and 1.21 ± 0.07 for the ﬁrst assay, and
1.68 ± 0.03 and 1.95 ± 0.05 for the second assay, respectively. No
signiﬁcant differences were seen in these parameters during the
course of the experiments, indicating that the overall condition
of the animals was maintained during the experimental periods
(Ricker, 1975; Grant and Brown, 1999).
2.6. BaP determination in water and food samples
To determine the real concentration of BaP in the water of the
experimental aquaria, BaP was extracted from water samples
according to the method described by Cheikyula et al. (2008),
and assessed by the method of Rey-Salgueiro et al. (2008). After
the addition of the contaminant, the real concentrations of BaP in
water samples were 10.49, 22.51, 41.46 and 84.77 lg L1, respec-
tively for the nominal concentrations of 10, 25, 50 and 100 lg L1.
After 24 h, and before the addition of fresh contaminant to the
aquaria, the amount of BaP still present in each one of the treat-
ment groups was 0.34, 0.69, 12.19 and 25.70 lg L1. In water col-
lected from control and solvent control groups no BaP was
detected at both times.
Food pellets supplied to the ﬁsh in dietary exposures were also
analyzed in terms of BaP concentration, according to the method
described by Rey-Salgueiro et al. (2009). The real BaP concentra-
tions in the food pellets were 0.06, 0.07, 0.42, 3.99, 36.24 and
92.70 lg g1, respectively for control, solvent, 1, 10, 100 and
200 lg g1.
2.7. Biochemical analysis
EROD activity was measured according to Ferreira et al. (2008)
in the microsomal fraction of liver, gills and the ﬁrst one-third of
the intestine. Brieﬂy, tissues were homogenized in ice cold buffer
(50 mM Tris–HCl, 0.15 M KCl, pH 7.4), and microsomes were ob-
tained by centrifugation of the 9000g supernatant at 36 000g for
90 min at 4 C. The pellet was then ressuspended in buffer
(50 mM Tris–HCl, 1 mM Na2EDTA, 1 mM dithiothreitol, 20% v/v
glycerol pH 7.4) and spun down at 36 000g for 120 min (Bucheli
and Fent, 1995). Microsomes were suspended in EDTA-free resus-
pension buffer and stored at 80 C until use. Microsomal suspen-
sion (20 lL), with average protein concentration of
3.01 ± 0.20 mg mL1, was incubated with ethoxyresoruﬁn (2 lM
in 50 mM Tris–HCl, 1 mM dithiothreitol, 0.15 M KCl, pH 8.0) for
1 min, and the enzymatic reaction was initiated by the addition
of NADPH 4.5 lM. EROD activity was measured for 5 min at
kex530 nm and kem585 nm, by ﬂuorometry, and determined by
comparison to a resoruﬁn standard curve (concentrations range
from 3 to 100 nM). Hepatic EROD activity was expressed in
pmol min1 mg1 protein. During the procedure of microsomes
isolation, an aliquot of the cytosolic fraction (obtained after the
9000g centrifugation) was separated for the analysis of GST activ-
ity. GST was determined according to the method of Habig et al.
(1974), adapted to microplates as described in Ferreira et al.
(2008), using glutathione (GSH) 10 mM in phosphate buffer
0.1 M, pH 6.5, CDNB 60 mM in ethanol prepared just before the as-
say. The reaction mixture was composed by 1.5 mM GSH and
1.5 mM CDNB in phosphate buffer. In the microplate, 0.2 mL of
the reaction mixture was added to 0.1 mL of sample, corresponding
to 0.3 mg of protein, with a ﬁnal concentration of 1 mM GSH and
1 mM CDNB in the assay. The GST activity was measured immedi-
ately every 20 s, at 340 nm, during the ﬁrst 5 min, and calculated in
the period of linear change of the absorbance. GST activity was ex-
pressed in nmol min1 mg1 protein. In each treatment group,
EROD and GST activities were analysed in 4–10 individuals,
depending on the tissue. Protein content in all assays was deter-
mined by Lowry method (Lowry et al., 1951), in the correspondent
fraction.
2.8. BaP metabolites in ﬁsh bile
BaP metabolites in the bile were determined through ﬁxed
wavelength ﬂuorescence (FF). Bile samples from control and sol-
vent control of water exposed animals, and from food exposed
groups were diluted 1:1000 in ethanol 48%. Bile from water ex-
posed animals was further diluted to 1:10000 (10 and 25 lg L1)
and 1:100000 (50 and 100 lg L1). FF was performed at the excita-
tion/emission wavelength pair 380/430 nm, since BaP metabolites
are more efﬁciently detected at these wavelengths (Krahn et al.,
1993; Lin et al., 1996). Measurements were performed on a BIOTEK
SFM25 ﬂuorimeter. The FF values were expressed as arbitrary ﬂuo-
rescence units (a.f.u.) after subtracting the signal levels of the sol-
vent. The bile pigment biliverdin was measured at 380 nm in all
samples to estimate bile density, and BaP metabolites ﬂuorescence
was normalised to biliverdin, to check if differences in ﬂuorescence
intensity could result from differences in bile densities. BaP metab-
olites were analysed in bile of 4–10 individuals of each treatment
group.
2.9. Statistical analysis
Exposure time and treatment effects were evaluated by means
of a one-way ANOVA for each one of the mentioned factors, fol-
lowed by a multiple comparison test (Tukey’s test) at a 5% signiﬁ-
cance level. Some data had to be log transformed in order to ﬁt
ANOVA assumptions. Correlations and all the tests were performed
using the software Statistica 7 (Statsoft, Inc., 2004). No differences
were observed between replicates of the same treatment, nor in
control treatments between days, nor between control and solvent
control during the exposure time. Therefore, in all biomarkers ana-
lysed, results were presented as percentage in relation to solvent
control only. Results were shown as mean ± standard error.
2.10. Ethics statement
The animals used in the research that is described in this paper
were treated in accordance with the Portuguese Animals and Wel-
fare Law (Decreto-Lei n 197/96) approved by the Portuguese Par-
liament in 1996.
3. Results
Mean control values of EROD activity in all assays were
38.09 ± 3.85, 2.09 ± 0.23 and 1.10 ± 0.10 pmol min1 mg1 of pro-
tein, respectively for liver, gill and intestine. GST had mean activi-
ties in control groups of 120.79 ± 4.46, 63.96 ± 3.51 and
49.16 ± 3.73 nmol min1 mg1 of protein, in liver, gill and intes-
tine, respectively. BaP metabolites in bile were 4584 ± 410 a.f.u.
in control animals.
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3.1. Water exposure
Biomarkers evaluated after waterborne exposure to BaP are
shown in Fig. 1 (EROD activity), 2 (GST activity) and 3a (BaP metab-
olites in bile).
Results show that water exposure caused BaP dose-related in-
creases of EROD activity in liver (Fig. 1a), gills (Fig. 1b) and intes-
tine (Fig. 1c). Moreover, EROD activity was, in most of the
treatments, signiﬁcantly different from solvent control (p < 0.05)
in all three tissues. Exceptions were exposure to 10 and 25 lg L1
at day 14 in liver, and in intestine exposure to 10 lg L1 (at days 7
and 14) and 25 lg L1 (at day 7). Regarding the effects of time of
exposure, a signiﬁcant increase between days 7 and 14 was seen
in gills and intestine after exposure to 25 lg L1 of BaP. When com-
paring the extent of EROD activity increase over the solvent con-
trol, maximum increases were seen in intestine (from 105% to
2876% increase, Fig. 1c), followed by gills (from 544% to 1639% in-
crease, Fig. 1b) and liver (from 70% to 644% increase, Fig. 1a).
Regarding phase II enzyme, GST, its activity, increased signiﬁ-
cantly (p < 0.05) in liver (after 14 d of exposure – Fig. 2a) and gills
(after 7 d of exposure – Fig. 2b) upon exposure to 100 lg L1 of BaP
(39 and 66% increases respectively). At day 7 no differences were
seen in GST intestine activity, but after 14 of exposure its activity
decreased signiﬁcantly (p < 0.05) after exposure to 50 and
100 lg L1, achieving a maximum decrease over solvent control
of 64% after exposure to 100 lg L1 of BaP (Fig. 2c).
BaP metabolites in bile of exposed animals (10, 25, 50 and
100 lg L1) were always signiﬁcantly higher than the levels re-
corded in solvent, and increased with the concentration of the con-
taminant and with the time of exposure, with the exception of
Fig. 1. EROD activities in liver (a), gill (b) and intestine (c) of Nile Tilapia after
waterborne exposure to BaP (Solvent, 10, 25, 50 and 100 lg L1). Values are
expressed in percent of activity (pmol min1 mg1 of protein) in relation to solvent
set to 100%, and are shown as mean ± standard error. Asterisks (⁄) denote
signiﬁcant differences (p < 0.05) in comparison to solvent. Capital letters denote
signiﬁcant differences (p < 0.05) between days within the same treatment. n = 4–10.
Fig. 2. GST activities in liver (a), gill (b) and intestine (c) of Nile Tilapia after
waterborne exposure to BaP (Solvent, 10, 25, 50 and 100 lg L1). Values are
expressed in percent of activity (nmolmin1 mg1 of protein) in relation to solvent
set to 100%, and are shown as mean ± standard error. Asterisks (⁄) denote
signiﬁcant differences (p < 0.05) in comparison to solvent. Capital letters denote
signiﬁcant differences (p < 0.05) between days within the same treatment. n = 4–10.
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100 lg L1 at day 14 (Fig. 3a). Results showed that after 7 d of
exposure to 10 lg L1, BaP type metabolites were 83 times higher
when comparing to the solvent (8256% increase), and the maxi-
mum levels were seen after 14 d of exposure to 50 lg L1, with a
356 fold increase (35 590%). Moreover, BaP metabolites showed
signiﬁcant positive correlations (p < 0.05) with EROD activity in li-
ver (r = 0.92), gills (r = 0.89) and intestine (r = 0.65).
3.2. Diet exposure
Results of EROD and GST activities in Nile tilapia after dietary
exposure to 1 and 10 lg of BaP g1 of food are shown in Figs. 4
and 5, respectively.
EROD activity in exposed animals was not different from sol-
vent control during the exposure periods in any of the tissues ana-
lyzed (Fig. 4). A signiﬁcant decrease in EROD activity was seen from
day 7 to day 14 at 1 lg g1 of BaP in liver (Fig. 4a) and in gills
(Fig. 4b). Phase II enzyme activity, GST, did not change in liver
(Fig. 5a) nor in gill (Fig. 5b), and was only induced in the intestine,
and after 7 d of exposure to 10 lg g1; however this induction was
not sustained until day 14 (Fig. 5c). Regarding BaP metabolites in
bile (Fig. 3b), BaP exposed groups showed higher levels when com-
paring to the solvent group, with signiﬁcant differences at
10 lg g1 of BaP at days 7 (149% increase) and 14 (158% increase)
(p < 0.05).
EROD and GST activities in liver, gills and intestine measured
after exposure to 100 and 200 lg of BaP g1 of food are displayed
in Figs. 6 and 7, respectively.
In liver (Fig. 6a), results point to a pattern of EROD activity
reduction after dietary exposure to 100 and 200 lg of BaP g1 of
food. This reduction was statistically supported at day 7 after
Fig. 3. BaP type metabolites in bile after waterborne exposure to BaP (a), ﬁrst
dietary exposure to BaP (b) and second dietary exposure to BaP (c). Values are
expressed percent of arbitrary units of ﬂuorescence (a.f.u.) in relation to solvent set
to 100%, and are shown as mean ± standard error. Asterisks (⁄) denote signiﬁcant
differences (p < 0.05) in comparison to solvent. Capital letters denote signiﬁcant
differences (p < 0.05) between days within the same treatment. n = 4–10.
Fig. 4. EROD activities in liver (a), gill (b) and intestine (c) of Nile tilapia after the
ﬁrst dietary exposure to BaP (Solvent, 1 and 10 lg of BaP g1 of food). Values are
expressed in percent of activity (pmol min1 mg1 of protein) in relation to solvent
set to 100%, and are shown as mean ± standard error. Asterisks (⁄) denote
signiﬁcant differences (p < 0.05) in comparison to solvent. Capital letters denote
signiﬁcant differences (p < 0.05) between days within the same treatment. n = 4–8.
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exposure to 200 lg of BaP g1 (of food 45% decrease), and at days
14 and 21 to both BaP concentrations (p < 0.05), with a maximum
decrease of 68% after 14 d of exposure to 200 lg g1. Moreover,
lower levels of EROD activity were detected in 200 lg g1 than
in 100 lg g1 at days 7 and 14, and at day 21 similar levels of
EROD were recorded in both concentrations. Gill EROD activity
did not change during the exposure to dietary BaP (Fig. 6b). How-
ever, a signiﬁcant increase of intestinal EROD activity was seen in
exposed animals during the course of the experiment, with a max-
imum increase occurring after 21 d of exposure to 100 lg g1
(3142% increase over solvent control). Furthermore, there was a
signiﬁcant increase in intestinal EROD activity from day 14 to
day 21 at this BaP concentration (Fig. 6c).
High dietary exposures caused no signiﬁcant changes in GST
activity in any of the tissues analysed, as it can be seen in Fig. 7.
BaP type metabolites (Fig. 3c) were always signiﬁcantly higher in
exposed animals (100 and 200 lg g1), with increases in relation
to solvent ranging from 471% (200 lg g1, day 7) to 980%
(200 lg g1, day 14).
4. Discussion
In recent years, there has been an increasing concern over the
possible degradation of aquatic environments due to chemical pol-
lution caused by PAHs, among other pollutants. The main reasons
for that concern lie in the fact that these are widely spread contam-
inants with a high toxic potential for living organisms (Icarus Allen
Fig. 5. GST activities in liver (a), gill (b) and intestine (c) of Nile tilapia after the ﬁrst
dietary exposure to BaP (Solvent, 1 and 10 lg of BaP g1 of food). Values are
expressed in percent of activity (nmolmin1 mg1 of protein) in relation to solvent
set to 100%, and are shown as mean ± standard error. Asterisks (⁄) denote
signiﬁcant differences (p < 0.05) in comparison to solvent. Capital letters denote
signiﬁcant differences (p < 0.05) between days within the same treatment. n = 4–8.
Fig. 6. EROD activities in liver (a), gill (b) and intestine (c) of Nile tilapia after the
second dietary exposure to BaP (Solvent, 100 and 200 lg of BaP g1 of food). Values
are expressed in percent of activity (pmol min1 mg1 of protein) in relation to
solvent set to 100%, and are shown as mean ± standard error. Asterisks (⁄) denote
signiﬁcant differences (p < 0.05) in comparison to solvent. Capital letters denote
signiﬁcant differences (p < 0.05) between days within the same treatment. n = 4–10.
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and Moore, 2004). As a result, increased efforts have been made in
order to understand the causal relationships between contaminant
exposure and measurable biological and biochemical effects in
aquatic organisms, with the integrated use of biomarkers of expo-
sure. In the present study we aimed to achieve a deeper under-
standing of the effects of BaP in Nile tilapia, after two routes of
exposure, waterborne and dietary exposures, and also to assess
the usefulness of widely used biomarkers in monitoring studies.
After water exposure to BaP, EROD activity in liver (Fig. 1a), gills
(Fig. 1b) and intestine (Fig. 1c) increased during the exposure per-
iod. These results show that waterborne exposure led to BaP
metabolism in liver and also in extrahepatic tissues, as gills and
intestine. Liver is considered to be the main metabolizing organ
in ﬁsh, having larger amounts of CYP1A enzymes than other tissues
(as gills and intestine) (Hinton et al., 2008), and induction of hepa-
tic EROD activity upon exposure to PAHs has been described in
other studies (Whyte et al., 2000; van der Oost et al., 2003; Or-
tiz-Delgado et al., 2008; Kopecka-Pilarczyk and Correia, 2009). This
is in agreement with our study since hepatic EROD was strongly in-
duced after exposure to waterborne BaP, and the levels of EROD
activity were considerably higher in liver than in gill or intestine.
The strong gill EROD induction observed after waterborne expo-
sure to BaP, also indicates that a rapid absorption of this compound
occurs in this tissue, and supports the idea that gills work in the
ﬁrst-pass metabolism of BaP. Similar results, with gill EROD induc-
tion following BaP exposure, were obtained in other ﬁsh species as
polar cod (Nahrgang et al., 2010a) and rainbow trout (Jönsson
et al., 2006). EROD induction observed in the intestine of BaP ex-
posed animals was due to ingested contaminated water, that was
metabolized by intestine CYP1A enzymes, before reaching the li-
ver. Although Nile tilapia is a freshwater specie, and therefore a
specie who does not drink water in large quantities, there is always
some ingestion of water during feeding and breathing behaviours.
Furthermore, our results are in agreement with immunohisto-
chemical studies that compared the cellular expression of CYP1A
in different tissues, and that showed that exposure to waterborne
BaP resulted in high staining in gill pillar cells and hepatocytes and
mildly staining in gut mucosal epithelium (Van Veld et al., 1997).
Some authors have shown that gill EROD activity turned out to
be more sensitive than the liver in terms of CYP1A induction to
waterborne BaP (Jönsson et al., 2006). The same happened in our
study, with gill and intestine showing to be more sensitive than li-
ver to the presence of BaP, which strengthens the idea that it be-
comes useful to measure EROD activity in extrahepatic tissues,
that are involved in the ﬁrst-pass metabolism of this compound
(Levine and Oris, 1999).
After dietary exposures to BaP, the most signiﬁcant result was
the induction of EROD activity in the intestine, after exposure to
the highest BaP concentrations (Fig. 6c). This type of response, with
induction of intestinal but not hepatic EROD activity, have also
been shown in other studies in liver (Van Veld et al., 1987; Rey-
nolds et al., 2003) and intestine (Van Veld et al., 1987; McElroy
and Kleinow, 1992; James et al., 1997) of ﬁsh exposed to dietary
PAHs. Also, immunohistochemical studies showed that exposure
to dietary BaP resulted in moderate CYP1A staining in liver but
high intensity staining in gut mucosal epithelium (Van Veld
et al., 1997; Ortiz-Delgado et al., 2005). We believe that, in our
study, the absence of hepatic EROD induction following dietary
exposures maybe directly related to partial BaP biotransformation
in the intestine (by CYP1A enzymes), limiting the amount of parent
compound that reaches the liver for hepatic metabolism, as con-
ﬁrmed by the induced intestinal EROD activity of these animals.
However, in the second dietary assay, a reduction of hepatic EROD
activity was seen after exposure to high BaP concentrations
(Fig. 6a), being statiscally signiﬁcant at both concentrations at
day 21. This situation could have been a result of protein degrada-
tion caused by the high concentrations of BaP used (reviewed in
Whyte et al., 2000), or due to suppression of CYP1A at a post-tran-
scriptional level mediated through a down regulation of the CYP1A
protein (Schlezinger and Stegeman, 2001). On the other hand, it is
well known that BaP biotransformation can originate more toxic
metabolites (Bauer et al., 1995; Kim et al., 1998; Morthy et al.,
2003), and it is possible that part of this metabolites (formed
mostly after intestinal CYP1A metabolism) could have entered sys-
temic circulation (Kleinow et al., 1998), causing toxic effects at he-
patic level that may have reﬂected in the lower EROD activities of
this tissue. However, although the decrease of hepatic EROD activ-
ity was statistically signiﬁcant, it was relatively weak, leading us to
also consider the hypothesis of not being physiologically relevant.
BaP type metabolites measured in bile, increased after water
exposure to BaP (Fig. 3a), and were highly correlated with liver
(r = 0.92; p < 0.05), gill (r = 0.89; p < 0.05) and intestine (r = 0.65;
Fig. 7. GST activities in liver (a), gill (b) and intestine (c) of Nile tilapia after the
second dietary exposure to BaP (Solvent, 100 and 200 lg of BaP g1 of food). Values
are expressed in percent of activity (nmolmin1 mg1 of protein) in relation to
solvent set to 100%, and are shown as mean ± standard error. Asterisks (⁄) denote
signiﬁcant differences (p < 0.05) in comparison to solvent. Capital letters denote
signiﬁcant differences (p < 0.05) between days within the same treatment. n = 4–9.
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p < 0.05) EROD activities. The liver correlation corroborates the fact
that exposure of ﬁsh to waterborne BaP, leads to a pathway of high
hepatic metabolism by CYP1A enzymes. Moreover, correlations be-
tween EROD and bile metabolites in extrahepatic tissues also sug-
gest that the majority of BaP metabolites formed in gill and
intestine are reabsorbed into the blood stream and then released
in the gall bladder. Regarding BaP type metabolites in the dietary
experiments, an increase was also seen in BaP exposed animals
(Fig. 3b and c), that was correlated with intestinal EROD activity
(r = 0.62, p > 0.05), but not with hepatic EROD activity. Taken to-
gether these results indicate that, probably, dietary BaP metabo-
lites formed in the intestine were reabsorbed into the blood for
enterohepatic circulation and then excreted in the bile, as shown
by Kleinow et al., 1998. Although we cannot compare the real
amount of BaP that is metabolized under each one of the routes
of exposure, it seems also important to highlight the fact that, lev-
els of BaP metabolites were much more elevated after water expo-
sure (achieving a fold increase of 356 times over solvent) than after
dietary exposures (achieving a fold increase of 10 times over the
solvent), despite the very high levels of BaP used after both expo-
sures routes. These results suggest that, in ﬁeld studies, the levels
of biliary metabolites may give an indication of the main route of
exposure to the contaminant.
Results obtained for phase II enzyme GST were not very clear,
since in the case of changes in activity after BaP exposure, only
slight variations were seen. The data available in the literature
regarding GST use as a biomarker of exposure to pollutants is not
very consistent, since some authors reported increases in this en-
zyme activity, while others did not observe any changes or even re-
ported considerable reductions in its activity after exposure to PAH
contaminants (reviewed in van der Oost et al., 2003). Induction of
GST activity was reported after waterborne exposure to BaP of P.
microps (Vieira et al., 2008) and S. marmoratus (Wu et al., 2007).
When it comes to dietary exposures to contaminants, some
authors reported inductions of intestinal GST activities, but no
induction of hepatic GST (Van Veld et al., 1991; James et al.,
1997), suggesting a complementary role with phase I EROD in bio-
transformation of contaminants. Our ﬁndings corroborate the idea
that phase II enzyme GST with CDNB as substrate has low sensibil-
ity to the presence of BaP, and should not be applied per se, as a
biomarker of exposure to this pollutant. However, on the basis of
substrate speciﬁcity, immunological cross reactivity and protein
sequence data, mammalian citosolic GSTs have been grouped into
seven classes: Alpha, Mu, Pi, Theta, Sigma, Omega and Zeta (Hayes
et al., 2005) and previous publications have considered that the
GST isoforms have distinct afﬁnities towards the substrate CDNB
(Martinez-Lara et al., 1996; Hoarau et al., 2002). Moreover, some
studies have shown that, in ﬁsh, different responses are seen in
GST isoforms after exposure to xenobiotics (Martinez-Lara et al.,
1996; Pérez-Lopez et al., 2002; Kim et al., 2010), with some show-
ing inducing patterns, while others do not. Therefore it is possible
that, if some isoforms were upregulated and others downregulated
due to BaP exposure, the net result could be no change on total GST
activity, which can possibly mean that the lack of changes in GST
activity after BaP exposure does not necessarily indicate that this
compound had no effect on GST activity.
In conclusion, this study has shown that the disposition and ef-
fects of BaP in biotransformation pathways in Nile tilapia depend
on the route of exposure to the contaminant. Waterborne exposure
to BaP resulted in an induction of phase I enzyme EROD in liver, gill
and intestine, while in dietary exposure route induction of EROD
was only seen in intestine, and after exposure to the highest con-
centrations of the pollutant. Therefore, EROD activity is a reliable
biomarker of exposure to BaP in Nile tilapia and, besides liver, bar-
rier tissues, like gills and intestine, should also be considered in
biomonitoring studies. BaP metabolites are good reﬂectors of expo-
sure to BaP, despite the route of exposure, and the levels of metab-
olites can also be indicative of the route of exposure, since water
exposure leads to much higher levels of the metabolites than die-
tary exposure. The activity of phase II enzyme GST with CDNB does
not seem as a reliable biomarker of exposure to BaP regardless the
route of exposure.
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3-Hydroxy-benzo[a]pyrene (3-OH-BaP), a toxic compound with the ability to
covalently bind with the macromolecules (proteins and DNA), is one of the major
phenolic metabolites of benzo[a]pyrene (BaP). The purpose of this study was to
evaluate the presence of 3-OH-BaP in the bile and plasma of Nile tilapia by
HPLC with fluorescence detection, after waterborne exposure to BaP (10 and
100mgL1). Metabolites were detected in bile and plasma, and conjugates of 3-
OH-BaP (glucuronide and/or sulphate conjugates) were the majority forms in
both biological fluids, glucuronide 3-OH-BaP being the main metabolite in bile.
Our data suggest that extrahepatic tissues as intestine or gill are important in BaP
metabolism and need to be the considered sources of metabolites released into the
blood. Although, low levels of 3-OH-BaP in toxic form (free form) were detected
in plasma, one cannot exclude the possibility of circulating the levels leading to
adverse effects.
Keywords: PAHs; metabolites; plasma; fish; bile; HPLC-fluorescence
Introduction
Polycyclic aromatic hydrocarbons (PAH) are ubiquitous contaminants present in the
marine environment as a result of natural sources, such as incomplete combustion of
organic material, but mainly arising from human activities, as uncontrolled spills, river
transport, surface runoff, and atmospheric deposition (Latimer and Zheng 2003).
Benzo[a]pyrene (BaP), one of the 16 PAH selected by the US Environmental Protection
Agency (EPA) as priority pollutants, is probably the most thoroughly studied and the
most common representative of this class of contaminants due to its carcinogenic and
mutagenic properties (ATSDR 1995; IPCS 1998).
Fish absorb BaP through the body surface, gills, and by the ingestion of contaminated
sediment or food being distributed to tissues by blood flow (Di Giulio and Hinton 2008;
Fragoso, Hodson, and Zambon 2006; Varanasi, Stein, and Nishimoto 1989).
Upon exposure, fish have a well-developed system that rapidly metabolizes BaP in two
phases (Varanasi, Stein, and Nishimoto 1989), in a complex mixture of quinones,
phenols, dihydrodiols, triols, and tretols (Kennedy and Tierney 2008; Willett et al. 2000;
*Corresponding author. Email: lrey@ciimar.up.pt
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Zhu et al. 2008). In phase I, BaP is metabolized into hydroxylated derivatives (OH-BaP)
by the multienzymatic system cytochrome P450 (CYP450), CYP 1A1 isozyme being the
predominant, although 1A2, 2A1, and 1B1 can also be active to a minor extent (Kim et al.
1998). In phase II, the OH-BaP metabolites are conjugated with polar endogenous
constituents such as glucuronic acid, sulphate, or glutathione by UDP-glucuronyl
transferase, sulfotransferase, and glutathione-S-transferase, respectively, to produce
water-soluble conjugates that are easily excreted by fish (Ferreira et al. 2010; Tuvikene
1995). BaP metabolites produced in the liver are secreted into the bile, concentrated and
stored in the gallbladder before excretion into the intestine (Ferreira, Moradas-Ferreira,
and Reis-Henriques 2006; Wang et al. 2008; Zhu et al. 2008). Although the liver is a major
site of biotransformation of BaP, metabolism can also occur in extrahepatic tissues such as
intestine, gills, and kidney (Costa et al. 2011; James et al. 1996; Kleinow et al. 1998;
Lemaire et al. 1990). Reactive metabolites produced in these tissues can not only be
transferred to the blood for elimination but can also be re-distributed to other organs,
interfering with their functions and, as a consequence, producing toxicity.
BaP itself is a relatively inert molecule, but their electrophilic metabolites are toxic,
mutagenic, with the ability to covalently bind with the macromolecules, such as proteins
and DNA (Cachot et al. 2004; Fertuck, Matthews, and Zacharewski 2001; James et al.
1991). One of the major phenolic metabolites of BaP formed in many species, including
fish, is the 3-hydroxy-benzo[a]pyrene (3-OH-BaP) which is produced in the liver (Wang
et al. 2008; Zhu et al. 2008) and intestine (James et al. 2001). Due to the toxic features of 3-
OH-BaP, it was of interest to further study the toxicity including the distribution to fish
tissues. Although the blood plays an important role in the distribution of chemicals to
organs, there is a lack of studies that measure BaP and metabolites in this tissue. Recently,
BaP metabolism in extrahepatic tissues was confirmed in Nile tilapia (Costa et al. 2011), as
evidenced from the presence of metabolites in blood.
Nile tilapia has been used in several toxicological studies and is considered a reliable
model species to assess the influence of pollutants on biological systems (Coimbra,
Figueiredo-Fernandes, and Reis-Henriques 2007; Pereira Trı´dico et al. 2010). The main
aim of this study was to determine the presence of BaP and the metabolite, 3-OH-BaP, free
and conjugated, in the plasma and bile of Nile tilapia (Oreochromis niloticus) after
waterborne exposure to BaP. Possible correlations with biotransformation enzymes in the
liver, intestine, and gill, were also assessed.
Material and methods
Chemicals and materials
Benzo[a]pyrene (99% purity), 3-hydroxy-benzo[a]pyrene, tert-butyl hydroquinone (97%
purity), 4-methylumbelliferone, -glucuronidase from bovine liver and uridine 50-dipho-
sphoglucuronic acid triammonium salt were purchased from Sigma Aldrich (Spain). -
Glucuronidase/aryl sulfatase from Helix pomatia was supplied by Merck (Germany) and
Sep-Pak Plus C18 cartridges were obtained from Waters (USA). All other chemicals were
of analytical grade and were purchased from local companies.
Animals and exposure experiment
Nile tilapias used in this study were born and raised at CIIMAR, Porto, Portugal. Prior to
the experiments, animals (N¼ 112, average weight 70.3 23 g) were randomly distributed
Toxicological & Environmental Chemistry 2041
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(n¼ 10) in the experimental aquaria (52L) and subjected to an acclimation period of 1
week before the addition of the contaminant. All tanks were supplied with biological
filtration, and continuous aeration to maintain dissolved oxygen near saturation.
Dechlorinated tap water was used at a temperature of 21 1C with a 12 h (light:dark)
photoperiod.
After the acclimatization period, fish were exposed to nominal water concentrations of
10 and 100 mg of BaPL1 for 14 days. BaP stock solutions (1.04 and 5.20 gL1,
respectively) were prepared in acetone and were administered directly into the aquaria.
The solvent concentration never exceeded 0.002%. A solvent control group (acetone
alone) was also used. Experiment was conducted under semi-static conditions and daily
80% of the water was renewed, followed by the addition of fresh BaP solution or solvent
to each one of the treatment groups. Animals were fasted for 48 h before each sampling,
performed at 7 and 14 days.
Sampling
Water samples were collected, in triplicate, at the beginning (0 day) and at the end of the
experiment (14 days) from two aquaria, at 0, 8, and 24 h after the addition of the
contaminant, for both BaP nominal concentrations.
Fish were anesthetized in ice cold water and blood was collected from the caudal vein
using heparinized syringes. After blood collection, animals were sacrificed by decapitation.
The blood was centrifuged at 4000 g for 7min at 4C and the plasma obtained was
stored at 80C until analysis. The liver, intestine, and gills were excised from the animal,
and bile was collected from the gall bladder, immediately frozen in liquid nitrogen, and
stored at 80C until further use.
Biochemical analysis
Microsomal fractions of the liver, intestine and gills were prepared as described in
Fernandes, Porte, and Bebianno (2007). Briefly, tissues were homogenized in ice cold
100mM KH2PO4/K2HPO4 (pH 7.4), containing 150mM KCl, 1mM dithiothreitol,
0.1mM PMSF, and 1mM Na2EDTA. Homogenates were centrifuged at 12,000 g for
20min and the resulting supernatant was further centrifuged at 100,000 g for 60min, to
obtain the microsomal fractions. Microsomal pellets were resuspended in a ratio of
0.5mLbuffer g1 tissue in homogenization buffer containing 20% glycerol.
UDP-glucuronyl transferase (UDPGT) activity was assayed according Collier et al.
(2000). Fifteen mL 20mM uridine 50-diphosphate glucuronic acid was added to a reaction
mixture containing 15 mL microsomal fraction and 120 mL 125 mM 4-methylumbelliferone
(4MU) in 0.1M Tris-HCl containing 5mM MgCl2 and 0.05% BSA (pH 7.4) and
incubated for 10min at 37C. Fluorescence was measured at EX¼ 355 nm/EM¼ 586 nm.
Activities were expressed as pmol min1mg1 protein using a standard curve generated
with 4MU (0.031–2.50 mM). Protein content in all assays was determined by Lowry et al.
(1951) method, in the correspondent fraction.
Determination of BaP
The pre-analytical treatment for the determination of BaP in water was performed
according to the procedure for the extraction of PAH in water previously described by
2042 L. Rey-Salgueiro et al.
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Cheikyula et al. (2008), based on liquid–liquid extraction with n-hexane followed by
HPLC analysis under the conditions described below.
For the analysis of BaP in bile and plasma, an analytical procedure similar to BaP
extraction procedure in blood developed by Singh et al. (2008) was carried out. Bile
(0.05mL) and plasma samples (0.5mL) were subjected to three consecutive ultrasound-
assisted solvent extractions (UASEs) with 1 and 3mL n-hexane, respectively, for 15min
each and the upper organic layer was collected and dehydrated with anhydrous sodium
sulfate. The n-hexane extracts were evaporated to dryness under a gentle steam of nitrogen
and the residue obtained was re-dissolved in methanol (0.1 and 0.2mL for bile and plasma,
respectively) and filtered through PTFE membranes (0.45 mm) for analysis. Pooled
samples were used (2–8 fish per pool, depending on the volume of blood collected from
each fish) for the determination of BaP in plasma, while for bile, individual samples were
analyzed.
Determination of free and conjugates of 3-OH-BaP
The measurement of 3-OH-BaP in bile was performed according to the method of
Ruddock, Bird, and McCalley (2002), which included a prior enzymatic hydrolysis of the
glucuronide and sulfate conjugated metabolites with a mixture of -glucuronidase and aryl
sulfatase (30 and 60UmL1 activity, respectively) or -glucuronidase alone
(1624UmL1). Briefly, 10 mL bile and 10 mL enzyme solution were added to 230 mL
ultrapure water and the mixture was incubated at 37C. After 45min, the reaction was
stopped by the addition of 250 mL chilled methanol. After centrifugation (16,000 g for
10min), supernatants contain total 3-OH-BaP (T-3-OH-BaP) (conjugated and free 3-OH-
BaP) after -glucuronidase/aryl sulfatase hydrolysis or a mixture of glucuronide 3-OH-
BaP conjugate (G-3-OH-BaP) and free 3-OH-BaP after incubation with -glucuronidase.
For the determination of free 3-OH-BaP, the analytical procedure was carried out without
enzymatic hydrolysis and an extraction step was added. Bile (50 mL) was subjected to
UASE with 100 mL methanol for 10min and, finally, the extracts were also centrifuged and
filtered for HPLC analysis.
In plasma samples, the pre-analytical treatment was based on procedures for the
determination of T-3-OH-BaP in biological samples such as urine or milk (Rey-Salgueiro
et al. 2009; Wang et al. 2005), with the extraction and enzymatic hydrolysis steps
optimized. To optimize the extraction step, plasma of non-exposed animals were spiked
with 3-OH-BaP (10 mgL1) and extracted with different solvents (acetone, methanol,
methanol:ethyl acetate (50:50)). Despite that the higher efficiency of extraction was
obtained using methanol:ethyl acetate (97%), acetone (95%) was selected as the extraction
solvent because of its higher vapor pressure, which facilitates the extraction step by being
less time consuming. Plasma samples (1 or 0.5mL, for 10 and 100 mgL1 exposure levels,
respectively) were subjected to three consecutive UASE with 2 1 1mL acetone for
5min each and the obtained extract was centrifuged (3000 g) for 3min to facilitate the
separation of the liquid fraction, which was evaporated until dryness. To extract phase II
metabolites from plasma samples, an enzymatic hydrolysis was conducted with a mixture
of -glucuronidase/aryl sulfatase to obtain T-3-OH-BaP. Then, the obtained residues were
filled up to a final volume of 50mL buffer (0.10M ammonium acetate buffer, 0.80 gL1
tert-butyl hydroquinone and acid acetic until pH 5.5). The dissolved oxygen in the solution
was then displaced with a nitrogen stream. The optimization of the enzymatic hydrolysis
step was carried out directly in pooled plasma samples of exposed individuals
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to 100mgL1 BaP for 14 days. Volume of enzyme (10, 20 or 40 mL) and incubation time
(0–16 h) were optimized for deconjugation and 20 mL was found to be an adequate enzyme
amount to de-conjugate 3-OH-BaP (data not shown). Deconjugation time was optimized
by adding 20 mL enzyme solution and incubating at 37C. Conjugated metabolites were
rapidly hydrolyzed in the first 2 h of incubation and slowly until 16 h (data not shown), so
an overnight deconjugation (16 h) was selected to be sufficient for the hydrolysis of 3-OH-
BaP in plasma samples. The hydrolysis conditions selected were in agreement with Fan
et al. (2006) and Lutz et al. (2006), to enable the hydrolysis of conjugated 3-OH-BaP in
urine and milk samples, respectively. Afterwards, 5mL methanol was added and the
mixture was loaded onto a C18 sep-pack cartridge (previously activated with 5mL
methanol followed by 10mL ultrapure water). Before the elution step with 10mL
methanol:ethyl acetate (50/50), the minicolumns were dried for 15min under nitrogen
stream at 15 bars. The eluate obtained was evaporated to dryness, re-dissolved in 0.2mL
methanol and filtered for HPLC analysis. For the determination of the free 3-OH-BaP, the
analytical procedure was carried out without enzymatic hydrolysis. Pooled samples were
used (2–8 fish per pool) for the determination of free 3-OH-BaP and T-3-OH-BaP in
plasma. The number of animals per pool was dependent on the volume of blood collected
from each fish. As the available blood sample was in small amount, no G-3-OH-BaP was
detected in plasma.
Methods validation
To validate the analytical methods which were modified or optimized, plasma of non-
exposed animals were spiked with BaP or 3-OH-BaP and were processed (n¼ 5). The set of
samples analyzed was processed with a blank to test for the background BaP and 3-OH-
BaP levels in the material. Similar recovery rates of 3-OH-BaP, 59% and 60%, with RSD
lower than 6.8%, were obtained at two spiked concentration levels of 1 and 10 mgL1,
respectively, for the analytical method to measure 3-OH-BaP in plasma (Table 1). Other
methods based on solid phase extraction showed similar, 60–66% (Fan et al. 2006), and
lower recoveries, 550% (Wang et al. 2005), in urine samples. Fan et al. (2006) suggested
that this % 3-OH-BaP is not due to the method, but due to the instability of the compound
in the acetate buffer, though it is stable in methanol. Therefore, the selected method was
Table 1. RecoveriesRSD, instrument linear dynamic ranges, determination coefficients (r2), and
limits of detection (LOD) and quantification (LOQ) in mgL1 (n¼ 5).
Compounds Matrix LOD LOQ
Instrument linearity
Added
(mg L1)
Recoveryb
RSD (%)
Standardsa
concentrations
range r2
BaP Bile 0.83 2.50 2.5–50 0.999 5.0 96.8 4.6
Plasma 0.33 1.00 2.5–50 0.999 5.0 89.9 6.0
3-OH-BaP Bile 0.17 0.50 0.5–50 0.999 1.0 98.1 5.5
Plasma 0.07 0.5–50 0.999 1.0 59.3 6.0
10 60.4 6.8
Notes: a(n¼ 12; 7 levels in mgL1 methanol in duplicate).
b(n¼ 5 determinations).
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robust enough to quantify 3-OH-BaP in plasma samples. Detection and quantification
limits (LOD and LOQ) were evaluated on the basis of the noise obtained with the analysis
of unfortified blank samples (n¼ 5) (Table 1). LOD and LOQ were defined as the
concentration of the analyte that produced a signal-to-noise ratio of 3 and 10, respectively,
(ACS 1980) and were then tested experimentally by spiking blank samples at such levels.
External standard calibration was used to quantify the samples by HPLC-FD technique
using standard solutions of BaP and 3-OH-BaP (Table 1).
Chromatographic conditions
The liquid chromatographic system used was a Hitachi LaChrom Elite HPLC, which
constituted an L-2130 quaternary pump and an in line degasser, a L-2485 FL detector
(FD), and an L-2200 autosampler. Separations were performed with a 250 4.6mm
(length i.d.), 5 mm particle, Purospher STAR RP-18 e analytical column obtained from
Merck (Germany), and a 4 4Chmm i.d., 5 mm particle, guard column with the same
packing material.
Mobile phases used, methanol (A) and water (B), were at a flow rate of 1mLmin1.
The injection volume was set to 50 mL. For BaP elution, the temperature of the column was
maintained at 33C, and the following gradient was used: 95% A change to 100% A in
5min, hold for 10min, change to 95% A in 1min, and, finally, hold for 10min giving an
analysis time of 26min. For 3-OH-BaP elution, the temperature of the HPLC column was
kept constant at 40C and the gradient was: 70% A for 5min, change to 95% A in 1min,
hold for 10min, change to 70% A in 1min, and, finally, hold for 10min. Total run time
was 27min per sample. The excitation and emission wavelengths for BaP and 3-OH-BaP
detection, were 296/406 and 308/432, respectively (Rey-Salgueiro et al. 2008).
Statistical analysis
Exposure time and treatment effects were evaluated by means of a one-way ANOVA for
each one of the mentioned factors, followed by a multiple comparison test (Tukey’s test) at
a 5% significance level. Some data had to be log or sqrt transformed in order to fit
ANOVA assumptions. Correlation (¼r) between all the parameters measured was tested
by Pearson correlation analysis. All the statistical tests were performed using the software
Statistica 7 (Statsoft, Inc., 2004).
Ethics statement
The animals used in the research described in this article were treated in accordance with
the Portuguese Animals and Welfare Law (Decreto-Lei no. 197/96) approved by the
Portuguese Parliament in 1996.
Result
BaP concentration in water
In order to determine the real concentration of BaP in the water of experimental aquaria,
BaP levels were measured at different times after the addition of chemical at 0 and 14 days
of the experiment. No marked differences were observed between day 0 and 14 in any of
Toxicological & Environmental Chemistry 2045
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the collection periods, so the results presented were combined (Figure 1). There was a fall
in BaP concentrations over time at both concentrations and no BaP was detected in the
solvent control group. Eight hours after the addition of BaP stock solution, there was a
marked decrease in BaP, mainly at the lower concentration (88%) while for 100 mgL1 it
was 41%. The fall in BaP concentration was even more significant, for both concentra-
tions, and 24 h after the addition, disappearing almost completely at lower concentration.
Bile and plasma analysis
BaP was not found in the bile and plasma of non-exposed and exposed animals. The
metabolite, 3-OH-BaP, was detected in free and conjugated forms in the bile of exposed
animals, as seen in Figure 2. The metabolite was not found in the bile of solvent control
animals, neither as free nor as conjugated form. Free 3-OH-BaP represented 0.04 0.01%
and 0.03 0.01% of the T-3-OH-BaP for 10 and 100 mgL1 treatments (Figure 2a),
respectively; thus conjugated metabolites were the major forms of 3-OH-BaP in bile, with
G-3-OH-BaP as the main conjugated form present (Figure 2c). An increase in the BaP
dose in water resulted in a significant increase in free 3-OH-BaP, T-3-OH-BaP, and G-3-
OH-BaP levels in bile at both concentrations (Figure 2). Regarding the effect of exposure
time, a significant rise in free 3-OH-BaP after 14 days exposure to higher BaP
concentration was detected in comparison to 7 days. However, no significant
differences were observed between days within the same treatment for T-3-OH-BaP and
G-3-OH-BaP.
In plasma, only one pooled sample contained measurable levels of free 3-OH-BaP
(0.4 ngmL1) from the longer exposure period to the higher BaP exposure levels. T-3-OH-
BaP concentration in animals exposed to 10 mgL1 was near the detection limit and the
highest levels were quantified in fish exposed to100 mgL1 (Figure 3). In contrast to bile,
there was a significant increase of T-3-OH-BaP at 14 days after exposure to higher
BaP concentration in comparison to 7 days. The levels of free 3-OH-BaP (r¼ 0.73),
T-3-OH-BaP (r¼ 0.89), and G-3-OH-BaP (r¼ 0.88) in bile were significantly correlated
with T-3-OH-BaP levels measured in plasma
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Figure 1. BaP (in percentage) in water at 0, 8, and 24 h after the addition of 10 or 100mg of BaPL1
of water. Values are presented as mean standard error.
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UDPGT activities and correlations between biotransformation enzymes and
3-OH-BaP levels
UDPGT displayed mean activities in control groups of 833.35 37.9, 528.36 72.78,
and 794.52 92.62 pmolmin1mg1 protein in liver, intestine and gill, respectively.
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Figure 2. Free (a), total (b) and glucuronide (c) 3-OH-BaP levels in bile after waterborne exposure to
BaP (10 or 100mgL1) for 7 and 14 days. Values are shown as mean standard error. Different
lowercase letters denote significant differences (p5 0.05) between groups within the same day of
exposure. Different capital letters denote significant differences (p5 0.05) between days within the
same treatment.
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UDPGT activity in exposed animals was not markedly different from solvent control in
any of the tissues analyzed; however, a significant increase in UDPGT activity was seen
from 7 to 14 days at 10 mgL1 in intestine and gill. UDPGT activity at 100 mgL1 exposure
was significantly lower than at 10 mgL1 at 14 days in intestine and gill (Table 2).
Nile tilapia EROD and GST activities in liver, intestine and gills after waterborne
exposure to BaP (10 or 100 mgL1 were determined by Costa et al. (2011) and UDPGT
activities measured in this study are presented in Table 2. Positive statistically significant
correlations were observed between T-3-OH-BaP concentrations in plasma and EROD
activities in the liver (r¼ 0.51), intestine (r¼ 0.73), and gills (r¼ 0.76). The same was also
observed between free 3-OH-BaP level in bile and EROD activities in intestine (r¼ 0.71)
and gill (r¼ 0.59). In contrast, the free metabolite was not correlated with this enzyme
activity in liver. Positive statistically significant correlations were obtained between T-3-
OH-BaP concentration, in plasma and in bile, and GST activity in the liver (r¼ 0.82 and
r¼ 0.68, respectively) but, were not correlated with activity in intestine and gill.
Discussion
The contamination of aquatic ecosystems by organic contaminants as PAH is a matter of
great concern in environmental toxicology. BaP is one of the most common and toxic
PAH, and its toxicity is mainly linked to the capacity of fish species to biotransform the
compound into reactive metabolites. This study aimed at evaluating BaP metabolism into
3-OH-BaP, a toxic metabolite, and the metabolite bioavailability in bile and plasma of
Nile tilapia after waterborne exposure.
The real concentration of BaP detected in the water from the experimental aquaria was
significantly lower than the nominal concentration (Figure 1). The decrease of BaP
concentration observed in the water is in agreement with studies where the stability of BaP
was evaluated in similar conditions as the ones in our study, but without fish (Swietlik,
Kowalczyk, and Dojlido 2002); the higher decrease of BaP observed in our experiment
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Figure 3. Total 3-OH-BaP levels in plasma after waterborne exposure to BaP (10 or 100mgL1)
for 7 and 14 days. Values are shown as mean standard error. Different lower case letters denote
significant differences (p5 0.05) between groups within the same day of exposure. Different capital
letters denote significant differences (p5 0.05) between days within the same treatment.
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could be explained by the presence of fish. Moreover, due to the same number of animals
in aquaria (at both concentrations), a higher decline of BaP was also observed at the lower
concentration.
Fish have a high capacity to metabolize PAH, thus no BaP was detected in bile and
plasma of Nile tilapia and only BaP metabolites (free and conjugated) were detected.
Hence, our results show the uptake and the ability of Nile tilapia to metabolize BaP and
neutralize the toxic metabolite, which demonstrates a well-developed biotransformation
system, eliminating the most toxic forms of BaP (free 3-OH-BaP) into non-toxic forms
(conjugated form). In bile, the predominance of conjugates over free metabolites, mainly
G-3-OH-BaP, was consistent with results observed in Fundulus heteroclitus after
waterborne exposure at the same concentrations of BaP (Zhu et al. 2008). In different
exposure conditions, by single intraperitoneal injection (10mgkg1), Ictalurid catfish bile
was found to have also a higher % biliary G-3-OH-BaP (Willett et al. 2000). Contrary to
the observed dose-dependent response, time-dependence responses were observed only
with free 3-OH-BaP in bile. Comparable results, upon waterborne exposure to BaP, were
reported in Sparus macocephalus (Wang et al. 2008) and in sole (Solea solea), after dietary
exposure to an equimolar mixture of BaP, pyrene, and fluoranthene (Wessel et al. 2010). In
contrast, when measuring total BaP metabolites as fluorescent aromatic compounds
(FAC) in bile by fixed wavelength fluorescence, instead of the HPLC analysis, as in the
previous studies (including this one), significant time-dependent responses after BaP
waterborne exposure were reported (Boleas et al. 1998; Costa et al. 2011). The assessment
of FAC in bile gives the total metabolites and not specific ones, so analytical techniques,
like HPLC, that allow the measurement of individual compounds yield more precise
information regarding PAH metabolism, especially when it applies to free metabolites and
conjugation.
In plasma, free 3-OH-BaP was detected in some plasma samples, but quantification
was only possible in one pooled sample of animals exposed to higher BaP concentration
for 14 days (0.4 ngmL1). The low concentrations of free 3-OH-BaP detected in plasma
might be due to its propensity to bind with the components of the blood and form
unextractable products (James et al. 2001), or due to the rapid phase II conjugation in liver
and extrahepatic tissues (James et al. 1996). T-3-OH-BaP metabolite was detected and the
levels were considerably lower than the ones detected in bile (0.3 0.04 ngmL1 vs.
2.5 0.1 mgmL1 in 10 mgL1 at 14 days).
In this study, despite the high G-3-OH-BaP levels detected in bile, no induction of
UDPGT was observed in liver, intestine, or gill. Even though an increase in UDPGT
activity over time was noted at lower BaP exposure levels in intestine and gill, the lack of
UDPGT induction by BaP in Nile tilapia in this study is in agreement with the low
sensitivity of this enzyme that was reported in fish collected in field (Della Torre et al.
2010; Schreiber, Otter, and Van Den Hurk 2006). Moreover, after exposure via
intraperitoneal injection (10 or 50mgkg1), similar results were found in longear sunfish
(Lepomis megalottis) (Brammell et al. 2010). In a previous study, EROD and GST
induction activities were shown in liver, intestine, and gill of Nile tilapia after BaP
exposure under similar experimental conditions (Costa et al. 2011). A joint analysis of the
results obtained in this study and those previously published showed positive correlations
between enzymatic activities and free and T-3-OH-BaP levels in bile and plasma. The gill
and intestine EROD induction (Costa et al. 2011) and the positive correlations between
enzymatic activities and T-3-OH-BaP concentration in plasma and free 3-OH-BaP in bile
strengthen the notion that these extrahepatic tissues are involved in the metabolism of
BaP, and that the metabolites formed are released into the blood stream. Moreover, phase
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II enzymes activity (GST and UDPGT) in intestine and gill and the predominance of
conjugates metabolites in plasma corroborate that these extrahepatic tissues also play an
important role in the elimination of the toxic form of 3-OH-BaP. Taken together, these
results indicate that liver and extrahepatic tissues such as intestine and gill may be
important sources of metabolites into the blood but in addition, they work together to
reduce the circulating levels of free 3-OH-BaP.
The major concern regarding the exposure to BaP is the adverse effects produced by
the presence of the toxic form of 3-OH-BaP. Some studies evaluated the in vitro 3-OH-BaP
effects and showed that low concentrations of 3-OH-BaP (from 8 to 67 ngmL1) may exert
estrogenic activity (van Lipzig et al. 2005) and form covalent bonds with macromolecules
(Moorthy et al. 2003; Sugihara and James 2003), leading to adverse consequences at the
organism level. Although adverse effects were not assessed and the levels of free 3-OH-BaP
measured in plasma (0.4 ngmL1) were lower than concentrations capable of producing
toxic effects, as it was quantified in one pooled sample, the levels obtained in our study
may have been diluted. Hence, individual fish may have higher concentrations than the
ones determined and as a consequence exposed to adverse outcomes from this reactive
form of 3-OH-BaP.
Conclusions
This study showed that the capacity of Nile tilapia to metabolize BaP resulted in high
concentrations of metabolites in bile and plasma. The predominance of conjugated over
free forms of 3-OH-BaP in bile and plasma indicated the importance of phase II in
metabolism and elimination of BaP in Nile tilapia. Our data suggest the presence of
extrahepatic metabolism of BaP which may be responsible for the presence of 3-OH-BaP
metabolite in plasma. Although low levels of free 3-OH-BaP, reactive form, were detected
in plasma, one can not exclude the possible adverse effects to Nile tilapia.
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The aim of this study was to evaluate the response of ABC transporters, CYP1A and class alpha (α) GST genes,
upon water and dietary exposures to benzo(a)pyrene (BaP) in Oreochromis niloticus. Partial mRNA sequences
of ABC transporters (ABCB1b, ABCB11, ABCC1, ABCC2 and ABCG2) were identiﬁed, and their tissue distribu-
tion patterns evaluated in liver, gill and intestine, showing similarities with other ﬁsh and mammals. After
14 days of water exposure to BaP, ABC transporters mRNA expression was up-regulated, namely ABCC2
in gill (up to 16-fold) and ABCG2 in liver (up to 2-fold) and proximal intestine (up to 7-fold). CYP1A
mRNA expression was up-regulated in water exposed animals, with maximum fold inductions of 5, 35 and
155, respectively in liver, gill and proximal intestine. After dietary exposure, intestinal CYP1A mRNA showed
a 13-fold increase in exposed animals. No signiﬁcant changes were seen in ABCB1b, ABCC1 and GSTα mRNA
expression after both routes of exposure to BaP. In conclusion, this study has shown that transcriptional
expression of some ABC transporters and CYP1A respond to the presence of BaP, indicating a possible
involvement and cooperation in the detoxiﬁcation process in Nile tilapia.
© 2011 Elsevier Inc. All rights reserved.
1. Introduction
The ATP binding cassette (ABC) superfamily is a highly conserved
family of transmembrane proteins (Dean and Annilo, 2005), and
some of its members confer Multixenobiotic Resistance (MXR) in
aquatic organisms by acting as efﬂux pumps of a wide variety of
putative toxicants, and/or its metabolites (Kurelec, 1992). MXR is
similar to a previously described phenotype of Multi-Drug Resistance
(MDR), ﬁrst observed in mammalian tumor cells (Gottesman et al.,
1996), and related to the over expression of an ABC transporter
(ABCB1) responsible for the efﬂux of a high number of anti-cancer
agents (Chan et al., 2004). In addition to ABCB1 (P-glycoprotein,
Pgp), studies using various animal models, have indicated ABCCs
1–5 (Multiresistance Associated Proteins, MRPs) and ABCG2 (Breast
Cancer Resistance Associated Protein, BCRP) as the most relevant in
the toxicological context (reviewed in Leslie et al., 2005). Another
transporter from the ABCB family, ABCB11 (Bile Salt Export Pump,
BSEP), has also been studied in aquatic organisms (Zaja et al.,
2008a; Zaja et al., 2008b; Loncar et al., 2010) mostly due to its high
degree of similarity with ABCB1, since mammalian studies indicate
that ABCB11 exports bile salts from hepatocytes into bile canaliculus,
and is not involved in the efﬂux of xenobiotics (Gerloff et al., 1998). In
aquatic toxicology, research on these transporters has been mainly
focused on ABCB1 (Kurelec, 1992; Bard et al., 2002a; Bard et al.,
2002b) while the remaining ABC transporters are less studied.
Although they have been identiﬁed in different ﬁsh species (Zaja
et al., 2008a; Zaja et al., 2008c; Paetzold et al., 2009; Fischer et al.,
2010; Loncar et al., 2010) both at gene and protein levels, only a
few studies have investigated the modulation of these transporters
by environmental pollutants in ﬁsh (Bard et al., 2002a; Bard et al.,
2002b; Paetzold et al., 2009; Zucchi et al., 2010; Long et al., 2011a;
Long et al., 2011b).
These proteins translocate a wide variety of substances and,
although there is some overlap in substrate speciﬁcity, there are
differences in transport mechanisms and chemical composition of
substrates. ABCB1 transports moderately hydrophobic, amphiphilic,
neutral or positively charged substances, including exogenous and
endogenous compounds, while ABCCs and ABCG2 primarily transport
organic anions conjugated to glutathione, glucoronide, sulfate or
other polar groups (Leslie et al., 2005). Considering these characteris-
tics, it has been previously suggested that ABC transporters may be
similarly regulated in a coordinated fashion with phase I and II
enzymes, providing an important mean of protection to the cell
from xenobiotic insults (Bard, 2000; Leslie et al., 2005; Xu et al.,
2005). It is believed that ABCB1 acts as a ﬁrst line of defense prevent-
ing unmodiﬁed compounds from accumulating in the cell (phase 0 of
cellular detoxiﬁcation), while ABCCs and ABCG2 transport phase I and
II metabolites, therefore acting in phase III of cellular detoxiﬁcation
(Bard, 2000; Sturm and Segner, 2005). Induction of phase I cyto-
chrome P4501A (CYP1A) and phase II glutathione S-transferases
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(GSTs) towards many environmental pollutants has been widely
studied, including to Polycyclic Aromatic Hydrocarbons (PAHs)
which are known agonists of the Aryl hydrocarbon Receptor (AhR)
that controls the expression of these genes (for a review see van der
Oost et al., 2003). Recent studies have evaluated the hepatic expres-
sion of some ABC transporters and phase I and/or phase II enzymes
in the presence of pollutants (Paetzold et al., 2009; Della Torre
et al., 2010; Zucchi et al., 2010), but the exact way of action of these
putatively important parts of the cellular detoxiﬁcation has not
been experimentally demonstrated yet. Based on substrate speciﬁci-
ty, immunological cross reactivity and protein sequence data, mam-
malian citosolic GSTs have been grouped into seven classes: Alpha
(α), Mu, Pi, Theta, Sigma, Omega and Zeta (Hayes et al., 2005).
GSTα is one of the most expressed classes in ﬁsh (Fu and Xie,
2006; Li et al., 2010) and has been associated with a multidrug-
resistance phenotype observed in rats (Hayes and Pulford, 1995).
Benzo(a)pyrene (BaP) is an common PAH, widely spread in the
aquatic environments, whose carcinogenic and mutagenic properties
have been extensively studied (Buhler and Williams, 1989; Tsukatani
et al., 2003), and was used as a model contaminant in this study. BaP
is a known inducer of phase I and II enzymes, like CYP1A and GSTs,
and the transport of the parent compound and/or its metabolites by
ABC transporters proteins has been hypothesized (Chao Yeh et al.,
1992; Buesen et al., 2002; Bard, 2000; Lampen et al., 2004;
Myllynen et al., 2007) and remains a matter of debate. Taking in ac-
count that in aquatic animals the uptake of pollutants can occur
through water, or through contact with food or sediments, we have
exposed the model specie Nile tilapia (Oreochromis niloticus) to BaP,
by waterborne and dietary exposure routes. Besides of being an
economically important cultured species, namely in Asia and Africa,
Nile tilapia is also a well established model in many toxicological
studies (Almeida et al., 2001; Straus, 2003; Coimbra et al., 2005;
Figueiredo-Fernandes et al., 2006; Coimbra et al., 2007; Costa et al.,
2011; Rey-Salgueiro et al., 2011).
The main objectives of this work were 1) the identiﬁcation and
sequence characterization of toxicologically relevant ABC trans-
porters (ABCB1, ABCB11, ABCC1, ABCC2 and ABCG2) in O. niloticus,
and 2) the quantiﬁcation of mRNA expression of ABC transporters,
CYP1A and GSTα after waterborne and dietary exposures to BaP, in
tissues involved with the uptake and metabolism of pollutants, as
liver, gills and intestine, in order to evaluate, at a transcriptional
level, the possible correlations between ABC transporters, CYP1A
and GST. Novel information is provided regarding ABC transporters
identiﬁcation in O. niloticus, and on gene expression changes upon
BaP exposure in different tissues.
2. Materials and methods
2.1. Animals
Animals (O. niloticus) used in this study were hatched and raised
in the laboratory (CIIMAR, Porto, Portugal). The corresponding
breeder stock was obtained from the Aquaculture Station of UTAD
(Universidade de Trás-os-Montes, Portugal). Animals were juvenile,
and therefore not sexually mature, as conﬁrmed by macroscopic
analysis of the gonads when animals were sampled. Until the start
of the exposure assays, ﬁsh were kept in 60 L aquaria supplied
with biological ﬁltration. Prior to the experiments, animals were
randomly distributed in the experimental aquaria (30 L), and sub-
mitted to an acclimatation period of one week. All tanks were
supplied with continuous aeration to maintain dissolved oxygen
near saturation. Dechlorinated tap water was used at a temperature
of 20±2 °C, with a 12 h:12 h (light:dark) photoperiod. Fish were
fed commercial food pellets (Aquasoja, Portugal), until satiation,
once a day.
2.2. Stock solutions of BaP and preparation of contaminated food
For the waterborne exposures, stock solutions of BaP were pre-
pared in acetone (0.5, 1.25 and 2.5 g/L) and were administered direct-
ly to the experimental aquaria. The percentage of solvent added to the
experimental aquaria was 0.002%. For the dietary exposures a stock
solution of BaP with a concentration of 40 g/L was prepared. The con-
taminated diets were prepared by immersion of food pellets in BaP
stock solutions diluted in acetone, in a proportion of 0.32 mL/g of
food. For control groups, nothing was added to the food pellets, and
for solvent control groups only acetone was added to the food pellets.
Acetone was evaporated under forced air current for 24 h, until the
pellets were completely dry, and diets were stored at −20 °C.
2.3. Xenobiotic exposures
After the acclimatation period, ﬁsh were exposed to BaP either via
water or via food. For thewater exposure, juvenile Nile tilapia (N=20,
average mass 16.36±0.82 g, average length 9.99±0.19 cm) were
exposed to nominal water concentrations of 10, 25 and 50 μg of BaP/
L for 14 days. Also, a control group and a solvent control group
(acetone alone) were maintained. The tested concentrations have
been found in pore waters of estuaries polluted with petrochemical
products (Maskaoui et al., 2002). Waterborne exposures were con-
ducted in semi-static conditions in 30 L aquaria. Daily, 80% of the
water was renewed, followed by the addition of fresh BaP solution
or solvent to each one of the treatment groups. Animals were fed to
satiation every two days, with the exception of the day before
sampling. Sampling was performed 14 days after the contaminant
addition.
For dietary exposures, ﬁsh were maintained in 30 L aquaria in con-
tinuous water ﬂow conditions, which assured 100% of water renewal
per day. Juvenile tilapia (N=16, averagemass 10.88±0.52 g, average
length 8.53±0.16 cm) were exposed to 100 and 200 μg of BaP/g of
food for 14 days. A control (uncontaminated food) and a solvent con-
trol (acetone alone) were maintained. Fish were fed daily at a rate of
3% of body weight. After feeding, animals were observed to assure
that the total of the food was consumed in 2 to 3 min. Fish were sam-
pled after14 days of exposure. The chosen levels of dietary exposure
fall within a range of PAH concentrations that may be found in prey
or in sediment that is ingested during feeding at heavily contaminat-
ed locations (Naes et al., 1995; Viguri et al., 2002).
2.4. BaP determination in water and food samples
To determine the real concentration of BaP in the water of the ex-
perimental aquaria, BaP was extracted from water samples according
to the method described by Cheikyula et al. (2008), based on liquid–
liquid extraction with n-hexane followed by HPLC analysis, under the
conditions described in Rey-Salgueiro et al. (2008). After the addition
of the contaminant, the real concentrations of BaP in water samples
were 10.49, 22.51 and 41.46 μg/L, respectively for the nominal con-
centrations of 10, 25 and 50 μg/L. After 24 h, and before the addition
of fresh contaminant to the aquaria, the amount of BaP still present
in each one of the treatment groups was 0.34, 0.69, 12.19 and
25.70 μg/L. In water collected from control and solvent control groups
no BaP was detected at both times. Food pellets supplied to the ﬁsh in
dietary exposures were also analyzed in terms of BaP concentration,
according to the method described by Rey-Salgueiro et al. (2009),
based on ultrasound-assisted solvent extraction, followed by HPLC
analysis. The real BaP concentrations in the food pellets were 0.06,
0.07, 36.24 and 92.70 μg/g, respectively for control, solvent, 100 and
200 μg/g. When referring to the concentrations of BaP used in water
and dietary treatments nominal concentrations are mentioned
throughout the manuscript.
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2.5. Sampling
Fish were anesthetized on ice cold water and sacriﬁced by decapita-
tion. Liver, gills and proximal intestine (ﬁrst one third of the intestine)
were excised from the animal, placed in RNA later at 4 °C overnight,
and stored at−80 °C.
2.6. RNA isolation, RT-PCR, cloning and sequence analysis
Primer pairs for ABCB1b, ABCB11, ABCC1, ABCC2 and ABCG2 genes
were designed based on highly conserved regions among mammalian
and ﬁsh species. The oligonucleotides were purchased from Stabvida
(Portugal). Total RNA from liver, gills and proximal intestine was iso-
lated from, approximately 20 mg of tissue, using the Illustra RNAspin
Mini (GE Healthcare), according to manufacturer's protocol. Total
RNA was quantiﬁed through the measure of the optical density at
λ260 nm, and its quality was assessed by separation in 1% agarose
gel electrophoresis (in Tris-acetate-EDTA – TAE – buffer) stained
with ethidium bromide, and by measurement of the ratio of the opti-
cal density at λ260/280 nm (1.8–2.0). One microgram of total RNA was
reverse transcribed to produce the ﬁrst strain of cDNA (iScript cDNA
Synthesis Kit, BioRad), according to the manufacturer's instructions.
PCR was performed in a Biometra Thermocycler with 100 ng of
cDNA (composed by a mixture of cDNA from liver, gill and proximal
intestine in equal amounts), 0.2 mM of DNTPs, 0.4 μM of each primer
and 2.5 mM of MgCl2 in a total volume of 50 μL, using Taq DNA
Polymerase (5-Prime, Inc, EUA), with the following conditions:
2 min denaturation at 94 °C, 40 cycles of denaturation for 30 s, 30 s
of annealing (different annealing temperatures — Table 1) and
1 min of 72 °C of polymerization, and 10 min of ﬁnal extension at
72 °C. The aliquots of the PCR reactions were separated by gel-
electrophoresis on a 2% agarose gel in TAE buffer stained with ethi-
dium bromide, and the PCR products were visualized under UV
light. The bands of expected size were excised, and eluted from the
gel according to manufacturer's protocol, using the commercial kit
Illustra GFX Tm PCR DNA and Gel Band Puriﬁcation Kit, GE Healthcare.
The isolated fragments were then inserted in pGEM plasmid vector
(pGEM® – T Easy Vector Systems – Promega) and incorporated in
E. coli using Nova Blue Competent Cells (Novagen). After the selection
of the correct colonies developed for 10 h in solid medium (35 g/L
LB Broth, ampicillin 0.1 mg/mL, IPTG 0.1 mM and X-gal 100 mM)
at 37 °C, the plasmids were isolated from 5 mL of overnight culture
(at 37 °C) using Wizard Plus SV Minipreps DNA Puriﬁcation System
(Promega). The inserts were sequenced by Stabvida (Portugal), and
the identities of all sequences were checked using the Basic Local
Alignment Search Tool (Blast) at National Center for Biotechnology
Information (NCBI) (http://www.ncbi.nlm.nih.gov). Predicted topol-
ogies for the aminoacid partial identiﬁed sequences were performed
with the Polyphobius algorithm (http://phobius.sbc.su.se/poly.
html). Alignments of the obtained sequences with other mammal
and ﬁsh species were conducted with ClustalW Multiple Alignment
(Thompson et al., 1994). Phylogenetic analysis was performed with
Mega 4.0.2 (Tamura et al., 2007) using neighbor-joining method
and a percentage of concordance based on 1000 bootstrap iterations.
2.7. Quantitative real-time PCR (qRT-PCR)
Gene expression quantiﬁcation of ABCB1b, ABCB11, ABCC1,
ABCC2, ABCG2, CYP1A, GSTα was performed in liver, gill and proxi-
mal intestine, by means of quantitative real time PCR (qRT-PCR).
Elongation factor 1 (EF1) and 18S ribosomal RNA (18SRNA) were
both evaluated as possible reference genes, and 18SRNA was chosen
since its expression proved not to be affected by the treatments,
and to be stable between the analyzed tissues (data not shown). For
qRT-PCR, 1 μg of total RNA was subjected to digestion of genomic
DNA using Deoxyribonuclease I, Ampliﬁcation Grade (Invitrogen)
and ﬁrst strand cDNAwas synthesized using the iScript cDNA Synthe-
sis Kit from BioRad. Speciﬁc primers for ABCB1b, ABCB11, ABCC1,
ABCC2 and ABCG2 were designed based on the previously partially
sequenced genes in Nile tilapia, using Beacon DesignerTM software.
Primers for CYP1A, GSTα, 18SRNA and EF1 were designed based
on partial mRNA sequences of O. niloticus, available on Genbank
(accession numbers GI13365614 for CYP1A, EU234530 for GSTα,
DQ397879 for 18SRNA and AB075952 for EF1), using the Primer-
Blast software (http://www.ncbi.nlm.nih.gov). To conﬁrm the identi-
ties of the amplicons for qRT-PCR, RT-PCR reactions were conducted
and, after excision from the gel, products were cloned and sequenced
(as described in section 2.6). Optimal primers concentrations were
determined (600/600 nM) after evaluation of the highest ﬂuores-
cence signal at lower Ct number. Primer sequences and amplicon
lengths of target gene sequences are given in Table 2. Real-time PCR
ampliﬁcation was done in a IQ5 Bio Rad, with the use of IQ Sybr
Green Supermix (Bio Rad), with 10 μL SYBR Green mix, 2 μL of each
primer (6 μM) and 1 μL of cDNA in a total volume of 20 μL. Reactions
were conducted under the following conditions: 95 °C for 3 min,
followed by 40 cycles at 95 °C for 10 s, 54 °C for 30 s and 72 °C for
30 s. At the end of each run a melting curve analysis was done
(from 55 °C to 95 °C) to determine the formation of speciﬁc products.
Table 1
Primer sequences, sequence lengths, annealing temperatures, GenBank accession numbers and homology percentages with other animal species of ABC transporters identiﬁed in
Nile tilapia.
Target
gene
Sense Antisense Sequence
length (bp)
Annealing
temperature
Acession
number
Homology with other species
ABCB1b cctgtgtcgttcctcaaggt cctctcttgtgaggcagac 922 56 °C GQ911571 Poeciliopsis lúcida — 80%; Oncorhynchus mykiss — 75%; Trematomus
bernachii — 75%; Homo sapiens — 63%
ABCB11 catttcagcctggtgttcag gtcagagttctggatggtgg 820 60 °C GQ911570 Platichthys ﬂesus — 93%; Fundulus heteroclitus — 93%; Oncorhynchus
mykiss — 91%; Danio rerio — 91%; Homo sapiens — 84%
ABCC1 atgttcatgggctccatgttca ggatccaggttcatcctcaga 1062 56 °C GQ911567 Danio rerio — 84%; Oncorhynchus mykiss — 66%; Homo sapiens — 75%
ABCC2 ctcagtgtatctgcagtacct ctaaacaggcagttggtaagac 1134 56 °C GQ911569 Oncorhynchus mykiss — 88%; Danio rerio — 86%; Monodelphis domestica —
71%; Homo sapiens — 72%
ABCG2 atcggactcaatggcatcatga gatgaagagttcagctgctga 1100 56 °C GQ911568 Oncorhynchus mykiss — 90%; Danio rerio 88%; Salmo salar — 85%; Homo
sapiens — 73%
Table 2
Primer sequences, amplicon lengths and efﬁciency of reaction, used in ABC transporters,
CYP1A, GSTα and 18SRNA gene expression quantiﬁcation by qRT-PCR in Nile tilapia.
Target
gene
Sense Antisense Amplicon
length
Efﬁciency
of the PCR
reaction
ABCB1b cgttcctcaaggtgatggct ggctgcattgcaccattgat 91 pb 98.5%
ABCB11 ctggtcagacactggccttt caggaaagacacgttgacgc 143 pb 110.0%
ABCC1 atccgtgagagtgaccag caaatgacacaatgaagtttcc 117 pb 99.7%
ABCC2 cctggttggcttgtctatatcc ctcgctgtattcactcactctc 123 pb 107.6%
ABCG2 tcatgaagccgggtctcaac agacctgcagggtcctttct 96 pb 103.9%
CYP1A cgtcgtcgtctctgttgcc catcgtcgtggtggtcatagc 70 pb 96.6%
GSTα aaatggatggcatgaagctc tcgttctttgggatcctttg 92 pb 109.8%
18SRNA cggaaggatcattactggctacac agaccctcggcggcaaag 78 pb 100.1%
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a) ABCB1b multiple alignment 
O. niloticus  ------VSFLKVMALNTSELPYILLGTLCAIINGAMQPAFAVVFSKIINVFIEPD-QDVVRQGSVFFSLM 63    
P. lucida     EEDVPMVSFFRVLRLNASEWPYIVVGLICATINGAIQPLFAVLFSKIITVFAEPD-KNVVRERSNFFSLM 764   
T. bernachii  DENIPPVSFFKIMRLNIPEWPYILVGTICAIINGVMQPLFAIIFSNIITVFAHPD-PAVIRTRASYFSLM 651   
O. mykiss     -------SFVGSEKGDKDKT------------------------EVEEEVFAEQD-QELVRQRSSFYSIM 708   
H. sapiens    DESIPPVSFWRIMKLNLTEWPYFVVGVFCAIINGGLQPAFAIIFSKIIGVFTRIDDPETKRQNSNLFSLL 758   
O. niloticus  FAAIGAVSFVTMFLQGFCFGKSGEVLTLKLRLGAFKSMMRQDLGWFDQPKNSVGALTTRLATDAAQVQGA 133   
P. lucida     FVAIGVVCFFTMFLQGFCFGKSGEILTLKLRLGAFKSMMRQDLGWFDSPKNSVGALTTRLATDAAQVQGA 834   
T. bernachii  FVLIGAVSFVAMFFQGFCFGKSGEILTLKLRLGAFKAMMRQDLGWFDNPKNSVGALTTRLATDAAQVQGA 721   
O. mykiss     FALIGVVSFITMFLQGFCFGKAGEILTMKLRLMAFKAMMRQELGWYDSHKNSVGALTTRLATDAAQVQGA 778   
H. sapiens    FLALGIISFITFFLQGFTFGKAGEILTKRLRYMVFRSMLRQDVSWFDDPKNTTGALTTRLANDAAQVKGA 828   
O. niloticus  AGVRMATLAQNFANMGTGLILGFVYGWELTLLLLSLVPIIAVAGAIEMKMLAGHAAEDKKELEKAGKIAT 203   
P. lucida     SGVRLATFAQNIANLGTGVILAFVYGWELTLLVLAVVPVIALAGAVQMKMLTGHAAEDKKELEKAGKIAT 904   
T. bernachii  TGVRMATLAQNLANMGTSIIISFVYGWELTLLVLSVVPFMAVAGAVEMKALTGHATEDKKELEKSGKIAT 791   
O. mykiss     TGVRLATLAQNVANLGTSLIISFVYGWQLTLLILCVVPVMAVAGGIQMKMLSGHAVKDKKELEQAGKTAT 848   
H. sapiens    IGSRLAVITQNIANLGTGIIISFIYGWQLTLLLLAIVPIIAIAGVVEMKMLSGQALKDKKELEGAGKIAT 898   
O. niloticus  EAIENIRTVVCLTRELQSHPLYQENLDVPYKNSKKMAHIYGLTFSFSQAMIYFAHAACFRFGAWLIIAGR 273   
P. lucida     EAIENIRTVASLTREPKFESLYQENLVVPYKNSQKKAHVYGFTFSFSQAMIYFAYAACFRFGAWLIIEGR 974   
T. bernachii  EAIDNIRTVVSLNREPKFESLYQENLEIPFRNSQRNAHVHGLTFSFSQAMIYFAYAGCFRFGAWLVEENR 861   
O. mykiss     EAIENIRTVASLTREQKFESLYQENLIVPYKNSQKKAHVYGITFSFSQAMIYFAYVGCFRFGAWLIEEGI 918   
H. sapiens    EAIENFRTVVSLTQEQKFEHMYAQSLQVPYRNSLRKAHIFGITFSFTQAMMYFSYAGCFRFGAYLVAHKL 968   
O. niloticus  MDVEDVFLVISAILCGAMAVGQVNSFAPNYAK-------------------------------------- 305   
P. lucida     MDVEGVFLVISAVLFGAMAVGEANSFAPNYAKAKMSASHLLMLLNKEPAIDNLSEQGDTPDIFHGNVSFE 1044  
T. bernachii  MDIQGVFLVVSAILYGAMALGEANSFAPNYAKAKISAAHLMALMGREPAIDNLSQAGESPDTFDGNVQFD 931   
O. mykiss     MTFENVFLVISAVLYGAMAVGEANSFTPNYAKAKISASHLMFLINREPAIDNCSQGGETPDHFDGNVRFQ 988   
H. sapiens    MSFEDVLLVFSAVVFGAMAVGQVSSFAPDYAKAKISAAHIIMIIEKTPLIDSYSTEGLMPNTLEGNVTFG 1038  
b) ABCB11 multiple alignment 
O. niloticus     ----------HFSLVFRVISAIVTSGTALGRASSYTPDYAKAKISAAR-FFQLLDRVPQISVYNDKGEKW 59
P. flesus        GGYLVRQEGLHFSLVFRVISAIVTSGTALGKASSYTPDYAKAKISAAR-FFKLLDRVPQISVYSDKGDKW 1106
F. heteroclitus  GGYLVEQEGLHFSLVFRVISAIVTSGTALGRASSYTPDYAKAKTSAARFFFQLLDRVPPISVYSNRGEKW 515
O. mykiss        GGYLVRQEGLHFSLVFRVISAIVTSGTALGRASSYTPDYAKAKISAAR-FFQLLDRVPKIRVYSNEGDKW 1086
D. rerio         GGYLVYHEGLHFSFVFRVISAIVTSGTALGRASSYTPDYAKAKISAAR-FFQLLDRIPKISVYSKDGQKW 1047
H. sapiens       GGYLISNEGLHFSYVFRVISAVVLSATALGRAFSYTPSYAKAKISAAR-FFQLLDRQPPISVYNTAGEKW 1080
O. niloticus     DNFQGNIEFIECKFTYPSRPDIQVLNGLNVSVKPGQTLAFVGSSGCGKSTSVQLLERFYDPDHGKVLIDG 129
P. flesus        DNFQGNLEFIDCKFTYPTRPDIQVLNGLNVSVRPGQTLAFVGSSGCGKSTSVQLLERFYDPDHGRVLIDG 1176
F. heteroclitus  DNFQGNLEFVHCKFTYPTRPDIQVLNGLNVSVRPGQTLAFVGSSGCGKSTSAQLLERFYDPDHGKVLIDG 585
O. mykiss        PDFRGNLEFIDCKFTYPTRPDIQVLNGLNVSVKPGQTLAFVGSSGCGKSTSVQLLERFYDPDQGKVIIDG 1156
D. rerio         DNFKGDIEFIDCKFTYPSRPDIQVLNGLNVSVKPGQTLAFVGSSGCGKSTSVQLLERFYDPNSGRVLIDG 1117
H. sapiens       DNFQGKIDFVDCKFTYPSRPDSQVLNGLSVSISPGQTLAFVGSSGCGKSTSIQLLERFYDPDQGKVMIDG 1150
O. niloticus     HDTTRVNVSFLRSKIGIVSQEPILFDCSIAENIKYGDNLREISMNEVISAAKKAQLHDFVMALPEKYDTN 199
P. flesus        HDSTGVNVPFLRSKIGIVSQEPILFDCSIADNIKYGDNSREISLNDVMSAAKKAQLHNFVMALPEKYDTN 1246
F. heteroclitus  HESTRVSVPFLRSKIGIVSQEPVLFDCSIAENIKYGDNLREISMNEVISAAKKAQLHDFVMSLPEKYDAN 655
O. mykiss        HDSTQVNVSYLRSKIGIVSQEPILFDCSIGDNIKYGDNLREVSMNDIISASKKAQLHNFVMTLPEKYDTN 1226
D. rerio         RESSQINVAYLRSKIGIVSQEPILFDCSIAENIRYGDNQRELSMNDVISAAKKAQLHDFVMSLPEKYDTN 1187
H. sapiens       HDSKKVNVQFLRSNIGIVSQEPVLFACSIMDNIKYGDNTKEIPMERVIAAAKQAQLHDFVMSLPEKYETN 1220
O. niloticus     VGSQGSQLSRGQKQRIAIARAIIRDPKILLLDEATSALDTESEKTVQEALDKARQGRTCIVIAHRLSTIQ 269
P. flesus        VGAQGSQLSRGQKQRIAIARAIIRDPKILLLDEATSALDTESEKIVQEALDKAREGRTCIVIAHRLSTIQ 1316
F. heteroclitus  VGSQGSQLSRGQKQRIAIARAIIRDPKILLLDEATSALDTESEKTVQEALDKRREGRTCIVIAHRLSTIQ 725
O. mykiss        VGSQGSQLSRGQKQRIAIARAIIRDPKILLLDEATSALDTESEKTVQEALDKAREGRTCIVIAHRLSTIQ 1296
D. rerio         VGSQGSQLSRGQKQRIAIARAIIRDPKILLLDEATSALDTESEKTVQEALDKAREGRTCIVIAHRLSTIQ 1257
H. sapiens       VGSQGSQLSRGEKQRIAIARAIVRDPKILLLDEATSALDTESEKTVQVALDKAREGRTCIVIAHRLSTIQ 1290
O. niloticus     NSD------------------------------------- 272   
P. flesus        NSDIIAVMSRGYVIEKGTHNQLMLLKGAYYKLVTTGAPIS 1356  
F. heteroclitus  NSDIIAVMSRGFVIEKGSHDQLMALKGAYYKLVTTGAPIS 765   
O. mykiss        NSDIIAVMSRGFVIEQGPHDQLMALKGAYYKLVTTGAPIS 1336  
D. rerio         NSDIIAVMSRGYVIEKGTHDYLMGLKGAYYKLVTTGAPIS 1297  
H. sapiens       NADIIAVMAQGVVIEKGTHEELMAQKGAYYKLVTTGSPIS 1330  
TMH 8 TMH 9
TMH 10 
TMH 11
TMH 12 
W-A
C-Motif W-B
Fig. 1. Multiple alignments of the deduced amino acid sequences for ABCB1b (a), ABCB11 (b), ABCC1 (c), ABCC2 (d) and ABCG2 (e) in N. tilapia with other ﬁsh species and human. Arrows
indicate transmembrane helices (TMH), and/or ABC signature regions (C-Motif),Walker-A (W-A) andWalker-B (W-B), in each partial amino acid sequence. Identical and similar amino acids
are indicated in dark and light gray, respectively. ABCB1: Poeciliopsis lucida ADQ20481.1; Trematomus bernachii ACX30417.1; Oncorhynchus mykiss AAW56424; Homo sapiens NP000918.2.
ABCB11: Platichthys ﬂesus CAC86593.1, Fundulus heteroclitus AAD29692.1, O. mykiss NP001118128.1, Danio rerio XP001923538, H. sapiens NP003733.2. ABCC1: D. rerio XP001341895.3, O.
mykiss NP001161802.1, H. sapiens NP004987.2. ABCC2: O. mykiss NP001118127.1, D. rerio XP002664118,Monodelphis domestica XP001372990.1, H. sapiens CAB45309.1. ABCG2: O. mykiss
NP001118155.1, D. rerio NP001036240.1, Salmo salar NP001167126.1, H. sapiens AAH92408.1. Alignments were done with Clustal W program.
472 J. Costa et al. / Comparative Biochemistry and Physiology, Part C 155 (2012) 469–482
Author's personal copy
c) ABCC1 multiple alignment 
O. niloticus   --GLIYFFVQRFYVSSSRQLKRLESVSRSPIYTHFNETPLGTSVIRAFGEQERFIRESDQRVDHNQKAYY 68
D. rerio      PLGLLYFFVQRFYVASSRQMKRLESVSRSPVYTHFNETLLGTSVIRAFGEQQRFIKESDGRVDHNQKAYF 1187
O. mykiss     PLTLLYAFIQSFYVATSCQLRRLEAVSRSPIYTHFNETFQGASVIRAFSEQERFTLQANGRIDHNQTAYF 1124
H. sapiens    PLGLIYFFVQRFYVASSRQLKRLESVSRSPVYSHFNETLLGVSVIRAFEEQERFIHQSDLKVDENQKAYY 1075
O. niloticus  PSIVANRWLAVRLEFVGNFIVSFAALFAVIARESLSPGIMGLAISYALQLTASLTWLVRMSSDVETNIVA 138
D. rerio      PSIVANRWLAVRLEFVGNCIVTFAALFAVMARNNLSPGIMGLSISYALQVTASLNWLVRMSSELETNIVA 1257
O. mykiss     PRFVATRWLAVNLEFLGNLLVLAAATLAVMGRDTLSPGIVGLAVSHSLQVTGILSWIVRSWTDVENNIVS 1194
H. sapiens    PSIVANRWLAVRLECVGNCIVLFAALFAVISRHSLSAGLVGLSVSYSLQVTTYLNWLVRMSSEMETNIVA 1145
O. niloticus  VERVKEYSDTEKEAEWKQESSSLPPGWPTKGCTDIRGFSLRYRHDLDPAIHNINININGGEKVGIVGRTG 208
D. rerio      VERVKEYGDTEKEAEWKLENSNLPPGWPTAGHIEIHKFGLRYREDLELAICDISVNIAGGEKVGIVGRTG 1327
O. mykiss     VERVKEYADTPKEAPWTIEGSMLPLAWPTHGTIEMEEYGLQYRKGLDWALKGISLSIQEKEKVGIVGRTG 1264
H. sapiens     VERLKEYSETEKEAPWQIQETAPPSSWPQVGRVEFRNYCLRYREDLDFVLRHINVTINGGEKVGIVGRTG 1215
O. niloticus   AGKSSLTLGLFRIIEAAEGHIFIDGVDIAQLGLHDLRSRITIIPQDPVLFSGSLRMNLD----------- 267
D. rerio       AGKSSLTLGLFRIIEAAEGEIRIDGVNIADLGLHELRSRITIIPQDPVLFSGSLRMNLDPFDGYTDEEVW 1397
O. mykiss      AGKSSLALGIFRILEAAKGEIYIDGINIAQIGLHELRSRITIIPQDPVLFSGSLRMNLDPFDGYSDEEVW 1334
H. sapiens     AGKSSLTLGLFRINESAEGEIIIDGINIAKIGLHDLRFKITIIPQDPVLFSGSLRMNLDPFSQYSDEEVW 1285
d) ABCC2 multiple alignment
O. niloticus   NRFAKDIFTIDEAIPNSFRSWLLCFLGVLGTLFVICLATPFFAIVIIPLAVIYFFVQRFYVATSRQLRRL 70
O. mykiss      NRFAKDIFTVDEAIPQSFRSWIMCFLGVLGTLFVICLATPIFTAIIIPLAVVYYFVQRFYVASSRQLRRL 1175
D. rerio       NRFAKDIFTVDEMIPMSFRSWILCLLGVLGTLFVICLATPIFTAVVVPMAVVYYFVQRFYVATSRQLRRL 1154
M. domestica   NRFANDISTVDDTIPMSFRSWTMCFLSIISTAVMICVATPVFIVVIIPLAIIYIFVQRFYMATSRQLRRL 1161
H. sapiens     NRFAGDISTVDDTLPQSLRSWITCFLGIISTLVMICMATPVFTIIVIPLGIIYVSVQMFYVSTSRQLRRL 1151
O. niloticus   DSVSRSPIYSHFGETVSGLSVIRAYKHQDRFLKHNEVTIDENLKSVYPWIVSNRWLAIRLEFVGNLVVFF 140
O. mykiss      DSVSRSPIYSHFGETVSGLSVIRAYGHQDRFLKHNEKIIDENPKSVYLWIISNRWLAIRLEFLGNLVVFF 1245
D. rerio       DSVSRSPIYSHFGETVSGLSVIRAYGHQDRFLKHNEHTIDQNLKSVYPWIVSNRWLAMRLESLGNLVVFF 1224
M. domestica   DSVTKSPIYSHFSETVSGLSIIRAFEHQQRFLKHSEGIIDTNQKCVFSWIISNRWLAVRLELVGNLVVFF 1231
H. sapiens     DSVTRSPIYSHFSETVSGLPVIRAFEHQQRFLKHNEVRIDTNQKCVFSWITSNRWLAIRLELVGNLTVFF 1221
O. niloticus   SALFAVTSRDSIDSGLVGLSISYALNVTQTLNWLVRMTSELETNIVAVERVSEYTELENEADWVTDTRPP 210
O. mykiss      LALLAVIARDSLDSGLVGLSISYALNVTQTLNWLVRMTSELETNIVAVERVSEYTEMENEADWVSGIRPS 1315
D. rerio       AALFAVISRDSLNSGLVGLSISYALNVTQTLNWLVRMTSELETNIVAVERVREYAEIQNEAPWVTSVRPP 1294
M. domestica   SALLIVIYRDNLKGDMVGLVLSNALNITQTLNWLVRMTSELETNIVSVERINEYIKVKNEAPWLLEKRPP 1301
H. sapiens     SALMMVIYRDTLSGDTVGFVLSNALNITQTLNWLVRMTSEIETNIVAVERITEYTKVENEAPWVTDKRPP 1291
O. niloticus   QQWPEAGRVQFENYKVRYRPELDLVLHGITCDIDSTEKIGIVGRTGAGKSSLTNCLF------------- 267
O. mykiss      EKWPEAGRLRFENFKVRYRPELDLVLHGITCDIDSTEKIGIVGRTGAGKSSLTNCLFRIIEAAEGRILID 1385
D. rerio       DDWPSAGNIRFEDYKVRYRPELELVLHGVTCDIQSTEKIGIVGRTGAGKSSLTNCLFRIVEAADGRILID 1364
M. domestica   DNWPSKGEIRFTDYKVRYRPELDLILHGITCNIEGTEKIGVVGRTGAGKSSLTNCLFRILEAAEGQITID 1371
H. sapiens     PDWPSKGKIQFNNYQVRYRPELDLVLRGITCDIGSMEKIGVVGRTGAGKSSLTNCLFRILEAAGGQIIID 1361
e) ABCG2 multiple alignment
O. niloticus   ----IGLNGIMKPGLNAIMGATGSGKSSFLDVLAARKDPAGLTGEVLIDGAPQPPNFKCLSGYVVQDDVV 66
O. mykiss      KDILIDLNGLMKPGLNAIMGATGSGKSSFLDVLAARKDPAGLAGEVLMDGAPQPPNFKCLSGYVVQDDVV 131
D. rerio       KNILIGLNGIMKPGLNAILGATGSGKSSFLDVLAARKDPAGLSGEVLIDGAPQPPNFKCLSGYVVQDDVV 125
S. salar       REILVDLNGIMRPGLNAILGPTGSGKSSFLDVLAARKDPSGLSGEVLIDGAPQPPNFKCLSGYVVQDDVV 139
H. sapiens     KEILSNINGIMKPGLNAILGPTGGGKSSLLDVLAARKDPSGLSGDVLINGAPRPANFKCNSGYVVQDDVV 130
O. niloticus   MGTLTVRENFTFSAALRLPSSISQKEKKAKVDRLIKELGLGRVADSRVGTQLIRGISGGERKRTNIGMEL 136
O. mykiss      LGTLTVRENFRFSAALRLPSSVSQKEKEDKVNRLITELGLTKVADSRVGTQLIRGISGGERKRTNIGMEL 201
D. rerio       MGTLTVRENLRFSAALRLPKSIKQREKDEKVERLIQELGLSKVADSRVGTQLIRGVSGGERKRTNIGMEL 195
S. salar       MGTLTVRENLRFSAALRLPRSVPQKEKEARVNDLITELGLTKVADAKVGTQMIRGISGGERKRTNIGMEL 209
H. sapiens     MGTLTVRENLQFSAALRLATTMTNHEKNERINRVIQELGLDKVADSKVGTQFIRGVSGGERKRTSIGMEL 200
O. niloticus   IIDPPVLFLDEPTTGLDASTANSVLLLLKRMANSGRTIILSIHQPRYTIYRLFDSLTMLVNGHQVYHGPA 206
O. mykiss      IIDPPVLFLDEPTTGLDASTANSVLLLLKRMSSHGRTIILSIHQPRYSIFRLFDSLTLLVSGKQVYHGPA 271
TMH 16 TMH 17
W-A
TMH 15
TMH 16
TMH 17
W-A
W-A
C-motif
D. rerio       IIDPPVLFLDEPTTGLDASTANSVLMLLKKMGNNGRTIILSIHQPRYSIYRLFDSLTLLVGGKLVYHGPA 265
S. salar       IIDPSVLFLDEPTTGLDASTANSVLLLLKRMANQGRTIIMSIHQPRYSIYRLFDSLTLLVSGKQVYHGPA 279
H. sapiens     ITDPSILFLDEPTTGLDSSTANAVLLLLKRMSKQGRTIIFSIHQPRYSIFKLFDSLTLLASGRLMFHGPA 270
O. niloticus   RSALEYFSDIGYT--------------------------------------------------------- 219
O. mykiss      QSALDYFSNIGYTCEPHNNPADFFLDVINGDSTSIAFDRIKEADDSDPDRVTSSKQNIEDHLVQEYRGSQ 341
D. rerio       QDALSYFSQIGYTCEPHNNPADFFLDVINGDSSAVTLNKLY--EEVDQDQLSSSLKGIEDRLVEEYQRSS 333
S.salar       QNALDYFADIGYACEAHNNPADFFLDVINGDSTATAMNKIQ-GEDIDFEELSGSRQTIEERLVEEYRNCS 348
H. sapiens     QEALGYFESAGYHCEAYNNPADFFLDIINGDSTAVALNREEDFKATEIIEPSKQDKPLIEKLAEIYVNSS 340
W-B
Fig. 1 (continued).
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Samples were run in duplicate. No template controls were run to
exclude contamination and the formation of primer dimers. To deter-
mine the efﬁciency of the PCR reactions (Table 2), standard curves
were made for all the genes, with 6 serial dilutions of the template
(concentrations range from 0.05 to 50 ng/μL), and the slopes and re-
gression curves were calculated. Quantiﬁcation of the expression of
the genes in study, ABCB1b, ABCB11, ABCC1, ABCC2, ABCG2, CYP1A
and GSTα, after exposures to BaP, was done by normalization against
the reference gene (18S RNA). The ΔCt values were calibrated against
the control ΔCt, and the relative expression of the target genes was
calculated by the 2−ΔΔCt method, considering efﬁciencies close to
100% (Livak and Schmittgen, 2001). For the purpose of inter-gene
comparison throughout one tissue, relative quantiﬁcation was used
as a method of choice. Target genes were normalized to the reference
gene (18SRNA), according to the equation,
MNE=Eref
Ct(ref,mean)/EtargetCt(target,mean), described in detail by Simon
(2003), where MNE stands for mean normalized expression; Eref
is the efﬁciency of reference gene; Etarget is target gene efﬁciency;
Ctref,mean is the mean CT value of the reference gene; and Cttarget,mean
stands for the mean Ct value of the target gene. Tissues from control
animals were used, and results were presented as target gene expres-
sion relative to reference gene expression multiplied by 10000.
2.8. Statistical analysis
Treatment effects were evaluated by means of a one-way ANOVA,
followed by a multiple comparision test (Tukeys test) at a 5% signiﬁ-
cance level. Some data had to be log or square root transformed in
order to ﬁt ANOVA assumptions. All tests were performed using the
software Statistica 7 (Statsoft, Inc.).
2.9. Ethics statement
The animals used in the research that is described in this paper
were treated in accordance with the Portuguese Animals and Welfare
Law (Decreto-Lei nº 197/96) approved by the Portuguese Parliament
in 1996. Institutional animal approval by CIIMAR/UP and DGV was
granted for this study.
3. Results
3.1. Identiﬁcation of ABC transporters related genes
Based on the degrees of homologywith the same genes inmammals
and other ﬁsh species, we were able to identify partial gene sequences
for ABCB1b, ABCB11, ABCC1, ABCC2 and ABCG2 in Nile tilapia.
A 922 bp sequence similar to ABCB1b, a 816 bp sequence similar
to ABCB11, a 804 bp sequence similar to ABCC1, a 805 bp sequence
similar to ABCC2 and a 659 bp sequence similar to ABCG2 were iden-
tiﬁed. Sequences were submitted to GenBank and given the accession
numbers provided in Table 1. Analysis performed using blastx align-
ments, showed high degrees of homology of the identiﬁed transcripts
with other ﬁsh and mammal species, including human (Table 1).
Multiple alignments of the deduced amino acid (aa) sequences in
Nile tilapia with other ﬁsh species and human are shown in Fig. 1.
In the partial aa sequences of ABCB11 and ABCG2 the following highly
conserved regions were identiﬁed: Walker-A, Walker-B and C-Motif
(Fig. 1b and 1e). Topology analysis revealed that partial aa sequence
of ABCB11 and ABCG2 covered almost completely a nucleotide bind-
ing domain (NBD 2 for ABCB11 — Fig. 2b, and NBD 1 for ABCG2 —
Fig. 2e). The Walker A region was also identiﬁed in the partial aa
sequences of ABCC1 (Fig. 1c) and ABCC2 (Fig. 1 d), and according to
the topology predictions, the identiﬁed sequences partially covered
membrane spanning domain 2 (MSD2) and NBD2, for both ABCC1
(Fig. 2c) and ABCC2 (Fig. 2 d). No highly conserved regions were
identiﬁed in the ABCB1b partial aa sequence (Fig. 1a), and topology
analysis revealed that ABCB1b sequence covered almost completely
the MSD2 (Fig. 2a). Results of the phylogenetic analysis revealed
that sequences identiﬁed in Nile tilapia are evolutionarily closer to
the same genes in other ﬁsh species, than to mammals (Fig. 3).
3.2. Quantiﬁcation of ABCB1b, ABCB11, ABCC1, ABCC2, ABCG2, CYP1A
and GSTα mRNA expression in liver, gill and proximal intestine of Nile
tilapia, after BaP exposures
3.2.1. ABC transporters, CYP1A and GSTα mRNA expression in the
different tissues
Relative quantiﬁcation was used for comparison of different genes
mRNA expression within each target tissue, and results are given in
Fig. 4 (a–c). The highest levels of ABCB1b mRNA relative expression
were found in proximal intestine (155-fold), while in liver expression
was about 9 times lower; oppositely, ABCB11 mRNA expression was
about 8 times higher in liver (26.2-fold) than in proximal intestine
(3.4-fold). Neither ABCB1 nor ABCB11 mRNA expression were
detected in gill. ABCC1 mRNA expression increased from liver (8.6-
fold), to proximal intestine (14.1-fold) and to gill (36.9-fold). Liver
and gill showed similar levels of ABCC2 mRNA expression (15.1 and
8.9-fold, respectively) while in proximal intestine expression was
about 10 times higher (104.1-fold). ABCG2 was about 3 times more
expressed in proximal intestine (23.5-fold) than in liver and gill
(7.9-fold). CYP1A mRNA was much more expressed in liver and gill
(3183 and 3462-fold, respectively), than in proximal intestine,
where its expression was about 17 times lower (199.2-fold). The
highest mRNA expression of GSTα was seen in gill (1842-fold). In
proximal intestine and liver its expression was 20 and 100 times
lower (86 and 19-fold, respectively). Considering each tissue individ-
ually, in liver, CYP1A mRNA expression was different (pb0.05) from
all ABC transporters and GSTα, and ABCB1b and ABCB11 were the
most expressed transporters (Fig. 3a). In gill, CYP1A and GSTα
showed a markedly higher expression than ABC transporters, and
ABCC1 was the highest expressed transporter (Fig. 4b). In proximal
intestine, results showed similar expressions of ABCB1b, ABCC2 and
CYP1A, while ABCB11, ABCC1, ABCG2 and GSTα mRNA expression
was lower (Fig. 4c).
3.2.2. Water exposure to BaP
ABC transporters, CYP1A and GSTα mRNA expression levels after
water exposure to different BaP concentrations are displayed in
Fig. 5 (a–f).
Relative mRNA expressions of ABCC2 (in gill) and ABCG2 (in liver
and proximal intestine) were up regulated after BaP exposure,
with signiﬁcant differences to control animals. Gill mRNA ABCC2
fold induction over control was dose-dependent, ranging from 6
(in 10 μg/L) to 16 (in 50 μg/L) (Fig. 5c). Similar results were seen in
intestinal ABCG2 mRNA expression, where a maximum 7-fold
increase was detected in animals exposed to 50 μg/L of BaP. In liver,
ABCG2 mRNA expression had a maximum fold increase of 2 after ex-
posure to 25 μg/L (Fig. 5 d). ABCB1b followed a pattern of increasing
mRNA expression in both liver and proximal intestine as the concen-
tration of BaP rose (Fig. 5a), even though without statistical support.
CYP1A mRNA was signiﬁcantly up-regulated after waterborne BaP
exposure in all three tissues (Fig. 5e). In liver, animals exposed to
50 μg/L of BaP showed a relative 5-fold induction in CYP1A mRNA ex-
pression. In gill and proximal intestine, induction of CYP1A mRNA
was seen at all BaP concentrations, with relative increases of 14 and
19-fold (at 10 μg/L), 11 and 81-fold (at 25 μg/L) and 35 and 155-
fold (at 50 μg/L), respectively for gill and proximal intestine. No
signiﬁcant differences were seen in GSTα mRNA expression in all
three tissues, although an increasing pattern with BaP concentration
was patent in gill (Fig. 5f).
Expression of CYP1A was highly correlated with ABCC2 mRNA in
gill (r=0.99, p=0.002) and with ABCG2 mRNA expression in
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intestine (r=0.99, p=0.05). Both in gill and proximal intestine,
high CYP1A correlations matched the ABC transporters that showed
dose-dependent mRNA up-regulations after BaP waterborne expo-
sure. GSTα and ABCC2 mRNA expressions were highly correlated
(0.97, p=0.004) in gill tissue. Biliary BaP metabolites (measured
as Fluorescent Aromatic Compounds — FACs), 7-ethoxyresoruﬁn O-
deethylase (EROD) and glutathione S-transferase activity in liver,
gill and intestine from the same animals were previously determined
in our laboratory (results published in Costa et al., 2011). Biliary BaP
metabolites were signiﬁcantly correlated with liver CYP1A mRNA
(r=0.91, p=0.004), gill ABCC2 mRNA (r=0.93, p=0.022), gill
CYP1A mRNA (r=0.95, p=0.013) and gill GSTα mRNA (r=0.90,
p=0.036). EROD activity and CYP1A mRNA correlations were
r=0.95 in liver (p=0.014), r=0.76 in gill (p=0.131) and r=0.86
in proximal intestine (p=0.062).
3.2.3. Dietary exposure to BaP
Gene expression levels of ABCB1b, ABCC1, ABCC2, ABCG2, CYP1A
and GSTα of animals from dietary exposure to 100 and 200 μg of
BaP/g of food are displayed in Fig. 6 (a–f).
In this exposure route, high variability between animals of the
same treatment was seen in mRNA expression levels of the ABC trans-
porters. Unexpectedly, expression of ABCC1 (Fig. 6b) and ABCG2
(Fig. 6 d) in proximal intestine of solvent exposed animals was higher
than the levels seen in the remaining treatments. Gill of animals
exposed to 100 μg of BaP/g of food had the highest levels of ABCC2
mRNA expression (Fig. 6c). Moreover, although without signiﬁcant
differences to control groups, ABCB1b gene expression in liver in-
creased in animals exposed to 100 and 200 μg of BaP/g of food
(Fig. 6a). No signiﬁcant changes were seen in GSTαmRNA expression
after Bap exposure (Fig. 6f).
In this assay, the most signiﬁcant result was the induction of intes-
tinal CYP1A mRNA in dietary exposed animals (Fig. 6e), seen after
exposure to 100 and 200 μg of BaP/g of food (maximum of 13-fold
increase in the latter BaP concentration). Biliary BaP metabolites
(measured as FACs), EROD and GST activities in liver, gill and intestine
from the same animals were previously determined in our laboratory
(results published in Costa et al., 2011). Intestinal CYP1A mRNA
expression was highly correlated with EROD activity (r=0.95,
p=0.048) and biliary BaP metabolites (r=0.97, p=0.025).
4. Discussion
In this study, expressional changes of ABC transporters (ABCB1b,
ABCB11, ABCC1, ABCC2 and ABCG2), CYP1A and GSTα were deter-
mined upon waterborne and dietary BaP exposures in O. niloticus.
After the identiﬁcation of the target partial sequences in this specie,
relative mRNA expression was measured in tissues involved with
the captation and excretion of pollutants and/or its metabolites
(liver, gill and proximal intestine).
Fig. 2. Predicted topologies of Nile tilapia partial ABCB1b (a), ABCB11 (b), ABCC1 (c), ABCC2 (d) and ABCG2 (e) proteins with membrane spanning domains (MSDs) and nucleotide
binding domains (NBDs) according to the Polyphobius algorithm. In NBDs, highly conserved regions of the ABC transporters superfamily are indicated: W-A (Walker A), C-motif
(Signature motif) and W-B (Walker B). Regions of partial ABC transporters aa sequences identiﬁed in this study are enclosed in red frame.
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Fig. 3. Phylogenetic trees based on the multiple alignments (Clustal W) of closely related proteins from ABCB, ABCC and ABCG subfamilies found in other species. Evolutionary
history was inferred using neighbor-joining method and the percentage of concordance based on 1000 bootstrap iterations is shown at the nodes. a) ABCB subfamily: ABCB1
fc — Felis catus NP001164535.1, hs — Homo sapiens NP000918.2, mm — Mus musculus NP035205.1, gg — Gallus gallus NP990225.1, dr — Danio rerio a ENSDARG00000021787,
xl — Xenopus laevis NP001081394.1, tb — Trematomus bernachii ACX30417.1, om — Oncorhynchus mykiss AAW56424, dr — D. rerio b ENSDARG00000010936, pl — Poeciliopsis lucida
ADQ20481.1; ABCB11 mm — M. musculus NP066302.2, rn — Rattus norvegicus NP113948.1, dr — D. rerio XP001923538, pf — Platichthys ﬂesus CAC86593.1, om — O. mykiss
NP001118128.1; b) ABCC subfamily: ABCC1 ec — Equus caballus NP001075232, hs — Homo sapiens NP004987.2, clv — Canis lupus vulgaris NP001002971.1, mm — M. musculus
NP032602, rn — R. norvegicus NP071617, gg — G. gallus NP001012540.1, dr — D. rerio XP001341895.3, om — O. mykiss NP001161802.1, dm — Drosophila melanogaster
NP723772.2-a, NP609591.2-b, NP995699.1-c; ABCC2 hs — H. sapiens CAB45309.1, le — Leucoraja erinacea AAL92112.1, dr — D. rerio XP002664118; c) ABCG subfamily: ABCG2 hs —
H. sapiens AAH92408.1, mm — Macaca mulatta NP001028091.1, clv — Canis lupus vulgaris NP 001041486, musmus — M. musculus NP036050.1, xl — Xenopus laevis NP001091141, ss —
Salmo salar NP001167126.1, dr — D. rerio NP001036240.1, om — O. mykiss NP 001118155.1. Tree was designed using Mega 4.0.2 software.
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4.1. Identiﬁcation and tissue distribution of ABC transporters, CYP1A and
GSTα
Molecular data on Nile tilapia obtained in this study, demonstrat-
ed that, with exception of ABCB1b, all the remain deduced aa se-
quences of the target ABC transporters (ABCB11, ABCC1, ABCC2 and
ABCG2), have at least one of the classical features of this protein fam-
ily, C-Motif (LSGGQ), Walker A (GxxGxGKS/T, where x equals any aa)
and/orWalker B (xxxxD, where x equals hydrophobic residues), cyto-
plasmatic highly conserved amino acid sequences that can be found
in all vertebrate ABC proteins (Hyde et al., 1990). Topology analysis
(Fig. 2) revealed that partial aa sequences for the ABC transporters
identiﬁed in this study are analogous to what has been described
for other species (Lage, 2003; Leslie et al., 2005). Moreover, the high
degree of homologies with other ﬁsh and mammals seen after multi-
ple alignments (Fig. 1), and clustering of the sequences with other
ﬁsh species in phylogenetic analysis (Fig. 3), consequently demon-
strate the presence of the genes for the ABC transporters in Nile tila-
pia. In the case of ABCB1, two copies of ABCB1 gene can be found in
zebraﬁsh genome, called ABCB1a and ABCB1b (Annilo et al., 2006).
Recently, a novel ABCB1 isoform was identiﬁed in trout and named
ABCB1b (Fischer et al., 2011). Results show that Nile tilapia sequence
has higher degree of identity with zebraﬁsh ABCB1b (ABCB4), and
trout ABCB1a, than to zebraﬁsh ABCB1a (Fig. 3). Thus, based on the
similarities with the isoforms originally named in zebraﬁsh, Nile tila-
pia ABCB1 identiﬁed in this study should be of type b. Regarding
ABCG2 gene, four isoforms (from a to d) are described in the zebraﬁsh
genome (Annilo et al., 2006). Our results have shown that ABCG2
identiﬁed in Nile tilapia has higher degree of homology with zebraﬁsh
ABCG2a (Fig. 3).
In this study, relative mRNA expression of the different ABC trans-
porters, CYP1A and GSTα in liver, gill and proximal intestine of
O. niloticuswas assessed. Only a few studies have described the distri-
bution pattern of ABC transporters in aquatic organisms, namely in
different tissues of trout (Zaja et al., 2008a; Zaja et al., 2008c;
Loncar et al., 2010), zebraﬁsh (Long et al., 2011a), little skate (Cai
et al., 2003), shipshead meadow (Hemmer et al., 1998) and Poecilia
reticulata (Hemmer et al., 1995). The distribution pattern of ABCB1b,
ABCB11, ABCC1, ABCC2 and ABCG2 found in Nile tilapia follows the
ones described in those studies, and is also in agreement with tissue
distribution pattern determined in mammals (Flens et al., 1996;
Keppler and Konig, 1997; Gerloff et al., 1998; Mottino et al., 2000;
Maliepaard et al., 2001; Brady et al., 2002), with highest expression
levels of ABC transporters found in important physiological/pharmaco-
logical barriers (Szakács et al., 2008).
ABCB1b and ABCB11 mRNA expression was not detected in
gill, and these results are in agreement to what is described in the lit-
erature for other ﬁsh species (Zaja et al., 2008a; Loncar et al., 2010).
Zaja et al. (2008a) suggested that the high blood content in the gills
could potentially mask the gene expression in speciﬁc cells types,
such as gill epithelial cells, and indicated primary gill epithelial cells
as a more adequate model for studying ABC transporters in gills. In
subsequent works, ABCB1 and ABCB11 were detected at low levels
in a gill cell line in trout (Fischer et al., 2011). ABCB11 mRNA tissue
distribution pattern observed in this study, with almost exclusive
expression in liver (very low expression was seen in intestine
and no expression in gill), is in agreement with its described function
of transporter of bile salts from hepatocytes into the bile (Gerloff
et al., 1998). Similarly to what has been described for mammals and
other ﬁsh species, this study has shown that, also in Nile tilapia ABC
transporters have distinct mRNA expression patterns in different tis-
sues. In mammals, these different patterns of expression have been
shown to be function related (Szakács et al., 2008). Therefore, this
might also be true for Nile tilapia, although more research on this
matter remains necessary, namely at a post-transcriptional level and
on cellular localization of ABC transporters in ﬁsh. However, this
kind of approach is still difﬁcult to achieve since, with exception of
ABCB1, no functional antibodies are available for ABC transporters
in ﬁsh species.
Higher levels of CYP1A mRNA expression were seen in liver and
gill when comparing to the proximal intestine, with gill showing
slightly higher levels of CYP1A mRNA expression than liver (Fig. 4).
This data is in agreement with previous results reported in Salmo
salar, where gill tissue had highest basal levels of CYP1A mRNA,
Fig. 4. Relative mRNA expression of ABC transporters, CYP1A and GST α in Nile tilapia
liver (a), gill (b) and proximal intestine (c). Neither ABCB1b nor ABCB11 mRNA expres-
sion was detected in gill. 18SRNA mRNA expression was set to 10000 in all tissues.
Different letters denote signiﬁcant differences (pb0.05) between genetic expression
of target genes (ABCB1b, ABCB11, ABCC1, ABCC2, ABCG2, CYP1A and GSTα) within
the same tissues. Results are presented as mean±SE (n=4).
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than liver, kidney and brain (Rees et al., 2003). Considering that
mRNA CYP1A expression found in tilapia tissues is well correlated
with the levels of CYP1A activitymeasured in the same animals in a pre-
vious study (Costa et al., 2011), the higher basal levels of steady state
CYP1A mRNA found in gill tissue may reﬂect the biotransformation
function of gills, when the exposure to contaminants is mainly through
water (Levine and Oris, 1999; Rees et al., 2003). Additionally, major
CYP1A expression and/or activity typically found in liver, is consistent
with the role of this organ in xenobiotic metabolism and excretion
(Levine and Oris, 1999; Sarasquete and Segner, 2000), whose overall
contribution to detoxiﬁcation is well accepted. GSTαmRNA expression
was considerably higher in gill, than in liver and intestine (Fig. 4). GST
sequences have been isolated and characterized in several ﬁsh species,
such as plaice (Leaver et al., 1993; Martinez-Lara et al., 2002), large-
mouth bass (Doi et al., 2004), red-seabream (Konishi et al., 2005),
mangrove killiﬁsh (Lee et al., 2005), river pufferﬁsh (Kim et al., 2010),
common carp (Fu and Xie, 2006) and bighead carp (Li et al., 2010).
Themajority of these works reported high hepatic expression of several
GST isoforms, indicating that different GST isoforms are associated with
hepatic detoxiﬁcation of xenobiotics (Kim et al., 2010). Moreover, high
intestinal levels of GSTs have also been reported inﬁsh (Kim et al., 2010;
Li et al., 2010) and mammals (Landi, 2000), indicating a role of this
Fig. 5. Relative mRNA expression of ABCB1b (a), ABCC1 (b), ABCC2 (c), ABCG2 (d), CYP1A (e) and GSTα (f) in liver, gill and proximal intestine of animals exposed to waterborne
BaP. ABCB1b mRNA expression was not detected in gill. Insert in (e) refers to detailed CYP1A mRNA expression in control and solvent. Expression was quantiﬁed by qRT-PCR,
and fold changes to control were determined using the 2−ΔΔCT method. Results are given as mean±SE (n=4). Different letters denote signiﬁcant differences (pb0.05) between
treatments within the same tissue.
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tissue in xenobiotic breakdown. Studies that compared GSTα expres-
sion inﬁsh tissues indicated that this speciﬁc isoformhas higher expres-
sion in liver and intestine than gill in bighead carp (Li et al., 2010) and
river pufferﬁsh (Kim et al., 2010), oppositely to what was found in
Nile tilapia. Higher GSTα mRNA levels in gill reinforce the idea that
gills also display an important role in xenobiotic metabolism (Jönsson
et al., 2006; Nahrgang et al., 2010; Costa et al., 2011).
4.2. ABC transporters CYP1A and GSTα transcriptional responses upon
BaP exposure
After exposure to BaP, mRNA levels of some of the studied ABC
transporters, and of CYP1A were up-regulated in Nile tilapia. The
most signiﬁcant results were seen after water exposure, with
increased mRNA expression of ABCC2 (in gill), ABCG2 (in liver and
proximal intestine) and CYP1A (in liver, gill and proximal intestine).
Although without signiﬁcant differences, hepatic and intestinal
ABCB1b and gill GSTα mRNA showed a tendency to increase in ani-
mals exposed to waterborne BaP. In dietary assays only intestinal
CYP1A mRNA was signiﬁcantly up-regulated in BaP exposed animals.
A small number of studies have addressed the modulation of ABC
transporters in liver of ﬁsh species, and an increase of the hepatic
transcripts of ABCC2 and ABCG2 in killiﬁsh exposed to PAHs
(Paetzold et al., 2009) and of hepatic mRNA ABCC2 in zebraﬁsh and
Antartic ﬁsh exposed to heavy metals (Zucchi et al., 2010; Long
et al., 2011b) has been reported. Our results follow the pattern of
expression seen in those studies, since ABCC2 and ABCG2 were the
transporters with more pronounced changes to BaP exposure.
Fig. 6. Relative mRNA expression of ABCB1b (a), ABCC1 (b), ABCC2 (c), ABCG2 (d), CYP1A (e) and GSTα (f) in liver, gill and proximal intestine of animals exposed to dietary BaP.
ABCB1b mRNA expression was not detected in gill. Expression was quantiﬁed by qRT-PCR, and fold changes to control were determined using the 2−ΔΔCT method. Results are given
as mean±SE (n=4). Different letters denote signiﬁcant differences (pb0.05) between treatments within the same tissue.
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CYP1A mRNA up-regulation in liver, gill and proximal intestine of
water exposed animals, is consistent to what is described in the liter-
ature (Van Veld et al., 1997; Ortiz-Delgado et al., 2005; Ortiz-Delgado
et al., 2008). Correlations between CYP1A mRNA and CYP1A catalytic
activity (EROD) measured in a previous study performed in our labo-
ratory using the same animals (Costa et al., 2011), were high for all
tissues, although only signiﬁcant in the liver (r=0.95, p=0.014),
providing evidence that an increase in mRNA expression of CYP1A
reﬂects an increase in protein functionality. In Costa et al., 2011, we
have demonstrated that waterborne BaP exposure results in high
rates of metabolism (by CYP1A enzymes) in liver, gill and intestine,
and that total BaP metabolites measured in bile are correlated with
CYP1A activity (measured as EROD activity), in the different tissues.
Probably, BaP metabolites formed in extra-hepatic tissues are reab-
sorbed into the blood stream and released in the gall bladder
(Kleinow et al., 1998; Costa et al., 2011). Moreover, BaP metabolites
proﬁle in plasma and bile of Nile tilapia exposed to BaP in water
showed that these are mostly phase II conjugates (Rey-Salgueiro
et al., 2011). In our study, high correlations were also found between
total BaP metabolites (Costa et al., 2011) and 1) ABCC2 mRNA expres-
sion in gill (r=0.93, p=0.022), and 2) ABCG2 mRNA expression in
intestine (r=0.85, p=0.066). Although we cannot draw any conclu-
sions about the activity of these transporters, since no protein or
functionality studies were done, mRNA up-regulation and the corre-
lations observed with biliary BaP metabolites can suggest that, after
water exposure, efﬂux of phase II BaP metabolites most probably
occurs via ABCC2 in gill, and ABCG2 in intestine. Previous studies
have reported that ABCC2 efﬂux of xenobiotics occurs through a co-
transport mechanism with reduced glutathione (GSH) (reviewed in
Leslie et al., 2005), and the signiﬁcant correlation seen between
GSTα and ABCC2 mRNA in gill further supports this hypothesis. Re-
garding the intestine, it has been hypothesized that ABC transporter
proteins may be involved in the luminal directed transport of BaP
metabolites in a human colon adenocarcinoma cell line and ABCB1,
ABCC1 and ABCC2 transporters were ruled out as possible candidates
involved in this efﬂux (Buesen et al., 2002; Lampen et al., 2004).
However, Ebert et al. (2005) have identiﬁed ABCG2 as one of the ef-
ﬂux transporters of BaP conjugates formed in Caco-2 cells back into
the intestinal lumen, supporting our results of ABCG2 mRNA expres-
sion in Nile tilapia intestine. Moreover, Mao (2005) reported that
ABCG2 seems to preferentially transport sulfated conjugates of ste-
roids and xenobiotics over GSH and glucoronide metabolites, which
is in agreement with the lack of correlation seen between mRNA
expression of this transporter and GSTα mRNA.
Despite the lack of statistical signiﬁcance, we also observed an in-
crease in ABCB1b transcriptional levels in liver and proximal intestine
of water exposed animals. Up-regulation of ABCB1 in response to
xenobiotics is not usually large (1–2-fold) (Smital et al., 2003), and
the individual variability can be masking that response in this study.
Although BaP itself has been indicated as a non-substrate for ABCB1
in mammals (Schuetz et al., 1998; Buesen et al., 2002), others indicate
the opposite (Chao Yeh et al., 1992; Fardel et al., 1996) and the subject
remains in discussion. Nevertheless, in a recent work by Zaja et al.
(2011) no BaP interactionwas seenwith ABCB1 activity in a hepatoma
cell line of Poeciliopsis lucida. In general, mRNA up-regulation of ABC
transporters reported in this study could be a response to the presence
of BaP and/or its metabolites. However, more work is necessary at
post-transcriptional and protein levels, in order to conﬁrm these hy-
pothesis. Induction of ABC transporters has also been associated
with a non-speciﬁc general stress response in Mytilus californianus,
rather than to the presence of speciﬁc substrates of those transporters
(Eufemia and Epel, 2000). In our study, morphological and behavioral
indices (data not shown) were not altered in the animals exposed to
BaP, which gives us an indication that these animals were not under
stressful conditions, and that they were responding to the presence
of the contaminant or its metabolites.
As previously stated, no signiﬁcant changes were seen in ABC
transporters after dietary exposures to BaP. Intestinal, but not hepatic,
up-regulation of CYP1A transcriptional levels can indicate that
animals were under BaP induced stress, and that the majority of BaP
metabolism will occur at intestinal level, limiting the amount of
parent compound that reaches the liver to be metabolized. This type
of response has been reported at post-transcriptional levels in liver
(Van Veld et al., 1987; Reynolds et al., 2003; Costa et al., 2011) and
intestine (McElroy and Kleinow, 1992; James et al., 1997; Costa et
al., 2011) of ﬁsh exposed to dietary PAHs. Moreover, high correlations
were seen between intestinal CYP1A mRNA and intestinal EROD
activity and biliary BaP metabolites (Costa et al., 2011) reinforcing
the idea that mRNA expression of CYP1A reﬂects protein functionality,
similarly to what was observed in water exposure.
Among the ABC transporters identiﬁed in this study, ABCC1 mRNA
expression was not signiﬁcantly altered by the presence of BaP and/or
its metabolites, and was not correlated with the remaining parame-
ters evaluated. Despite our results, much of the in vitro evidence indi-
cates that ABCC1 has a role in the removal of toxins as glutathione,
glucoronide or sulfate conjugated metabolites from cells (reviewed
in Leslie et al., 2001). Additionally, ABCC1 gene induction was seen
in zebraﬁsh exposed to heavy metals (Long et al., 2011a) indicating
that this transporter can be involved in heavy metal detoxiﬁcation
in this specie.
In dietary exposure to BaP, high variability was observed within
each treatment, probably due to the fact that it is not possible to con-
trol the exact amount of food that each animal eats. This variability
can be masking a possible response of ABC transporters mRNA
expression, which is usually not very large, as opposed to CYP1A
mRNA response (10–100 fold induction) (Epel et al., 2008; Smital
et al., 2003). The induction of intestinal ABCC2 and ABCG2 mRNA
expression in solvent exposed animals is an unexplainable result, as
we cannot input the observed up-regulation to the presence of the
solvent, since BaP exposed groups did not show the same response
pattern, and were simultaneously exposed to same quantity of sol-
vent. Moreover, this response to the solvent was only seen in these
genes and, in waterborne exposure, no such effect was seen for any
of the assessed genes.
5. Conclusion
In conclusion, partial mRNA sequences of ABCB1b, ABCB11,
ABCC1, ABCC2 and ABCG2 were identiﬁed in O. niloticus, and the
gene expression tissue distribution pattern of these transporters in
Nile tilapia follows the ones already described in mammals and in
other aquatic species. Furthermore, novel information about ABC
transporters transcriptional levels after controlled exposure to BaP,
an ubiquitous contaminant in aquatic environments, in liver, gill
and proximal intestine is provided. Up-regulation of ABCC2 and
ABCG2 transcriptional levels could be related to a possible role of
these transporters in the efﬂux of BaP metabolites in these tissues.
New information about ABC transporters provided in this work can
be applied in future toxicological or physiological studies, helping to
achieve a wider knowledge of the contribution of these proteins in
the overall process of xenobiotic detoxiﬁcation in aquatic species.
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